data_1sqr_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1sqr _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.122 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 11.3 mt -145.29 163.46 12.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.926 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.8 ptpt -139.04 177.08 8.16 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.111 0.482 . . . . 0.0 110.805 -179.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -170.44 -176.04 39.62 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 -178.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.9 t -140.35 127.51 23.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.086 0.47 . . . . 0.0 110.2 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 66.1 t -63.23 151.71 8.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.558 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 37.1 mt -109.86 -61.32 1.66 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.272 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.5 t -166.4 133.48 2.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.634 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -106.59 115.48 30.27 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.357 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.33 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 98.5 t . . . . . 0 N--CA 1.465 0.323 0 CA-C-O 120.629 0.252 . . . . 0.0 110.64 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.541 ' SD ' ' CE1' ' A' ' 71' ' ' PHE . 23.6 ttt -143.71 123.37 13.31 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.565 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.4 HG22 HD11 ' A' ' 23' ' ' ILE . 16.1 mm -98.97 134.77 36.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.775 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 38.4 mt -125.61 153.91 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.637 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.2 ttmm -137.45 98.51 10.0 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.885 -179.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.479 ' O ' ' C ' ' A' ' 27' ' ' LEU . 3.5 Cg_exo -70.74 135.55 28.37 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 122.265 1.977 . . . . 0.0 110.722 178.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.479 ' C ' ' O ' ' A' ' 26' ' ' PRO . 7.6 mp -19.33 -85.32 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -179.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.439 ' CG ' ' H ' ' A' ' 29' ' ' VAL . 5.2 p30 -93.1 -91.86 0.17 Allowed 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.526 -179.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.443 ' O ' ' CG1' ' A' ' 29' ' ' VAL . 91.2 t 48.19 46.39 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.145 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 -178.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.469 ' H ' ' ND2' ' A' ' 30' ' ' ASN . 1.6 p30 -89.58 51.16 2.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.841 -178.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -159.2 111.42 2.16 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.68 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 14.9 ttt85 -48.26 -29.94 4.31 Favored 'General case' 0 N--CA 1.462 0.143 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -61.05 -58.19 9.45 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.754 178.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.96 -49.34 70.7 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.374 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -53.79 -60.96 2.64 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.5 t -54.65 -39.6 68.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.847 179.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 51.3 mttt -69.84 -19.95 63.44 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.486 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.483 ' O ' ' HG ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -85.34 -14.08 47.55 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.768 -179.304 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 71.7 mt -55.48 127.95 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 N-CA-C 110.148 -0.315 . . . . 0.0 110.148 178.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 107.89 -14.75 37.64 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 61.9 mtt180 -69.78 162.29 28.13 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.8 tp -103.14 128.21 50.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.207 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.0 m -94.9 105.65 17.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.316 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.412 ' CB ' ' O ' ' A' ' 87' ' ' VAL . 6.1 tt -102.61 95.37 6.18 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.476 ' CE2' ' O ' ' A' ' 46' ' ' LYS . 15.9 t90 -99.59 136.8 38.98 Favored 'General case' 0 C--O 1.238 0.452 0 O-C-N 124.632 1.208 . . . . 0.0 111.21 -178.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.476 ' O ' ' CE2' ' A' ' 45' ' ' TRP . 58.1 mttt -82.33 169.13 16.84 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.315 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.464 0.236 0 N-CA-C 110.351 -0.24 . . . . 0.0 110.351 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.9 ttmp? . . . . . 0 C--O 1.233 0.22 0 CA-C-O 120.892 0.377 . . . . 0.0 110.803 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 27.1 mm -84.25 114.37 24.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 10.8 mt -98.46 146.97 25.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.019 0.437 . . . . 0.0 110.493 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.06 107.02 3.98 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.546 -178.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -103.98 -151.42 21.99 Favored Glycine 0 CA--C 1.521 0.464 0 N-CA-C 109.866 -1.293 . . . . 0.0 109.866 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 24.3 tttm -155.49 140.98 17.81 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.985 0.421 . . . . 0.0 111.351 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 65.6 mt -72.84 135.27 28.09 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.583 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -99.0 -63.46 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.973 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.8 mtt85 -143.88 159.29 42.8 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.657 0.265 . . . . 0.0 110.574 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 6.4 p -86.78 140.27 16.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.747 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -140.74 80.09 1.73 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.595 179.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 153.44 11.83 0.07 OUTLIER Glycine 0 CA--C 1.521 0.424 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 69.4 p 51.1 -94.85 0.03 OUTLIER 'General case' 0 C--O 1.231 0.104 0 CA-C-N 115.277 -0.462 . . . . 0.0 110.85 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 15.0 mtmt -94.5 50.17 1.33 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.115 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -156.22 -125.13 0.88 Allowed Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.526 -0.845 . . . . 0.0 111.809 -178.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.29 179.54 1.57 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.243 -0.978 . . . . 0.0 111.982 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.1 m -150.73 166.66 2.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.145 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 44.9 ttt180 -88.93 148.37 23.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.841 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -147.62 166.05 28.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.323 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 60.8 mtp180 -148.01 146.99 29.14 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.28 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.541 ' CE1' ' SD ' ' A' ' 22' ' ' MET . 53.3 m-85 -133.84 117.46 16.87 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.793 -179.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -84.73 -26.32 27.72 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.104 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.1 tttm -85.08 -11.03 56.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.217 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 61.73 168.67 0.66 Allowed Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.402 ' CB ' ' CD ' ' A' ' 76' ' ' PRO . 0.6 OUTLIER -100.04 174.98 2.62 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 179.877 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.402 ' CD ' ' CB ' ' A' ' 75' ' ' LEU . 3.3 Cg_exo -73.63 171.15 18.37 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.665 2.243 . . . . 0.0 111.695 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -49.94 110.76 0.92 Allowed Glycine 0 CA--C 1.526 0.765 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 47.66 95.07 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.864 0.364 . . . . 0.0 110.911 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -130.16 22.29 5.26 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.025 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.465 ' N ' ' CD2' ' A' ' 80' ' ' LEU . 4.0 mm? -76.03 92.6 3.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.759 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 153.32 -16.19 0.67 Allowed Glycine 0 CA--C 1.528 0.894 0 C-N-CA 120.999 -0.62 . . . . 0.0 111.974 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -72.68 139.05 47.03 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 117.272 0.536 . . . . 0.0 110.118 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -69.4 137.29 52.65 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 29.3 m -91.47 158.64 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 -148.2 153.5 38.85 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.194 0.521 . . . . 0.0 110.961 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.9 mp -109.4 73.49 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.412 ' O ' ' CB ' ' A' ' 44' ' ' LEU . 1.5 t . . . . . 0 CA--C 1.528 0.132 0 C-N-CA 120.018 -0.673 . . . . 0.0 111.03 -178.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 4.5 ptt-85 . . . . . 0 C--O 1.232 0.173 0 CA-C-O 120.936 0.398 . . . . 0.0 110.921 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -145.98 -177.69 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.902 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 11.9 ptpt -146.96 107.17 4.02 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.131 0.491 . . . . 0.0 111.311 -178.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -98.61 -176.55 32.57 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 179.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.8 t -140.16 139.12 36.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-O 121.044 0.449 . . . . 0.0 110.348 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.6 t -78.5 154.59 5.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.265 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 56.3 mt -125.24 -44.39 1.88 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.31 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -165.14 126.97 2.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.841 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -102.38 122.37 44.14 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.814 179.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 12.5 ttm-85 . . . . . 0 N--CA 1.464 0.234 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.912 -179.434 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 18.8 t . . . . . 0 N--CA 1.462 0.139 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.44 ' SD ' ' CD1' ' A' ' 71' ' ' PHE . 9.6 ttt -147.55 121.91 9.65 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.681 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 91.9 mt -96.13 129.83 45.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.405 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.449 ' CG2' ' N ' ' A' ' 25' ' ' LYS . 96.8 mt -132.86 160.14 42.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.024 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.521 ' O ' ' N ' ' A' ' 27' ' ' LEU . 60.1 tttt -138.12 96.37 10.19 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.326 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -59.57 72.41 0.06 OUTLIER 'Trans proline' 0 N--CA 1.489 1.252 0 C-N-CA 122.291 1.994 . . . . 0.0 111.464 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.521 ' N ' ' O ' ' A' ' 25' ' ' LYS . 14.1 tp 51.99 -116.33 1.01 Allowed 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.353 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.498 ' CG ' ' H ' ' A' ' 29' ' ' VAL . 6.4 p-10 -74.0 -92.78 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.47 -179.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.498 ' H ' ' CG ' ' A' ' 28' ' ' ASP . 53.8 t 56.07 54.74 0.33 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.194 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -178.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -92.29 47.4 1.32 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.038 -178.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.7 t -158.3 123.6 4.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.11 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.445 ' HE ' ' HB ' ' A' ' 63' ' ' THR . 27.8 ttm180 -56.55 -31.75 64.49 Favored 'General case' 0 C--O 1.222 -0.382 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.132 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -61.82 -52.22 65.04 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.998 179.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.2 tp10 -65.64 -51.59 58.35 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -55.59 -48.48 74.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.532 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.441 ' CB ' ' O ' ' A' ' 32' ' ' ARG . 93.4 p -62.34 -33.64 75.09 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.793 178.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 43.9 tttm -66.63 -61.23 2.08 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.118 -177.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.415 ' N ' HD22 ' A' ' 38' ' ' LEU . 0.8 OUTLIER -77.88 5.76 9.01 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.756 -0.377 . . . . 0.0 111.235 -178.758 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.505 ' CG2' ' O ' ' A' ' 39' ' ' ILE . 12.9 tt -53.22 113.94 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 178.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 102.07 15.72 25.29 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 111.538 -0.625 . . . . 0.0 111.538 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.9 tpt180 -69.63 155.79 39.95 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 24.7 tp -84.55 105.59 15.48 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.869 0.366 . . . . 0.0 110.724 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.2 m -87.37 109.39 19.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.532 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.427 ' CD2' ' C ' ' A' ' 44' ' ' LEU . 5.0 tt -108.37 97.15 6.87 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.238 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 10.6 t90 -99.0 117.61 33.9 Favored 'General case' 0 C--O 1.237 0.406 0 O-C-N 124.824 1.328 . . . . 0.0 110.707 -179.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 43.6 tttp -85.87 100.75 12.29 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.447 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.411 ' HG ' ' HG2' ' A' ' 76' ' ' PRO . 0.1 OUTLIER . . . . . 0 CA--C 1.536 0.441 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.819 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.443 ' HZ1' ' HA ' ' A' ' 76' ' ' PRO . 3.7 ttpt . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.905 0.383 . . . . 0.0 110.399 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 18.1 mm -84.65 108.21 16.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.625 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.7 mt -105.81 143.26 34.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.552 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.05 116.72 5.84 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.394 -178.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -113.8 -153.95 11.15 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 179.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt -151.51 136.75 17.54 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 121.024 0.44 . . . . 0.0 110.849 179.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 45.8 mt -65.33 140.32 19.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.0 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -106.09 -45.14 8.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.831 -179.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 44.5 mtp85 -149.23 159.49 44.21 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.794 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.1 p -93.06 117.21 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.039 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 37.8 t60 -102.59 121.19 41.89 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.428 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.75 10.28 50.32 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 111.556 -0.617 . . . . 0.0 111.556 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.573 ' HG1' ' H ' ' A' ' 64' ' ' LYS . 81.3 p 51.55 -88.11 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.573 ' H ' ' HG1' ' A' ' 63' ' ' THR . 51.4 mttt -90.18 51.74 2.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.12 -179.268 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -156.97 -126.06 0.9 Allowed Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.43 -0.891 . . . . 0.0 112.277 -179.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.71 -177.89 1.06 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 113.859 -1.17 . . . . 0.0 112.237 -178.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.8 m -147.19 153.59 12.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.802 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 27.6 ttm180 -87.85 157.13 19.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.765 0.317 . . . . 0.0 110.985 -179.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -151.04 166.23 31.37 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.035 179.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 13.9 ttt180 -149.37 116.85 6.14 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.76 0.314 . . . . 0.0 110.692 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.44 ' CD1' ' SD ' ' A' ' 22' ' ' MET . 34.4 m-85 -100.43 117.88 35.51 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.088 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -80.13 -19.95 46.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.804 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 35.3 mttt -81.55 -77.72 0.21 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.981 0.42 . . . . 0.0 110.947 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 140.92 169.74 11.87 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 -179.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.427 ' C ' ' H ' ' A' ' 77' ' ' GLY . 0.7 OUTLIER -97.02 175.57 2.55 Favored Pre-proline 0 C--N 1.33 -0.241 0 N-CA-C 110.272 -0.269 . . . . 0.0 110.272 -179.81 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.443 ' HA ' ' HZ1' ' A' ' 51' ' ' LYS . 2.9 Cg_endo -77.39 19.32 0.73 Allowed 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.99 2.46 . . . . 0.0 111.376 179.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.427 ' H ' ' C ' ' A' ' 75' ' ' LEU . . . 97.67 -100.55 2.41 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 -179.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -90.67 106.71 18.69 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.817 0.341 . . . . 0.0 110.2 179.397 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -163.1 23.8 0.09 Allowed 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.149 0.499 . . . . 0.0 110.085 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.1 tp -70.53 95.22 1.05 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.563 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 139.1 -1.76 2.53 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.807 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -71.28 136.99 48.2 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -69.13 129.61 40.35 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.4 m -91.29 162.58 2.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -148.95 161.89 40.99 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.334 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.2 mm -107.97 72.46 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.417 ' O ' ' CB ' ' A' ' 44' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.462 0.154 0 C-N-CA 119.945 -0.702 . . . . 0.0 111.293 -178.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 22.6 ptt180 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.838 0.352 . . . . 0.0 110.978 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.477 HG22 ' H ' ' A' ' 4' ' ' LYS . 1.1 mt -144.41 179.41 1.36 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.852 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.477 ' H ' HG22 ' A' ' 3' ' ' ILE . 0.0 OUTLIER -144.24 103.81 4.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.363 0.601 . . . . 0.0 110.382 -179.528 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.402 ' HA2' ' H ' ' A' ' 27' ' ' LEU . . . -90.71 -179.09 43.54 Favored Glycine 0 CA--C 1.522 0.527 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.268 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.1 t -145.59 137.14 19.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.919 0.39 . . . . 0.0 109.987 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 74.3 t -74.72 140.37 17.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.69 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 43.1 mt -107.52 -45.42 4.06 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.687 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.2 p -162.84 125.92 2.81 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.92 0.391 . . . . 0.0 111.082 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -101.49 97.65 8.08 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.306 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 17.7 ttm180 . . . . . 0 C--N 1.333 -0.135 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.348 179.792 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 98.6 t . . . . . 0 N--CA 1.465 0.322 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.404 ' SD ' ' CE1' ' A' ' 71' ' ' PHE . 41.9 ttm -145.39 115.85 7.6 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.717 0.294 . . . . 0.0 110.506 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 6.4 mt -96.07 129.42 46.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.435 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.489 ' CG2' ' N ' ' A' ' 25' ' ' LYS . 83.0 mt -133.56 162.61 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.547 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.489 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 45.1 tttm -142.51 105.25 5.46 Favored Pre-proline 0 CA--C 1.531 0.224 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.804 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -61.44 87.54 0.09 OUTLIER 'Trans proline' 0 C--N 1.313 -1.327 0 C-N-CA 122.315 2.01 . . . . 0.0 112.276 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.402 ' H ' ' HA2' ' A' ' 5' ' ' GLY . 2.7 tp 36.32 -133.82 0.07 Allowed 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.377 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.471 ' O ' ' C ' ' A' ' 29' ' ' VAL . 1.3 p-10 -44.04 -92.73 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 111.593 0.22 . . . . 0.0 111.593 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.488 ' O ' ' CG1' ' A' ' 29' ' ' VAL . 55.1 t 41.1 43.64 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 -178.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.667 ' ND2' ' H ' ' A' ' 30' ' ' ASN . 0.0 OUTLIER -82.6 41.69 0.73 Allowed 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 113.819 -1.537 . . . . 0.0 110.58 -178.014 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.3 p -158.87 126.89 5.1 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.907 178.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 35.9 ttt180 -59.15 -25.72 64.14 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -63.19 -54.18 41.56 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.456 178.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -66.16 -43.32 87.31 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.977 179.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -59.95 -60.69 3.42 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.301 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 27.7 t -52.31 -22.52 4.61 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.654 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.9 tptt -69.97 -64.74 0.83 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.094 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.481 ' O ' ' HG ' ' A' ' 38' ' ' LEU . 0.5 OUTLIER -79.59 13.34 2.08 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.307 -179.058 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.414 HD11 ' H ' ' A' ' 60' ' ' VAL . 18.5 tt -48.52 -19.88 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.341 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -108.25 18.22 33.55 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 121.154 -0.546 . . . . 0.0 111.994 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.438 ' HA ' ' NE ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -71.09 172.57 8.92 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 117.2 0.5 . . . . 0.0 110.547 179.777 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.434 ' H ' ' HD3' ' A' ' 41' ' ' ARG . 5.0 tp -118.87 121.63 40.44 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.5 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.454 ' CG2' ' O ' ' A' ' 43' ' ' VAL . 6.4 m -88.03 110.43 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.1 tp -105.55 102.86 12.29 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 4.7 t90 -83.32 105.15 14.04 Favored 'General case' 0 C--O 1.235 0.332 0 O-C-N 125.135 1.522 . . . . 0.0 110.302 -178.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 54.2 tttp -84.5 88.43 7.3 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.729 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.477 ' OG ' ' N ' ' A' ' 51' ' ' LYS . 11.5 p . . . . . 0 CA--C 1.534 0.333 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.79 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.477 ' N ' ' OG ' ' A' ' 47' ' ' SER . 1.1 tmtm? . . . . . 0 CA--C 1.527 0.08 0 CA-C-O 120.916 0.388 . . . . 0.0 109.965 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 12.1 mm -83.08 112.55 20.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.917 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 60.0 mt -98.1 126.21 43.45 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.18 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 60.8 mttt -96.41 104.75 16.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.917 -179.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -103.44 168.12 17.26 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 178.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -152.74 130.15 11.36 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 117.193 0.496 . . . . 0.0 111.261 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 71.5 mt -71.42 134.06 30.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.52 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -106.1 -28.78 2.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.398 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.1 ptp180 -164.89 154.47 13.22 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 120.63 -0.428 . . . . 0.0 112.018 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.42 ' O ' ' CG1' ' A' ' 60' ' ' VAL . 9.5 p -97.71 116.44 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.417 178.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 13.0 t60 -142.06 115.08 8.73 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 120.126 -0.63 . . . . 0.0 112.054 -179.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.414 ' O ' ' OG1' ' A' ' 63' ' ' THR . . . 147.19 -14.33 1.47 Allowed Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.646 -0.582 . . . . 0.0 111.646 179.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.615 ' C ' ' H ' ' A' ' 65' ' ' GLY . 12.5 p 55.95 156.41 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 122.613 0.365 . . . . 0.0 110.769 -179.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.425 ' HB3' ' HZ3' ' A' ' 64' ' ' LYS . 0.5 OUTLIER 68.98 -21.05 0.15 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.985 0.421 . . . . 0.0 109.926 -178.194 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.615 ' H ' ' C ' ' A' ' 63' ' ' THR . . . 141.41 122.45 1.83 Allowed Glycine 0 CA--C 1.52 0.37 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 179.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 176.38 147.57 0.1 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.5 m -156.6 137.16 4.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.933 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 21.6 ttm-85 -89.02 154.51 20.15 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -145.07 161.06 40.36 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.051 0.453 . . . . 0.0 110.866 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 78.4 mtt-85 -146.45 116.7 7.42 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.171 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.49 ' C ' ' H ' ' A' ' 73' ' ' LYS . 17.2 m-85 -95.89 135.46 37.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.57 -179.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 82.6 mt-10 -61.07 -1.64 0.48 Allowed 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.476 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.49 ' H ' ' C ' ' A' ' 71' ' ' PHE . 5.8 tmtm? -156.28 -65.19 0.11 Allowed 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.642 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 134.86 -171.61 22.32 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.3 mt -92.06 171.05 8.27 Favored Pre-proline 0 C--N 1.327 -0.392 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -75.3 114.37 3.98 Favored 'Trans proline' 0 C--N 1.313 -1.335 0 C-N-CA 122.655 2.237 . . . . 0.0 112.064 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 75.97 -65.23 2.62 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.474 HE21 ' CA ' ' A' ' 78' ' ' GLN . 0.0 OUTLIER -169.01 -69.25 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.645 0.259 . . . . 0.0 110.594 179.472 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 64.13 24.23 13.4 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.969 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.5 tt -60.58 104.08 0.31 Allowed 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.575 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 110.5 5.71 27.74 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 111.652 -0.579 . . . . 0.0 111.652 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -73.98 144.09 45.35 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.726 0.263 . . . . 0.0 110.3 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -69.88 113.49 7.16 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 30.2 m -90.87 169.68 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -150.0 156.4 41.64 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.272 0.558 . . . . 0.0 110.985 -178.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 9.7 mt -105.76 72.74 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 177.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.338 0.1 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.918 -178.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 22.9 mtm-85 . . . . . 0 C--O 1.232 0.133 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.4 mt -147.76 145.3 18.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.079 0.466 . . . . 0.0 111.055 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.3 mmmm -90.07 178.59 6.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.282 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 84' ' ' VAL . . . -173.75 173.64 45.91 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.0 t -148.98 137.01 14.38 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 CA-C-O 120.914 0.388 . . . . 0.0 110.705 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 91.4 t -80.4 148.32 5.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.158 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 49.4 mt -106.41 -44.45 4.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.249 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.9 m -168.53 137.08 2.21 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.603 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -94.67 115.37 27.46 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.333 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.487 ' O ' ' N ' ' A' ' 21' ' ' VAL . 89.2 mtt180 . . . . . 0 C--N 1.331 -0.224 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.921 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.523 ' CG1' ' N ' ' A' ' 22' ' ' MET . 53.0 t . . . . . 0 N--CA 1.47 0.553 0 CA-C-O 120.698 0.285 . . . . 0.0 110.318 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.523 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 2.6 ptp -147.03 135.99 22.33 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.917 0.389 . . . . 0.0 110.848 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.432 HG21 HD12 ' A' ' 23' ' ' ILE . 87.0 mt -94.89 156.84 3.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.195 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.451 ' CG2' ' N ' ' A' ' 25' ' ' LYS . 23.5 mt -143.51 158.14 16.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.68 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.451 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 49.4 tttm -140.69 101.49 6.55 Favored Pre-proline 0 C--O 1.235 0.308 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.195 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -58.89 144.96 98.54 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 121.706 1.604 . . . . 0.0 110.466 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.8 tp -34.05 -82.91 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -178.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.513 ' CG ' ' H ' ' A' ' 29' ' ' VAL . 3.6 p-10 -87.09 -86.84 0.15 Allowed 'General case' 0 CA--C 1.521 -0.163 0 C-N-CA 120.251 -0.58 . . . . 0.0 110.259 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.513 ' H ' ' CG ' ' A' ' 28' ' ' ASP . 41.2 t 41.42 56.68 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.14 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -179.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -91.98 33.82 1.04 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.365 -1.289 . . . . 0.0 111.513 -177.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 24.4 m -159.48 131.03 6.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.759 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.8 ttp180 -57.81 -26.6 62.2 Favored 'General case' 0 CA--C 1.521 -0.14 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -61.58 -37.38 83.65 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.325 178.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -87.82 -39.07 15.16 Favored 'General case' 0 CA--C 1.527 0.087 0 CA-C-N 115.63 -0.713 . . . . 0.0 109.611 178.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.425 ' O ' ' CD2' ' A' ' 38' ' ' LEU . . . -61.21 -58.38 8.57 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 41.9 t -55.48 -23.3 25.01 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.732 178.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.1 tttm -68.83 -58.01 4.78 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.619 -179.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.425 ' CD2' ' O ' ' A' ' 35' ' ' ALA . 0.5 OUTLIER -80.19 8.89 6.39 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.231 -178.828 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.472 HG21 HD12 ' A' ' 39' ' ' ILE . 0.1 OUTLIER -45.59 -41.12 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.368 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.459 ' N ' ' CG2' ' A' ' 39' ' ' ILE . . . -103.42 96.33 1.32 Allowed Glycine 0 CA--C 1.521 0.463 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 178.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 11.5 ttm180 -167.62 150.3 5.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.024 0.44 . . . . 0.0 110.382 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.0 tp -88.07 123.08 32.39 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.5 -178.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.6 m -93.83 109.76 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.444 ' O ' HG22 ' A' ' 87' ' ' VAL . 6.0 mp -105.93 102.68 12.09 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 116.348 -0.387 . . . . 0.0 109.959 -179.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.609 ' HE1' ' CG ' ' A' ' 82' ' ' ASP . 34.7 t90 -91.56 123.42 34.95 Favored 'General case' 0 C--O 1.236 0.384 0 O-C-N 124.749 1.281 . . . . 0.0 110.761 -179.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 9.3 tttm -85.32 90.29 7.88 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.682 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.5 p . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.753 179.745 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 71.4 tttt . . . . . 0 C--O 1.231 0.121 0 CA-C-O 121.072 0.463 . . . . 0.0 110.161 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.7 mm -82.49 111.6 19.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.011 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 45.1 mt -101.61 123.23 45.28 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.208 0.528 . . . . 0.0 111.489 -179.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 16.4 mttt -94.04 100.72 12.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.798 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -100.55 -172.46 29.43 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.544 -1.022 . . . . 0.0 110.544 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 39.7 tttp -155.09 138.85 16.17 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 120.428 -0.509 . . . . 0.0 111.57 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.7 mt -75.04 134.8 28.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.511 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.444 HG22 ' H ' ' A' ' 59' ' ' ARG . 0.8 OUTLIER -98.3 -50.92 10.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.855 -179.562 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.444 ' H ' HG22 ' A' ' 58' ' ' VAL . 16.0 mtp180 -153.05 153.98 33.96 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.878 0.371 . . . . 0.0 110.822 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.421 HG22 ' H ' ' A' ' 61' ' ' HIS . 3.4 p -71.89 157.81 6.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.085 179.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.442 ' C ' ' H ' ' A' ' 63' ' ' THR . 12.0 t-160 -140.43 135.29 31.88 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.019 0.438 . . . . 0.0 110.825 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.429 ' O ' ' O ' ' A' ' 63' ' ' THR . . . 74.36 -15.51 3.45 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 111.487 -0.645 . . . . 0.0 111.487 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.442 ' H ' ' C ' ' A' ' 61' ' ' HIS . 81.4 p 56.35 142.47 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.021 0.438 . . . . 0.0 111.225 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.514 ' CG ' ' O ' ' A' ' 64' ' ' LYS . 16.5 ttpp 57.59 17.85 4.25 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.269 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -149.9 -126.39 1.42 Allowed Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.032 -178.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.7 -178.43 1.17 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.357 -0.922 . . . . 0.0 111.963 -178.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.6 m -154.33 163.89 1.63 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.158 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.364 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 56.4 ttt180 -89.51 153.95 20.39 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 178.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -149.29 156.48 42.17 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.349 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 -149.25 121.88 8.6 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.307 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.475 ' H ' ' HE1' ' A' ' 22' ' ' MET . 6.9 m-85 -97.34 106.4 18.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.9 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -48.76 -26.04 2.15 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.609 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 53.0 mttt -81.59 -78.28 0.19 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.478 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 131.47 139.33 4.37 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -94.99 150.07 37.19 Favored Pre-proline 0 C--O 1.233 0.216 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -53.61 -81.06 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 122.409 2.073 . . . . 0.0 111.857 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 171.99 0.89 0.03 OUTLIER Glycine 0 CA--C 1.527 0.795 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.23 -22.44 16.7 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.783 0.325 . . . . 0.0 110.671 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -83.88 39.68 0.71 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.938 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.2 tp -72.79 -23.69 60.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.501 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -137.53 14.94 3.66 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 121.037 -0.602 . . . . 0.0 111.94 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.609 ' CG ' ' HE1' ' A' ' 45' ' ' TRP . 19.4 t0 -72.18 143.12 49.01 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -69.26 134.04 48.68 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.308 -0.405 . . . . 0.0 109.937 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.45 ' O ' ' N ' ' A' ' 5' ' ' GLY . 33.1 m -97.57 155.99 3.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.403 ' HG3' ' O ' ' A' ' 84' ' ' VAL . 16.1 mp0 -148.26 154.49 40.11 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.08 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.1 mp -100.57 72.41 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.444 HG22 ' O ' ' A' ' 44' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--O 1.227 -0.081 0 C-N-CA 119.982 -0.687 . . . . 0.0 110.238 -179.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 15.2 ptt180 . . . . . 0 CA--C 1.528 0.12 0 CA-C-O 120.701 0.286 . . . . 0.0 110.443 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.7 mp -100.78 163.87 2.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.184 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 9.9 ptpt -150.71 110.48 4.06 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 121.343 0.592 . . . . 0.0 111.874 -179.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.411 ' CA ' HG23 ' A' ' 84' ' ' VAL . . . -99.0 -176.13 31.96 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 178.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 24.5 t -142.05 134.37 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-O 120.991 0.424 . . . . 0.0 111.001 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 43.1 t -80.29 148.88 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 115.602 -0.727 . . . . 0.0 109.875 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -125.77 -23.16 4.06 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 121.062 -0.255 . . . . 0.0 111.402 -179.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.3 t -166.05 148.04 7.02 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.204 0.526 . . . . 0.0 111.995 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -107.43 163.87 12.68 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.155 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 7.2 ttp180 . . . . . 0 C--O 1.232 0.174 0 CA-C-O 121.033 0.444 . . . . 0.0 110.529 179.858 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 N--CA 1.463 0.193 0 CA-C-O 120.667 0.27 . . . . 0.0 110.307 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -150.63 148.32 28.48 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.043 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.4 mm -92.21 140.9 15.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.044 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.403 HD11 HG22 ' A' ' 24' ' ' ILE . 96.5 mt -130.97 155.2 41.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.744 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.92 100.42 9.8 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.847 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.546 ' O ' ' N ' ' A' ' 28' ' ' ASP . 3.4 Cg_exo -66.02 82.81 0.26 Allowed 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 122.451 2.101 . . . . 0.0 111.352 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.4 tp 33.04 -82.95 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.801 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.546 ' N ' ' O ' ' A' ' 26' ' ' PRO . 10.5 p30 -98.4 -87.27 0.34 Allowed 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.58 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.483 ' O ' ' CG1' ' A' ' 29' ' ' VAL . 43.5 t 43.02 57.55 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.238 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -178.009 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -91.81 42.01 1.09 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.584 -1.189 . . . . 0.0 110.74 -178.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.4 m -158.25 124.8 4.78 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.565 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.447 ' N ' ' HB3' ' A' ' 64' ' ' LYS . 0.6 OUTLIER -59.31 -26.7 65.22 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.315 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 65.6 mm-40 -60.88 -49.46 77.36 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.486 179.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -73.54 -45.71 51.98 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.211 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.26 -60.62 3.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.198 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.2 t -55.26 -38.73 68.91 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.837 179.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.1 mtpt -69.13 -20.56 64.05 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.927 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.505 ' O ' ' HG ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -85.99 -16.29 38.76 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.586 -179.624 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 68.4 mt -52.38 121.24 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-O 120.842 0.354 . . . . 0.0 110.441 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 111.75 -6.56 27.76 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.6 mmm-85 -69.96 156.83 38.54 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.823 0.344 . . . . 0.0 110.54 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.0 tp -101.92 122.56 44.25 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.771 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.7 m -92.03 106.52 17.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.712 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.435 ' CB ' ' O ' ' A' ' 87' ' ' VAL . 6.2 tt -102.61 103.36 13.65 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.402 -179.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.427 ' CZ3' ' HB2' ' A' ' 47' ' ' SER . 80.1 t90 -95.64 105.49 17.49 Favored 'General case' 0 CA--C 1.53 0.205 0 O-C-N 124.91 1.381 . . . . 0.0 109.295 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.5 ttmt -81.76 102.05 10.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.223 -178.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.446 ' HB3' ' H ' ' A' ' 51' ' ' LYS . 10.1 t . . . . . 0 C--N 1.332 -0.161 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.881 179.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.446 ' H ' ' HB3' ' A' ' 47' ' ' SER . 9.9 ttmt . . . . . 0 C--O 1.233 0.202 0 CA-C-O 120.737 0.304 . . . . 0.0 110.23 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.3 mp -82.39 107.25 14.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.216 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 64.8 mt -93.95 152.18 19.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.683 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 6.3 pttt -152.3 104.18 2.92 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 120.913 0.387 . . . . 0.0 111.758 -178.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -90.29 -158.52 34.61 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.004 -1.239 . . . . 0.0 110.004 178.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 48.4 tttp -151.87 129.29 11.35 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.981 0.42 . . . . 0.0 111.009 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 32.1 mt -66.04 140.22 19.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.819 179.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -102.71 -47.86 10.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.209 -179.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.56 163.08 35.4 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.2 0.524 . . . . 0.0 111.333 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.2 p -78.9 154.74 4.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.514 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.425 ' HD1' ' H ' ' A' ' 62' ' ' GLY . 1.4 t60 -140.52 130.03 24.05 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.599 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.425 ' H ' ' HD1' ' A' ' 61' ' ' HIS . . . 83.21 -7.62 66.84 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.482 -0.647 . . . . 0.0 111.482 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.428 ' O ' ' CG ' ' A' ' 64' ' ' LYS . 38.4 p 58.67 138.57 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.892 0.377 . . . . 0.0 111.241 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.447 ' HB3' ' N ' ' A' ' 32' ' ' ARG . 5.2 ptmm? 43.99 32.17 0.6 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.053 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -149.76 -125.05 1.32 Allowed Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 111.44 -0.664 . . . . 0.0 111.44 -178.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.73 179.61 1.36 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.528 -0.836 . . . . 0.0 111.862 -178.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 28.1 m -154.73 151.3 10.94 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.841 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.6 ttp180 -88.96 148.28 23.87 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.44 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -148.71 160.78 42.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.048 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 63.5 mtt180 -145.75 121.1 10.27 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.835 0.35 . . . . 0.0 110.704 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -97.04 113.47 25.02 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.04 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -68.38 -25.73 65.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.467 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 9.8 mmtm -84.05 -80.43 0.19 Allowed 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.741 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 127.5 153.67 8.26 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.5 mt -90.36 153.46 46.32 Favored Pre-proline 0 N--CA 1.464 0.267 0 CA-C-O 120.699 0.285 . . . . 0.0 110.964 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.433 ' O ' ' C ' ' A' ' 77' ' ' GLY . 3.0 Cg_endo -66.7 157.06 62.89 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.714 2.276 . . . . 0.0 112.306 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 76' ' ' PRO . . . 29.04 -96.46 0.01 OUTLIER Glycine 0 N--CA 1.466 0.672 0 O-C-N 123.77 0.668 . . . . 0.0 111.614 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 20.0 tp60 -156.05 103.42 2.21 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.832 0.349 . . . . 0.0 110.669 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -112.71 40.59 2.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.58 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.34 115.57 9.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.126 -179.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 108.6 -3.17 32.41 Favored Glycine 0 CA--C 1.525 0.685 0 CA-C-N 116.248 -0.433 . . . . 0.0 112.153 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -70.07 143.24 52.51 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -67.94 136.67 54.33 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.411 HG23 ' CA ' ' A' ' 5' ' ' GLY . 6.9 m -90.75 160.08 2.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -144.64 150.38 37.3 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.207 -178.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 29.5 mt -110.1 72.79 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 178.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.435 ' O ' ' CB ' ' A' ' 44' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.463 0.203 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.03 -179.161 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 16.1 mtm180 . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.538 0.209 . . . . 0.0 110.727 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.7 mt -147.06 147.73 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.71 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 17.5 tptt -92.88 161.43 14.49 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.309 -0.859 . . . . 0.0 111.008 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -167.8 178.7 41.54 Favored Glycine 0 CA--C 1.528 0.886 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 179.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 30.7 t -149.31 136.03 12.79 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-O 121.126 0.489 . . . . 0.0 111.29 -178.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 47.8 t -74.21 148.35 8.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.118 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.7 mt -109.49 -60.84 1.72 Allowed 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.392 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.0 t -167.04 144.32 4.69 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.876 0.37 . . . . 0.0 111.162 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -95.91 118.55 32.76 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.335 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 40.1 mtt180 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.822 -179.859 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.497 ' CG1' ' H ' ' A' ' 22' ' ' MET . 48.1 t . . . . . 0 N--CA 1.461 0.113 0 CA-C-O 120.797 0.332 . . . . 0.0 110.333 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.497 ' H ' ' CG1' ' A' ' 21' ' ' VAL . 23.9 ttt -147.45 131.57 17.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.141 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.8 mm -95.19 141.86 14.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.86 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.404 HG21 HD12 ' A' ' 24' ' ' ILE . 21.8 mt -139.95 154.31 23.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.678 179.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.428 ' O ' ' N ' ' A' ' 27' ' ' LEU . 68.0 tttt -138.2 100.63 8.6 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.731 -179.379 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.514 ' O ' ' N ' ' A' ' 28' ' ' ASP . 4.0 Cg_exo -64.41 70.9 0.22 Allowed 'Trans proline' 0 N--CA 1.488 1.168 0 C-N-CA 122.1 1.867 . . . . 0.0 111.749 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.428 ' N ' ' O ' ' A' ' 25' ' ' LYS . 15.0 tp 51.01 -79.98 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.77 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 26' ' ' PRO . 3.2 p30 -109.81 -87.17 0.52 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.662 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.469 ' O ' ' CG1' ' A' ' 29' ' ' VAL . 43.4 t 45.64 57.83 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -178.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -91.88 43.3 1.13 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.295 -1.321 . . . . 0.0 110.548 -178.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.9 t -157.85 120.92 3.92 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.643 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 39.7 ttt-85 -58.31 -27.76 64.41 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.507 179.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.0 tm-20 -60.32 -39.12 85.87 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -86.27 -46.95 9.85 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.282 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.01 -58.69 6.83 Favored 'General case' 0 CA--C 1.527 0.083 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.0 t -53.23 -24.59 11.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.712 178.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 9.6 ttpp -69.95 -60.22 2.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.761 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.426 ' O ' ' HG ' ' A' ' 38' ' ' LEU . 0.4 OUTLIER -78.2 8.07 5.43 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 120.915 0.388 . . . . 0.0 110.87 -179.105 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 14.1 tt -52.33 -12.36 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.725 179.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.425 ' H ' ' C ' ' A' ' 38' ' ' LEU . . . -117.16 4.72 18.21 Favored Glycine 0 CA--C 1.53 0.982 0 N-CA-C 111.87 -0.492 . . . . 0.0 111.87 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -71.01 155.28 41.02 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.976 0.417 . . . . 0.0 110.996 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.8 tt -98.55 130.79 45.12 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.634 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 20.7 m -94.42 121.75 45.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.451 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.41 ' CB ' ' O ' ' A' ' 87' ' ' VAL . 7.1 tt -120.69 100.79 7.32 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.374 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.432 ' CH2' ' HB2' ' A' ' 47' ' ' SER . 66.4 t90 -95.93 136.5 36.28 Favored 'General case' 0 C--N 1.349 0.569 0 O-C-N 125.225 1.578 . . . . 0.0 109.358 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.6 mtpt -81.87 165.28 20.95 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.921 -178.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.432 ' HB2' ' CH2' ' A' ' 45' ' ' TRP . 0.2 OUTLIER . . . . . 0 CA--C 1.533 0.313 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.577 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 29.6 ttpt . . . . . 0 N--CA 1.463 0.192 0 CA-C-O 120.776 0.322 . . . . 0.0 111.155 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.411 HD11 HG23 ' A' ' 52' ' ' ILE . 22.7 mm -74.32 146.44 9.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 178.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 67.5 mt -138.19 119.35 14.53 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.269 0.557 . . . . 0.0 111.874 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.1 mptt -90.54 177.91 6.24 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.87 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -165.25 -176.95 37.3 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 178.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 55.4 tttt -154.66 129.62 9.47 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.765 0.317 . . . . 0.0 110.817 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 26.6 mt -72.67 130.2 35.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.641 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.5 m -102.66 -45.54 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.537 -0.302 . . . . 0.0 110.854 -179.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 22.1 mtt85 -144.42 158.97 43.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.859 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.7 p -87.39 156.17 3.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.143 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 74.5 t60 -140.84 117.7 11.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.151 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.08 5.62 63.86 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 -179.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.45 ' OG1' ' N ' ' A' ' 64' ' ' LYS . 32.4 p 58.69 -89.32 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 122.813 0.445 . . . . 0.0 111.513 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.45 ' N ' ' OG1' ' A' ' 63' ' ' THR . 15.4 pttm -90.84 55.51 2.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.835 0.35 . . . . 0.0 110.93 -179.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -159.58 -126.18 0.83 Allowed Glycine 0 N--CA 1.442 -0.952 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.22 -177.65 1.15 Allowed 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.454 -0.873 . . . . 0.0 111.757 -179.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.1 m -148.85 158.69 6.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.197 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 14.8 ttp180 -87.35 150.17 24.01 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-O 121.056 0.455 . . . . 0.0 111.072 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -148.32 159.72 43.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.814 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 24.1 mtm180 -148.34 122.99 9.84 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.847 0.356 . . . . 0.0 110.765 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -101.21 117.65 35.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.387 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -70.76 -24.48 62.61 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -82.68 -77.87 0.22 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.628 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 126.2 150.3 7.59 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 17.3 mt -98.16 148.14 34.08 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 120.505 0.193 . . . . 0.0 110.862 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -49.16 -179.26 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 122.877 2.385 . . . . 0.0 112.494 179.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.9 -4.52 11.07 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 121.201 -0.524 . . . . 0.0 111.907 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.573 ' C ' ' H ' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -135.01 -142.71 0.19 Allowed 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.295 179.734 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.522 ' H ' ' CD ' ' A' ' 78' ' ' GLN . . . 64.32 -10.12 0.15 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.562 -178.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.573 ' H ' ' C ' ' A' ' 78' ' ' GLN . 2.1 tt -66.64 99.34 0.58 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.279 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 125.97 3.11 7.04 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -72.21 175.99 5.59 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-O 121.095 0.474 . . . . 0.0 110.716 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -92.66 128.13 38.41 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 26.3 m -92.66 156.91 3.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.233 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -147.9 153.24 38.83 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.704 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.418 ' O ' ' CG2' ' A' ' 86' ' ' ILE . 1.8 mp -103.65 74.08 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.41 ' O ' ' CB ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.466 0.373 0 C-N-CA 118.966 -1.094 . . . . 0.0 110.79 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 34.4 mtm105 . . . . . 0 C--O 1.233 0.218 0 CA-C-O 120.865 0.364 . . . . 0.0 111.052 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.461 HG23 ' H ' ' A' ' 4' ' ' LYS . 2.0 mt -145.15 168.9 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.487 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.461 ' H ' HG23 ' A' ' 3' ' ' ILE . 0.0 OUTLIER -152.39 120.59 6.28 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.262 0.553 . . . . 0.0 111.949 -179.499 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -107.07 -175.66 22.8 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.4 t -140.29 137.87 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-O 121.126 0.489 . . . . 0.0 110.57 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 72.3 t -71.07 144.88 13.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.841 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 14.8 mt -106.71 -52.6 2.75 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.391 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.6 t -166.15 154.64 10.9 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.182 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.489 ' O ' ' CG ' ' A' ' 10' ' ' TYR . 0.5 OUTLIER -99.46 126.84 45.46 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.004 0.43 . . . . 0.0 110.42 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.437 ' N ' ' O ' ' A' ' 21' ' ' VAL . 47.7 mtp180 . . . . . 0 C--N 1.326 -0.432 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.085 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.443 ' CG1' ' N ' ' A' ' 22' ' ' MET . 72.9 t . . . . . 0 CA--C 1.528 0.111 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.443 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 21.2 ptm -151.65 138.4 18.86 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.833 0.349 . . . . 0.0 110.881 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 55.2 mt -92.08 139.56 17.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.122 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 77.5 mt -134.7 156.52 40.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.523 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -144.24 120.79 6.37 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.867 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -61.14 169.36 6.27 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 121.872 1.715 . . . . 0.0 111.503 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -49.55 -77.49 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.625 -0.262 . . . . 0.0 110.951 -179.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.521 ' CG ' ' H ' ' A' ' 29' ' ' VAL . 2.8 p-10 -94.51 -88.61 0.24 Allowed 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.521 -0.472 . . . . 0.0 111.107 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.521 ' H ' ' CG ' ' A' ' 28' ' ' ASP . 82.5 t 41.32 55.7 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.165 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 -178.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -88.51 40.62 0.97 Allowed 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 114.365 -1.289 . . . . 0.0 110.998 -177.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 68.7 m -158.84 128.11 5.54 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.862 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 47.4 ttp180 -61.25 -25.38 67.04 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -62.32 -52.01 65.37 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.602 178.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -69.57 -38.41 77.38 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.434 178.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -59.24 -60.66 3.51 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.003 179.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.7 t -55.92 -22.96 28.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.732 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 34.4 tttp -70.86 -61.66 1.68 Allowed 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.749 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.52 5.94 8.05 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.243 -178.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 8.1 tt -51.08 133.97 12.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.229 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.436 ' O ' ' NZ ' ' A' ' 56' ' ' LYS . . . 81.2 25.32 55.36 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.3 ptt180 -71.57 171.29 11.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.713 0.292 . . . . 0.0 110.367 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 23.5 tp -100.82 112.18 24.54 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.135 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.2 m -88.19 121.37 38.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.13 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.0 tt -123.49 98.41 5.83 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.73 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.486 ' CZ3' ' OG ' ' A' ' 47' ' ' SER . 75.8 t90 -100.73 109.92 21.98 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 125.089 1.493 . . . . 0.0 109.676 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 5.9 pttp -83.72 105.11 14.37 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 121.073 0.463 . . . . 0.0 111.41 -178.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.486 ' OG ' ' CZ3' ' A' ' 45' ' ' TRP . 0.9 OUTLIER . . . . . 0 CA--C 1.531 0.233 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.707 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 27.7 tttp . . . . . 0 C--O 1.227 -0.088 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 23.2 mm -83.49 111.15 19.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.444 -178.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 71.4 mt -100.15 143.31 30.5 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.855 179.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.6 pttp -150.24 116.35 5.66 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 120.945 0.403 . . . . 0.0 110.95 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -104.09 -150.64 21.27 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.436 ' NZ ' ' O ' ' A' ' 40' ' ' GLY . 0.2 OUTLIER -154.26 130.42 10.35 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.782 0.325 . . . . 0.0 110.881 179.9 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 34.6 mt -65.13 147.89 12.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -107.01 -40.56 5.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 C-N-CA 120.596 -0.442 . . . . 0.0 111.491 -178.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -164.55 155.14 14.66 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 120.392 -0.523 . . . . 0.0 111.853 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.3 p -92.82 116.33 33.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.322 178.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -140.21 123.87 17.22 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.265 -178.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 136.24 -16.84 3.86 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 121.327 -0.463 . . . . 0.0 112.056 178.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.654 ' C ' ' H ' ' A' ' 65' ' ' GLY . 80.7 p 54.79 164.91 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.776 0.322 . . . . 0.0 111.025 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 38.2 tttp 67.1 -17.3 0.14 Allowed 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.148 0.499 . . . . 0.0 110.0 -178.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.654 ' H ' ' C ' ' A' ' 63' ' ' THR . . . 131.57 121.12 2.24 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 174.68 149.01 0.08 Allowed 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 8.7 m -157.13 139.15 5.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 120.253 -0.579 . . . . 0.0 111.404 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -90.97 146.63 23.71 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 178.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -146.35 160.1 42.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.229 0.537 . . . . 0.0 111.278 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 5.8 ttp180 -148.3 131.97 16.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.675 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.479 ' C ' ' H ' ' A' ' 73' ' ' LYS . 17.5 m-85 -92.87 141.81 28.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.991 0.424 . . . . 0.0 110.828 -179.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -62.35 -0.47 0.58 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.444 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.479 ' H ' ' C ' ' A' ' 71' ' ' PHE . 33.3 ttmt -154.88 -64.7 0.13 Allowed 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.629 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 142.53 -177.24 21.82 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.3 mt -95.48 165.76 16.07 Favored Pre-proline 0 CA--C 1.53 0.175 0 CA-C-O 120.705 0.288 . . . . 0.0 110.99 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -76.14 99.94 1.33 Allowed 'Trans proline' 0 N--CA 1.489 1.235 0 C-N-CA 122.971 2.447 . . . . 0.0 112.214 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 42.48 -113.06 0.54 Allowed Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.762 -0.535 . . . . 0.0 111.762 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.497 ' NE2' ' H ' ' A' ' 80' ' ' LEU . 0.8 OUTLIER -81.8 116.05 21.3 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.77 0.319 . . . . 0.0 110.787 -179.746 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -154.4 8.14 0.32 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.322 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.497 ' H ' ' NE2' ' A' ' 78' ' ' GLN . 5.5 tp -68.56 117.04 9.8 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.768 0.318 . . . . 0.0 110.491 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 118.5 -10.92 12.64 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.408 ' HB3' ' HE1' ' A' ' 45' ' ' TRP . 2.1 m-20 -68.36 131.08 44.7 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -67.55 135.78 53.51 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.4 m -90.78 163.21 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.509 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 52.0 mp0 -148.14 145.11 28.22 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.5 mp -101.06 73.3 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.463 0.219 0 C-N-CA 119.749 -0.78 . . . . 0.0 110.67 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 17.3 ptt85 . . . . . 0 C--O 1.233 0.195 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.4 mt -148.4 144.88 18.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.266 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 52.0 mttt -83.17 173.45 11.66 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.646 -179.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 84' ' ' VAL . . . -171.47 174.66 45.05 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 22.0 t -149.15 143.97 18.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.262 0.553 . . . . 0.0 111.236 -178.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 75.7 t -79.88 147.46 6.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.972 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 13.4 mt -111.05 -52.43 2.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.644 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.7 t -163.88 124.27 2.17 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.402 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -99.36 105.67 17.68 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.325 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 35.9 mtt180 . . . . . 0 C--N 1.331 -0.232 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.772 179.819 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.407 HG13 ' N ' ' A' ' 22' ' ' MET . 45.5 t . . . . . 0 N--CA 1.456 -0.173 0 CA-C-O 120.902 0.382 . . . . 0.0 110.083 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.482 ' SD ' ' CE1' ' A' ' 71' ' ' PHE . 13.1 ttt -148.59 112.75 5.21 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.874 -179.067 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 19.2 mt -85.19 136.26 23.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 41.2 mt -137.07 154.15 30.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.245 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.4 tttt -146.79 122.0 5.37 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.361 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -60.74 164.47 13.63 Favored 'Trans proline' 0 N--CA 1.489 1.228 0 C-N-CA 121.418 1.412 . . . . 0.0 111.152 178.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.7 tp -45.28 -80.79 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.888 -179.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.466 ' O ' ' C ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -93.8 -84.9 0.3 Allowed 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.964 -0.295 . . . . 0.0 110.444 179.383 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.466 ' C ' ' O ' ' A' ' 28' ' ' ASP . 64.7 t 39.99 53.63 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 -178.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.658 ' ND2' ' H ' ' A' ' 30' ' ' ASN . 0.0 OUTLIER -88.53 44.36 1.2 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.441 -1.254 . . . . 0.0 110.727 -177.089 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.9 m -157.98 124.7 4.89 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.085 -0.962 . . . . 0.0 109.964 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 11.6 ttp180 -58.5 -26.95 64.0 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -61.21 -50.37 73.39 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.876 179.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.3 tp10 -72.46 -37.96 68.39 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.468 ' C ' ' N ' ' A' ' 37' ' ' LYS . . . -60.4 -69.4 0.22 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.308 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.1 t -44.38 -18.61 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.831 0.348 . . . . 0.0 110.424 179.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.468 ' N ' ' C ' ' A' ' 35' ' ' ALA . 2.1 tmtt? -72.39 -63.04 1.23 Allowed 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.22 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.424 ' O ' ' HG ' ' A' ' 38' ' ' LEU . 0.5 OUTLIER -74.53 9.75 1.63 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.964 0.412 . . . . 0.0 110.324 -179.053 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.44 ' H ' ' C ' ' A' ' 37' ' ' LYS . 18.4 tt -48.63 -16.31 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.407 179.023 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -123.33 6.96 9.19 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.933 -178.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.8 mmt180 -72.15 175.68 5.81 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 117.591 0.696 . . . . 0.0 110.616 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.403 HD22 ' N ' ' A' ' 43' ' ' VAL . 6.5 tt -98.38 169.56 9.47 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.056 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.403 ' N ' HD22 ' A' ' 42' ' ' LEU . 33.8 m -140.84 99.5 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.185 0.517 . . . . 0.0 109.929 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.9 tt -102.16 99.72 9.87 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.742 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 10.4 t90 -106.2 116.51 32.06 Favored 'General case' 0 C--O 1.234 0.278 0 O-C-N 124.682 1.239 . . . . 0.0 109.738 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.8 pttp -84.01 105.7 15.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.935 0.398 . . . . 0.0 110.487 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.4 t . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.245 179.844 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.0 ttmm . . . . . 0 CA--C 1.527 0.078 0 CA-C-O 120.661 0.267 . . . . 0.0 110.614 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.474 HG21 HD12 ' A' ' 52' ' ' ILE . 28.7 mm -82.04 109.79 16.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.453 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 75.5 mt -104.51 143.55 32.89 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.063 0.459 . . . . 0.0 110.869 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -151.87 101.99 2.79 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.885 -178.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -104.98 -142.25 11.27 Favored Glycine 0 N--CA 1.464 0.504 0 N-CA-C 109.771 -1.331 . . . . 0.0 109.771 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 23.9 tttm -154.98 139.7 17.09 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.068 0.461 . . . . 0.0 111.122 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 80.0 mt -69.85 138.95 21.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.059 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -105.43 -34.14 3.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -178.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.477 ' NH2' ' NH2' ' A' ' 70' ' ' ARG . 5.0 ptt-85 -165.69 157.45 14.44 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 120.435 -0.506 . . . . 0.0 111.319 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.465 ' C ' ' HD1' ' A' ' 61' ' ' HIS . 7.3 p -97.98 121.44 48.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.543 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.465 ' HD1' ' C ' ' A' ' 60' ' ' VAL . 11.3 m80 -141.11 132.78 27.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.113 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.429 ' O ' ' OG1' ' A' ' 63' ' ' THR . . . 124.94 -12.8 7.66 Favored Glycine 0 CA--C 1.519 0.288 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.472 ' O ' ' N ' ' A' ' 65' ' ' GLY . 19.9 p 53.53 171.87 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 -179.117 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt 65.57 -52.94 0.36 Allowed 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -178.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 63' ' ' THR . . . 165.81 121.64 0.57 Allowed Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 178.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.428 ' O ' ' CG1' ' A' ' 67' ' ' VAL . . . 174.87 159.59 0.19 Allowed 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.428 ' CG1' ' O ' ' A' ' 66' ' ' ALA . 7.9 m -159.11 144.32 6.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 C-N-CA 120.044 -0.663 . . . . 0.0 111.212 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 23.2 ttm180 -90.51 154.89 19.29 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -146.15 168.63 20.51 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.209 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.477 ' NH2' ' NH2' ' A' ' 59' ' ' ARG . 92.8 mtt180 -147.25 111.91 5.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.216 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.482 ' CE1' ' SD ' ' A' ' 22' ' ' MET . 51.8 m-85 -96.43 109.95 22.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.748 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -82.31 -13.33 57.11 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.122 0.487 . . . . 0.0 109.835 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 45.4 mmtt -80.96 -77.6 0.2 Allowed 'General case' 0 C--O 1.231 0.116 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.742 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 135.41 154.91 7.14 Favored Glycine 0 C--N 1.335 0.508 0 N-CA-C 111.241 -0.744 . . . . 0.0 111.241 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -89.13 174.45 4.94 Favored Pre-proline 0 N--CA 1.463 0.183 0 N-CA-C 110.414 -0.217 . . . . 0.0 110.414 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -76.06 -82.89 0.0 OUTLIER 'Trans proline' 0 C--N 1.315 -1.197 0 C-N-CA 122.305 2.003 . . . . 0.0 111.044 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -176.21 104.45 0.19 Allowed Glycine 0 N--CA 1.451 -0.304 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 179.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.499 ' NE2' ' C ' ' A' ' 78' ' ' GLN . 0.0 OUTLIER 70.32 62.93 0.22 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.92 0.391 . . . . 0.0 111.087 179.514 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -115.43 -0.6 13.07 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.511 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.9 tp -52.6 114.49 1.41 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.818 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 125.52 -13.27 7.37 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 111.744 -0.542 . . . . 0.0 111.744 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -70.35 136.67 49.92 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 120.442 -0.503 . . . . 0.0 109.983 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -69.56 125.59 27.18 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.773 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.441 ' O ' ' N ' ' A' ' 5' ' ' GLY . 18.0 m -94.36 154.96 3.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -149.94 164.29 35.84 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.323 0.582 . . . . 0.0 110.65 -178.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.1 mp -103.44 74.48 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 178.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.468 0.456 0 C-N-CA 120.093 -0.643 . . . . 0.0 110.946 -179.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 11.5 mmt180 . . . . . 0 C--O 1.232 0.172 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.0 mm -138.13 169.85 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 9.4 ptpt -150.81 103.85 3.12 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 121.259 0.552 . . . . 0.0 111.329 -179.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -94.57 -177.3 38.51 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 179.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 p -146.5 135.38 16.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-O 121.222 0.534 . . . . 0.0 111.359 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 99.0 t -79.86 140.19 17.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.655 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 17.3 mt -105.52 -57.24 2.06 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.288 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.8 m -165.86 142.29 5.21 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.294 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -100.44 138.75 37.08 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 120.859 0.361 . . . . 0.0 110.689 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 10.6 mmt180 . . . . . 0 C--N 1.331 -0.2 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.485 -179.756 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.1 t . . . . . 0 C--O 1.231 0.128 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 30.8 tpp -143.65 119.18 10.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.046 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 6.2 mm -83.23 133.0 30.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.584 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.419 ' CG2' ' N ' ' A' ' 25' ' ' LYS . 12.3 mt -138.9 156.72 28.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.523 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.419 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 11.4 ttmm -140.67 119.89 8.49 Favored Pre-proline 0 C--N 1.33 -0.28 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.458 ' O ' ' N ' ' A' ' 28' ' ' ASP . 2.9 Cg_endo -67.86 59.2 0.86 Allowed 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.313 2.009 . . . . 0.0 111.273 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.0 tp 54.31 -79.76 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.638 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.602 ' CG ' ' H ' ' A' ' 29' ' ' VAL . 9.2 p-10 -101.29 -90.75 0.33 Allowed 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.503 -0.479 . . . . 0.0 111.44 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.602 ' H ' ' CG ' ' A' ' 28' ' ' ASP . 53.3 t 44.7 55.95 0.33 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.194 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 -178.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -89.23 50.29 1.91 Allowed 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 114.356 -1.293 . . . . 0.0 110.812 -178.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 10.1 m -158.85 108.76 1.99 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.101 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 26.9 ttt85 -47.79 -31.8 5.29 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.161 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -62.59 -55.33 28.15 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.933 179.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -65.42 -39.37 92.04 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.104 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -58.93 -59.83 4.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.18 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.5 m -53.65 -22.07 8.12 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.614 179.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.0 tttp -68.96 -63.42 1.06 Allowed 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.067 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.433 ' O ' ' HG ' ' A' ' 38' ' ' LEU . 0.4 OUTLIER -80.32 16.8 1.19 Allowed 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 121.019 0.437 . . . . 0.0 111.053 -179.423 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 19.3 tt -50.38 -32.75 10.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.233 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -102.9 24.03 31.9 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -71.15 146.15 49.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.747 0.308 . . . . 0.0 110.569 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 7.8 tp -96.19 121.02 37.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.156 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.8 m -87.08 122.62 39.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.282 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.4 ' H ' ' HA ' ' A' ' 86' ' ' ILE . 0.5 OUTLIER -107.84 98.23 7.84 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.441 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 37.3 t90 -86.61 113.02 22.16 Favored 'General case' 0 C--O 1.234 0.246 0 O-C-N 125.209 1.568 . . . . 0.0 110.448 -178.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -83.56 93.63 7.89 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.004 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.1 p . . . . . 0 CA--C 1.532 0.264 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.049 -179.968 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt . . . . . 0 CA--C 1.529 0.14 0 CA-C-O 120.566 0.222 . . . . 0.0 110.616 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.2 mp -79.18 108.01 12.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.7 mt -90.34 126.25 35.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.375 0.607 . . . . 0.0 110.943 -178.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 28.5 mttm -91.49 110.17 21.48 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.88 -1.055 . . . . 0.0 111.281 -179.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -95.46 178.81 35.68 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 178.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 38.7 tttt -152.84 131.45 12.28 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.528 -0.469 . . . . 0.0 111.426 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.2 mt -75.6 142.47 14.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.867 179.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -104.83 -34.29 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.81 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -164.85 156.23 15.08 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.045 0.45 . . . . 0.0 111.466 179.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.9 p -98.24 139.22 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.656 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.504 ' CG ' ' N ' ' A' ' 62' ' ' GLY . 56.7 t-80 -142.2 168.77 18.95 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.46 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.545 ' C ' ' H ' ' A' ' 64' ' ' LYS . . . 91.12 -34.14 4.4 Favored Glycine 0 CA--C 1.525 0.683 0 CA-C-N 116.19 -0.459 . . . . 0.0 112.707 178.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.41 ' OG1' ' O ' ' A' ' 62' ' ' GLY . 4.3 p 68.22 -34.18 0.25 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.682 0.241 . . . . 0.0 110.849 -179.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.545 ' H ' ' C ' ' A' ' 62' ' ' GLY . 0.8 OUTLIER -89.31 -7.42 55.39 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.579 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 130.65 119.78 2.15 Favored Glycine 0 CA--C 1.522 0.476 0 CA-C-N 114.517 -1.22 . . . . 0.0 110.224 178.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.447 ' CB ' ' O ' ' A' ' 61' ' ' HIS . . . 172.68 150.26 0.06 Allowed 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 17.4 m -156.19 141.0 9.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.539 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -88.91 150.39 22.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.421 179.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -146.85 163.59 35.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.963 0.411 . . . . 0.0 111.055 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 53.2 mtt180 -146.4 121.24 9.93 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.079 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.593 ' C ' ' H ' ' A' ' 73' ' ' LYS . 60.3 m-85 -97.48 138.85 34.29 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.116 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.573 ' O ' ' CB ' ' A' ' 73' ' ' LYS . 8.9 pt-20 -74.95 36.5 0.11 Allowed 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.136 178.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.593 ' H ' ' C ' ' A' ' 71' ' ' PHE . 9.9 ttpt 93.28 -32.97 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 115.008 -0.997 . . . . 0.0 110.18 -179.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.497 ' C ' ' O ' ' A' ' 73' ' ' LYS . . . -10.97 -59.84 0.01 OUTLIER Glycine 0 CA--C 1.53 0.997 0 O-C-N 124.431 1.082 . . . . 0.0 113.164 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.448 ' N ' ' O ' ' A' ' 73' ' ' LYS . 10.9 mt -56.67 113.71 6.52 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-N 116.709 0.254 . . . . 0.0 110.552 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -69.34 -174.9 0.9 Allowed 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 122.436 2.091 . . . . 0.0 112.347 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -51.13 115.09 3.29 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 9.3 tm0? 69.48 145.81 0.06 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.914 0.388 . . . . 0.0 110.708 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 166.91 -21.0 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.242 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.4 tp -43.7 129.13 5.49 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.224 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 98.53 -7.64 61.64 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.827 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -71.5 135.94 47.34 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -68.58 129.41 39.86 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.1 m -90.3 170.99 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -149.88 151.16 33.02 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.4 ' HA ' ' H ' ' A' ' 44' ' ' LEU . 16.8 mt -108.69 73.2 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 178.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.4 t . . . . . 0 N--CA 1.464 0.231 0 C-N-CA 120.115 -0.634 . . . . 0.0 111.015 -178.628 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 20.9 mtm180 . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.973 0.416 . . . . 0.0 110.836 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.2 mt -144.32 158.51 15.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.419 -0.81 . . . . 0.0 108.86 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.78 107.85 4.05 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.467 0.651 . . . . 0.0 112.082 -178.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -95.85 -177.35 36.61 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 178.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 75.2 t -145.42 135.68 18.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.202 0.525 . . . . 0.0 110.468 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.9 t -73.0 142.72 14.69 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.391 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 52.0 mt -110.49 -33.71 6.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.055 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.6 m -161.28 134.56 6.46 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.935 0.397 . . . . 0.0 110.886 -179.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -106.44 101.15 10.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.541 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.43 ' O ' ' O ' ' A' ' 21' ' ' VAL . 5.8 mpt_? . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.373 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.43 ' O ' ' O ' ' A' ' 11' ' ' ARG . 88.1 t . . . . . 0 N--CA 1.464 0.274 0 CA-C-O 120.871 0.367 . . . . 0.0 110.468 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 15.2 ptm -145.81 143.04 29.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.961 0.41 . . . . 0.0 111.093 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.406 HG23 HD13 ' A' ' 23' ' ' ILE . 29.4 mm -92.65 143.15 12.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.106 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.428 ' CG2' ' N ' ' A' ' 25' ' ' LYS . 31.5 mt -133.19 156.87 42.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.399 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.428 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -140.3 99.8 7.12 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.644 179.824 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.537 ' O ' ' N ' ' A' ' 28' ' ' ASP . 3.3 Cg_exo -65.17 74.12 0.25 Allowed 'Trans proline' 0 C--N 1.314 -1.268 0 C-N-CA 121.984 1.789 . . . . 0.0 111.051 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.415 ' N ' ' O ' ' A' ' 25' ' ' LYS . 0.9 OUTLIER 37.92 -82.64 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 114.849 -1.069 . . . . 0.0 112.097 -179.758 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.537 ' N ' ' O ' ' A' ' 26' ' ' PRO . 1.1 p-10 -99.24 -87.11 0.36 Allowed 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.363 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.511 ' O ' ' CG1' ' A' ' 29' ' ' VAL . 19.1 t 44.14 62.27 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-O 122.245 1.022 . . . . 0.0 108.294 -177.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.401 HD21 ' HB2' ' A' ' 28' ' ' ASP . 2.6 p30 -93.63 47.22 1.22 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.15 -1.386 . . . . 0.0 110.941 -178.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 70.3 m -156.72 118.99 3.94 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.541 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.409 ' H ' ' HB3' ' A' ' 64' ' ' LYS . 1.4 ttt85 -51.89 -30.93 26.12 Favored 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.429 ' O ' ' CB ' ' A' ' 37' ' ' LYS . 45.3 mt-10 -63.01 -63.15 1.29 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.643 179.038 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -54.86 -46.62 74.72 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.03 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -57.84 -69.48 0.17 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.985 179.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 65.0 m -50.82 -36.68 38.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.677 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.429 ' CB ' ' O ' ' A' ' 33' ' ' GLU . 60.5 tttt -71.35 -14.75 62.29 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.304 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.462 ' O ' ' HG ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -86.47 -11.31 52.16 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 120.853 0.358 . . . . 0.0 110.628 -179.524 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.425 HD11 HG21 ' A' ' 39' ' ' ILE . 53.7 mt -55.16 121.63 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.658 178.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 103.79 -4.05 45.94 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.714 -0.554 . . . . 0.0 111.714 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -70.37 142.33 52.13 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.854 0.359 . . . . 0.0 110.206 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 11.6 tp -81.51 111.29 17.7 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.089 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.444 ' O ' ' CG2' ' A' ' 43' ' ' VAL . 6.7 m -88.81 107.4 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 121.581 0.705 . . . . 0.0 111.182 -178.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.1 mp -102.98 92.97 4.78 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.442 ' CZ3' HD11 ' A' ' 53' ' ' LEU . 1.2 t90 -91.87 129.08 37.9 Favored 'General case' 0 C--O 1.235 0.304 0 O-C-N 124.717 1.26 . . . . 0.0 110.736 -178.065 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.6 ttmp? -81.76 91.96 6.57 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.966 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.326 -0.435 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.011 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 7.0 ttpm? . . . . . 0 CA--C 1.519 -0.226 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 28.5 mm -83.97 112.92 22.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.442 HD11 ' CZ3' ' A' ' 45' ' ' TRP . 16.9 mt -99.66 125.21 45.46 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.265 0.555 . . . . 0.0 111.301 -179.109 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.3 mtpt -89.1 166.85 13.59 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.572 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -161.99 178.57 37.78 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.6 tttt -152.2 123.7 7.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.826 0.346 . . . . 0.0 111.023 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 22.4 mt -66.02 144.8 14.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.315 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.3 m -109.36 -34.54 2.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.584 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -163.37 158.02 20.7 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.745 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.4 p -88.54 153.8 3.24 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.431 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -140.86 125.08 17.45 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.25 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.3 13.82 55.13 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 -179.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 82.2 p 52.92 -99.99 0.09 Allowed 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 122.44 0.296 . . . . 0.0 111.348 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.409 ' HB3' ' H ' ' A' ' 32' ' ' ARG . 16.4 pttt -88.16 55.93 3.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.829 -179.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -156.13 -125.41 0.9 Allowed Glycine 0 N--CA 1.446 -0.7 0 N-CA-C 111.366 -0.694 . . . . 0.0 111.366 -178.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.9 -177.5 0.82 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.25 -0.975 . . . . 0.0 111.688 -178.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.3 m -153.11 156.85 5.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.099 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 8.7 tpp180 -88.88 154.49 20.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.933 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -149.85 154.38 38.29 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.199 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -148.79 128.76 13.49 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.909 0.385 . . . . 0.0 111.156 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -103.96 117.05 33.39 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.54 179.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -80.96 -10.9 59.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.818 -178.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 24.7 ttpt -160.03 -45.66 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 120.36 -0.536 . . . . 0.0 111.933 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.84 51.77 0.1 Allowed Glycine 0 CA--C 1.529 0.968 0 O-C-N 123.513 0.508 . . . . 0.0 112.015 -178.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.4 91.26 12.64 Favored Pre-proline 0 C--N 1.329 -0.289 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -59.08 -80.95 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 121.945 1.764 . . . . 0.0 112.107 -179.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -173.84 9.65 0.03 OUTLIER Glycine 0 CA--C 1.525 0.681 0 C-N-CA 120.743 -0.742 . . . . 0.0 111.589 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.87 107.35 2.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.844 0.354 . . . . 0.0 110.51 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -139.92 4.3 2.08 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.741 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.8 tp -77.15 98.94 5.23 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.265 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 123.61 -26.84 5.88 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 121.224 -0.512 . . . . 0.0 112.183 178.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -70.9 129.4 38.95 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 117.232 0.516 . . . . 0.0 109.924 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -68.59 134.02 49.36 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 29.7 m -90.73 160.13 2.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -147.61 151.33 36.04 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.336 -0.546 . . . . 0.0 110.565 -178.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 33.5 mt -110.01 72.05 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 178.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.7 t . . . . . 0 C--N 1.332 -0.195 0 C-N-CA 119.7 -0.8 . . . . 0.0 110.826 -178.824 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.9 tpt . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.85 174.67 9.14 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.096 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 11.3 mt -145.29 163.46 12.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.926 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.8 ptpt -139.04 177.08 8.16 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.111 0.482 . . . . 0.0 110.805 -179.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -170.44 -176.04 39.62 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 -178.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.9 t -140.35 127.51 23.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.086 0.47 . . . . 0.0 110.2 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 66.1 t -63.23 151.71 8.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.558 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 37.1 mt -109.86 -61.32 1.66 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.272 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.5 t -166.4 133.48 2.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.634 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -106.59 115.48 30.27 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.357 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.32 116.82 27.82 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.33 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.16 62.51 1.11 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.31 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.9 t -38.8 117.63 0.68 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.901 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 13.0 tttp -62.27 -61.04 2.74 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.562 -179.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.544 ' CD ' ' H ' ' A' ' 15' ' ' GLU . 1.0 OUTLIER -58.33 -162.35 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.376 179.973 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -151.8 95.44 2.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.243 0.544 . . . . 0.0 110.64 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.482 ' O ' ' CG ' ' A' ' 18' ' ' HIS . 0.0 OUTLIER -158.47 16.71 0.21 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.295 179.884 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.482 ' CG ' ' O ' ' A' ' 17' ' ' GLN . 3.0 m170 -173.79 -5.25 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.862 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.9 t30 68.3 173.66 0.28 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.42 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -78.23 142.75 37.67 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.749 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 98.5 t -113.68 154.81 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.64 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.541 ' SD ' ' CE1' ' A' ' 71' ' ' PHE . 23.6 ttt -143.71 123.37 13.31 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.565 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.4 HG22 HD11 ' A' ' 23' ' ' ILE . 16.1 mm -98.97 134.77 36.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.775 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 38.4 mt -125.61 153.91 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.637 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.2 ttmm -137.45 98.51 10.0 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.885 -179.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.479 ' O ' ' C ' ' A' ' 27' ' ' LEU . 3.5 Cg_exo -70.74 135.55 28.37 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 122.265 1.977 . . . . 0.0 110.722 178.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.479 ' C ' ' O ' ' A' ' 26' ' ' PRO . 7.6 mp -19.33 -85.32 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -179.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.439 ' CG ' ' H ' ' A' ' 29' ' ' VAL . 5.2 p30 -93.1 -91.86 0.17 Allowed 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.526 -179.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.443 ' O ' ' CG1' ' A' ' 29' ' ' VAL . 91.2 t 48.19 46.39 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.145 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 -178.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.469 ' H ' ' ND2' ' A' ' 30' ' ' ASN . 1.6 p30 -89.58 51.16 2.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.841 -178.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -159.2 111.42 2.16 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.68 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 14.9 ttt85 -48.26 -29.94 4.31 Favored 'General case' 0 N--CA 1.462 0.143 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -61.05 -58.19 9.45 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.754 178.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.96 -49.34 70.7 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.374 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -53.79 -60.96 2.64 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.5 t -54.65 -39.6 68.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.847 179.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 51.3 mttt -69.84 -19.95 63.44 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.486 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.483 ' O ' ' HG ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -85.34 -14.08 47.55 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.768 -179.304 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 71.7 mt -55.48 127.95 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 N-CA-C 110.148 -0.315 . . . . 0.0 110.148 178.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 107.89 -14.75 37.64 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 61.9 mtt180 -69.78 162.29 28.13 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.8 tp -103.14 128.21 50.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.207 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.0 m -94.9 105.65 17.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.316 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.412 ' CB ' ' O ' ' A' ' 87' ' ' VAL . 6.1 tt -102.61 95.37 6.18 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.476 ' CE2' ' O ' ' A' ' 46' ' ' LYS . 15.9 t90 -99.59 136.8 38.98 Favored 'General case' 0 C--O 1.238 0.452 0 O-C-N 124.632 1.208 . . . . 0.0 111.21 -178.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.476 ' O ' ' CE2' ' A' ' 45' ' ' TRP . 58.1 mttt -82.33 169.13 16.84 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.315 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -177.17 152.21 0.97 Allowed Pre-proline 0 N--CA 1.464 0.236 0 N-CA-C 110.351 -0.24 . . . . 0.0 110.351 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -47.96 178.11 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 123.233 2.622 . . . . 0.0 112.415 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 14.5 m 60.17 9.72 2.0 Allowed 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.13 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 63.62 9.53 32.59 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.9 ttmp? -75.74 96.19 3.58 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.892 0.377 . . . . 0.0 110.803 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 27.1 mm -84.25 114.37 24.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 10.8 mt -98.46 146.97 25.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.019 0.437 . . . . 0.0 110.493 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.06 107.02 3.98 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.546 -178.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -103.98 -151.42 21.99 Favored Glycine 0 CA--C 1.521 0.464 0 N-CA-C 109.866 -1.293 . . . . 0.0 109.866 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 24.3 tttm -155.49 140.98 17.81 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.985 0.421 . . . . 0.0 111.351 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 65.6 mt -72.84 135.27 28.09 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.583 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -99.0 -63.46 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.973 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.8 mtt85 -143.88 159.29 42.8 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.657 0.265 . . . . 0.0 110.574 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 6.4 p -86.78 140.27 16.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.747 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -140.74 80.09 1.73 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.595 179.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 153.44 11.83 0.07 OUTLIER Glycine 0 CA--C 1.521 0.424 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 69.4 p 51.1 -94.85 0.03 OUTLIER 'General case' 0 C--O 1.231 0.104 0 CA-C-N 115.277 -0.462 . . . . 0.0 110.85 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 15.0 mtmt -94.5 50.17 1.33 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.115 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -156.22 -125.13 0.88 Allowed Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.526 -0.845 . . . . 0.0 111.809 -178.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.29 179.54 1.57 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.243 -0.978 . . . . 0.0 111.982 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.1 m -150.73 166.66 2.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.145 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 44.9 ttt180 -88.93 148.37 23.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.841 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -147.62 166.05 28.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.323 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 60.8 mtp180 -148.01 146.99 29.14 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.28 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.541 ' CE1' ' SD ' ' A' ' 22' ' ' MET . 53.3 m-85 -133.84 117.46 16.87 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.793 -179.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -84.73 -26.32 27.72 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.104 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.1 tttm -85.08 -11.03 56.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.217 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 61.73 168.67 0.66 Allowed Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.402 ' CB ' ' CD ' ' A' ' 76' ' ' PRO . 0.6 OUTLIER -100.04 174.98 2.62 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 179.877 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.402 ' CD ' ' CB ' ' A' ' 75' ' ' LEU . 3.3 Cg_exo -73.63 171.15 18.37 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.665 2.243 . . . . 0.0 111.695 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -49.94 110.76 0.92 Allowed Glycine 0 CA--C 1.526 0.765 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 47.66 95.07 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.864 0.364 . . . . 0.0 110.911 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -130.16 22.29 5.26 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.025 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.465 ' N ' ' CD2' ' A' ' 80' ' ' LEU . 4.0 mm? -76.03 92.6 3.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.759 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 153.32 -16.19 0.67 Allowed Glycine 0 CA--C 1.528 0.894 0 C-N-CA 120.999 -0.62 . . . . 0.0 111.974 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -72.68 139.05 47.03 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 117.272 0.536 . . . . 0.0 110.118 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -69.4 137.29 52.65 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 29.3 m -91.47 158.64 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 -148.2 153.5 38.85 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.194 0.521 . . . . 0.0 110.961 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.9 mp -109.4 73.49 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.412 ' O ' ' CB ' ' A' ' 44' ' ' LEU . 1.5 t . . . . . 0 CA--C 1.528 0.132 0 C-N-CA 120.018 -0.673 . . . . 0.0 111.03 -178.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 30.0 mtt . . . . . 0 N--CA 1.492 1.657 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 4.5 ptt-85 -101.73 175.32 5.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.921 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -145.98 -177.69 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.902 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 11.9 ptpt -146.96 107.17 4.02 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.131 0.491 . . . . 0.0 111.311 -178.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -98.61 -176.55 32.57 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 179.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.8 t -140.16 139.12 36.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-O 121.044 0.449 . . . . 0.0 110.348 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.6 t -78.5 154.59 5.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.265 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 56.3 mt -125.24 -44.39 1.88 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.31 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -165.14 126.97 2.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.841 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -102.38 122.37 44.14 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.814 179.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 12.5 ttm-85 -88.0 108.69 19.34 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.912 -179.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.451 ' O ' ' N ' ' A' ' 14' ' ' LYS . 53.3 ttt180 -91.66 59.31 3.72 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.507 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.493 ' OG ' ' N ' ' A' ' 14' ' ' LYS . 0.1 OUTLIER 56.09 -82.74 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.077 179.838 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.493 ' N ' ' OG ' ' A' ' 13' ' ' SER . 20.8 mtmt 63.22 -170.84 0.18 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.515 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.472 ' CD ' ' H ' ' A' ' 15' ' ' GLU . 1.3 pm0 -55.34 -179.49 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.608 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 47.35 92.86 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.912 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 -37.91 133.0 0.9 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.936 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 -176.41 11.13 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.374 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.496 ' ND2' ' HE ' ' A' ' 70' ' ' ARG . 0.4 OUTLIER 53.7 171.29 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.98 -179.202 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.405 ' N ' HD21 ' A' ' 19' ' ' ASN . 10.8 p-10 -80.6 113.18 18.62 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.314 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 18.8 t -107.46 168.49 3.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.032 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.44 ' SD ' ' CD1' ' A' ' 71' ' ' PHE . 9.6 ttt -147.55 121.91 9.65 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.681 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 91.9 mt -96.13 129.83 45.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.405 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.449 ' CG2' ' N ' ' A' ' 25' ' ' LYS . 96.8 mt -132.86 160.14 42.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.024 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.521 ' O ' ' N ' ' A' ' 27' ' ' LEU . 60.1 tttt -138.12 96.37 10.19 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.326 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -59.57 72.41 0.06 OUTLIER 'Trans proline' 0 N--CA 1.489 1.252 0 C-N-CA 122.291 1.994 . . . . 0.0 111.464 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.521 ' N ' ' O ' ' A' ' 25' ' ' LYS . 14.1 tp 51.99 -116.33 1.01 Allowed 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.353 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.498 ' CG ' ' H ' ' A' ' 29' ' ' VAL . 6.4 p-10 -74.0 -92.78 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.47 -179.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.498 ' H ' ' CG ' ' A' ' 28' ' ' ASP . 53.8 t 56.07 54.74 0.33 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.194 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -178.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -92.29 47.4 1.32 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.038 -178.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.7 t -158.3 123.6 4.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.11 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.445 ' HE ' ' HB ' ' A' ' 63' ' ' THR . 27.8 ttm180 -56.55 -31.75 64.49 Favored 'General case' 0 C--O 1.222 -0.382 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.132 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -61.82 -52.22 65.04 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.998 179.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.2 tp10 -65.64 -51.59 58.35 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -55.59 -48.48 74.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.532 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.441 ' CB ' ' O ' ' A' ' 32' ' ' ARG . 93.4 p -62.34 -33.64 75.09 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.793 178.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 43.9 tttm -66.63 -61.23 2.08 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.118 -177.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.415 ' N ' HD22 ' A' ' 38' ' ' LEU . 0.8 OUTLIER -77.88 5.76 9.01 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.756 -0.377 . . . . 0.0 111.235 -178.758 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.505 ' CG2' ' O ' ' A' ' 39' ' ' ILE . 12.9 tt -53.22 113.94 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 178.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 102.07 15.72 25.29 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 111.538 -0.625 . . . . 0.0 111.538 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.9 tpt180 -69.63 155.79 39.95 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 24.7 tp -84.55 105.59 15.48 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.869 0.366 . . . . 0.0 110.724 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.2 m -87.37 109.39 19.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.532 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.427 ' CD2' ' C ' ' A' ' 44' ' ' LEU . 5.0 tt -108.37 97.15 6.87 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.238 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 10.6 t90 -99.0 117.61 33.9 Favored 'General case' 0 C--O 1.237 0.406 0 O-C-N 124.824 1.328 . . . . 0.0 110.707 -179.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 43.6 tttp -85.87 100.75 12.29 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.447 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.424 ' CB ' ' CD ' ' A' ' 48' ' ' PRO . 0.1 OUTLIER -64.9 178.43 0.49 Allowed Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.819 179.877 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.5 ' C ' ' H ' ' A' ' 50' ' ' GLY . 3.1 Cg_exo -74.93 -53.07 0.1 Allowed 'Trans proline' 0 N--CA 1.495 1.561 0 C-N-CA 122.823 2.349 . . . . 0.0 112.934 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.515 ' C ' ' H ' ' A' ' 51' ' ' LYS . 74.5 m -69.01 39.97 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.536 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.5 ' H ' ' C ' ' A' ' 48' ' ' PRO . . . 55.23 2.64 0.26 Allowed Glycine 0 CA--C 1.526 0.777 0 N-CA-C 111.958 -0.457 . . . . 0.0 111.958 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.515 ' H ' ' C ' ' A' ' 49' ' ' SER . 3.7 ttpt -74.76 100.67 4.08 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.905 0.383 . . . . 0.0 110.399 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 18.1 mm -84.65 108.21 16.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.625 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.7 mt -105.81 143.26 34.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.552 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.05 116.72 5.84 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.394 -178.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -113.8 -153.95 11.15 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 179.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt -151.51 136.75 17.54 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 121.024 0.44 . . . . 0.0 110.849 179.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 45.8 mt -65.33 140.32 19.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.0 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -106.09 -45.14 8.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.831 -179.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 44.5 mtp85 -149.23 159.49 44.21 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.794 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.1 p -93.06 117.21 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.039 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 37.8 t60 -102.59 121.19 41.89 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.428 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.75 10.28 50.32 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 111.556 -0.617 . . . . 0.0 111.556 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.573 ' HG1' ' H ' ' A' ' 64' ' ' LYS . 81.3 p 51.55 -88.11 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.573 ' H ' ' HG1' ' A' ' 63' ' ' THR . 51.4 mttt -90.18 51.74 2.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.12 -179.268 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -156.97 -126.06 0.9 Allowed Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.43 -0.891 . . . . 0.0 112.277 -179.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.71 -177.89 1.06 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 113.859 -1.17 . . . . 0.0 112.237 -178.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.8 m -147.19 153.59 12.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.802 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 27.6 ttm180 -87.85 157.13 19.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.765 0.317 . . . . 0.0 110.985 -179.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -151.04 166.23 31.37 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.035 179.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.496 ' HE ' ' ND2' ' A' ' 19' ' ' ASN . 13.9 ttt180 -149.37 116.85 6.14 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.76 0.314 . . . . 0.0 110.692 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.44 ' CD1' ' SD ' ' A' ' 22' ' ' MET . 34.4 m-85 -100.43 117.88 35.51 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.088 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -80.13 -19.95 46.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.804 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 35.3 mttt -81.55 -77.72 0.21 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.981 0.42 . . . . 0.0 110.947 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 140.92 169.74 11.87 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 -179.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.427 ' C ' ' H ' ' A' ' 77' ' ' GLY . 0.7 OUTLIER -97.02 175.57 2.55 Favored Pre-proline 0 C--N 1.33 -0.241 0 N-CA-C 110.272 -0.269 . . . . 0.0 110.272 -179.81 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.443 ' HA ' ' HZ1' ' A' ' 51' ' ' LYS . 2.9 Cg_endo -77.39 19.32 0.73 Allowed 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.99 2.46 . . . . 0.0 111.376 179.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.427 ' H ' ' C ' ' A' ' 75' ' ' LEU . . . 97.67 -100.55 2.41 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 -179.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -90.67 106.71 18.69 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.817 0.341 . . . . 0.0 110.2 179.397 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -163.1 23.8 0.09 Allowed 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.149 0.499 . . . . 0.0 110.085 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.1 tp -70.53 95.22 1.05 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.563 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 139.1 -1.76 2.53 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.807 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -71.28 136.99 48.2 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -69.13 129.61 40.35 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.4 m -91.29 162.58 2.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -148.95 161.89 40.99 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.334 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.2 mm -107.97 72.46 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.417 ' O ' ' CB ' ' A' ' 44' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.462 0.154 0 C-N-CA 119.945 -0.702 . . . . 0.0 111.293 -178.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.6 mtt . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 22.6 ptt180 -105.56 170.14 8.06 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.978 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.477 HG22 ' H ' ' A' ' 4' ' ' LYS . 1.1 mt -144.41 179.41 1.36 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.852 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.477 ' H ' HG22 ' A' ' 3' ' ' ILE . 0.0 OUTLIER -144.24 103.81 4.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.363 0.601 . . . . 0.0 110.382 -179.528 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.402 ' HA2' ' H ' ' A' ' 27' ' ' LEU . . . -90.71 -179.09 43.54 Favored Glycine 0 CA--C 1.522 0.527 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.268 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.1 t -145.59 137.14 19.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.919 0.39 . . . . 0.0 109.987 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 74.3 t -74.72 140.37 17.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.69 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 43.1 mt -107.52 -45.42 4.06 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.687 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.2 p -162.84 125.92 2.81 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.92 0.391 . . . . 0.0 111.082 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -101.49 97.65 8.08 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.306 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 17.7 ttm180 -89.17 142.87 27.27 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.348 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -104.57 61.11 0.71 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.878 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.538 ' HG ' ' H ' ' A' ' 18' ' ' HIS . 23.0 t 36.65 60.18 0.95 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.503 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 30.3 mmtt -38.78 -80.09 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.958 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -66.1 -88.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -163.89 102.69 0.89 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.253 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.46 ' HG3' HH22 ' A' ' 70' ' ' ARG . 9.1 tp60 -124.18 -38.7 2.42 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.451 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.538 ' H ' ' HG ' ' A' ' 13' ' ' SER . 1.3 t-160 -169.69 -59.25 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.596 HD21 ' N ' ' A' ' 20' ' ' ASN . 0.2 OUTLIER 166.72 -32.59 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 114.964 -1.017 . . . . 0.0 110.401 178.364 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.596 ' N ' HD21 ' A' ' 19' ' ' ASN . 57.3 m-80 -159.0 116.42 2.78 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.493 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 98.6 t -106.74 154.78 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.05 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.404 ' SD ' ' CE1' ' A' ' 71' ' ' PHE . 41.9 ttm -145.39 115.85 7.6 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.717 0.294 . . . . 0.0 110.506 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 6.4 mt -96.07 129.42 46.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.435 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.489 ' CG2' ' N ' ' A' ' 25' ' ' LYS . 83.0 mt -133.56 162.61 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.547 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.489 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 45.1 tttm -142.51 105.25 5.46 Favored Pre-proline 0 CA--C 1.531 0.224 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.804 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -61.44 87.54 0.09 OUTLIER 'Trans proline' 0 C--N 1.313 -1.327 0 C-N-CA 122.315 2.01 . . . . 0.0 112.276 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.402 ' H ' ' HA2' ' A' ' 5' ' ' GLY . 2.7 tp 36.32 -133.82 0.07 Allowed 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.377 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.471 ' O ' ' C ' ' A' ' 29' ' ' VAL . 1.3 p-10 -44.04 -92.73 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 111.593 0.22 . . . . 0.0 111.593 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.488 ' O ' ' CG1' ' A' ' 29' ' ' VAL . 55.1 t 41.1 43.64 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 -178.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.667 ' ND2' ' H ' ' A' ' 30' ' ' ASN . 0.0 OUTLIER -82.6 41.69 0.73 Allowed 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 113.819 -1.537 . . . . 0.0 110.58 -178.014 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.3 p -158.87 126.89 5.1 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.907 178.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 35.9 ttt180 -59.15 -25.72 64.14 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -63.19 -54.18 41.56 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.456 178.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -66.16 -43.32 87.31 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.977 179.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -59.95 -60.69 3.42 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.301 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 27.7 t -52.31 -22.52 4.61 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.654 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.9 tptt -69.97 -64.74 0.83 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.094 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.481 ' O ' ' HG ' ' A' ' 38' ' ' LEU . 0.5 OUTLIER -79.59 13.34 2.08 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.307 -179.058 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.414 HD11 ' H ' ' A' ' 60' ' ' VAL . 18.5 tt -48.52 -19.88 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.341 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -108.25 18.22 33.55 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 121.154 -0.546 . . . . 0.0 111.994 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.438 ' HA ' ' NE ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -71.09 172.57 8.92 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 117.2 0.5 . . . . 0.0 110.547 179.777 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.434 ' H ' ' HD3' ' A' ' 41' ' ' ARG . 5.0 tp -118.87 121.63 40.44 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.5 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.454 ' CG2' ' O ' ' A' ' 43' ' ' VAL . 6.4 m -88.03 110.43 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.1 tp -105.55 102.86 12.29 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 4.7 t90 -83.32 105.15 14.04 Favored 'General case' 0 C--O 1.235 0.332 0 O-C-N 125.135 1.522 . . . . 0.0 110.302 -178.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 54.2 tttp -84.5 88.43 7.3 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.729 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.477 ' OG ' ' N ' ' A' ' 51' ' ' LYS . 11.5 p -64.04 171.95 2.21 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.79 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.436 ' C ' ' H ' ' A' ' 50' ' ' GLY . 3.0 Cg_endo -77.0 -48.34 0.12 Allowed 'Trans proline' 0 N--CA 1.491 1.351 0 C-N-CA 123.031 2.488 . . . . 0.0 112.759 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 10.5 p -69.66 5.07 1.57 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.972 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.436 ' H ' ' C ' ' A' ' 48' ' ' PRO . . . 87.61 5.66 78.17 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.318 -0.713 . . . . 0.0 111.318 179.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.477 ' N ' ' OG ' ' A' ' 47' ' ' SER . 1.1 tmtm? -72.64 94.26 1.71 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.916 0.388 . . . . 0.0 109.965 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 12.1 mm -83.08 112.55 20.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.917 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 60.0 mt -98.1 126.21 43.45 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.18 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 60.8 mttt -96.41 104.75 16.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.917 -179.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -103.44 168.12 17.26 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 178.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -152.74 130.15 11.36 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 117.193 0.496 . . . . 0.0 111.261 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 71.5 mt -71.42 134.06 30.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.52 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -106.1 -28.78 2.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.398 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.1 ptp180 -164.89 154.47 13.22 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 120.63 -0.428 . . . . 0.0 112.018 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.42 ' O ' ' CG1' ' A' ' 60' ' ' VAL . 9.5 p -97.71 116.44 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.417 178.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 13.0 t60 -142.06 115.08 8.73 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 120.126 -0.63 . . . . 0.0 112.054 -179.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.414 ' O ' ' OG1' ' A' ' 63' ' ' THR . . . 147.19 -14.33 1.47 Allowed Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.646 -0.582 . . . . 0.0 111.646 179.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.615 ' C ' ' H ' ' A' ' 65' ' ' GLY . 12.5 p 55.95 156.41 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 122.613 0.365 . . . . 0.0 110.769 -179.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.425 ' HB3' ' HZ3' ' A' ' 64' ' ' LYS . 0.5 OUTLIER 68.98 -21.05 0.15 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.985 0.421 . . . . 0.0 109.926 -178.194 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.615 ' H ' ' C ' ' A' ' 63' ' ' THR . . . 141.41 122.45 1.83 Allowed Glycine 0 CA--C 1.52 0.37 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 179.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 176.38 147.57 0.1 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.5 m -156.6 137.16 4.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.933 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 21.6 ttm-85 -89.02 154.51 20.15 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -145.07 161.06 40.36 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.051 0.453 . . . . 0.0 110.866 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.46 HH22 ' HG3' ' A' ' 17' ' ' GLN . 78.4 mtt-85 -146.45 116.7 7.42 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.171 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.49 ' C ' ' H ' ' A' ' 73' ' ' LYS . 17.2 m-85 -95.89 135.46 37.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.57 -179.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 82.6 mt-10 -61.07 -1.64 0.48 Allowed 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.476 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.49 ' H ' ' C ' ' A' ' 71' ' ' PHE . 5.8 tmtm? -156.28 -65.19 0.11 Allowed 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.642 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 134.86 -171.61 22.32 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.3 mt -92.06 171.05 8.27 Favored Pre-proline 0 C--N 1.327 -0.392 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -75.3 114.37 3.98 Favored 'Trans proline' 0 C--N 1.313 -1.335 0 C-N-CA 122.655 2.237 . . . . 0.0 112.064 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 75.97 -65.23 2.62 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.474 HE21 ' CA ' ' A' ' 78' ' ' GLN . 0.0 OUTLIER -169.01 -69.25 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.645 0.259 . . . . 0.0 110.594 179.472 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 64.13 24.23 13.4 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.969 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.5 tt -60.58 104.08 0.31 Allowed 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.575 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 110.5 5.71 27.74 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 111.652 -0.579 . . . . 0.0 111.652 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -73.98 144.09 45.35 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.726 0.263 . . . . 0.0 110.3 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -69.88 113.49 7.16 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 30.2 m -90.87 169.68 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -150.0 156.4 41.64 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.272 0.558 . . . . 0.0 110.985 -178.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 9.7 mt -105.76 72.74 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 177.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.338 0.1 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.918 -178.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.6 mtt . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 22.9 mtm-85 -115.74 161.2 19.06 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.968 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.4 mt -147.76 145.3 18.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.079 0.466 . . . . 0.0 111.055 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.3 mmmm -90.07 178.59 6.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.282 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 84' ' ' VAL . . . -173.75 173.64 45.91 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.0 t -148.98 137.01 14.38 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 CA-C-O 120.914 0.388 . . . . 0.0 110.705 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 91.4 t -80.4 148.32 5.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.158 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 49.4 mt -106.41 -44.45 4.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.249 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.9 m -168.53 137.08 2.21 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.603 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -94.67 115.37 27.46 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.333 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.487 ' O ' ' N ' ' A' ' 21' ' ' VAL . 89.2 mtt180 -91.19 97.52 11.18 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.921 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 64.8 ttt180 -83.18 59.0 4.73 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.985 0.421 . . . . 0.0 110.436 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.457 ' OG ' ' N ' ' A' ' 14' ' ' LYS . 30.5 t -178.48 -124.27 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.132 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.467 ' O ' ' N ' ' A' ' 16' ' ' ASN . 16.0 tttm 66.98 0.42 1.97 Allowed 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.254 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.465 ' C ' ' ND2' ' A' ' 16' ' ' ASN . 7.2 mt-10 63.08 -73.23 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.627 -0.261 . . . . 0.0 110.662 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.467 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.0 OUTLIER 39.19 -109.71 0.09 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.562 179.484 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.5 ' O ' ' CD2' ' A' ' 18' ' ' HIS . 0.0 OUTLIER -151.79 36.33 0.56 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.993 0.425 . . . . 0.0 110.117 -179.766 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.5 ' CD2' ' O ' ' A' ' 17' ' ' GLN . 34.9 m-70 -163.85 -9.48 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 66.91 9.67 7.02 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.839 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -157.75 109.44 2.31 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.822 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.523 ' CG1' ' N ' ' A' ' 22' ' ' MET . 53.0 t -109.27 167.1 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.318 179.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.523 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 2.6 ptp -147.03 135.99 22.33 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.917 0.389 . . . . 0.0 110.848 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.432 HG21 HD12 ' A' ' 23' ' ' ILE . 87.0 mt -94.89 156.84 3.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.195 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.451 ' CG2' ' N ' ' A' ' 25' ' ' LYS . 23.5 mt -143.51 158.14 16.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.68 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.451 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 49.4 tttm -140.69 101.49 6.55 Favored Pre-proline 0 C--O 1.235 0.308 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.195 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -58.89 144.96 98.54 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 121.706 1.604 . . . . 0.0 110.466 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.8 tp -34.05 -82.91 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -178.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.513 ' CG ' ' H ' ' A' ' 29' ' ' VAL . 3.6 p-10 -87.09 -86.84 0.15 Allowed 'General case' 0 CA--C 1.521 -0.163 0 C-N-CA 120.251 -0.58 . . . . 0.0 110.259 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.513 ' H ' ' CG ' ' A' ' 28' ' ' ASP . 41.2 t 41.42 56.68 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.14 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -179.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -91.98 33.82 1.04 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.365 -1.289 . . . . 0.0 111.513 -177.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 24.4 m -159.48 131.03 6.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.759 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.8 ttp180 -57.81 -26.6 62.2 Favored 'General case' 0 CA--C 1.521 -0.14 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -61.58 -37.38 83.65 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.325 178.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -87.82 -39.07 15.16 Favored 'General case' 0 CA--C 1.527 0.087 0 CA-C-N 115.63 -0.713 . . . . 0.0 109.611 178.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.425 ' O ' ' CD2' ' A' ' 38' ' ' LEU . . . -61.21 -58.38 8.57 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 41.9 t -55.48 -23.3 25.01 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.732 178.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.1 tttm -68.83 -58.01 4.78 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.619 -179.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.425 ' CD2' ' O ' ' A' ' 35' ' ' ALA . 0.5 OUTLIER -80.19 8.89 6.39 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.231 -178.828 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.472 HG21 HD12 ' A' ' 39' ' ' ILE . 0.1 OUTLIER -45.59 -41.12 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.368 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.459 ' N ' ' CG2' ' A' ' 39' ' ' ILE . . . -103.42 96.33 1.32 Allowed Glycine 0 CA--C 1.521 0.463 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 178.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 11.5 ttm180 -167.62 150.3 5.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.024 0.44 . . . . 0.0 110.382 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.0 tp -88.07 123.08 32.39 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.5 -178.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.6 m -93.83 109.76 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.444 ' O ' HG22 ' A' ' 87' ' ' VAL . 6.0 mp -105.93 102.68 12.09 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 116.348 -0.387 . . . . 0.0 109.959 -179.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.609 ' HE1' ' CG ' ' A' ' 82' ' ' ASP . 34.7 t90 -91.56 123.42 34.95 Favored 'General case' 0 C--O 1.236 0.384 0 O-C-N 124.749 1.281 . . . . 0.0 110.761 -179.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 9.3 tttm -85.32 90.29 7.88 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.682 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.5 p -61.59 171.87 1.22 Allowed Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.753 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -77.5 -33.19 2.53 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 122.823 2.349 . . . . 0.0 112.166 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.403 ' C ' ' H ' ' A' ' 51' ' ' LYS . 18.7 m -85.55 28.56 0.75 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.759 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 63.23 2.71 5.61 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.403 ' H ' ' C ' ' A' ' 49' ' ' SER . 71.4 tttt -74.73 92.38 2.47 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.072 0.463 . . . . 0.0 110.161 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.7 mm -82.49 111.6 19.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.011 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 45.1 mt -101.61 123.23 45.28 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.208 0.528 . . . . 0.0 111.489 -179.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 16.4 mttt -94.04 100.72 12.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.798 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -100.55 -172.46 29.43 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.544 -1.022 . . . . 0.0 110.544 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 39.7 tttp -155.09 138.85 16.17 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 120.428 -0.509 . . . . 0.0 111.57 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.7 mt -75.04 134.8 28.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.511 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.444 HG22 ' H ' ' A' ' 59' ' ' ARG . 0.8 OUTLIER -98.3 -50.92 10.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.855 -179.562 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.444 ' H ' HG22 ' A' ' 58' ' ' VAL . 16.0 mtp180 -153.05 153.98 33.96 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.878 0.371 . . . . 0.0 110.822 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.421 HG22 ' H ' ' A' ' 61' ' ' HIS . 3.4 p -71.89 157.81 6.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.085 179.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.442 ' C ' ' H ' ' A' ' 63' ' ' THR . 12.0 t-160 -140.43 135.29 31.88 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.019 0.438 . . . . 0.0 110.825 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.429 ' O ' ' O ' ' A' ' 63' ' ' THR . . . 74.36 -15.51 3.45 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 111.487 -0.645 . . . . 0.0 111.487 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.442 ' H ' ' C ' ' A' ' 61' ' ' HIS . 81.4 p 56.35 142.47 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.021 0.438 . . . . 0.0 111.225 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.514 ' CG ' ' O ' ' A' ' 64' ' ' LYS . 16.5 ttpp 57.59 17.85 4.25 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.269 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -149.9 -126.39 1.42 Allowed Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.032 -178.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.7 -178.43 1.17 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.357 -0.922 . . . . 0.0 111.963 -178.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.6 m -154.33 163.89 1.63 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.158 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.364 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 56.4 ttt180 -89.51 153.95 20.39 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 178.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -149.29 156.48 42.17 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.349 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 -149.25 121.88 8.6 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.307 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.475 ' H ' ' HE1' ' A' ' 22' ' ' MET . 6.9 m-85 -97.34 106.4 18.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.9 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -48.76 -26.04 2.15 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.609 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 53.0 mttt -81.59 -78.28 0.19 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.478 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 131.47 139.33 4.37 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -94.99 150.07 37.19 Favored Pre-proline 0 C--O 1.233 0.216 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -53.61 -81.06 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 122.409 2.073 . . . . 0.0 111.857 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 171.99 0.89 0.03 OUTLIER Glycine 0 CA--C 1.527 0.795 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.23 -22.44 16.7 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.783 0.325 . . . . 0.0 110.671 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -83.88 39.68 0.71 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.938 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.2 tp -72.79 -23.69 60.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.501 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -137.53 14.94 3.66 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 121.037 -0.602 . . . . 0.0 111.94 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.609 ' CG ' ' HE1' ' A' ' 45' ' ' TRP . 19.4 t0 -72.18 143.12 49.01 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -69.26 134.04 48.68 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.308 -0.405 . . . . 0.0 109.937 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.45 ' O ' ' N ' ' A' ' 5' ' ' GLY . 33.1 m -97.57 155.99 3.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.403 ' HG3' ' O ' ' A' ' 84' ' ' VAL . 16.1 mp0 -148.26 154.49 40.11 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.08 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.1 mp -100.57 72.41 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.444 HG22 ' O ' ' A' ' 44' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--O 1.227 -0.081 0 C-N-CA 119.982 -0.687 . . . . 0.0 110.238 -179.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.6 mmt . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 15.2 ptt180 -83.74 165.51 18.81 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.443 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.7 mp -100.78 163.87 2.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.184 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 9.9 ptpt -150.71 110.48 4.06 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 121.343 0.592 . . . . 0.0 111.874 -179.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.411 ' CA ' HG23 ' A' ' 84' ' ' VAL . . . -99.0 -176.13 31.96 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 178.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 24.5 t -142.05 134.37 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-O 120.991 0.424 . . . . 0.0 111.001 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 43.1 t -80.29 148.88 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 115.602 -0.727 . . . . 0.0 109.875 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -125.77 -23.16 4.06 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 121.062 -0.255 . . . . 0.0 111.402 -179.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.3 t -166.05 148.04 7.02 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.204 0.526 . . . . 0.0 111.995 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -107.43 163.87 12.68 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.155 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 7.2 ttp180 -152.23 111.04 3.81 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.033 0.444 . . . . 0.0 110.529 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -77.02 59.61 1.7 Allowed 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.265 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 66.22 171.7 0.24 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.469 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 15.0 tttm -170.54 49.83 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.413 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -163.64 -61.85 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.22 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.401 ' O ' ' C ' ' A' ' 17' ' ' GLN . 19.7 m120 -155.9 -164.95 1.83 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.031 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.401 ' C ' ' O ' ' A' ' 16' ' ' ASN . 16.7 mm100 35.83 -110.76 0.06 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.91 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 14.0 t60 -173.39 25.49 0.01 OUTLIER 'General case' 0 C--O 1.234 0.247 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -39.38 121.65 1.2 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.509 -178.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.473 ' N ' ' ND2' ' A' ' 20' ' ' ASN . 0.1 OUTLIER -81.1 103.31 10.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.328 -179.764 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.3 t -108.99 146.2 14.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.307 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -150.63 148.32 28.48 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.043 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.4 mm -92.21 140.9 15.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.044 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.403 HD11 HG22 ' A' ' 24' ' ' ILE . 96.5 mt -130.97 155.2 41.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.744 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.92 100.42 9.8 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.847 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.546 ' O ' ' N ' ' A' ' 28' ' ' ASP . 3.4 Cg_exo -66.02 82.81 0.26 Allowed 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 122.451 2.101 . . . . 0.0 111.352 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.4 tp 33.04 -82.95 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.801 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.546 ' N ' ' O ' ' A' ' 26' ' ' PRO . 10.5 p30 -98.4 -87.27 0.34 Allowed 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.58 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.483 ' O ' ' CG1' ' A' ' 29' ' ' VAL . 43.5 t 43.02 57.55 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.238 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -178.009 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -91.81 42.01 1.09 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.584 -1.189 . . . . 0.0 110.74 -178.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.4 m -158.25 124.8 4.78 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.565 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.447 ' N ' ' HB3' ' A' ' 64' ' ' LYS . 0.6 OUTLIER -59.31 -26.7 65.22 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.315 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 65.6 mm-40 -60.88 -49.46 77.36 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.486 179.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -73.54 -45.71 51.98 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.211 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.26 -60.62 3.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.198 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.2 t -55.26 -38.73 68.91 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.837 179.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.1 mtpt -69.13 -20.56 64.05 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.927 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.505 ' O ' ' HG ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -85.99 -16.29 38.76 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.586 -179.624 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 68.4 mt -52.38 121.24 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-O 120.842 0.354 . . . . 0.0 110.441 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 111.75 -6.56 27.76 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.6 mmm-85 -69.96 156.83 38.54 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.823 0.344 . . . . 0.0 110.54 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.0 tp -101.92 122.56 44.25 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.771 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.7 m -92.03 106.52 17.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.712 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.435 ' CB ' ' O ' ' A' ' 87' ' ' VAL . 6.2 tt -102.61 103.36 13.65 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.402 -179.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.427 ' CZ3' ' HB2' ' A' ' 47' ' ' SER . 80.1 t90 -95.64 105.49 17.49 Favored 'General case' 0 CA--C 1.53 0.205 0 O-C-N 124.91 1.381 . . . . 0.0 109.295 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.5 ttmt -81.76 102.05 10.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.223 -178.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.446 ' HB3' ' H ' ' A' ' 51' ' ' LYS . 10.1 t -62.38 141.86 96.31 Favored Pre-proline 0 C--N 1.332 -0.161 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.881 179.081 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -49.01 91.56 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 122.456 2.104 . . . . 0.0 111.898 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 56.2 p 38.69 60.86 1.3 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.172 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -140.36 -63.86 0.03 OUTLIER Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.446 ' H ' ' HB3' ' A' ' 47' ' ' SER . 9.9 ttmt -165.48 126.17 1.89 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.737 0.304 . . . . 0.0 110.23 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.3 mp -82.39 107.25 14.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.216 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 64.8 mt -93.95 152.18 19.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.683 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 6.3 pttt -152.3 104.18 2.92 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 120.913 0.387 . . . . 0.0 111.758 -178.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -90.29 -158.52 34.61 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.004 -1.239 . . . . 0.0 110.004 178.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 48.4 tttp -151.87 129.29 11.35 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.981 0.42 . . . . 0.0 111.009 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 32.1 mt -66.04 140.22 19.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.819 179.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -102.71 -47.86 10.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.209 -179.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.56 163.08 35.4 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.2 0.524 . . . . 0.0 111.333 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.2 p -78.9 154.74 4.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.514 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.425 ' HD1' ' H ' ' A' ' 62' ' ' GLY . 1.4 t60 -140.52 130.03 24.05 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.599 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.425 ' H ' ' HD1' ' A' ' 61' ' ' HIS . . . 83.21 -7.62 66.84 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.482 -0.647 . . . . 0.0 111.482 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.428 ' O ' ' CG ' ' A' ' 64' ' ' LYS . 38.4 p 58.67 138.57 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.892 0.377 . . . . 0.0 111.241 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.447 ' HB3' ' N ' ' A' ' 32' ' ' ARG . 5.2 ptmm? 43.99 32.17 0.6 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.053 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -149.76 -125.05 1.32 Allowed Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 111.44 -0.664 . . . . 0.0 111.44 -178.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.73 179.61 1.36 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.528 -0.836 . . . . 0.0 111.862 -178.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 28.1 m -154.73 151.3 10.94 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.841 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.6 ttp180 -88.96 148.28 23.87 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.44 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -148.71 160.78 42.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.048 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 63.5 mtt180 -145.75 121.1 10.27 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.835 0.35 . . . . 0.0 110.704 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -97.04 113.47 25.02 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.04 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -68.38 -25.73 65.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.467 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 9.8 mmtm -84.05 -80.43 0.19 Allowed 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.741 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 127.5 153.67 8.26 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.5 mt -90.36 153.46 46.32 Favored Pre-proline 0 N--CA 1.464 0.267 0 CA-C-O 120.699 0.285 . . . . 0.0 110.964 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.433 ' O ' ' C ' ' A' ' 77' ' ' GLY . 3.0 Cg_endo -66.7 157.06 62.89 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.714 2.276 . . . . 0.0 112.306 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 76' ' ' PRO . . . 29.04 -96.46 0.01 OUTLIER Glycine 0 N--CA 1.466 0.672 0 O-C-N 123.77 0.668 . . . . 0.0 111.614 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 20.0 tp60 -156.05 103.42 2.21 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.832 0.349 . . . . 0.0 110.669 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -112.71 40.59 2.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.58 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.34 115.57 9.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.126 -179.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 108.6 -3.17 32.41 Favored Glycine 0 CA--C 1.525 0.685 0 CA-C-N 116.248 -0.433 . . . . 0.0 112.153 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -70.07 143.24 52.51 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -67.94 136.67 54.33 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.411 HG23 ' CA ' ' A' ' 5' ' ' GLY . 6.9 m -90.75 160.08 2.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -144.64 150.38 37.3 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.207 -178.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 29.5 mt -110.1 72.79 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 178.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.435 ' O ' ' CB ' ' A' ' 44' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.463 0.203 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.03 -179.161 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.0 ptm . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 16.1 mtm180 -102.25 156.51 17.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.727 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.7 mt -147.06 147.73 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.71 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 17.5 tptt -92.88 161.43 14.49 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.309 -0.859 . . . . 0.0 111.008 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -167.8 178.7 41.54 Favored Glycine 0 CA--C 1.528 0.886 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 179.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 30.7 t -149.31 136.03 12.79 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-O 121.126 0.489 . . . . 0.0 111.29 -178.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 47.8 t -74.21 148.35 8.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.118 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.7 mt -109.49 -60.84 1.72 Allowed 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.392 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.0 t -167.04 144.32 4.69 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.876 0.37 . . . . 0.0 111.162 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -95.91 118.55 32.76 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.335 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 40.1 mtt180 -88.47 139.34 30.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.822 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 8.5 ttm-85 -132.09 79.78 1.88 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.383 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 82.7 p -47.12 165.71 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.655 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 9.1 mmtp -120.95 -96.15 0.48 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.859 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -87.48 -10.71 51.05 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.744 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -76.35 114.27 14.85 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.379 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.452 ' O ' ' CG ' ' A' ' 18' ' ' HIS . 1.4 tp-100 -58.71 100.99 0.08 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.56 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.452 ' CG ' ' O ' ' A' ' 17' ' ' GLN . 8.3 m-70 -174.76 -12.11 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.634 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.402 ' H ' ' H ' ' A' ' 18' ' ' HIS . 51.9 t30 67.43 -178.02 0.21 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.19 -179.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -81.27 139.6 35.34 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.141 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.497 ' CG1' ' H ' ' A' ' 22' ' ' MET . 48.1 t -120.28 173.58 6.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.333 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.497 ' H ' ' CG1' ' A' ' 21' ' ' VAL . 23.9 ttt -147.45 131.57 17.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.141 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.8 mm -95.19 141.86 14.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.86 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.404 HG21 HD12 ' A' ' 24' ' ' ILE . 21.8 mt -139.95 154.31 23.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.678 179.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.428 ' O ' ' N ' ' A' ' 27' ' ' LEU . 68.0 tttt -138.2 100.63 8.6 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.731 -179.379 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.514 ' O ' ' N ' ' A' ' 28' ' ' ASP . 4.0 Cg_exo -64.41 70.9 0.22 Allowed 'Trans proline' 0 N--CA 1.488 1.168 0 C-N-CA 122.1 1.867 . . . . 0.0 111.749 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.428 ' N ' ' O ' ' A' ' 25' ' ' LYS . 15.0 tp 51.01 -79.98 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.77 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 26' ' ' PRO . 3.2 p30 -109.81 -87.17 0.52 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.662 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.469 ' O ' ' CG1' ' A' ' 29' ' ' VAL . 43.4 t 45.64 57.83 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -178.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -91.88 43.3 1.13 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.295 -1.321 . . . . 0.0 110.548 -178.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.9 t -157.85 120.92 3.92 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.643 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 39.7 ttt-85 -58.31 -27.76 64.41 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.507 179.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.0 tm-20 -60.32 -39.12 85.87 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -86.27 -46.95 9.85 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.282 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.01 -58.69 6.83 Favored 'General case' 0 CA--C 1.527 0.083 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.0 t -53.23 -24.59 11.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.712 178.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 9.6 ttpp -69.95 -60.22 2.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.761 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.426 ' O ' ' HG ' ' A' ' 38' ' ' LEU . 0.4 OUTLIER -78.2 8.07 5.43 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 120.915 0.388 . . . . 0.0 110.87 -179.105 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 14.1 tt -52.33 -12.36 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.725 179.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.425 ' H ' ' C ' ' A' ' 38' ' ' LEU . . . -117.16 4.72 18.21 Favored Glycine 0 CA--C 1.53 0.982 0 N-CA-C 111.87 -0.492 . . . . 0.0 111.87 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -71.01 155.28 41.02 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.976 0.417 . . . . 0.0 110.996 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.8 tt -98.55 130.79 45.12 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.634 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 20.7 m -94.42 121.75 45.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.451 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.41 ' CB ' ' O ' ' A' ' 87' ' ' VAL . 7.1 tt -120.69 100.79 7.32 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.374 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.432 ' CH2' ' HB2' ' A' ' 47' ' ' SER . 66.4 t90 -95.93 136.5 36.28 Favored 'General case' 0 C--N 1.349 0.569 0 O-C-N 125.225 1.578 . . . . 0.0 109.358 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.6 mtpt -81.87 165.28 20.95 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.921 -178.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.432 ' HB2' ' CH2' ' A' ' 45' ' ' TRP . 0.2 OUTLIER -173.47 79.77 0.39 Allowed Pre-proline 0 CA--C 1.533 0.313 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.577 179.633 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -73.62 152.65 48.43 Favored 'Trans proline' 0 N--CA 1.49 1.273 0 C-N-CA 123.061 2.507 . . . . 0.0 111.116 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 67.71 5.31 4.36 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.968 -179.087 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -137.17 -91.71 0.29 Allowed Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 29.6 ttpt -175.0 139.09 0.47 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.776 0.322 . . . . 0.0 111.155 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.411 HD11 HG23 ' A' ' 52' ' ' ILE . 22.7 mm -74.32 146.44 9.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 178.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 67.5 mt -138.19 119.35 14.53 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.269 0.557 . . . . 0.0 111.874 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.1 mptt -90.54 177.91 6.24 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.87 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -165.25 -176.95 37.3 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 178.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 55.4 tttt -154.66 129.62 9.47 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.765 0.317 . . . . 0.0 110.817 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 26.6 mt -72.67 130.2 35.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.641 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.5 m -102.66 -45.54 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.537 -0.302 . . . . 0.0 110.854 -179.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 22.1 mtt85 -144.42 158.97 43.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.859 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.7 p -87.39 156.17 3.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.143 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 74.5 t60 -140.84 117.7 11.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.151 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.08 5.62 63.86 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 -179.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.45 ' OG1' ' N ' ' A' ' 64' ' ' LYS . 32.4 p 58.69 -89.32 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 122.813 0.445 . . . . 0.0 111.513 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.45 ' N ' ' OG1' ' A' ' 63' ' ' THR . 15.4 pttm -90.84 55.51 2.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.835 0.35 . . . . 0.0 110.93 -179.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -159.58 -126.18 0.83 Allowed Glycine 0 N--CA 1.442 -0.952 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.22 -177.65 1.15 Allowed 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.454 -0.873 . . . . 0.0 111.757 -179.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.1 m -148.85 158.69 6.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.197 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 14.8 ttp180 -87.35 150.17 24.01 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-O 121.056 0.455 . . . . 0.0 111.072 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -148.32 159.72 43.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.814 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 24.1 mtm180 -148.34 122.99 9.84 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.847 0.356 . . . . 0.0 110.765 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -101.21 117.65 35.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.387 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -70.76 -24.48 62.61 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -82.68 -77.87 0.22 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.628 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 126.2 150.3 7.59 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 17.3 mt -98.16 148.14 34.08 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 120.505 0.193 . . . . 0.0 110.862 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -49.16 -179.26 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 122.877 2.385 . . . . 0.0 112.494 179.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.9 -4.52 11.07 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 121.201 -0.524 . . . . 0.0 111.907 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.573 ' C ' ' H ' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -135.01 -142.71 0.19 Allowed 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.295 179.734 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.522 ' H ' ' CD ' ' A' ' 78' ' ' GLN . . . 64.32 -10.12 0.15 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.562 -178.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.573 ' H ' ' C ' ' A' ' 78' ' ' GLN . 2.1 tt -66.64 99.34 0.58 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.279 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 125.97 3.11 7.04 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -72.21 175.99 5.59 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-O 121.095 0.474 . . . . 0.0 110.716 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -92.66 128.13 38.41 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 26.3 m -92.66 156.91 3.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.233 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -147.9 153.24 38.83 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.704 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.418 ' O ' ' CG2' ' A' ' 86' ' ' ILE . 1.8 mp -103.65 74.08 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.41 ' O ' ' CB ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.466 0.373 0 C-N-CA 118.966 -1.094 . . . . 0.0 110.79 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.4 ptp . . . . . 0 N--CA 1.492 1.645 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 34.4 mtm105 -110.53 171.2 7.6 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.052 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.461 HG23 ' H ' ' A' ' 4' ' ' LYS . 2.0 mt -145.15 168.9 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.487 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.461 ' H ' HG23 ' A' ' 3' ' ' ILE . 0.0 OUTLIER -152.39 120.59 6.28 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.262 0.553 . . . . 0.0 111.949 -179.499 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -107.07 -175.66 22.8 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.4 t -140.29 137.87 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-O 121.126 0.489 . . . . 0.0 110.57 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 72.3 t -71.07 144.88 13.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.841 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 14.8 mt -106.71 -52.6 2.75 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.391 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.6 t -166.15 154.64 10.9 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.182 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.489 ' O ' ' CG ' ' A' ' 10' ' ' TYR . 0.5 OUTLIER -99.46 126.84 45.46 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.004 0.43 . . . . 0.0 110.42 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.437 ' N ' ' O ' ' A' ' 21' ' ' VAL . 47.7 mtp180 -90.21 152.19 21.19 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.085 179.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 33.0 ttp180 -115.31 75.3 0.93 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.862 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.403 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 5.5 t -48.7 165.49 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.817 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.9 pttm -141.01 78.43 1.65 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.525 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -144.31 -55.83 0.36 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.786 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -80.15 -156.76 0.13 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.521 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.485 ' NE2' ' N ' ' A' ' 17' ' ' GLN . 0.1 OUTLIER -100.87 -7.2 23.74 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.708 -179.669 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.489 ' CG ' ' O ' ' A' ' 18' ' ' HIS . 86.3 t60 -156.93 21.41 0.32 Allowed 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.403 ' ND2' ' O ' ' A' ' 13' ' ' SER . 0.4 OUTLIER -40.7 148.92 0.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.149 -1.387 . . . . 0.0 111.772 -179.313 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -171.8 122.25 0.5 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 121.002 0.429 . . . . 0.0 110.95 179.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.443 ' CG1' ' N ' ' A' ' 22' ' ' MET . 72.9 t -116.27 164.26 12.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.884 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.443 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 21.2 ptm -151.65 138.4 18.86 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.833 0.349 . . . . 0.0 110.881 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 55.2 mt -92.08 139.56 17.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.122 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 77.5 mt -134.7 156.52 40.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.523 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -144.24 120.79 6.37 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.867 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -61.14 169.36 6.27 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 121.872 1.715 . . . . 0.0 111.503 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -49.55 -77.49 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.625 -0.262 . . . . 0.0 110.951 -179.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.521 ' CG ' ' H ' ' A' ' 29' ' ' VAL . 2.8 p-10 -94.51 -88.61 0.24 Allowed 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.521 -0.472 . . . . 0.0 111.107 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.521 ' H ' ' CG ' ' A' ' 28' ' ' ASP . 82.5 t 41.32 55.7 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.165 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 -178.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -88.51 40.62 0.97 Allowed 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 114.365 -1.289 . . . . 0.0 110.998 -177.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 68.7 m -158.84 128.11 5.54 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.862 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 47.4 ttp180 -61.25 -25.38 67.04 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -62.32 -52.01 65.37 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.602 178.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -69.57 -38.41 77.38 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.434 178.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -59.24 -60.66 3.51 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.003 179.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.7 t -55.92 -22.96 28.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.732 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 34.4 tttp -70.86 -61.66 1.68 Allowed 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.749 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.52 5.94 8.05 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.243 -178.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 8.1 tt -51.08 133.97 12.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.229 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.436 ' O ' ' NZ ' ' A' ' 56' ' ' LYS . . . 81.2 25.32 55.36 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.3 ptt180 -71.57 171.29 11.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.713 0.292 . . . . 0.0 110.367 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 23.5 tp -100.82 112.18 24.54 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.135 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.2 m -88.19 121.37 38.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.13 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.0 tt -123.49 98.41 5.83 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.73 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.486 ' CZ3' ' OG ' ' A' ' 47' ' ' SER . 75.8 t90 -100.73 109.92 21.98 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 125.089 1.493 . . . . 0.0 109.676 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 5.9 pttp -83.72 105.11 14.37 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 121.073 0.463 . . . . 0.0 111.41 -178.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.486 ' OG ' ' CZ3' ' A' ' 45' ' ' TRP . 0.9 OUTLIER -64.33 172.64 1.9 Allowed Pre-proline 0 CA--C 1.531 0.233 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.707 179.655 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.407 ' C ' ' H ' ' A' ' 50' ' ' GLY . 2.9 Cg_endo -76.0 -32.88 4.01 Favored 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 122.813 2.342 . . . . 0.0 112.449 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.443 ' C ' ' H ' ' A' ' 51' ' ' LYS . 38.0 p -78.72 21.54 0.4 Allowed 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.24 -179.366 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.407 ' H ' ' C ' ' A' ' 48' ' ' PRO . . . 70.19 -7.04 4.88 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.443 ' H ' ' C ' ' A' ' 49' ' ' SER . 27.7 tttp -73.24 100.5 3.13 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 23.2 mm -83.49 111.15 19.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.444 -178.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 71.4 mt -100.15 143.31 30.5 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.855 179.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.6 pttp -150.24 116.35 5.66 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 120.945 0.403 . . . . 0.0 110.95 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -104.09 -150.64 21.27 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.436 ' NZ ' ' O ' ' A' ' 40' ' ' GLY . 0.2 OUTLIER -154.26 130.42 10.35 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.782 0.325 . . . . 0.0 110.881 179.9 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 34.6 mt -65.13 147.89 12.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -107.01 -40.56 5.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 C-N-CA 120.596 -0.442 . . . . 0.0 111.491 -178.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -164.55 155.14 14.66 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 120.392 -0.523 . . . . 0.0 111.853 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.3 p -92.82 116.33 33.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.322 178.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -140.21 123.87 17.22 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.265 -178.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 136.24 -16.84 3.86 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 121.327 -0.463 . . . . 0.0 112.056 178.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.654 ' C ' ' H ' ' A' ' 65' ' ' GLY . 80.7 p 54.79 164.91 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.776 0.322 . . . . 0.0 111.025 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 38.2 tttp 67.1 -17.3 0.14 Allowed 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.148 0.499 . . . . 0.0 110.0 -178.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.654 ' H ' ' C ' ' A' ' 63' ' ' THR . . . 131.57 121.12 2.24 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 174.68 149.01 0.08 Allowed 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 8.7 m -157.13 139.15 5.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 120.253 -0.579 . . . . 0.0 111.404 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -90.97 146.63 23.71 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 178.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -146.35 160.1 42.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.229 0.537 . . . . 0.0 111.278 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 5.8 ttp180 -148.3 131.97 16.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.675 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.479 ' C ' ' H ' ' A' ' 73' ' ' LYS . 17.5 m-85 -92.87 141.81 28.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.991 0.424 . . . . 0.0 110.828 -179.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -62.35 -0.47 0.58 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.444 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.479 ' H ' ' C ' ' A' ' 71' ' ' PHE . 33.3 ttmt -154.88 -64.7 0.13 Allowed 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.629 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 142.53 -177.24 21.82 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.3 mt -95.48 165.76 16.07 Favored Pre-proline 0 CA--C 1.53 0.175 0 CA-C-O 120.705 0.288 . . . . 0.0 110.99 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -76.14 99.94 1.33 Allowed 'Trans proline' 0 N--CA 1.489 1.235 0 C-N-CA 122.971 2.447 . . . . 0.0 112.214 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 42.48 -113.06 0.54 Allowed Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.762 -0.535 . . . . 0.0 111.762 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.497 ' NE2' ' H ' ' A' ' 80' ' ' LEU . 0.8 OUTLIER -81.8 116.05 21.3 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.77 0.319 . . . . 0.0 110.787 -179.746 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -154.4 8.14 0.32 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.322 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.497 ' H ' ' NE2' ' A' ' 78' ' ' GLN . 5.5 tp -68.56 117.04 9.8 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.768 0.318 . . . . 0.0 110.491 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 118.5 -10.92 12.64 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.408 ' HB3' ' HE1' ' A' ' 45' ' ' TRP . 2.1 m-20 -68.36 131.08 44.7 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -67.55 135.78 53.51 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.4 m -90.78 163.21 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.509 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 52.0 mp0 -148.14 145.11 28.22 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.5 mp -101.06 73.3 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.463 0.219 0 C-N-CA 119.749 -0.78 . . . . 0.0 110.67 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.2 mmm . . . . . 0 N--CA 1.488 1.443 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 17.3 ptt85 -96.43 170.02 9.51 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.4 mt -148.4 144.88 18.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.266 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 52.0 mttt -83.17 173.45 11.66 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.646 -179.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 84' ' ' VAL . . . -171.47 174.66 45.05 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 22.0 t -149.15 143.97 18.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.262 0.553 . . . . 0.0 111.236 -178.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 75.7 t -79.88 147.46 6.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.972 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 13.4 mt -111.05 -52.43 2.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.644 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.7 t -163.88 124.27 2.17 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.402 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -99.36 105.67 17.68 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.325 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 35.9 mtt180 -92.01 146.43 23.74 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.772 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.411 ' O ' ' C ' ' A' ' 13' ' ' SER . 59.1 ttt-85 -120.62 70.83 0.9 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.645 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.411 ' C ' ' O ' ' A' ' 12' ' ' ARG . 38.2 m -41.47 111.15 0.2 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 120.259 -0.576 . . . . 0.0 110.115 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 76.2 mttt -79.35 -7.11 58.1 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.559 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.518 ' C ' ' H ' ' A' ' 17' ' ' GLN . 61.9 mt-10 -68.44 -7.01 28.05 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.097 -179.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 64.21 -47.1 0.29 Allowed 'General case' 0 N--CA 1.467 0.421 0 O-C-N 123.697 0.623 . . . . 0.0 110.56 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.518 ' H ' ' C ' ' A' ' 15' ' ' GLU . 0.2 OUTLIER -77.84 45.8 0.53 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.659 179.831 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 4.7 m170 -161.74 -26.09 0.05 Allowed 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 69.92 161.15 0.21 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.212 -0.903 . . . . 0.0 109.972 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -73.42 131.51 41.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.843 0.354 . . . . 0.0 111.319 -179.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.407 HG13 ' N ' ' A' ' 22' ' ' MET . 45.5 t -100.24 160.41 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.083 179.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.482 ' SD ' ' CE1' ' A' ' 71' ' ' PHE . 13.1 ttt -148.59 112.75 5.21 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.874 -179.067 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 19.2 mt -85.19 136.26 23.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 41.2 mt -137.07 154.15 30.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.245 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.4 tttt -146.79 122.0 5.37 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.361 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -60.74 164.47 13.63 Favored 'Trans proline' 0 N--CA 1.489 1.228 0 C-N-CA 121.418 1.412 . . . . 0.0 111.152 178.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.7 tp -45.28 -80.79 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.888 -179.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.466 ' O ' ' C ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -93.8 -84.9 0.3 Allowed 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.964 -0.295 . . . . 0.0 110.444 179.383 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.466 ' C ' ' O ' ' A' ' 28' ' ' ASP . 64.7 t 39.99 53.63 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 -178.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.658 ' ND2' ' H ' ' A' ' 30' ' ' ASN . 0.0 OUTLIER -88.53 44.36 1.2 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.441 -1.254 . . . . 0.0 110.727 -177.089 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.9 m -157.98 124.7 4.89 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.085 -0.962 . . . . 0.0 109.964 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 11.6 ttp180 -58.5 -26.95 64.0 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -61.21 -50.37 73.39 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.876 179.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.3 tp10 -72.46 -37.96 68.39 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.468 ' C ' ' N ' ' A' ' 37' ' ' LYS . . . -60.4 -69.4 0.22 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.308 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.1 t -44.38 -18.61 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.831 0.348 . . . . 0.0 110.424 179.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.468 ' N ' ' C ' ' A' ' 35' ' ' ALA . 2.1 tmtt? -72.39 -63.04 1.23 Allowed 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.22 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.424 ' O ' ' HG ' ' A' ' 38' ' ' LEU . 0.5 OUTLIER -74.53 9.75 1.63 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.964 0.412 . . . . 0.0 110.324 -179.053 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.44 ' H ' ' C ' ' A' ' 37' ' ' LYS . 18.4 tt -48.63 -16.31 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.407 179.023 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -123.33 6.96 9.19 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.933 -178.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.8 mmt180 -72.15 175.68 5.81 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 117.591 0.696 . . . . 0.0 110.616 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.403 HD22 ' N ' ' A' ' 43' ' ' VAL . 6.5 tt -98.38 169.56 9.47 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.056 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.403 ' N ' HD22 ' A' ' 42' ' ' LEU . 33.8 m -140.84 99.5 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.185 0.517 . . . . 0.0 109.929 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.9 tt -102.16 99.72 9.87 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.742 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 10.4 t90 -106.2 116.51 32.06 Favored 'General case' 0 C--O 1.234 0.278 0 O-C-N 124.682 1.239 . . . . 0.0 109.738 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.8 pttp -84.01 105.7 15.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.935 0.398 . . . . 0.0 110.487 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.4 t -67.38 119.98 69.26 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.245 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -60.03 -7.44 6.33 Favored 'Trans proline' 0 N--CA 1.489 1.236 0 C-N-CA 121.474 1.45 . . . . 0.0 111.645 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 31.2 t -82.71 -6.16 59.25 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.963 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 95.47 57.34 1.2 Allowed Glycine 0 CA--C 1.52 0.392 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.0 ttmm -165.16 101.06 0.74 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.661 0.267 . . . . 0.0 110.614 -179.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.474 HG21 HD12 ' A' ' 52' ' ' ILE . 28.7 mm -82.04 109.79 16.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.453 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 75.5 mt -104.51 143.55 32.89 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.063 0.459 . . . . 0.0 110.869 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -151.87 101.99 2.79 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.885 -178.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -104.98 -142.25 11.27 Favored Glycine 0 N--CA 1.464 0.504 0 N-CA-C 109.771 -1.331 . . . . 0.0 109.771 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 23.9 tttm -154.98 139.7 17.09 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.068 0.461 . . . . 0.0 111.122 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 80.0 mt -69.85 138.95 21.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.059 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -105.43 -34.14 3.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -178.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.477 ' NH2' ' NH2' ' A' ' 70' ' ' ARG . 5.0 ptt-85 -165.69 157.45 14.44 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 120.435 -0.506 . . . . 0.0 111.319 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.465 ' C ' ' HD1' ' A' ' 61' ' ' HIS . 7.3 p -97.98 121.44 48.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.543 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.465 ' HD1' ' C ' ' A' ' 60' ' ' VAL . 11.3 m80 -141.11 132.78 27.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.113 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.429 ' O ' ' OG1' ' A' ' 63' ' ' THR . . . 124.94 -12.8 7.66 Favored Glycine 0 CA--C 1.519 0.288 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.472 ' O ' ' N ' ' A' ' 65' ' ' GLY . 19.9 p 53.53 171.87 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 -179.117 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt 65.57 -52.94 0.36 Allowed 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -178.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 63' ' ' THR . . . 165.81 121.64 0.57 Allowed Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 178.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.428 ' O ' ' CG1' ' A' ' 67' ' ' VAL . . . 174.87 159.59 0.19 Allowed 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.428 ' CG1' ' O ' ' A' ' 66' ' ' ALA . 7.9 m -159.11 144.32 6.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 C-N-CA 120.044 -0.663 . . . . 0.0 111.212 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 23.2 ttm180 -90.51 154.89 19.29 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -146.15 168.63 20.51 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.209 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.477 ' NH2' ' NH2' ' A' ' 59' ' ' ARG . 92.8 mtt180 -147.25 111.91 5.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.216 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.482 ' CE1' ' SD ' ' A' ' 22' ' ' MET . 51.8 m-85 -96.43 109.95 22.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.748 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -82.31 -13.33 57.11 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.122 0.487 . . . . 0.0 109.835 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 45.4 mmtt -80.96 -77.6 0.2 Allowed 'General case' 0 C--O 1.231 0.116 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.742 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 135.41 154.91 7.14 Favored Glycine 0 C--N 1.335 0.508 0 N-CA-C 111.241 -0.744 . . . . 0.0 111.241 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -89.13 174.45 4.94 Favored Pre-proline 0 N--CA 1.463 0.183 0 N-CA-C 110.414 -0.217 . . . . 0.0 110.414 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -76.06 -82.89 0.0 OUTLIER 'Trans proline' 0 C--N 1.315 -1.197 0 C-N-CA 122.305 2.003 . . . . 0.0 111.044 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -176.21 104.45 0.19 Allowed Glycine 0 N--CA 1.451 -0.304 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 179.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.499 ' NE2' ' C ' ' A' ' 78' ' ' GLN . 0.0 OUTLIER 70.32 62.93 0.22 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.92 0.391 . . . . 0.0 111.087 179.514 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -115.43 -0.6 13.07 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.511 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.9 tp -52.6 114.49 1.41 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.818 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 125.52 -13.27 7.37 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 111.744 -0.542 . . . . 0.0 111.744 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -70.35 136.67 49.92 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 120.442 -0.503 . . . . 0.0 109.983 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -69.56 125.59 27.18 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.773 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.441 ' O ' ' N ' ' A' ' 5' ' ' GLY . 18.0 m -94.36 154.96 3.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -149.94 164.29 35.84 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.323 0.582 . . . . 0.0 110.65 -178.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.1 mp -103.44 74.48 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 178.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.468 0.456 0 C-N-CA 120.093 -0.643 . . . . 0.0 110.946 -179.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.5 mtt . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 11.5 mmt180 -94.13 179.12 5.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.1 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.0 mm -138.13 169.85 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 9.4 ptpt -150.81 103.85 3.12 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 121.259 0.552 . . . . 0.0 111.329 -179.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -94.57 -177.3 38.51 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 179.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 p -146.5 135.38 16.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-O 121.222 0.534 . . . . 0.0 111.359 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 99.0 t -79.86 140.19 17.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.655 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 17.3 mt -105.52 -57.24 2.06 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.288 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.8 m -165.86 142.29 5.21 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.294 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -100.44 138.75 37.08 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 120.859 0.361 . . . . 0.0 110.689 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 10.6 mmt180 -89.78 117.47 28.66 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.485 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 -90.03 60.65 4.95 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.033 0.444 . . . . 0.0 110.133 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.7 m -70.15 149.42 47.57 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.032 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -148.47 -45.55 0.15 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.645 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.445 ' C ' ' H ' ' A' ' 17' ' ' GLN . 78.8 mt-10 -57.45 140.15 51.27 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.723 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.0 m120 68.61 -5.95 0.9 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.077 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.445 ' H ' ' C ' ' A' ' 15' ' ' GLU . 1.1 tm0? 65.93 124.83 0.02 OUTLIER 'General case' 0 C--O 1.232 0.173 0 CA-C-O 121.031 0.443 . . . . 0.0 110.779 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 11.8 t-80 -169.7 -6.36 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.513 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 69.74 161.82 0.22 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.376 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -78.79 128.81 33.88 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.911 0.386 . . . . 0.0 110.732 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.1 t -94.39 176.74 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.203 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 30.8 tpp -143.65 119.18 10.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.046 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 6.2 mm -83.23 133.0 30.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.584 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.419 ' CG2' ' N ' ' A' ' 25' ' ' LYS . 12.3 mt -138.9 156.72 28.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.523 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.419 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 11.4 ttmm -140.67 119.89 8.49 Favored Pre-proline 0 C--N 1.33 -0.28 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.458 ' O ' ' N ' ' A' ' 28' ' ' ASP . 2.9 Cg_endo -67.86 59.2 0.86 Allowed 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.313 2.009 . . . . 0.0 111.273 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.0 tp 54.31 -79.76 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.638 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.602 ' CG ' ' H ' ' A' ' 29' ' ' VAL . 9.2 p-10 -101.29 -90.75 0.33 Allowed 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.503 -0.479 . . . . 0.0 111.44 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.602 ' H ' ' CG ' ' A' ' 28' ' ' ASP . 53.3 t 44.7 55.95 0.33 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.194 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 -178.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -89.23 50.29 1.91 Allowed 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 114.356 -1.293 . . . . 0.0 110.812 -178.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 10.1 m -158.85 108.76 1.99 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.101 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 26.9 ttt85 -47.79 -31.8 5.29 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.161 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -62.59 -55.33 28.15 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.933 179.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -65.42 -39.37 92.04 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.104 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -58.93 -59.83 4.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.18 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.5 m -53.65 -22.07 8.12 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.614 179.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.0 tttp -68.96 -63.42 1.06 Allowed 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.067 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.433 ' O ' ' HG ' ' A' ' 38' ' ' LEU . 0.4 OUTLIER -80.32 16.8 1.19 Allowed 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 121.019 0.437 . . . . 0.0 111.053 -179.423 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 19.3 tt -50.38 -32.75 10.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.233 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -102.9 24.03 31.9 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -71.15 146.15 49.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.747 0.308 . . . . 0.0 110.569 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 7.8 tp -96.19 121.02 37.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.156 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.8 m -87.08 122.62 39.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.282 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.4 ' H ' ' HA ' ' A' ' 86' ' ' ILE . 0.5 OUTLIER -107.84 98.23 7.84 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.441 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 37.3 t90 -86.61 113.02 22.16 Favored 'General case' 0 C--O 1.234 0.246 0 O-C-N 125.209 1.568 . . . . 0.0 110.448 -178.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -83.56 93.63 7.89 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.004 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.1 p -64.28 167.57 8.07 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.049 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -77.9 -34.9 1.58 Allowed 'Trans proline' 0 C--N 1.314 -1.277 0 C-N-CA 123.01 2.473 . . . . 0.0 112.271 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 12.7 m -72.72 4.51 3.95 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.021 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.71 -9.64 73.12 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -77.57 100.27 6.04 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.566 0.222 . . . . 0.0 110.616 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.2 mp -79.18 108.01 12.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.7 mt -90.34 126.25 35.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.375 0.607 . . . . 0.0 110.943 -178.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 28.5 mttm -91.49 110.17 21.48 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.88 -1.055 . . . . 0.0 111.281 -179.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -95.46 178.81 35.68 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 178.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 38.7 tttt -152.84 131.45 12.28 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.528 -0.469 . . . . 0.0 111.426 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.2 mt -75.6 142.47 14.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.867 179.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -104.83 -34.29 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.81 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -164.85 156.23 15.08 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.045 0.45 . . . . 0.0 111.466 179.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.9 p -98.24 139.22 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.656 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.504 ' CG ' ' N ' ' A' ' 62' ' ' GLY . 56.7 t-80 -142.2 168.77 18.95 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.46 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.545 ' C ' ' H ' ' A' ' 64' ' ' LYS . . . 91.12 -34.14 4.4 Favored Glycine 0 CA--C 1.525 0.683 0 CA-C-N 116.19 -0.459 . . . . 0.0 112.707 178.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.41 ' OG1' ' O ' ' A' ' 62' ' ' GLY . 4.3 p 68.22 -34.18 0.25 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.682 0.241 . . . . 0.0 110.849 -179.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.545 ' H ' ' C ' ' A' ' 62' ' ' GLY . 0.8 OUTLIER -89.31 -7.42 55.39 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.579 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 130.65 119.78 2.15 Favored Glycine 0 CA--C 1.522 0.476 0 CA-C-N 114.517 -1.22 . . . . 0.0 110.224 178.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.447 ' CB ' ' O ' ' A' ' 61' ' ' HIS . . . 172.68 150.26 0.06 Allowed 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 17.4 m -156.19 141.0 9.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.539 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -88.91 150.39 22.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.421 179.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -146.85 163.59 35.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.963 0.411 . . . . 0.0 111.055 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 53.2 mtt180 -146.4 121.24 9.93 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.079 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.593 ' C ' ' H ' ' A' ' 73' ' ' LYS . 60.3 m-85 -97.48 138.85 34.29 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.116 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.573 ' O ' ' CB ' ' A' ' 73' ' ' LYS . 8.9 pt-20 -74.95 36.5 0.11 Allowed 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.136 178.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.593 ' H ' ' C ' ' A' ' 71' ' ' PHE . 9.9 ttpt 93.28 -32.97 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 115.008 -0.997 . . . . 0.0 110.18 -179.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.497 ' C ' ' O ' ' A' ' 73' ' ' LYS . . . -10.97 -59.84 0.01 OUTLIER Glycine 0 CA--C 1.53 0.997 0 O-C-N 124.431 1.082 . . . . 0.0 113.164 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.448 ' N ' ' O ' ' A' ' 73' ' ' LYS . 10.9 mt -56.67 113.71 6.52 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-N 116.709 0.254 . . . . 0.0 110.552 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -69.34 -174.9 0.9 Allowed 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 122.436 2.091 . . . . 0.0 112.347 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -51.13 115.09 3.29 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 9.3 tm0? 69.48 145.81 0.06 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.914 0.388 . . . . 0.0 110.708 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 166.91 -21.0 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.242 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.4 tp -43.7 129.13 5.49 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.224 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 98.53 -7.64 61.64 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.827 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -71.5 135.94 47.34 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -68.58 129.41 39.86 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.1 m -90.3 170.99 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -149.88 151.16 33.02 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.4 ' HA ' ' H ' ' A' ' 44' ' ' LEU . 16.8 mt -108.69 73.2 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 178.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.4 t . . . . . 0 N--CA 1.464 0.231 0 C-N-CA 120.115 -0.634 . . . . 0.0 111.015 -178.628 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.4 ptt? . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 20.9 mtm180 -105.68 173.1 6.46 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.836 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.2 mt -144.32 158.51 15.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.419 -0.81 . . . . 0.0 108.86 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.78 107.85 4.05 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.467 0.651 . . . . 0.0 112.082 -178.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -95.85 -177.35 36.61 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 178.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 75.2 t -145.42 135.68 18.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.202 0.525 . . . . 0.0 110.468 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.9 t -73.0 142.72 14.69 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.391 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 52.0 mt -110.49 -33.71 6.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.055 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.6 m -161.28 134.56 6.46 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.935 0.397 . . . . 0.0 110.886 -179.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -106.44 101.15 10.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.541 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.43 ' O ' ' O ' ' A' ' 21' ' ' VAL . 5.8 mpt_? -91.09 133.29 35.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.373 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 12.8 ptt85 -101.35 62.31 0.95 Allowed 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.184 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.1 t 59.69 164.58 0.06 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.021 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.8 ttmm -133.18 -69.67 0.55 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.386 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -111.05 43.4 1.46 Allowed 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.24 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.1 t30 46.29 81.42 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.913 0.387 . . . . 0.0 110.373 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -104.34 -27.92 11.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.55 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -175.46 -54.52 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.403 ' CG ' ' H ' ' A' ' 20' ' ' ASN . 20.3 t-20 -178.32 -153.87 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.574 178.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.403 ' H ' ' CG ' ' A' ' 19' ' ' ASN . 1.9 m-20 -75.37 126.47 31.07 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.442 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.43 ' O ' ' O ' ' A' ' 11' ' ' ARG . 88.1 t -105.64 153.1 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.468 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 15.2 ptm -145.81 143.04 29.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.961 0.41 . . . . 0.0 111.093 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.406 HG23 HD13 ' A' ' 23' ' ' ILE . 29.4 mm -92.65 143.15 12.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.106 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.428 ' CG2' ' N ' ' A' ' 25' ' ' LYS . 31.5 mt -133.19 156.87 42.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.399 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.428 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -140.3 99.8 7.12 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.644 179.824 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.537 ' O ' ' N ' ' A' ' 28' ' ' ASP . 3.3 Cg_exo -65.17 74.12 0.25 Allowed 'Trans proline' 0 C--N 1.314 -1.268 0 C-N-CA 121.984 1.789 . . . . 0.0 111.051 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.415 ' N ' ' O ' ' A' ' 25' ' ' LYS . 0.9 OUTLIER 37.92 -82.64 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 114.849 -1.069 . . . . 0.0 112.097 -179.758 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.537 ' N ' ' O ' ' A' ' 26' ' ' PRO . 1.1 p-10 -99.24 -87.11 0.36 Allowed 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.363 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.511 ' O ' ' CG1' ' A' ' 29' ' ' VAL . 19.1 t 44.14 62.27 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-O 122.245 1.022 . . . . 0.0 108.294 -177.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.401 HD21 ' HB2' ' A' ' 28' ' ' ASP . 2.6 p30 -93.63 47.22 1.22 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.15 -1.386 . . . . 0.0 110.941 -178.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 70.3 m -156.72 118.99 3.94 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.541 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.409 ' H ' ' HB3' ' A' ' 64' ' ' LYS . 1.4 ttt85 -51.89 -30.93 26.12 Favored 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.429 ' O ' ' CB ' ' A' ' 37' ' ' LYS . 45.3 mt-10 -63.01 -63.15 1.29 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.643 179.038 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -54.86 -46.62 74.72 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.03 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -57.84 -69.48 0.17 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.985 179.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 65.0 m -50.82 -36.68 38.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.677 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.429 ' CB ' ' O ' ' A' ' 33' ' ' GLU . 60.5 tttt -71.35 -14.75 62.29 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.304 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.462 ' O ' ' HG ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -86.47 -11.31 52.16 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 120.853 0.358 . . . . 0.0 110.628 -179.524 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.425 HD11 HG21 ' A' ' 39' ' ' ILE . 53.7 mt -55.16 121.63 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.658 178.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 103.79 -4.05 45.94 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.714 -0.554 . . . . 0.0 111.714 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -70.37 142.33 52.13 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.854 0.359 . . . . 0.0 110.206 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 11.6 tp -81.51 111.29 17.7 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.089 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.444 ' O ' ' CG2' ' A' ' 43' ' ' VAL . 6.7 m -88.81 107.4 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 121.581 0.705 . . . . 0.0 111.182 -178.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.1 mp -102.98 92.97 4.78 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.442 ' CZ3' HD11 ' A' ' 53' ' ' LEU . 1.2 t90 -91.87 129.08 37.9 Favored 'General case' 0 C--O 1.235 0.304 0 O-C-N 124.717 1.26 . . . . 0.0 110.736 -178.065 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.6 ttmp? -81.76 91.96 6.57 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.966 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.405 ' CB ' ' CD ' ' A' ' 48' ' ' PRO . 0.8 OUTLIER -63.65 176.48 0.61 Allowed Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.011 179.946 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.541 ' C ' ' H ' ' A' ' 50' ' ' GLY . 2.9 Cg_endo -76.23 -41.75 0.45 Allowed 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.663 2.242 . . . . 0.0 112.491 -179.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.546 ' C ' ' H ' ' A' ' 51' ' ' LYS . 6.8 t -70.5 20.64 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.203 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.541 ' H ' ' C ' ' A' ' 48' ' ' PRO . . . 66.19 -9.72 0.73 Allowed Glycine 0 CA--C 1.53 0.999 0 N-CA-C 111.051 -0.819 . . . . 0.0 111.051 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.546 ' H ' ' C ' ' A' ' 49' ' ' SER . 7.0 ttpm? -73.26 119.62 17.75 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 28.5 mm -83.97 112.92 22.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.442 HD11 ' CZ3' ' A' ' 45' ' ' TRP . 16.9 mt -99.66 125.21 45.46 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.265 0.555 . . . . 0.0 111.301 -179.109 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.3 mtpt -89.1 166.85 13.59 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.572 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -161.99 178.57 37.78 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.6 tttt -152.2 123.7 7.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.826 0.346 . . . . 0.0 111.023 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 22.4 mt -66.02 144.8 14.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.315 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.3 m -109.36 -34.54 2.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.584 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -163.37 158.02 20.7 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.745 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.4 p -88.54 153.8 3.24 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.431 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -140.86 125.08 17.45 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.25 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.3 13.82 55.13 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 -179.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 82.2 p 52.92 -99.99 0.09 Allowed 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 122.44 0.296 . . . . 0.0 111.348 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.409 ' HB3' ' H ' ' A' ' 32' ' ' ARG . 16.4 pttt -88.16 55.93 3.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.829 -179.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -156.13 -125.41 0.9 Allowed Glycine 0 N--CA 1.446 -0.7 0 N-CA-C 111.366 -0.694 . . . . 0.0 111.366 -178.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.9 -177.5 0.82 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.25 -0.975 . . . . 0.0 111.688 -178.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.3 m -153.11 156.85 5.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.099 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 8.7 tpp180 -88.88 154.49 20.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.933 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -149.85 154.38 38.29 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.199 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -148.79 128.76 13.49 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.909 0.385 . . . . 0.0 111.156 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -103.96 117.05 33.39 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.54 179.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -80.96 -10.9 59.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.818 -178.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 24.7 ttpt -160.03 -45.66 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 120.36 -0.536 . . . . 0.0 111.933 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.84 51.77 0.1 Allowed Glycine 0 CA--C 1.529 0.968 0 O-C-N 123.513 0.508 . . . . 0.0 112.015 -178.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.4 91.26 12.64 Favored Pre-proline 0 C--N 1.329 -0.289 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -59.08 -80.95 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 121.945 1.764 . . . . 0.0 112.107 -179.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -173.84 9.65 0.03 OUTLIER Glycine 0 CA--C 1.525 0.681 0 C-N-CA 120.743 -0.742 . . . . 0.0 111.589 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.87 107.35 2.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.844 0.354 . . . . 0.0 110.51 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -139.92 4.3 2.08 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.741 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.8 tp -77.15 98.94 5.23 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.265 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 123.61 -26.84 5.88 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 121.224 -0.512 . . . . 0.0 112.183 178.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -70.9 129.4 38.95 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 117.232 0.516 . . . . 0.0 109.924 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -68.59 134.02 49.36 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 29.7 m -90.73 160.13 2.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -147.61 151.33 36.04 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.336 -0.546 . . . . 0.0 110.565 -178.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 33.5 mt -110.01 72.05 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 178.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.7 t . . . . . 0 C--N 1.332 -0.195 0 C-N-CA 119.7 -0.8 . . . . 0.0 110.826 -178.824 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.122 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.419 HG22 ' N ' ' A' ' 4' ' ' LYS . 11.3 mt -145.29 163.46 12.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.926 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.419 ' N ' HG22 ' A' ' 3' ' ' ILE . 5.8 ptpt -139.04 177.08 8.16 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.111 0.482 . . . . 0.0 110.805 -179.072 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -170.44 -176.04 39.62 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 -178.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.9 t -140.35 127.51 23.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.086 0.47 . . . . 0.0 110.2 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 66.1 t -63.23 151.71 8.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.558 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.453 HD12 HG22 ' A' ' 23' ' ' ILE . 37.1 mt -109.86 -61.32 1.66 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.272 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.5 t -166.4 133.48 2.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.634 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -106.59 115.48 30.27 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.357 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.33 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 98.5 t . . . . . 0 N--CA 1.465 0.323 0 CA-C-O 120.629 0.252 . . . . 0.0 110.64 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.541 ' SD ' ' CE1' ' A' ' 71' ' ' PHE . 23.6 ttt -143.71 123.37 13.31 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.565 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.453 HG22 HD12 ' A' ' 8' ' ' LEU . 16.1 mm -98.97 134.77 36.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.775 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.595 ' O ' ' HB1' ' A' ' 66' ' ' ALA . 38.4 mt -125.61 153.91 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.637 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.2 ttmm -137.45 98.51 10.0 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.885 -179.261 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.479 ' O ' ' C ' ' A' ' 27' ' ' LEU . 3.5 Cg_exo -70.74 135.55 28.37 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 122.265 1.977 . . . . 0.0 110.722 178.77 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.479 ' C ' ' O ' ' A' ' 26' ' ' PRO . 7.6 mp -19.33 -85.32 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -179.068 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.409 ' CG ' ' H ' ' A' ' 29' ' ' VAL . 5.2 p30 -93.1 -91.86 0.17 Allowed 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.526 -179.223 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.705 ' O ' HG12 ' A' ' 29' ' ' VAL . 91.2 t 48.19 46.39 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.145 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 -178.25 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 11.2 p-10 -89.58 51.16 2.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.841 -178.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -159.2 111.42 2.16 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.68 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.423 ' H ' ' HG2' ' A' ' 64' ' ' LYS . 14.9 ttt85 -48.26 -29.94 4.31 Favored 'General case' 0 N--CA 1.462 0.143 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -61.05 -58.19 9.45 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.754 178.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.96 -49.34 70.7 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.374 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -53.79 -60.96 2.64 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.5 t -54.65 -39.6 68.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.847 179.111 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 51.3 mttt -69.84 -19.95 63.44 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.486 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.504 ' O ' ' HG ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -85.34 -14.08 47.55 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.768 -179.304 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 71.7 mt -55.48 127.95 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 N-CA-C 110.148 -0.315 . . . . 0.0 110.148 178.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 107.89 -14.75 37.64 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 61.9 mtt180 -69.78 162.29 28.13 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.501 ' O ' HG23 ' A' ' 86' ' ' ILE . 3.8 tp -103.14 128.21 50.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.207 -179.182 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.411 HG22 ' H ' ' A' ' 43' ' ' VAL . 3.0 m -94.9 105.65 17.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.316 179.531 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.593 HD23 ' C ' ' A' ' 44' ' ' LEU . 6.1 tt -102.61 95.37 6.18 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.492 ' CZ3' HD12 ' A' ' 53' ' ' LEU . 15.9 t90 -99.59 136.8 38.98 Favored 'General case' 0 C--O 1.238 0.452 0 O-C-N 124.632 1.208 . . . . 0.0 111.21 -178.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.476 ' O ' ' CE2' ' A' ' 45' ' ' TRP . 58.1 mttt -82.33 169.13 16.84 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.315 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.464 0.236 0 N-CA-C 110.351 -0.24 . . . . 0.0 110.351 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.9 ttmp? . . . . . 0 C--O 1.233 0.22 0 CA-C-O 120.892 0.377 . . . . 0.0 110.803 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.539 ' CG2' HD21 ' A' ' 44' ' ' LEU . 27.1 mm -84.25 114.37 24.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.492 HD12 ' CZ3' ' A' ' 45' ' ' TRP . 10.8 mt -98.46 146.97 25.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.019 0.437 . . . . 0.0 110.493 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.06 107.02 3.98 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.546 -178.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -103.98 -151.42 21.99 Favored Glycine 0 CA--C 1.521 0.464 0 N-CA-C 109.866 -1.293 . . . . 0.0 109.866 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 24.3 tttm -155.49 140.98 17.81 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.985 0.421 . . . . 0.0 111.351 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.463 HD13 HD21 ' A' ' 38' ' ' LEU . 65.6 mt -72.84 135.27 28.09 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.583 179.024 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -99.0 -63.46 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.973 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.8 mtt85 -143.88 159.29 42.8 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.657 0.265 . . . . 0.0 110.574 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 6.4 p -86.78 140.27 16.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.747 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.428 ' H ' ' HA ' ' A' ' 67' ' ' VAL . 3.9 m-70 -140.74 80.09 1.73 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.595 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 153.44 11.83 0.07 OUTLIER Glycine 0 CA--C 1.521 0.424 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 69.4 p 51.1 -94.85 0.03 OUTLIER 'General case' 0 C--O 1.231 0.104 0 CA-C-N 115.277 -0.462 . . . . 0.0 110.85 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.423 ' HG2' ' H ' ' A' ' 32' ' ' ARG . 15.0 mtmt -94.5 50.17 1.33 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.115 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -156.22 -125.13 0.88 Allowed Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.526 -0.845 . . . . 0.0 111.809 -178.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.595 ' HB1' ' O ' ' A' ' 24' ' ' ILE . . . -68.29 179.54 1.57 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.243 -0.978 . . . . 0.0 111.982 -178.528 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.428 ' HA ' ' H ' ' A' ' 61' ' ' HIS . 4.1 m -150.73 166.66 2.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.145 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 44.9 ttt180 -88.93 148.37 23.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.841 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -147.62 166.05 28.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.323 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 60.8 mtp180 -148.01 146.99 29.14 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.28 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.541 ' CE1' ' SD ' ' A' ' 22' ' ' MET . 53.3 m-85 -133.84 117.46 16.87 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.793 -179.534 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -84.73 -26.32 27.72 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.104 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.1 tttm -85.08 -11.03 56.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.217 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 61.73 168.67 0.66 Allowed Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.402 ' CB ' ' CD ' ' A' ' 76' ' ' PRO . 0.6 OUTLIER -100.04 174.98 2.62 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 179.877 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.402 ' CD ' ' CB ' ' A' ' 75' ' ' LEU . 3.3 Cg_exo -73.63 171.15 18.37 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.665 2.243 . . . . 0.0 111.695 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -49.94 110.76 0.92 Allowed Glycine 0 CA--C 1.526 0.765 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 47.66 95.07 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.864 0.364 . . . . 0.0 110.911 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -130.16 22.29 5.26 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.025 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.465 ' CD2' ' N ' ' A' ' 80' ' ' LEU . 4.0 mm? -76.03 92.6 3.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.759 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 153.32 -16.19 0.67 Allowed Glycine 0 CA--C 1.528 0.894 0 C-N-CA 120.999 -0.62 . . . . 0.0 111.974 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -72.68 139.05 47.03 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 117.272 0.536 . . . . 0.0 110.118 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -69.4 137.29 52.65 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 29.3 m -91.47 158.64 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 -148.2 153.5 38.85 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.194 0.521 . . . . 0.0 110.961 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.519 HG22 ' O ' ' A' ' 86' ' ' ILE . 3.9 mp -109.4 73.49 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.467 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.432 ' H ' ' HB3' ' A' ' 44' ' ' LEU . 1.5 t . . . . . 0 CA--C 1.528 0.132 0 C-N-CA 120.018 -0.673 . . . . 0.0 111.03 -178.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 4.5 ptt-85 . . . . . 0 C--O 1.232 0.173 0 CA-C-O 120.936 0.398 . . . . 0.0 110.921 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.439 HG22 ' H ' ' A' ' 4' ' ' LYS . 0.6 OUTLIER -145.98 -177.69 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.902 179.622 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.439 ' H ' HG22 ' A' ' 3' ' ' ILE . 11.9 ptpt -146.96 107.17 4.02 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.131 0.491 . . . . 0.0 111.311 -178.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.43 ' HA2' ' H ' ' A' ' 27' ' ' LEU . . . -98.61 -176.55 32.57 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 179.501 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.8 t -140.16 139.12 36.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-O 121.044 0.449 . . . . 0.0 110.348 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.6 t -78.5 154.59 5.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.265 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 56.3 mt -125.24 -44.39 1.88 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.31 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -165.14 126.97 2.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.841 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -102.38 122.37 44.14 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.814 179.462 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 12.5 ttm-85 . . . . . 0 N--CA 1.464 0.234 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.912 -179.434 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.575 HG12 ' N ' ' A' ' 22' ' ' MET . 18.8 t . . . . . 0 N--CA 1.462 0.139 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.575 ' N ' HG12 ' A' ' 21' ' ' VAL . 9.6 ttt -147.55 121.91 9.65 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.681 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 91.9 mt -96.13 129.83 45.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.405 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.503 HG22 ' N ' ' A' ' 25' ' ' LYS . 96.8 mt -132.86 160.14 42.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.024 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.521 ' O ' ' N ' ' A' ' 27' ' ' LEU . 60.1 tttt -138.12 96.37 10.19 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.326 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -59.57 72.41 0.06 OUTLIER 'Trans proline' 0 N--CA 1.489 1.252 0 C-N-CA 122.291 1.994 . . . . 0.0 111.464 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.521 ' N ' ' O ' ' A' ' 25' ' ' LYS . 14.1 tp 51.99 -116.33 1.01 Allowed 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.353 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.474 ' CG ' ' H ' ' A' ' 29' ' ' VAL . 6.4 p-10 -74.0 -92.78 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.47 -179.291 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.735 ' O ' HG12 ' A' ' 29' ' ' VAL . 53.8 t 56.07 54.74 0.33 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.194 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -178.612 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -92.29 47.4 1.32 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.038 -178.614 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.7 t -158.3 123.6 4.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.11 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.476 ' HE ' ' HB ' ' A' ' 63' ' ' THR . 27.8 ttm180 -56.55 -31.75 64.49 Favored 'General case' 0 C--O 1.222 -0.382 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.132 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -61.82 -52.22 65.04 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.998 179.069 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.2 tp10 -65.64 -51.59 58.35 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.278 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.471 ' O ' HD23 ' A' ' 38' ' ' LEU . . . -55.59 -48.48 74.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.532 179.26 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.441 ' CB ' ' O ' ' A' ' 32' ' ' ARG . 93.4 p -62.34 -33.64 75.09 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.793 178.569 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 43.9 tttm -66.63 -61.23 2.08 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.118 -177.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.471 HD23 ' O ' ' A' ' 35' ' ' ALA . 0.8 OUTLIER -77.88 5.76 9.01 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.756 -0.377 . . . . 0.0 111.235 -178.758 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.596 HG23 ' O ' ' A' ' 39' ' ' ILE . 12.9 tt -53.22 113.94 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 178.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.432 ' H ' ' HB ' ' A' ' 57' ' ' ILE . . . 102.07 15.72 25.29 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 111.538 -0.625 . . . . 0.0 111.538 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.9 tpt180 -69.63 155.79 39.95 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 24.7 tp -84.55 105.59 15.48 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.869 0.366 . . . . 0.0 110.724 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.608 HG23 ' O ' ' A' ' 43' ' ' VAL . 33.2 m -87.37 109.39 19.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.532 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.621 HD23 ' C ' ' A' ' 44' ' ' LEU . 5.0 tt -108.37 97.15 6.87 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.238 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.451 ' CZ3' HD12 ' A' ' 53' ' ' LEU . 10.6 t90 -99.0 117.61 33.9 Favored 'General case' 0 C--O 1.237 0.406 0 O-C-N 124.824 1.328 . . . . 0.0 110.707 -179.204 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 43.6 tttp -85.87 100.75 12.29 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.447 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.446 ' HB2' ' O ' ' A' ' 51' ' ' LYS . 0.1 OUTLIER . . . . . 0 CA--C 1.536 0.441 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.819 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.446 ' O ' ' HB2' ' A' ' 47' ' ' SER . 3.7 ttpt . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.905 0.383 . . . . 0.0 110.399 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.526 ' CG2' HD21 ' A' ' 44' ' ' LEU . 18.1 mm -84.65 108.21 16.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.625 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.451 HD12 ' CZ3' ' A' ' 45' ' ' TRP . 16.7 mt -105.81 143.26 34.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.552 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.05 116.72 5.84 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.394 -178.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -113.8 -153.95 11.15 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 179.082 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt -151.51 136.75 17.54 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 121.024 0.44 . . . . 0.0 110.849 179.27 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.637 HG23 ' O ' ' A' ' 68' ' ' ARG . 45.8 mt -65.33 140.32 19.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.0 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -106.09 -45.14 8.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.831 -179.137 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 44.5 mtp85 -149.23 159.49 44.21 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.794 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.513 HG13 ' O ' ' A' ' 60' ' ' VAL . 7.1 p -93.06 117.21 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.039 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.403 ' H ' ' HA ' ' A' ' 67' ' ' VAL . 37.8 t60 -102.59 121.19 41.89 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.428 179.432 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.75 10.28 50.32 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 111.556 -0.617 . . . . 0.0 111.556 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.476 ' HB ' ' HE ' ' A' ' 32' ' ' ARG . 81.3 p 51.55 -88.11 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.473 ' HG2' ' H ' ' A' ' 32' ' ' ARG . 51.4 mttt -90.18 51.74 2.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.12 -179.268 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -156.97 -126.06 0.9 Allowed Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.43 -0.891 . . . . 0.0 112.277 -179.007 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.71 -177.89 1.06 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 113.859 -1.17 . . . . 0.0 112.237 -178.305 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.403 ' HA ' ' H ' ' A' ' 61' ' ' HIS . 4.8 m -147.19 153.59 12.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.802 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.637 ' O ' HG23 ' A' ' 57' ' ' ILE . 27.6 ttm180 -87.85 157.13 19.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.765 0.317 . . . . 0.0 110.985 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -151.04 166.23 31.37 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.035 179.474 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 13.9 ttt180 -149.37 116.85 6.14 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.76 0.314 . . . . 0.0 110.692 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.44 ' CD1' ' SD ' ' A' ' 22' ' ' MET . 34.4 m-85 -100.43 117.88 35.51 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.088 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -80.13 -19.95 46.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.804 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 35.3 mttt -81.55 -77.72 0.21 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.981 0.42 . . . . 0.0 110.947 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 140.92 169.74 11.87 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 -179.519 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.409 ' CB ' ' CD ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -97.02 175.57 2.55 Favored Pre-proline 0 C--N 1.33 -0.241 0 N-CA-C 110.272 -0.269 . . . . 0.0 110.272 -179.81 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.409 ' CD ' ' CB ' ' A' ' 75' ' ' LEU . 2.9 Cg_endo -77.39 19.32 0.73 Allowed 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.99 2.46 . . . . 0.0 111.376 179.01 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 97.67 -100.55 2.41 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 6.9 tm0? -90.67 106.71 18.69 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.817 0.341 . . . . 0.0 110.2 179.397 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -163.1 23.8 0.09 Allowed 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.149 0.499 . . . . 0.0 110.085 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.1 tp -70.53 95.22 1.05 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.563 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 139.1 -1.76 2.53 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.807 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.407 ' CG ' ' HE1' ' A' ' 45' ' ' TRP . 7.9 t0 -71.28 136.99 48.2 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -69.13 129.61 40.35 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.4 m -91.29 162.58 2.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.401 ' C ' HD13 ' A' ' 86' ' ' ILE . 25.8 mt-10 -148.95 161.89 40.99 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.334 -179.469 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.401 HD13 ' C ' ' A' ' 85' ' ' GLU . 1.2 mm -107.97 72.46 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 178.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.417 ' O ' ' CB ' ' A' ' 44' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.462 0.154 0 C-N-CA 119.945 -0.702 . . . . 0.0 111.293 -178.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 22.6 ptt180 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.838 0.352 . . . . 0.0 110.978 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.525 HG22 ' H ' ' A' ' 4' ' ' LYS . 1.1 mt -144.41 179.41 1.36 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.852 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.525 ' H ' HG22 ' A' ' 3' ' ' ILE . 0.0 OUTLIER -144.24 103.81 4.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.363 0.601 . . . . 0.0 110.382 -179.528 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.43 ' HA2' ' H ' ' A' ' 27' ' ' LEU . . . -90.71 -179.09 43.54 Favored Glycine 0 CA--C 1.522 0.527 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.268 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.1 t -145.59 137.14 19.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.919 0.39 . . . . 0.0 109.987 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 74.3 t -74.72 140.37 17.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.69 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 43.1 mt -107.52 -45.42 4.06 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.687 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.2 p -162.84 125.92 2.81 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.92 0.391 . . . . 0.0 111.082 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -101.49 97.65 8.08 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.306 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 17.7 ttm180 . . . . . 0 C--N 1.333 -0.135 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.348 179.792 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.421 HG12 ' N ' ' A' ' 22' ' ' MET . 98.6 t . . . . . 0 N--CA 1.465 0.322 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.421 ' N ' HG12 ' A' ' 21' ' ' VAL . 41.9 ttm -145.39 115.85 7.6 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.717 0.294 . . . . 0.0 110.506 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 6.4 mt -96.07 129.42 46.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.435 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.531 HG22 ' N ' ' A' ' 25' ' ' LYS . 83.0 mt -133.56 162.61 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.547 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.531 ' N ' HG22 ' A' ' 24' ' ' ILE . 45.1 tttm -142.51 105.25 5.46 Favored Pre-proline 0 CA--C 1.531 0.224 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.804 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -61.44 87.54 0.09 OUTLIER 'Trans proline' 0 C--N 1.313 -1.327 0 C-N-CA 122.315 2.01 . . . . 0.0 112.276 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.43 ' H ' ' HA2' ' A' ' 5' ' ' GLY . 2.7 tp 36.32 -133.82 0.07 Allowed 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.377 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.471 ' O ' ' C ' ' A' ' 29' ' ' VAL . 1.3 p-10 -44.04 -92.73 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 111.593 0.22 . . . . 0.0 111.593 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.745 ' O ' HG12 ' A' ' 29' ' ' VAL . 55.1 t 41.1 43.64 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 -178.159 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.413 ' OD1' ' N ' ' A' ' 30' ' ' ASN . 2.6 p30 -82.6 41.69 0.73 Allowed 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 113.819 -1.537 . . . . 0.0 110.58 -178.014 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.3 p -158.87 126.89 5.1 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.907 178.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 35.9 ttt180 -59.15 -25.72 64.14 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.268 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -63.19 -54.18 41.56 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.456 178.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -66.16 -43.32 87.31 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.977 179.305 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.566 ' O ' HD23 ' A' ' 38' ' ' LEU . . . -59.95 -60.69 3.42 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.301 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 27.7 t -52.31 -22.52 4.61 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.654 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.9 tptt -69.97 -64.74 0.83 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.094 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.566 HD23 ' O ' ' A' ' 35' ' ' ALA . 0.5 OUTLIER -79.59 13.34 2.08 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.307 -179.058 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 18.5 tt -48.52 -19.88 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.341 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -108.25 18.22 33.55 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 121.154 -0.546 . . . . 0.0 111.994 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.442 ' HA ' ' NE ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -71.09 172.57 8.92 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 117.2 0.5 . . . . 0.0 110.547 179.777 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.564 ' O ' HG23 ' A' ' 86' ' ' ILE . 5.0 tp -118.87 121.63 40.44 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.5 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.624 HG23 ' O ' ' A' ' 43' ' ' VAL . 6.4 m -88.03 110.43 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.422 ' H ' ' HA ' ' A' ' 86' ' ' ILE . 2.1 tp -105.55 102.86 12.29 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.773 ' CD1' HG12 ' A' ' 84' ' ' VAL . 4.7 t90 -83.32 105.15 14.04 Favored 'General case' 0 C--O 1.235 0.332 0 O-C-N 125.135 1.522 . . . . 0.0 110.302 -178.648 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 54.2 tttp -84.5 88.43 7.3 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.729 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.477 ' OG ' ' N ' ' A' ' 51' ' ' LYS . 11.5 p . . . . . 0 CA--C 1.534 0.333 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.79 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.477 ' N ' ' OG ' ' A' ' 47' ' ' SER . 1.1 tmtm? . . . . . 0 CA--C 1.527 0.08 0 CA-C-O 120.916 0.388 . . . . 0.0 109.965 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 12.1 mm -83.08 112.55 20.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.917 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 60.0 mt -98.1 126.21 43.45 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.18 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 60.8 mttt -96.41 104.75 16.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.917 -179.299 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -103.44 168.12 17.26 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 178.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -152.74 130.15 11.36 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 117.193 0.496 . . . . 0.0 111.261 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 71.5 mt -71.42 134.06 30.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.52 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -106.1 -28.78 2.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.398 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.1 ptp180 -164.89 154.47 13.22 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 120.63 -0.428 . . . . 0.0 112.018 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.584 HG13 ' O ' ' A' ' 60' ' ' VAL . 9.5 p -97.71 116.44 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.417 178.682 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 13.0 t60 -142.06 115.08 8.73 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 120.126 -0.63 . . . . 0.0 112.054 -179.29 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.414 ' O ' ' OG1' ' A' ' 63' ' ' THR . . . 147.19 -14.33 1.47 Allowed Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.646 -0.582 . . . . 0.0 111.646 179.051 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.614 ' C ' ' H ' ' A' ' 65' ' ' GLY . 12.5 p 55.95 156.41 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 122.613 0.365 . . . . 0.0 110.769 -179.246 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.452 ' HZ2' ' HB3' ' A' ' 64' ' ' LYS . 0.5 OUTLIER 68.98 -21.05 0.15 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.985 0.421 . . . . 0.0 109.926 -178.194 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.614 ' H ' ' C ' ' A' ' 63' ' ' THR . . . 141.41 122.45 1.83 Allowed Glycine 0 CA--C 1.52 0.37 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 179.085 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.564 ' O ' HG23 ' A' ' 60' ' ' VAL . . . 176.38 147.57 0.1 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.443 HG13 ' O ' ' A' ' 66' ' ' ALA . 15.5 m -156.6 137.16 4.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.933 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 21.6 ttm-85 -89.02 154.51 20.15 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -145.07 161.06 40.36 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.051 0.453 . . . . 0.0 110.866 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.413 ' NH1' HG22 ' A' ' 21' ' ' VAL . 78.4 mtt-85 -146.45 116.7 7.42 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.171 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.472 ' C ' ' H ' ' A' ' 73' ' ' LYS . 17.2 m-85 -95.89 135.46 37.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.57 -179.603 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 82.6 mt-10 -61.07 -1.64 0.48 Allowed 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.476 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.472 ' H ' ' C ' ' A' ' 71' ' ' PHE . 5.8 tmtm? -156.28 -65.19 0.11 Allowed 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.642 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 134.86 -171.61 22.32 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.465 HD23 ' N ' ' A' ' 75' ' ' LEU . 1.3 mt -92.06 171.05 8.27 Favored Pre-proline 0 C--N 1.327 -0.392 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -75.3 114.37 3.98 Favored 'Trans proline' 0 C--N 1.313 -1.335 0 C-N-CA 122.655 2.237 . . . . 0.0 112.064 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 75.97 -65.23 2.62 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.574 HE22 HD12 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -169.01 -69.25 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.645 0.259 . . . . 0.0 110.594 179.472 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 64.13 24.23 13.4 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.969 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.574 HD12 HE22 ' A' ' 78' ' ' GLN . 1.5 tt -60.58 104.08 0.31 Allowed 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.575 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 110.5 5.71 27.74 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 111.652 -0.579 . . . . 0.0 111.652 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -73.98 144.09 45.35 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.726 0.263 . . . . 0.0 110.3 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -69.88 113.49 7.16 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.773 HG12 ' CD1' ' A' ' 45' ' ' TRP . 30.2 m -90.87 169.68 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -150.0 156.4 41.64 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.272 0.558 . . . . 0.0 110.985 -178.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.633 HG22 ' O ' ' A' ' 86' ' ' ILE . 9.7 mt -105.76 72.74 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 177.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.338 0.1 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.918 -178.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 22.9 mtm-85 . . . . . 0 C--O 1.232 0.133 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.4 mt -147.76 145.3 18.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.079 0.466 . . . . 0.0 111.055 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.3 mmmm -90.07 178.59 6.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.282 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 84' ' ' VAL . . . -173.75 173.64 45.91 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.0 t -148.98 137.01 14.38 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 CA-C-O 120.914 0.388 . . . . 0.0 110.705 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 91.4 t -80.4 148.32 5.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.158 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 49.4 mt -106.41 -44.45 4.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.249 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.9 m -168.53 137.08 2.21 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.603 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -94.67 115.37 27.46 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.333 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.511 ' O ' ' N ' ' A' ' 21' ' ' VAL . 89.2 mtt180 . . . . . 0 C--N 1.331 -0.224 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.921 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.59 HG12 ' N ' ' A' ' 22' ' ' MET . 53.0 t . . . . . 0 N--CA 1.47 0.553 0 CA-C-O 120.698 0.285 . . . . 0.0 110.318 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.59 ' N ' HG12 ' A' ' 21' ' ' VAL . 2.6 ptp -147.03 135.99 22.33 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.917 0.389 . . . . 0.0 110.848 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.458 HG22 ' N ' ' A' ' 24' ' ' ILE . 87.0 mt -94.89 156.84 3.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.195 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.458 ' N ' HG22 ' A' ' 23' ' ' ILE . 23.5 mt -143.51 158.14 16.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.68 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.451 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 49.4 tttm -140.69 101.49 6.55 Favored Pre-proline 0 C--O 1.235 0.308 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.195 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -58.89 144.96 98.54 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 121.706 1.604 . . . . 0.0 110.466 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.487 HD12 ' HA ' ' A' ' 27' ' ' LEU . 6.8 tp -34.05 -82.91 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -178.338 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.473 ' CG ' ' H ' ' A' ' 29' ' ' VAL . 3.6 p-10 -87.09 -86.84 0.15 Allowed 'General case' 0 CA--C 1.521 -0.163 0 C-N-CA 120.251 -0.58 . . . . 0.0 110.259 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.737 ' O ' HG12 ' A' ' 29' ' ' VAL . 41.2 t 41.42 56.68 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.14 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -179.089 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -91.98 33.82 1.04 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.365 -1.289 . . . . 0.0 111.513 -177.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 24.4 m -159.48 131.03 6.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.759 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.453 ' HA ' ' HB3' ' A' ' 35' ' ' ALA . 9.8 ttp180 -57.81 -26.6 62.2 Favored 'General case' 0 CA--C 1.521 -0.14 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.332 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -61.58 -37.38 83.65 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.325 178.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -87.82 -39.07 15.16 Favored 'General case' 0 CA--C 1.527 0.087 0 CA-C-N 115.63 -0.713 . . . . 0.0 109.611 178.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.623 ' O ' HD23 ' A' ' 38' ' ' LEU . . . -61.21 -58.38 8.57 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 41.9 t -55.48 -23.3 25.01 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.732 178.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.1 tttm -68.83 -58.01 4.78 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.619 -179.194 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.623 HD23 ' O ' ' A' ' 35' ' ' ALA . 0.5 OUTLIER -80.19 8.89 6.39 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.231 -178.828 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.735 HD13 ' O ' ' A' ' 39' ' ' ILE . 0.1 OUTLIER -45.59 -41.12 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.368 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.459 ' N ' ' CG2' ' A' ' 39' ' ' ILE . . . -103.42 96.33 1.32 Allowed Glycine 0 CA--C 1.521 0.463 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 178.208 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 11.5 ttm180 -167.62 150.3 5.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.024 0.44 . . . . 0.0 110.382 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.845 ' O ' HG23 ' A' ' 86' ' ' ILE . 3.0 tp -88.07 123.08 32.39 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.5 -178.716 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.6 m -93.83 109.76 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.739 HD22 ' O ' ' A' ' 87' ' ' VAL . 6.0 mp -105.93 102.68 12.09 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 116.348 -0.387 . . . . 0.0 109.959 -179.486 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.635 ' HE1' ' CG ' ' A' ' 82' ' ' ASP . 34.7 t90 -91.56 123.42 34.95 Favored 'General case' 0 C--O 1.236 0.384 0 O-C-N 124.749 1.281 . . . . 0.0 110.761 -179.425 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 9.3 tttm -85.32 90.29 7.88 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.682 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.424 ' HB2' ' CH2' ' A' ' 45' ' ' TRP . 4.5 p . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.753 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.413 ' HG2' HD21 ' A' ' 53' ' ' LEU . 71.4 tttt . . . . . 0 C--O 1.231 0.121 0 CA-C-O 121.072 0.463 . . . . 0.0 110.161 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.434 HD13 ' N ' ' A' ' 52' ' ' ILE . 3.7 mm -82.49 111.6 19.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.011 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.413 HD21 ' HG2' ' A' ' 51' ' ' LYS . 45.1 mt -101.61 123.23 45.28 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.208 0.528 . . . . 0.0 111.489 -179.149 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 16.4 mttt -94.04 100.72 12.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.798 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -100.55 -172.46 29.43 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.544 -1.022 . . . . 0.0 110.544 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 39.7 tttp -155.09 138.85 16.17 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 120.428 -0.509 . . . . 0.0 111.57 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.7 mt -75.04 134.8 28.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.511 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.404 ' O ' HD11 ' A' ' 39' ' ' ILE . 0.8 OUTLIER -98.3 -50.92 10.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.855 -179.562 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 16.0 mtp180 -153.05 153.98 33.96 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.878 0.371 . . . . 0.0 110.822 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.631 HG23 HG12 ' A' ' 67' ' ' VAL . 3.4 p -71.89 157.81 6.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.085 179.21 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 12.0 t-160 -140.43 135.29 31.88 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.019 0.438 . . . . 0.0 110.825 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.429 ' O ' ' O ' ' A' ' 63' ' ' THR . . . 74.36 -15.51 3.45 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 111.487 -0.645 . . . . 0.0 111.487 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.429 ' O ' ' O ' ' A' ' 62' ' ' GLY . 81.4 p 56.35 142.47 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.021 0.438 . . . . 0.0 111.225 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.514 ' CG ' ' O ' ' A' ' 64' ' ' LYS . 16.5 ttpp 57.59 17.85 4.25 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.269 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -149.9 -126.39 1.42 Allowed Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.032 -178.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.7 -178.43 1.17 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.357 -0.922 . . . . 0.0 111.963 -178.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.631 HG12 HG23 ' A' ' 60' ' ' VAL . 6.6 m -154.33 163.89 1.63 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.158 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.364 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 56.4 ttt180 -89.51 153.95 20.39 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 178.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -149.29 156.48 42.17 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.349 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 -149.25 121.88 8.6 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.307 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -97.34 106.4 18.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.9 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -48.76 -26.04 2.15 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.609 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 53.0 mttt -81.59 -78.28 0.19 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.478 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 131.47 139.33 4.37 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -94.99 150.07 37.19 Favored Pre-proline 0 C--O 1.233 0.216 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -53.61 -81.06 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 122.409 2.073 . . . . 0.0 111.857 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 171.99 0.89 0.03 OUTLIER Glycine 0 CA--C 1.527 0.795 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.23 -22.44 16.7 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.783 0.325 . . . . 0.0 110.671 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.536 ' HB2' ' CH2' ' A' ' 45' ' ' TRP . . . -83.88 39.68 0.71 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.938 -179.479 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.2 tp -72.79 -23.69 60.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.501 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -137.53 14.94 3.66 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 121.037 -0.602 . . . . 0.0 111.94 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.635 ' CG ' ' HE1' ' A' ' 45' ' ' TRP . 19.4 t0 -72.18 143.12 49.01 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -69.26 134.04 48.68 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.308 -0.405 . . . . 0.0 109.937 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.45 ' O ' ' N ' ' A' ' 5' ' ' GLY . 33.1 m -97.57 155.99 3.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.409 ' HG3' ' O ' ' A' ' 84' ' ' VAL . 16.1 mp0 -148.26 154.49 40.11 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.08 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.845 HG23 ' O ' ' A' ' 42' ' ' LEU . 5.1 mp -100.57 72.41 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.447 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.739 ' O ' HD22 ' A' ' 44' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--O 1.227 -0.081 0 C-N-CA 119.982 -0.687 . . . . 0.0 110.238 -179.25 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 15.2 ptt180 . . . . . 0 CA--C 1.528 0.12 0 CA-C-O 120.701 0.286 . . . . 0.0 110.443 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.486 HG22 ' N ' ' A' ' 4' ' ' LYS . 3.7 mp -100.78 163.87 2.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.184 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.486 ' N ' HG22 ' A' ' 3' ' ' ILE . 9.9 ptpt -150.71 110.48 4.06 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 121.343 0.592 . . . . 0.0 111.874 -179.286 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -99.0 -176.13 31.96 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 178.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 24.5 t -142.05 134.37 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-O 120.991 0.424 . . . . 0.0 111.001 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 43.1 t -80.29 148.88 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 115.602 -0.727 . . . . 0.0 109.875 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -125.77 -23.16 4.06 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 121.062 -0.255 . . . . 0.0 111.402 -179.699 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.3 t -166.05 148.04 7.02 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.204 0.526 . . . . 0.0 111.995 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.501 ' HB2' HD21 ' A' ' 80' ' ' LEU . 6.8 t80 -107.43 163.87 12.68 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.155 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 7.2 ttp180 . . . . . 0 C--O 1.232 0.174 0 CA-C-O 121.033 0.444 . . . . 0.0 110.529 179.858 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 N--CA 1.463 0.193 0 CA-C-O 120.667 0.27 . . . . 0.0 110.307 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -150.63 148.32 28.48 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.043 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.4 mm -92.21 140.9 15.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.044 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.431 HG22 ' N ' ' A' ' 25' ' ' LYS . 96.5 mt -130.97 155.2 41.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.744 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.431 ' N ' HG22 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -136.92 100.42 9.8 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.847 179.708 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.546 ' O ' ' N ' ' A' ' 28' ' ' ASP . 3.4 Cg_exo -66.02 82.81 0.26 Allowed 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 122.451 2.101 . . . . 0.0 111.352 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.4 tp 33.04 -82.95 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.801 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.546 ' N ' ' O ' ' A' ' 26' ' ' PRO . 10.5 p30 -98.4 -87.27 0.34 Allowed 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.58 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.747 ' O ' HG12 ' A' ' 29' ' ' VAL . 43.5 t 43.02 57.55 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.238 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -178.009 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -91.81 42.01 1.09 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.584 -1.189 . . . . 0.0 110.74 -178.288 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.4 m -158.25 124.8 4.78 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.565 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.465 ' H ' ' HB3' ' A' ' 64' ' ' LYS . 0.6 OUTLIER -59.31 -26.7 65.22 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.315 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 65.6 mm-40 -60.88 -49.46 77.36 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.486 179.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -73.54 -45.71 51.98 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.211 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.26 -60.62 3.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.198 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.2 t -55.26 -38.73 68.91 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.837 179.343 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.1 mtpt -69.13 -20.56 64.05 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.927 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.529 ' O ' ' HG ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -85.99 -16.29 38.76 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.586 -179.624 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 68.4 mt -52.38 121.24 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-O 120.842 0.354 . . . . 0.0 110.441 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 111.75 -6.56 27.76 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.6 mmm-85 -69.96 156.83 38.54 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.823 0.344 . . . . 0.0 110.54 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.597 ' O ' HG23 ' A' ' 86' ' ' ILE . 4.0 tp -101.92 122.56 44.25 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.771 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 43' ' ' VAL . 33.7 m -92.03 106.52 17.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.712 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.725 HD21 HG23 ' A' ' 52' ' ' ILE . 6.2 tt -102.61 103.36 13.65 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.402 -179.449 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.416 ' CZ3' ' HB2' ' A' ' 47' ' ' SER . 80.1 t90 -95.64 105.49 17.49 Favored 'General case' 0 CA--C 1.53 0.205 0 O-C-N 124.91 1.381 . . . . 0.0 109.295 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.5 ttmt -81.76 102.05 10.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.223 -178.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.416 ' HB2' ' CZ3' ' A' ' 45' ' ' TRP . 10.1 t . . . . . 0 C--N 1.332 -0.161 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.881 179.081 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.9 ttmt . . . . . 0 C--O 1.233 0.202 0 CA-C-O 120.737 0.304 . . . . 0.0 110.23 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.725 HG23 HD21 ' A' ' 44' ' ' LEU . 1.3 mp -82.39 107.25 14.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.216 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 64.8 mt -93.95 152.18 19.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.683 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 6.3 pttt -152.3 104.18 2.92 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 120.913 0.387 . . . . 0.0 111.758 -178.659 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -90.29 -158.52 34.61 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.004 -1.239 . . . . 0.0 110.004 178.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 48.4 tttp -151.87 129.29 11.35 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.981 0.42 . . . . 0.0 111.009 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 32.1 mt -66.04 140.22 19.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.819 179.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -102.71 -47.86 10.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.209 -179.337 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.56 163.08 35.4 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.2 0.524 . . . . 0.0 111.333 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.2 p -78.9 154.74 4.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.514 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -140.52 130.03 24.05 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.599 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.21 -7.62 66.84 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.482 -0.647 . . . . 0.0 111.482 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.428 ' O ' ' CG ' ' A' ' 64' ' ' LYS . 38.4 p 58.67 138.57 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.892 0.377 . . . . 0.0 111.241 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.465 ' HB3' ' H ' ' A' ' 32' ' ' ARG . 5.2 ptmm? 43.99 32.17 0.6 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.053 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -149.76 -125.05 1.32 Allowed Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 111.44 -0.664 . . . . 0.0 111.44 -178.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.73 179.61 1.36 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.528 -0.836 . . . . 0.0 111.862 -178.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 28.1 m -154.73 151.3 10.94 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.841 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.6 ttp180 -88.96 148.28 23.87 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.44 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -148.71 160.78 42.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.048 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 63.5 mtt180 -145.75 121.1 10.27 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.835 0.35 . . . . 0.0 110.704 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -97.04 113.47 25.02 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.04 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -68.38 -25.73 65.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.467 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 9.8 mmtm -84.05 -80.43 0.19 Allowed 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.741 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 127.5 153.67 8.26 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.5 mt -90.36 153.46 46.32 Favored Pre-proline 0 N--CA 1.464 0.267 0 CA-C-O 120.699 0.285 . . . . 0.0 110.964 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.433 ' O ' ' C ' ' A' ' 77' ' ' GLY . 3.0 Cg_endo -66.7 157.06 62.89 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.714 2.276 . . . . 0.0 112.306 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 76' ' ' PRO . . . 29.04 -96.46 0.01 OUTLIER Glycine 0 N--CA 1.466 0.672 0 O-C-N 123.77 0.668 . . . . 0.0 111.614 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -156.05 103.42 2.21 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.832 0.349 . . . . 0.0 110.669 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -112.71 40.59 2.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.58 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.501 HD21 ' HB2' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -70.34 115.57 9.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.126 -179.483 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 108.6 -3.17 32.41 Favored Glycine 0 CA--C 1.525 0.685 0 CA-C-N 116.248 -0.433 . . . . 0.0 112.153 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -70.07 143.24 52.51 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -67.94 136.67 54.33 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.9 m -90.75 160.08 2.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -144.64 150.38 37.3 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.207 -178.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.597 HG23 ' O ' ' A' ' 42' ' ' LEU . 29.5 mt -110.1 72.79 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 178.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.455 ' H ' ' HB3' ' A' ' 44' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.463 0.203 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.03 -179.161 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 16.1 mtm180 . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.538 0.209 . . . . 0.0 110.727 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.7 mt -147.06 147.73 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.71 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 17.5 tptt -92.88 161.43 14.49 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.309 -0.859 . . . . 0.0 111.008 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -167.8 178.7 41.54 Favored Glycine 0 CA--C 1.528 0.886 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 179.291 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 30.7 t -149.31 136.03 12.79 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-O 121.126 0.489 . . . . 0.0 111.29 -178.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 47.8 t -74.21 148.35 8.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.118 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.7 mt -109.49 -60.84 1.72 Allowed 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.392 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.0 t -167.04 144.32 4.69 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.876 0.37 . . . . 0.0 111.162 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -95.91 118.55 32.76 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.335 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 40.1 mtt180 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.822 -179.859 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.673 HG12 ' N ' ' A' ' 22' ' ' MET . 48.1 t . . . . . 0 N--CA 1.461 0.113 0 CA-C-O 120.797 0.332 . . . . 0.0 110.333 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.673 ' N ' HG12 ' A' ' 21' ' ' VAL . 23.9 ttt -147.45 131.57 17.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.141 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.8 mm -95.19 141.86 14.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.86 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.555 ' O ' ' HB1' ' A' ' 66' ' ' ALA . 21.8 mt -139.95 154.31 23.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.678 179.309 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.428 ' O ' ' N ' ' A' ' 27' ' ' LEU . 68.0 tttt -138.2 100.63 8.6 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.731 -179.379 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.514 ' O ' ' N ' ' A' ' 28' ' ' ASP . 4.0 Cg_exo -64.41 70.9 0.22 Allowed 'Trans proline' 0 N--CA 1.488 1.168 0 C-N-CA 122.1 1.867 . . . . 0.0 111.749 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.432 HD12 ' HA ' ' A' ' 27' ' ' LEU . 15.0 tp 51.01 -79.98 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.77 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 26' ' ' PRO . 3.2 p30 -109.81 -87.17 0.52 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.662 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.715 ' O ' HG12 ' A' ' 29' ' ' VAL . 43.4 t 45.64 57.83 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -178.744 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -91.88 43.3 1.13 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.295 -1.321 . . . . 0.0 110.548 -178.547 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.9 t -157.85 120.92 3.92 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.643 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 39.7 ttt-85 -58.31 -27.76 64.41 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.507 179.154 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.0 tm-20 -60.32 -39.12 85.87 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.511 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -86.27 -46.95 9.85 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.282 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.561 ' O ' HD23 ' A' ' 38' ' ' LEU . . . -56.01 -58.69 6.83 Favored 'General case' 0 CA--C 1.527 0.083 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.624 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.0 t -53.23 -24.59 11.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.712 178.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 9.6 ttpp -69.95 -60.22 2.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.761 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.561 HD23 ' O ' ' A' ' 35' ' ' ALA . 0.4 OUTLIER -78.2 8.07 5.43 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 120.915 0.388 . . . . 0.0 110.87 -179.105 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 14.1 tt -52.33 -12.36 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.725 179.042 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.411 ' N ' ' C ' ' A' ' 38' ' ' LEU . . . -117.16 4.72 18.21 Favored Glycine 0 CA--C 1.53 0.982 0 N-CA-C 111.87 -0.492 . . . . 0.0 111.87 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -71.01 155.28 41.02 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.976 0.417 . . . . 0.0 110.996 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.716 ' O ' HG23 ' A' ' 86' ' ' ILE . 2.8 tt -98.55 130.79 45.12 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.634 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 43' ' ' VAL . 20.7 m -94.42 121.75 45.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.451 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.536 HD23 ' C ' ' A' ' 44' ' ' LEU . 7.1 tt -120.69 100.79 7.32 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.374 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.457 ' CZ3' ' HB2' ' A' ' 47' ' ' SER . 66.4 t90 -95.93 136.5 36.28 Favored 'General case' 0 C--N 1.349 0.569 0 O-C-N 125.225 1.578 . . . . 0.0 109.358 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.6 mtpt -81.87 165.28 20.95 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.921 -178.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.457 ' HB2' ' CZ3' ' A' ' 45' ' ' TRP . 0.2 OUTLIER . . . . . 0 CA--C 1.533 0.313 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.577 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.445 ' N ' ' HG ' ' A' ' 47' ' ' SER . 29.6 ttpt . . . . . 0 N--CA 1.463 0.192 0 CA-C-O 120.776 0.322 . . . . 0.0 111.155 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 22.7 mm -74.32 146.44 9.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 178.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 53' ' ' LEU . 67.5 mt -138.19 119.35 14.53 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.269 0.557 . . . . 0.0 111.874 -179.232 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.1 mptt -90.54 177.91 6.24 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.87 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -165.25 -176.95 37.3 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 178.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 55.4 tttt -154.66 129.62 9.47 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.765 0.317 . . . . 0.0 110.817 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 26.6 mt -72.67 130.2 35.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.641 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.5 m -102.66 -45.54 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.537 -0.302 . . . . 0.0 110.854 -179.515 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 22.1 mtt85 -144.42 158.97 43.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.859 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.7 p -87.39 156.17 3.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.143 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 74.5 t60 -140.84 117.7 11.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.151 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.08 5.62 63.86 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 -179.28 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.45 ' OG1' ' N ' ' A' ' 64' ' ' LYS . 32.4 p 58.69 -89.32 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 122.813 0.445 . . . . 0.0 111.513 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.45 ' N ' ' OG1' ' A' ' 63' ' ' THR . 15.4 pttm -90.84 55.51 2.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.835 0.35 . . . . 0.0 110.93 -179.478 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -159.58 -126.18 0.83 Allowed Glycine 0 N--CA 1.442 -0.952 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.555 ' HB1' ' O ' ' A' ' 24' ' ' ILE . . . -69.22 -177.65 1.15 Allowed 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.454 -0.873 . . . . 0.0 111.757 -179.125 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.1 m -148.85 158.69 6.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.197 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 14.8 ttp180 -87.35 150.17 24.01 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-O 121.056 0.455 . . . . 0.0 111.072 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -148.32 159.72 43.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.814 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 24.1 mtm180 -148.34 122.99 9.84 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.847 0.356 . . . . 0.0 110.765 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -101.21 117.65 35.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.387 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -70.76 -24.48 62.61 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -82.68 -77.87 0.22 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.628 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 126.2 150.3 7.59 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 17.3 mt -98.16 148.14 34.08 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 120.505 0.193 . . . . 0.0 110.862 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -49.16 -179.26 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 122.877 2.385 . . . . 0.0 112.494 179.474 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.9 -4.52 11.07 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 121.201 -0.524 . . . . 0.0 111.907 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.559 ' C ' ' H ' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -135.01 -142.71 0.19 Allowed 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.295 179.734 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.506 ' N ' ' CD ' ' A' ' 78' ' ' GLN . . . 64.32 -10.12 0.15 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.562 -178.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.559 ' H ' ' C ' ' A' ' 78' ' ' GLN . 2.1 tt -66.64 99.34 0.58 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.279 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 125.97 3.11 7.04 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -72.21 175.99 5.59 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-O 121.095 0.474 . . . . 0.0 110.716 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -92.66 128.13 38.41 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 26.3 m -92.66 156.91 3.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.233 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -147.9 153.24 38.83 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.704 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.716 HG23 ' O ' ' A' ' 42' ' ' LEU . 1.8 mp -103.65 74.08 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.41 ' O ' ' CB ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.466 0.373 0 C-N-CA 118.966 -1.094 . . . . 0.0 110.79 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 34.4 mtm105 . . . . . 0 C--O 1.233 0.218 0 CA-C-O 120.865 0.364 . . . . 0.0 111.052 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.43 HG22 ' H ' ' A' ' 4' ' ' LYS . 2.0 mt -145.15 168.9 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.487 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.51 ' O ' HD13 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -152.39 120.59 6.28 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.262 0.553 . . . . 0.0 111.949 -179.499 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -107.07 -175.66 22.8 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.442 HG22 ' CE2' ' A' ' 83' ' ' TYR . 27.4 t -140.29 137.87 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-O 121.126 0.489 . . . . 0.0 110.57 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 72.3 t -71.07 144.88 13.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.841 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.41 HD11 ' HB2' ' A' ' 25' ' ' LYS . 14.8 mt -106.71 -52.6 2.75 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.391 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.6 t -166.15 154.64 10.9 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.182 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.489 ' O ' ' CG ' ' A' ' 10' ' ' TYR . 0.5 OUTLIER -99.46 126.84 45.46 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.004 0.43 . . . . 0.0 110.42 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.445 HH11 HG11 ' A' ' 21' ' ' VAL . 47.7 mtp180 . . . . . 0 C--N 1.326 -0.432 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.085 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.541 HG12 ' N ' ' A' ' 22' ' ' MET . 72.9 t . . . . . 0 CA--C 1.528 0.111 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.541 ' N ' HG12 ' A' ' 21' ' ' VAL . 21.2 ptm -151.65 138.4 18.86 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.833 0.349 . . . . 0.0 110.881 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 55.2 mt -92.08 139.56 17.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.122 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.455 HG22 ' N ' ' A' ' 25' ' ' LYS . 77.5 mt -134.7 156.52 40.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.523 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.455 ' N ' HG22 ' A' ' 24' ' ' ILE . 71.9 tttt -144.24 120.79 6.37 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.867 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -61.14 169.36 6.27 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 121.872 1.715 . . . . 0.0 111.503 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.51 HD13 ' O ' ' A' ' 4' ' ' LYS . 0.8 OUTLIER -49.55 -77.49 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.625 -0.262 . . . . 0.0 110.951 -179.334 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.483 ' CG ' ' H ' ' A' ' 29' ' ' VAL . 2.8 p-10 -94.51 -88.61 0.24 Allowed 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.521 -0.472 . . . . 0.0 111.107 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.626 ' O ' HG12 ' A' ' 29' ' ' VAL . 82.5 t 41.32 55.7 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.165 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 -178.42 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -88.51 40.62 0.97 Allowed 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 114.365 -1.289 . . . . 0.0 110.998 -177.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 68.7 m -158.84 128.11 5.54 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.862 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 47.4 ttp180 -61.25 -25.38 67.04 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.028 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -62.32 -52.01 65.37 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.602 178.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -69.57 -38.41 77.38 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.434 178.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.524 ' O ' HD23 ' A' ' 38' ' ' LEU . . . -59.24 -60.66 3.51 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.003 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.404 ' O ' HG22 ' A' ' 39' ' ' ILE . 11.7 t -55.92 -22.96 28.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.732 179.238 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 34.4 tttp -70.86 -61.66 1.68 Allowed 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.749 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.524 HD23 ' O ' ' A' ' 35' ' ' ALA . 0.4 OUTLIER -77.52 5.94 8.05 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.243 -178.955 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.503 ' N ' HD23 ' A' ' 38' ' ' LEU . 8.1 tt -51.08 133.97 12.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.229 179.268 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.431 ' O ' ' NZ ' ' A' ' 56' ' ' LYS . . . 81.2 25.32 55.36 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.686 ' HG3' HD12 ' A' ' 57' ' ' ILE . 5.3 ptt180 -71.57 171.29 11.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.713 0.292 . . . . 0.0 110.367 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.522 ' O ' HG23 ' A' ' 86' ' ' ILE . 23.5 tp -100.82 112.18 24.54 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.135 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 43' ' ' VAL . 4.2 m -88.19 121.37 38.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.13 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.677 HD21 ' CG2' ' A' ' 52' ' ' ILE . 6.0 tt -123.49 98.41 5.83 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.73 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.461 ' CZ3' ' OG ' ' A' ' 47' ' ' SER . 75.8 t90 -100.73 109.92 21.98 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 125.089 1.493 . . . . 0.0 109.676 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 5.9 pttp -83.72 105.11 14.37 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 121.073 0.463 . . . . 0.0 111.41 -178.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.461 ' OG ' ' CZ3' ' A' ' 45' ' ' TRP . 0.9 OUTLIER . . . . . 0 CA--C 1.531 0.233 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.707 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 27.7 tttp . . . . . 0 C--O 1.227 -0.088 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.677 ' CG2' HD21 ' A' ' 44' ' ' LEU . 23.2 mm -83.49 111.15 19.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.444 -178.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 71.4 mt -100.15 143.31 30.5 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.855 179.093 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.6 pttp -150.24 116.35 5.66 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 120.945 0.403 . . . . 0.0 110.95 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -104.09 -150.64 21.27 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.431 ' NZ ' ' O ' ' A' ' 40' ' ' GLY . 0.2 OUTLIER -154.26 130.42 10.35 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.782 0.325 . . . . 0.0 110.881 179.9 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.686 HD12 ' HG3' ' A' ' 41' ' ' ARG . 34.6 mt -65.13 147.89 12.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.134 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -107.01 -40.56 5.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 C-N-CA 120.596 -0.442 . . . . 0.0 111.491 -178.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -164.55 155.14 14.66 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 120.392 -0.523 . . . . 0.0 111.853 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.571 HG13 ' O ' ' A' ' 60' ' ' VAL . 13.3 p -92.82 116.33 33.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.322 178.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -140.21 123.87 17.22 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.265 -178.738 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 136.24 -16.84 3.86 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 121.327 -0.463 . . . . 0.0 112.056 178.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.633 ' C ' ' H ' ' A' ' 65' ' ' GLY . 80.7 p 54.79 164.91 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.776 0.322 . . . . 0.0 111.025 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 38.2 tttp 67.1 -17.3 0.14 Allowed 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.148 0.499 . . . . 0.0 110.0 -178.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.633 ' H ' ' C ' ' A' ' 63' ' ' THR . . . 131.57 121.12 2.24 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.555 ' O ' HG23 ' A' ' 60' ' ' VAL . . . 174.68 149.01 0.08 Allowed 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.504 HG13 ' O ' ' A' ' 66' ' ' ALA . 8.7 m -157.13 139.15 5.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 120.253 -0.579 . . . . 0.0 111.404 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -90.97 146.63 23.71 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 178.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -146.35 160.1 42.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.229 0.537 . . . . 0.0 111.278 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 5.8 ttp180 -148.3 131.97 16.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.675 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.457 ' C ' ' H ' ' A' ' 73' ' ' LYS . 17.5 m-85 -92.87 141.81 28.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.991 0.424 . . . . 0.0 110.828 -179.388 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -62.35 -0.47 0.58 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.444 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.457 ' H ' ' C ' ' A' ' 71' ' ' PHE . 33.3 ttmt -154.88 -64.7 0.13 Allowed 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.629 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 142.53 -177.24 21.82 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.3 mt -95.48 165.76 16.07 Favored Pre-proline 0 CA--C 1.53 0.175 0 CA-C-O 120.705 0.288 . . . . 0.0 110.99 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -76.14 99.94 1.33 Allowed 'Trans proline' 0 N--CA 1.489 1.235 0 C-N-CA 122.971 2.447 . . . . 0.0 112.214 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 42.48 -113.06 0.54 Allowed Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.762 -0.535 . . . . 0.0 111.762 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -81.8 116.05 21.3 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.77 0.319 . . . . 0.0 110.787 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -154.4 8.14 0.32 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.322 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.5 tp -68.56 117.04 9.8 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.768 0.318 . . . . 0.0 110.491 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 118.5 -10.92 12.64 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.437 ' HB3' ' HE1' ' A' ' 45' ' ' TRP . 2.1 m-20 -68.36 131.08 44.7 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.442 ' CE2' HG22 ' A' ' 6' ' ' VAL . 5.8 m-85 -67.55 135.78 53.51 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.4 m -90.78 163.21 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.509 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 52.0 mp0 -148.14 145.11 28.22 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.533 HG22 ' O ' ' A' ' 86' ' ' ILE . 3.5 mp -101.06 73.3 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 44' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.463 0.219 0 C-N-CA 119.749 -0.78 . . . . 0.0 110.67 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 17.3 ptt85 . . . . . 0 C--O 1.233 0.195 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.467 ' HB ' HD13 ' A' ' 86' ' ' ILE . 1.4 mt -148.4 144.88 18.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.266 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 52.0 mttt -83.17 173.45 11.66 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.646 -179.432 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 84' ' ' VAL . . . -171.47 174.66 45.05 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 22.0 t -149.15 143.97 18.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.262 0.553 . . . . 0.0 111.236 -178.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 75.7 t -79.88 147.46 6.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.972 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.486 HD11 ' HB2' ' A' ' 25' ' ' LYS . 13.4 mt -111.05 -52.43 2.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.644 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.7 t -163.88 124.27 2.17 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.402 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -99.36 105.67 17.68 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.325 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 35.9 mtt180 . . . . . 0 C--N 1.331 -0.232 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.772 179.819 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.54 HG12 ' N ' ' A' ' 22' ' ' MET . 45.5 t . . . . . 0 N--CA 1.456 -0.173 0 CA-C-O 120.902 0.382 . . . . 0.0 110.083 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.54 ' N ' HG12 ' A' ' 21' ' ' VAL . 13.1 ttt -148.59 112.75 5.21 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.874 -179.067 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.426 HG22 HD12 ' A' ' 8' ' ' LEU . 19.2 mt -85.19 136.26 23.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 41.2 mt -137.07 154.15 30.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.245 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.486 ' HB2' HD11 ' A' ' 8' ' ' LEU . 30.4 tttt -146.79 122.0 5.37 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.361 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -60.74 164.47 13.63 Favored 'Trans proline' 0 N--CA 1.489 1.228 0 C-N-CA 121.418 1.412 . . . . 0.0 111.152 178.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.7 tp -45.28 -80.79 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.888 -179.198 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.466 ' O ' ' C ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -93.8 -84.9 0.3 Allowed 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.964 -0.295 . . . . 0.0 110.444 179.383 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.701 ' O ' HG12 ' A' ' 29' ' ' VAL . 64.7 t 39.99 53.63 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 -178.436 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -88.53 44.36 1.2 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.441 -1.254 . . . . 0.0 110.727 -177.089 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.9 m -157.98 124.7 4.89 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.085 -0.962 . . . . 0.0 109.964 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.48 ' HA ' ' HB3' ' A' ' 35' ' ' ALA . 11.6 ttp180 -58.5 -26.95 64.0 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.333 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -61.21 -50.37 73.39 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.876 179.239 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.3 tp10 -72.46 -37.96 68.39 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.547 ' O ' HD23 ' A' ' 38' ' ' LEU . . . -60.4 -69.4 0.22 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.308 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.1 t -44.38 -18.61 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.831 0.348 . . . . 0.0 110.424 179.366 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.468 ' N ' ' C ' ' A' ' 35' ' ' ALA . 2.1 tmtt? -72.39 -63.04 1.23 Allowed 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.22 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.547 HD23 ' O ' ' A' ' 35' ' ' ALA . 0.5 OUTLIER -74.53 9.75 1.63 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.964 0.412 . . . . 0.0 110.324 -179.053 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.41 ' H ' ' C ' ' A' ' 37' ' ' LYS . 18.4 tt -48.63 -16.31 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.407 179.023 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -123.33 6.96 9.19 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.933 -178.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.8 mmt180 -72.15 175.68 5.81 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 117.591 0.696 . . . . 0.0 110.616 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.677 HD23 ' N ' ' A' ' 43' ' ' VAL . 6.5 tt -98.38 169.56 9.47 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.056 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.677 ' N ' HD23 ' A' ' 42' ' ' LEU . 33.8 m -140.84 99.5 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.185 0.517 . . . . 0.0 109.929 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.576 HD23 ' C ' ' A' ' 44' ' ' LEU . 5.9 tt -102.16 99.72 9.87 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.742 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.423 ' HE1' ' HB3' ' A' ' 82' ' ' ASP . 10.4 t90 -106.2 116.51 32.06 Favored 'General case' 0 C--O 1.234 0.278 0 O-C-N 124.682 1.239 . . . . 0.0 109.738 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.8 pttp -84.01 105.7 15.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.935 0.398 . . . . 0.0 110.487 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.4 t . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.245 179.844 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.0 ttmm . . . . . 0 CA--C 1.527 0.078 0 CA-C-O 120.661 0.267 . . . . 0.0 110.614 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 28.7 mm -82.04 109.79 16.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.453 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 75.5 mt -104.51 143.55 32.89 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.063 0.459 . . . . 0.0 110.869 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -151.87 101.99 2.79 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.885 -178.47 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -104.98 -142.25 11.27 Favored Glycine 0 N--CA 1.464 0.504 0 N-CA-C 109.771 -1.331 . . . . 0.0 109.771 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 23.9 tttm -154.98 139.7 17.09 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.068 0.461 . . . . 0.0 111.122 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 80.0 mt -69.85 138.95 21.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.059 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -105.43 -34.14 3.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -178.617 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.477 ' NH2' ' NH2' ' A' ' 70' ' ' ARG . 5.0 ptt-85 -165.69 157.45 14.44 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 120.435 -0.506 . . . . 0.0 111.319 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.56 HG13 ' O ' ' A' ' 60' ' ' VAL . 7.3 p -97.98 121.44 48.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.543 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.42 ' ND1' ' O ' ' A' ' 60' ' ' VAL . 11.3 m80 -141.11 132.78 27.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.113 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.428 ' O ' ' OG1' ' A' ' 63' ' ' THR . . . 124.94 -12.8 7.66 Favored Glycine 0 CA--C 1.519 0.288 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.545 ' O ' ' N ' ' A' ' 65' ' ' GLY . 19.9 p 53.53 171.87 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 -179.117 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt 65.57 -52.94 0.36 Allowed 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -178.502 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 63' ' ' THR . . . 165.81 121.64 0.57 Allowed Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 178.062 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.578 ' O ' HG13 ' A' ' 67' ' ' VAL . . . 174.87 159.59 0.19 Allowed 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.578 HG13 ' O ' ' A' ' 66' ' ' ALA . 7.9 m -159.11 144.32 6.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 C-N-CA 120.044 -0.663 . . . . 0.0 111.212 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 23.2 ttm180 -90.51 154.89 19.29 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.227 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -146.15 168.63 20.51 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.209 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.477 ' NH2' ' NH2' ' A' ' 59' ' ' ARG . 92.8 mtt180 -147.25 111.91 5.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.216 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.482 ' CE1' ' SD ' ' A' ' 22' ' ' MET . 51.8 m-85 -96.43 109.95 22.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.748 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -82.31 -13.33 57.11 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.122 0.487 . . . . 0.0 109.835 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 45.4 mmtt -80.96 -77.6 0.2 Allowed 'General case' 0 C--O 1.231 0.116 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.742 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 135.41 154.91 7.14 Favored Glycine 0 C--N 1.335 0.508 0 N-CA-C 111.241 -0.744 . . . . 0.0 111.241 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.432 HD23 ' N ' ' A' ' 75' ' ' LEU . 0.9 OUTLIER -89.13 174.45 4.94 Favored Pre-proline 0 N--CA 1.463 0.183 0 N-CA-C 110.414 -0.217 . . . . 0.0 110.414 -179.909 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -76.06 -82.89 0.0 OUTLIER 'Trans proline' 0 C--N 1.315 -1.197 0 C-N-CA 122.305 2.003 . . . . 0.0 111.044 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -176.21 104.45 0.19 Allowed Glycine 0 N--CA 1.451 -0.304 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 179.333 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 70.32 62.93 0.22 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.92 0.391 . . . . 0.0 111.087 179.514 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -115.43 -0.6 13.07 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.511 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.9 tp -52.6 114.49 1.41 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.818 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 125.52 -13.27 7.37 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 111.744 -0.542 . . . . 0.0 111.744 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.423 ' HB3' ' HE1' ' A' ' 45' ' ' TRP . 46.2 m-20 -70.35 136.67 49.92 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 120.442 -0.503 . . . . 0.0 109.983 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -69.56 125.59 27.18 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.773 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.441 ' O ' ' N ' ' A' ' 5' ' ' GLY . 18.0 m -94.36 154.96 3.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -149.94 164.29 35.84 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.323 0.582 . . . . 0.0 110.65 -178.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.496 ' N ' HD12 ' A' ' 86' ' ' ILE . 5.1 mp -103.44 74.48 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 178.73 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.468 0.456 0 C-N-CA 120.093 -0.643 . . . . 0.0 110.946 -179.212 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.431 ' O ' HD13 ' A' ' 3' ' ' ILE . 11.5 mmt180 . . . . . 0 C--O 1.232 0.172 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.56 HG22 ' H ' ' A' ' 4' ' ' LYS . 8.0 mm -138.13 169.85 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.56 ' H ' HG22 ' A' ' 3' ' ' ILE . 9.4 ptpt -150.81 103.85 3.12 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 121.259 0.552 . . . . 0.0 111.329 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -94.57 -177.3 38.51 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 179.391 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 p -146.5 135.38 16.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-O 121.222 0.534 . . . . 0.0 111.359 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 99.0 t -79.86 140.19 17.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.655 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 17.3 mt -105.52 -57.24 2.06 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.288 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.8 m -165.86 142.29 5.21 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.294 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -100.44 138.75 37.08 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 120.859 0.361 . . . . 0.0 110.689 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 10.6 mmt180 . . . . . 0 C--N 1.331 -0.2 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.485 -179.756 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.679 HG12 ' H ' ' A' ' 22' ' ' MET . 2.1 t . . . . . 0 C--O 1.231 0.128 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.679 ' H ' HG12 ' A' ' 21' ' ' VAL . 30.8 tpp -143.65 119.18 10.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.046 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 6.2 mm -83.23 133.0 30.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.584 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.419 ' CG2' ' N ' ' A' ' 25' ' ' LYS . 12.3 mt -138.9 156.72 28.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.523 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.419 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 11.4 ttmm -140.67 119.89 8.49 Favored Pre-proline 0 C--N 1.33 -0.28 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.458 ' O ' ' N ' ' A' ' 28' ' ' ASP . 2.9 Cg_endo -67.86 59.2 0.86 Allowed 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.313 2.009 . . . . 0.0 111.273 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.0 tp 54.31 -79.76 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.638 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.572 ' CG ' ' H ' ' A' ' 29' ' ' VAL . 9.2 p-10 -101.29 -90.75 0.33 Allowed 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.503 -0.479 . . . . 0.0 111.44 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.7 ' O ' HG12 ' A' ' 29' ' ' VAL . 53.3 t 44.7 55.95 0.33 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.194 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 -178.126 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -89.23 50.29 1.91 Allowed 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 114.356 -1.293 . . . . 0.0 110.812 -178.068 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 10.1 m -158.85 108.76 1.99 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.101 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 26.9 ttt85 -47.79 -31.8 5.29 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.161 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -62.59 -55.33 28.15 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.933 179.22 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -65.42 -39.37 92.04 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.104 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.56 ' O ' HD23 ' A' ' 38' ' ' LEU . . . -58.93 -59.83 4.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.18 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.5 m -53.65 -22.07 8.12 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.614 179.217 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.0 tttp -68.96 -63.42 1.06 Allowed 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.067 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.56 HD23 ' O ' ' A' ' 35' ' ' ALA . 0.4 OUTLIER -80.32 16.8 1.19 Allowed 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 121.019 0.437 . . . . 0.0 111.053 -179.423 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.59 HD12 HG12 ' A' ' 60' ' ' VAL . 19.3 tt -50.38 -32.75 10.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.233 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -102.9 24.03 31.9 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.412 ' HG2' HD13 ' A' ' 86' ' ' ILE . 1.8 tpp180 -71.15 146.15 49.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.747 0.308 . . . . 0.0 110.569 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.571 ' O ' HG23 ' A' ' 86' ' ' ILE . 7.8 tp -96.19 121.02 37.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.156 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 43' ' ' VAL . 10.8 m -87.08 122.62 39.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.282 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.436 ' H ' ' HA ' ' A' ' 86' ' ' ILE . 0.5 OUTLIER -107.84 98.23 7.84 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.441 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 37.3 t90 -86.61 113.02 22.16 Favored 'General case' 0 C--O 1.234 0.246 0 O-C-N 125.209 1.568 . . . . 0.0 110.448 -178.469 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.415 ' HG3' HD11 ' A' ' 52' ' ' ILE . 75.5 tttt -83.56 93.63 7.89 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.004 -179.374 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.1 p . . . . . 0 CA--C 1.532 0.264 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.049 -179.968 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt . . . . . 0 CA--C 1.529 0.14 0 CA-C-O 120.566 0.222 . . . . 0.0 110.616 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.415 HD11 ' HG3' ' A' ' 46' ' ' LYS . 1.2 mp -79.18 108.01 12.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.241 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.518 HD22 ' CA ' ' A' ' 74' ' ' GLY . 13.7 mt -90.34 126.25 35.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.375 0.607 . . . . 0.0 110.943 -178.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 28.5 mttm -91.49 110.17 21.48 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.88 -1.055 . . . . 0.0 111.281 -179.391 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -95.46 178.81 35.68 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 178.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 38.7 tttt -152.84 131.45 12.28 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.528 -0.469 . . . . 0.0 111.426 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.2 mt -75.6 142.47 14.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.867 179.164 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -104.83 -34.29 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.81 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -164.85 156.23 15.08 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.045 0.45 . . . . 0.0 111.466 179.292 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.59 HG12 HD12 ' A' ' 39' ' ' ILE . 14.9 p -98.24 139.22 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.656 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.93 ' O ' ' HB3' ' A' ' 66' ' ' ALA . 56.7 t-80 -142.2 168.77 18.95 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.46 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.515 ' C ' ' H ' ' A' ' 64' ' ' LYS . . . 91.12 -34.14 4.4 Favored Glycine 0 CA--C 1.525 0.683 0 CA-C-N 116.19 -0.459 . . . . 0.0 112.707 178.702 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.3 p 68.22 -34.18 0.25 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.682 0.241 . . . . 0.0 110.849 -179.042 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.515 ' H ' ' C ' ' A' ' 62' ' ' GLY . 0.8 OUTLIER -89.31 -7.42 55.39 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.579 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.423 ' O ' ' HB2' ' A' ' 66' ' ' ALA . . . 130.65 119.78 2.15 Favored Glycine 0 CA--C 1.522 0.476 0 CA-C-N 114.517 -1.22 . . . . 0.0 110.224 178.436 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.93 ' HB3' ' O ' ' A' ' 61' ' ' HIS . . . 172.68 150.26 0.06 Allowed 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.413 HG13 ' O ' ' A' ' 66' ' ' ALA . 17.4 m -156.19 141.0 9.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.539 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -88.91 150.39 22.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.421 179.292 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -146.85 163.59 35.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.963 0.411 . . . . 0.0 111.055 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 53.2 mtt180 -146.4 121.24 9.93 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.079 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.557 ' C ' ' H ' ' A' ' 73' ' ' LYS . 60.3 m-85 -97.48 138.85 34.29 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.116 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.573 ' O ' ' CB ' ' A' ' 73' ' ' LYS . 8.9 pt-20 -74.95 36.5 0.11 Allowed 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.136 178.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.573 ' CB ' ' O ' ' A' ' 72' ' ' GLU . 9.9 ttpt 93.28 -32.97 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 115.008 -0.997 . . . . 0.0 110.18 -179.485 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.518 ' CA ' HD22 ' A' ' 53' ' ' LEU . . . -10.97 -59.84 0.01 OUTLIER Glycine 0 CA--C 1.53 0.997 0 O-C-N 124.431 1.082 . . . . 0.0 113.164 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.448 ' N ' ' O ' ' A' ' 73' ' ' LYS . 10.9 mt -56.67 113.71 6.52 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-N 116.709 0.254 . . . . 0.0 110.552 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -69.34 -174.9 0.9 Allowed 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 122.436 2.091 . . . . 0.0 112.347 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -51.13 115.09 3.29 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.553 ' O ' ' HB2' ' A' ' 79' ' ' ALA . 9.3 tm0? 69.48 145.81 0.06 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.914 0.388 . . . . 0.0 110.708 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.553 ' HB2' ' O ' ' A' ' 78' ' ' GLN . . . 166.91 -21.0 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.242 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.4 tp -43.7 129.13 5.49 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.224 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 98.53 -7.64 61.64 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.827 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -71.5 135.94 47.34 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -68.58 129.41 39.86 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.1 m -90.3 170.99 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -149.88 151.16 33.02 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.571 HG23 ' O ' ' A' ' 42' ' ' LEU . 16.8 mt -108.69 73.2 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 178.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.4 t . . . . . 0 N--CA 1.464 0.231 0 C-N-CA 120.115 -0.634 . . . . 0.0 111.015 -178.628 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 20.9 mtm180 . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.973 0.416 . . . . 0.0 110.836 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.2 mt -144.32 158.51 15.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.419 -0.81 . . . . 0.0 108.86 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.78 107.85 4.05 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.467 0.651 . . . . 0.0 112.082 -178.776 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.419 ' C ' HG22 ' A' ' 84' ' ' VAL . . . -95.85 -177.35 36.61 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 178.343 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 75.2 t -145.42 135.68 18.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.202 0.525 . . . . 0.0 110.468 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.9 t -73.0 142.72 14.69 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.391 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 52.0 mt -110.49 -33.71 6.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.055 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.6 m -161.28 134.56 6.46 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.935 0.397 . . . . 0.0 110.886 -179.125 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -106.44 101.15 10.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.541 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.43 ' O ' ' O ' ' A' ' 21' ' ' VAL . 5.8 mpt_? . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.373 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.43 ' O ' ' O ' ' A' ' 11' ' ' ARG . 88.1 t . . . . . 0 N--CA 1.464 0.274 0 CA-C-O 120.871 0.367 . . . . 0.0 110.468 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 15.2 ptm -145.81 143.04 29.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.961 0.41 . . . . 0.0 111.093 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 29.4 mm -92.65 143.15 12.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.106 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.625 HD12 ' CB ' ' A' ' 69' ' ' ALA . 31.5 mt -133.19 156.87 42.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.399 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.428 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -140.3 99.8 7.12 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.644 179.824 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.537 ' O ' ' N ' ' A' ' 28' ' ' ASP . 3.3 Cg_exo -65.17 74.12 0.25 Allowed 'Trans proline' 0 C--N 1.314 -1.268 0 C-N-CA 121.984 1.789 . . . . 0.0 111.051 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.415 ' N ' ' O ' ' A' ' 25' ' ' LYS . 0.9 OUTLIER 37.92 -82.64 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 114.849 -1.069 . . . . 0.0 112.097 -179.758 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.537 ' N ' ' O ' ' A' ' 26' ' ' PRO . 1.1 p-10 -99.24 -87.11 0.36 Allowed 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.363 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.778 ' O ' HG12 ' A' ' 29' ' ' VAL . 19.1 t 44.14 62.27 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-O 122.245 1.022 . . . . 0.0 108.294 -177.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -93.63 47.22 1.22 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.15 -1.386 . . . . 0.0 110.941 -178.182 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 70.3 m -156.72 118.99 3.94 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.541 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.439 ' H ' ' HB3' ' A' ' 64' ' ' LYS . 1.4 ttt85 -51.89 -30.93 26.12 Favored 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.429 ' O ' ' CB ' ' A' ' 37' ' ' LYS . 45.3 mt-10 -63.01 -63.15 1.29 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.643 179.038 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -54.86 -46.62 74.72 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.03 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -57.84 -69.48 0.17 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.985 179.279 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 65.0 m -50.82 -36.68 38.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.677 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.429 ' CB ' ' O ' ' A' ' 33' ' ' GLU . 60.5 tttt -71.35 -14.75 62.29 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.304 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.529 HD21 HD13 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -86.47 -11.31 52.16 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 120.853 0.358 . . . . 0.0 110.628 -179.524 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 53.7 mt -55.16 121.63 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.658 178.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 103.79 -4.05 45.94 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.714 -0.554 . . . . 0.0 111.714 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -70.37 142.33 52.13 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.854 0.359 . . . . 0.0 110.206 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.455 ' O ' HG23 ' A' ' 86' ' ' ILE . 11.6 tp -81.51 111.29 17.7 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.089 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.64 HG23 ' O ' ' A' ' 43' ' ' VAL . 6.7 m -88.81 107.4 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 121.581 0.705 . . . . 0.0 111.182 -178.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.1 mp -102.98 92.97 4.78 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 1.2 t90 -91.87 129.08 37.9 Favored 'General case' 0 C--O 1.235 0.304 0 O-C-N 124.717 1.26 . . . . 0.0 110.736 -178.065 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.401 ' HA ' ' CD1' ' A' ' 52' ' ' ILE . 1.6 ttmp? -81.76 91.96 6.57 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.966 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.326 -0.435 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.011 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 7.0 ttpm? . . . . . 0 CA--C 1.519 -0.226 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.413 ' HA ' HD13 ' A' ' 52' ' ' ILE . 28.5 mm -83.97 112.92 22.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.562 HD22 ' CA ' ' A' ' 74' ' ' GLY . 16.9 mt -99.66 125.21 45.46 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.265 0.555 . . . . 0.0 111.301 -179.109 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.3 mtpt -89.1 166.85 13.59 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.572 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -161.99 178.57 37.78 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.6 tttt -152.2 123.7 7.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.826 0.346 . . . . 0.0 111.023 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.529 HD13 HD21 ' A' ' 38' ' ' LEU . 22.4 mt -66.02 144.8 14.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.315 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.3 m -109.36 -34.54 2.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.584 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -163.37 158.02 20.7 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.745 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.4 p -88.54 153.8 3.24 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.431 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -140.86 125.08 17.45 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.25 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.3 13.82 55.13 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 -179.376 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.4 ' HG1' ' H ' ' A' ' 64' ' ' LYS . 82.2 p 52.92 -99.99 0.09 Allowed 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 122.44 0.296 . . . . 0.0 111.348 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.439 ' HB3' ' H ' ' A' ' 32' ' ' ARG . 16.4 pttt -88.16 55.93 3.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.829 -179.448 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -156.13 -125.41 0.9 Allowed Glycine 0 N--CA 1.446 -0.7 0 N-CA-C 111.366 -0.694 . . . . 0.0 111.366 -178.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.422 ' HB1' ' O ' ' A' ' 24' ' ' ILE . . . -67.9 -177.5 0.82 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.25 -0.975 . . . . 0.0 111.688 -178.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.3 m -153.11 156.85 5.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.099 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 8.7 tpp180 -88.88 154.49 20.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.933 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.625 ' CB ' HD12 ' A' ' 24' ' ' ILE . . . -149.85 154.38 38.29 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.199 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -148.79 128.76 13.49 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.909 0.385 . . . . 0.0 111.156 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.466 ' HB2' HD23 ' A' ' 75' ' ' LEU . 23.3 m-85 -103.96 117.05 33.39 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.54 179.332 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -80.96 -10.9 59.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.818 -178.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.466 ' O ' ' N ' ' A' ' 75' ' ' LEU . 24.7 ttpt -160.03 -45.66 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 120.36 -0.536 . . . . 0.0 111.933 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.562 ' CA ' HD22 ' A' ' 53' ' ' LEU . . . -64.84 51.77 0.1 Allowed Glycine 0 CA--C 1.529 0.968 0 O-C-N 123.513 0.508 . . . . 0.0 112.015 -178.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.466 HD23 ' HB2' ' A' ' 71' ' ' PHE . 0.2 OUTLIER -138.4 91.26 12.64 Favored Pre-proline 0 C--N 1.329 -0.289 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -59.08 -80.95 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 121.945 1.764 . . . . 0.0 112.107 -179.075 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -173.84 9.65 0.03 OUTLIER Glycine 0 CA--C 1.525 0.681 0 C-N-CA 120.743 -0.742 . . . . 0.0 111.589 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -157.87 107.35 2.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.844 0.354 . . . . 0.0 110.51 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -139.92 4.3 2.08 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.741 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.8 tp -77.15 98.94 5.23 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.265 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 123.61 -26.84 5.88 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 121.224 -0.512 . . . . 0.0 112.183 178.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -70.9 129.4 38.95 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 117.232 0.516 . . . . 0.0 109.924 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -68.59 134.02 49.36 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.419 HG22 ' C ' ' A' ' 5' ' ' GLY . 29.7 m -90.73 160.13 2.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -147.61 151.33 36.04 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.336 -0.546 . . . . 0.0 110.565 -178.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.455 HG23 ' O ' ' A' ' 42' ' ' LEU . 33.5 mt -110.01 72.05 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 178.17 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.7 t . . . . . 0 C--N 1.332 -0.195 0 C-N-CA 119.7 -0.8 . . . . 0.0 110.826 -178.824 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.9 tpt . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.85 174.67 9.14 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.096 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.419 HG22 ' N ' ' A' ' 4' ' ' LYS . 11.3 mt -145.29 163.46 12.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.926 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.419 ' N ' HG22 ' A' ' 3' ' ' ILE . 5.8 ptpt -139.04 177.08 8.16 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.111 0.482 . . . . 0.0 110.805 -179.072 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -170.44 -176.04 39.62 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 -178.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.9 t -140.35 127.51 23.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.086 0.47 . . . . 0.0 110.2 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 66.1 t -63.23 151.71 8.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.558 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.453 HD12 HG22 ' A' ' 23' ' ' ILE . 37.1 mt -109.86 -61.32 1.66 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.272 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.5 t -166.4 133.48 2.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.634 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -106.59 115.48 30.27 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.357 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.32 116.82 27.82 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.33 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.16 62.51 1.11 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.31 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.9 t -38.8 117.63 0.68 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.901 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 13.0 tttp -62.27 -61.04 2.74 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.562 -179.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.617 ' CD ' ' H ' ' A' ' 15' ' ' GLU . 1.0 OUTLIER -58.33 -162.35 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.376 179.973 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -151.8 95.44 2.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.243 0.544 . . . . 0.0 110.64 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.482 ' O ' ' CG ' ' A' ' 18' ' ' HIS . 0.7 OUTLIER -158.47 16.71 0.21 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.295 179.884 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.482 ' CG ' ' O ' ' A' ' 17' ' ' GLN . 3.0 m170 -173.79 -5.25 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.862 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.457 ' H ' ' H ' ' A' ' 18' ' ' HIS . 1.5 t-20 68.3 173.66 0.28 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.42 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -78.23 142.75 37.67 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.749 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 98.5 t -113.68 154.81 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.64 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.541 ' SD ' ' CE1' ' A' ' 71' ' ' PHE . 23.6 ttt -143.71 123.37 13.31 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.565 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.453 HG22 HD12 ' A' ' 8' ' ' LEU . 16.1 mm -98.97 134.77 36.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.775 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.595 ' O ' ' HB1' ' A' ' 66' ' ' ALA . 38.4 mt -125.61 153.91 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.637 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.2 ttmm -137.45 98.51 10.0 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.885 -179.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.479 ' O ' ' C ' ' A' ' 27' ' ' LEU . 3.5 Cg_exo -70.74 135.55 28.37 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 122.265 1.977 . . . . 0.0 110.722 178.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.479 ' C ' ' O ' ' A' ' 26' ' ' PRO . 7.6 mp -19.33 -85.32 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -179.068 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.409 ' CG ' ' H ' ' A' ' 29' ' ' VAL . 5.2 p30 -93.1 -91.86 0.17 Allowed 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.526 -179.223 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.705 ' O ' HG12 ' A' ' 29' ' ' VAL . 91.2 t 48.19 46.39 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.145 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 -178.25 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 11.2 p-10 -89.58 51.16 2.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.841 -178.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -159.2 111.42 2.16 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.68 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.423 ' H ' ' HG2' ' A' ' 64' ' ' LYS . 14.9 ttt85 -48.26 -29.94 4.31 Favored 'General case' 0 N--CA 1.462 0.143 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -61.05 -58.19 9.45 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.754 178.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.96 -49.34 70.7 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.374 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -53.79 -60.96 2.64 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.5 t -54.65 -39.6 68.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.847 179.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 51.3 mttt -69.84 -19.95 63.44 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.486 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.504 ' O ' ' HG ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -85.34 -14.08 47.55 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.768 -179.304 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 71.7 mt -55.48 127.95 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 N-CA-C 110.148 -0.315 . . . . 0.0 110.148 178.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 107.89 -14.75 37.64 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 61.9 mtt180 -69.78 162.29 28.13 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.501 ' O ' HG23 ' A' ' 86' ' ' ILE . 3.8 tp -103.14 128.21 50.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.207 -179.182 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.411 HG22 ' H ' ' A' ' 43' ' ' VAL . 3.0 m -94.9 105.65 17.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.316 179.531 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.593 HD23 ' C ' ' A' ' 44' ' ' LEU . 6.1 tt -102.61 95.37 6.18 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.492 ' CZ3' HD12 ' A' ' 53' ' ' LEU . 15.9 t90 -99.59 136.8 38.98 Favored 'General case' 0 C--O 1.238 0.452 0 O-C-N 124.632 1.208 . . . . 0.0 111.21 -178.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.476 ' O ' ' CE2' ' A' ' 45' ' ' TRP . 58.1 mttt -82.33 169.13 16.84 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.315 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -177.17 152.21 0.97 Allowed Pre-proline 0 N--CA 1.464 0.236 0 N-CA-C 110.351 -0.24 . . . . 0.0 110.351 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -47.96 178.11 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 123.233 2.622 . . . . 0.0 112.415 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 14.5 m 60.17 9.72 2.0 Allowed 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.13 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 63.62 9.53 32.59 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.9 ttmp? -75.74 96.19 3.58 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.892 0.377 . . . . 0.0 110.803 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.539 ' CG2' HD21 ' A' ' 44' ' ' LEU . 27.1 mm -84.25 114.37 24.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.492 HD12 ' CZ3' ' A' ' 45' ' ' TRP . 10.8 mt -98.46 146.97 25.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.019 0.437 . . . . 0.0 110.493 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.06 107.02 3.98 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.546 -178.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -103.98 -151.42 21.99 Favored Glycine 0 CA--C 1.521 0.464 0 N-CA-C 109.866 -1.293 . . . . 0.0 109.866 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 24.3 tttm -155.49 140.98 17.81 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.985 0.421 . . . . 0.0 111.351 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.463 HD13 HD21 ' A' ' 38' ' ' LEU . 65.6 mt -72.84 135.27 28.09 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.583 179.024 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -99.0 -63.46 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.973 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.8 mtt85 -143.88 159.29 42.8 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.657 0.265 . . . . 0.0 110.574 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 6.4 p -86.78 140.27 16.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.747 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.428 ' H ' ' HA ' ' A' ' 67' ' ' VAL . 3.9 m-70 -140.74 80.09 1.73 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.595 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 153.44 11.83 0.07 OUTLIER Glycine 0 CA--C 1.521 0.424 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 69.4 p 51.1 -94.85 0.03 OUTLIER 'General case' 0 C--O 1.231 0.104 0 CA-C-N 115.277 -0.462 . . . . 0.0 110.85 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.423 ' HG2' ' H ' ' A' ' 32' ' ' ARG . 15.0 mtmt -94.5 50.17 1.33 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.115 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -156.22 -125.13 0.88 Allowed Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.526 -0.845 . . . . 0.0 111.809 -178.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.595 ' HB1' ' O ' ' A' ' 24' ' ' ILE . . . -68.29 179.54 1.57 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.243 -0.978 . . . . 0.0 111.982 -178.528 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.428 ' HA ' ' H ' ' A' ' 61' ' ' HIS . 4.1 m -150.73 166.66 2.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.145 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 44.9 ttt180 -88.93 148.37 23.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.841 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -147.62 166.05 28.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.323 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 60.8 mtp180 -148.01 146.99 29.14 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.28 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.541 ' CE1' ' SD ' ' A' ' 22' ' ' MET . 53.3 m-85 -133.84 117.46 16.87 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.793 -179.534 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -84.73 -26.32 27.72 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.104 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.1 tttm -85.08 -11.03 56.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.217 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 61.73 168.67 0.66 Allowed Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.402 ' CB ' ' CD ' ' A' ' 76' ' ' PRO . 0.6 OUTLIER -100.04 174.98 2.62 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 179.877 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.402 ' CD ' ' CB ' ' A' ' 75' ' ' LEU . 3.3 Cg_exo -73.63 171.15 18.37 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.665 2.243 . . . . 0.0 111.695 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -49.94 110.76 0.92 Allowed Glycine 0 CA--C 1.526 0.765 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 47.66 95.07 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.864 0.364 . . . . 0.0 110.911 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -130.16 22.29 5.26 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.025 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.465 ' CD2' ' N ' ' A' ' 80' ' ' LEU . 4.0 mm? -76.03 92.6 3.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.759 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 153.32 -16.19 0.67 Allowed Glycine 0 CA--C 1.528 0.894 0 C-N-CA 120.999 -0.62 . . . . 0.0 111.974 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -72.68 139.05 47.03 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 117.272 0.536 . . . . 0.0 110.118 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -69.4 137.29 52.65 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 29.3 m -91.47 158.64 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 -148.2 153.5 38.85 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.194 0.521 . . . . 0.0 110.961 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.519 HG22 ' O ' ' A' ' 86' ' ' ILE . 3.9 mp -109.4 73.49 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.467 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.432 ' H ' ' HB3' ' A' ' 44' ' ' LEU . 1.5 t . . . . . 0 CA--C 1.528 0.132 0 C-N-CA 120.018 -0.673 . . . . 0.0 111.03 -178.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 30.0 mtt . . . . . 0 N--CA 1.492 1.657 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 4.5 ptt-85 -101.73 175.32 5.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.921 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.439 HG22 ' H ' ' A' ' 4' ' ' LYS . 0.6 OUTLIER -145.98 -177.69 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.902 179.622 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.439 ' H ' HG22 ' A' ' 3' ' ' ILE . 11.9 ptpt -146.96 107.17 4.02 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.131 0.491 . . . . 0.0 111.311 -178.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.43 ' HA2' ' H ' ' A' ' 27' ' ' LEU . . . -98.61 -176.55 32.57 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 179.501 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.8 t -140.16 139.12 36.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-O 121.044 0.449 . . . . 0.0 110.348 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.6 t -78.5 154.59 5.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.265 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 56.3 mt -125.24 -44.39 1.88 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.31 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -165.14 126.97 2.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.841 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -102.38 122.37 44.14 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.814 179.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 12.5 ttm-85 -88.0 108.69 19.34 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.912 -179.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.451 ' O ' ' N ' ' A' ' 14' ' ' LYS . 53.3 ttt180 -91.66 59.31 3.72 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.507 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.493 ' OG ' ' N ' ' A' ' 14' ' ' LYS . 0.1 OUTLIER 56.09 -82.74 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.077 179.838 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.493 ' N ' ' OG ' ' A' ' 13' ' ' SER . 20.8 mtmt 63.22 -170.84 0.18 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.515 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.554 ' CD ' ' H ' ' A' ' 15' ' ' GLU . 1.3 pm0 -55.34 -179.49 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.608 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 47.35 92.86 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.912 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 -37.91 133.0 0.9 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.936 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.425 ' H ' ' H ' ' A' ' 19' ' ' ASN . 0.8 OUTLIER -176.41 11.13 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.374 -179.679 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.425 ' H ' ' H ' ' A' ' 18' ' ' HIS . 6.5 p30 53.7 171.29 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.98 -179.202 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 -80.6 113.18 18.62 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.314 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.575 HG12 ' N ' ' A' ' 22' ' ' MET . 18.8 t -107.46 168.49 3.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.032 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.575 ' N ' HG12 ' A' ' 21' ' ' VAL . 9.6 ttt -147.55 121.91 9.65 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.681 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 91.9 mt -96.13 129.83 45.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.405 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.503 HG22 ' N ' ' A' ' 25' ' ' LYS . 96.8 mt -132.86 160.14 42.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.024 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.521 ' O ' ' N ' ' A' ' 27' ' ' LEU . 60.1 tttt -138.12 96.37 10.19 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.326 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -59.57 72.41 0.06 OUTLIER 'Trans proline' 0 N--CA 1.489 1.252 0 C-N-CA 122.291 1.994 . . . . 0.0 111.464 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.521 ' N ' ' O ' ' A' ' 25' ' ' LYS . 14.1 tp 51.99 -116.33 1.01 Allowed 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.353 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.474 ' CG ' ' H ' ' A' ' 29' ' ' VAL . 6.4 p-10 -74.0 -92.78 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.47 -179.291 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.735 ' O ' HG12 ' A' ' 29' ' ' VAL . 53.8 t 56.07 54.74 0.33 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.194 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -178.612 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -92.29 47.4 1.32 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.038 -178.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.7 t -158.3 123.6 4.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.11 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.476 ' HE ' ' HB ' ' A' ' 63' ' ' THR . 27.8 ttm180 -56.55 -31.75 64.49 Favored 'General case' 0 C--O 1.222 -0.382 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.132 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -61.82 -52.22 65.04 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.998 179.069 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.2 tp10 -65.64 -51.59 58.35 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.471 ' O ' HD23 ' A' ' 38' ' ' LEU . . . -55.59 -48.48 74.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.532 179.26 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.441 ' CB ' ' O ' ' A' ' 32' ' ' ARG . 93.4 p -62.34 -33.64 75.09 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.793 178.569 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 43.9 tttm -66.63 -61.23 2.08 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.118 -177.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.471 HD23 ' O ' ' A' ' 35' ' ' ALA . 0.8 OUTLIER -77.88 5.76 9.01 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.756 -0.377 . . . . 0.0 111.235 -178.758 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.596 HG23 ' O ' ' A' ' 39' ' ' ILE . 12.9 tt -53.22 113.94 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 178.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.432 ' H ' ' HB ' ' A' ' 57' ' ' ILE . . . 102.07 15.72 25.29 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 111.538 -0.625 . . . . 0.0 111.538 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.9 tpt180 -69.63 155.79 39.95 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 24.7 tp -84.55 105.59 15.48 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.869 0.366 . . . . 0.0 110.724 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.608 HG23 ' O ' ' A' ' 43' ' ' VAL . 33.2 m -87.37 109.39 19.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.532 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.621 HD23 ' C ' ' A' ' 44' ' ' LEU . 5.0 tt -108.37 97.15 6.87 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.238 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.451 ' CZ3' HD12 ' A' ' 53' ' ' LEU . 10.6 t90 -99.0 117.61 33.9 Favored 'General case' 0 C--O 1.237 0.406 0 O-C-N 124.824 1.328 . . . . 0.0 110.707 -179.204 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 43.6 tttp -85.87 100.75 12.29 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.447 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.446 ' HB2' ' O ' ' A' ' 51' ' ' LYS . 0.1 OUTLIER -64.9 178.43 0.49 Allowed Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.819 179.877 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.464 ' C ' ' H ' ' A' ' 50' ' ' GLY . 3.1 Cg_exo -74.93 -53.07 0.1 Allowed 'Trans proline' 0 N--CA 1.495 1.561 0 C-N-CA 122.823 2.349 . . . . 0.0 112.934 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.48 ' C ' ' H ' ' A' ' 51' ' ' LYS . 74.5 m -69.01 39.97 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.536 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.464 ' H ' ' C ' ' A' ' 48' ' ' PRO . . . 55.23 2.64 0.26 Allowed Glycine 0 CA--C 1.526 0.777 0 N-CA-C 111.958 -0.457 . . . . 0.0 111.958 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.48 ' H ' ' C ' ' A' ' 49' ' ' SER . 3.7 ttpt -74.76 100.67 4.08 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.905 0.383 . . . . 0.0 110.399 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.526 ' CG2' HD21 ' A' ' 44' ' ' LEU . 18.1 mm -84.65 108.21 16.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.625 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.451 HD12 ' CZ3' ' A' ' 45' ' ' TRP . 16.7 mt -105.81 143.26 34.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.552 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.05 116.72 5.84 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.394 -178.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -113.8 -153.95 11.15 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 179.082 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt -151.51 136.75 17.54 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 121.024 0.44 . . . . 0.0 110.849 179.27 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.637 HG23 ' O ' ' A' ' 68' ' ' ARG . 45.8 mt -65.33 140.32 19.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.0 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -106.09 -45.14 8.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.831 -179.137 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 44.5 mtp85 -149.23 159.49 44.21 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.794 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.513 HG13 ' O ' ' A' ' 60' ' ' VAL . 7.1 p -93.06 117.21 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.039 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.403 ' H ' ' HA ' ' A' ' 67' ' ' VAL . 37.8 t60 -102.59 121.19 41.89 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.428 179.432 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.75 10.28 50.32 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 111.556 -0.617 . . . . 0.0 111.556 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.476 ' HB ' ' HE ' ' A' ' 32' ' ' ARG . 81.3 p 51.55 -88.11 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.473 ' HG2' ' H ' ' A' ' 32' ' ' ARG . 51.4 mttt -90.18 51.74 2.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.12 -179.268 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -156.97 -126.06 0.9 Allowed Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.43 -0.891 . . . . 0.0 112.277 -179.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.71 -177.89 1.06 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 113.859 -1.17 . . . . 0.0 112.237 -178.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.403 ' HA ' ' H ' ' A' ' 61' ' ' HIS . 4.8 m -147.19 153.59 12.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.802 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.637 ' O ' HG23 ' A' ' 57' ' ' ILE . 27.6 ttm180 -87.85 157.13 19.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.765 0.317 . . . . 0.0 110.985 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -151.04 166.23 31.37 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.035 179.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 13.9 ttt180 -149.37 116.85 6.14 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.76 0.314 . . . . 0.0 110.692 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.44 ' CD1' ' SD ' ' A' ' 22' ' ' MET . 34.4 m-85 -100.43 117.88 35.51 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.088 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -80.13 -19.95 46.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.804 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 35.3 mttt -81.55 -77.72 0.21 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.981 0.42 . . . . 0.0 110.947 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 140.92 169.74 11.87 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 -179.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.409 ' CB ' ' CD ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -97.02 175.57 2.55 Favored Pre-proline 0 C--N 1.33 -0.241 0 N-CA-C 110.272 -0.269 . . . . 0.0 110.272 -179.81 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.409 ' CD ' ' CB ' ' A' ' 75' ' ' LEU . 2.9 Cg_endo -77.39 19.32 0.73 Allowed 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.99 2.46 . . . . 0.0 111.376 179.01 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 97.67 -100.55 2.41 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 6.9 tm0? -90.67 106.71 18.69 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.817 0.341 . . . . 0.0 110.2 179.397 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -163.1 23.8 0.09 Allowed 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.149 0.499 . . . . 0.0 110.085 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.1 tp -70.53 95.22 1.05 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.563 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 139.1 -1.76 2.53 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.807 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.407 ' CG ' ' HE1' ' A' ' 45' ' ' TRP . 7.9 t0 -71.28 136.99 48.2 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -69.13 129.61 40.35 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.4 m -91.29 162.58 2.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.401 ' C ' HD13 ' A' ' 86' ' ' ILE . 25.8 mt-10 -148.95 161.89 40.99 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.334 -179.469 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.401 HD13 ' C ' ' A' ' 85' ' ' GLU . 1.2 mm -107.97 72.46 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 178.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.417 ' O ' ' CB ' ' A' ' 44' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.462 0.154 0 C-N-CA 119.945 -0.702 . . . . 0.0 111.293 -178.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.6 mtt . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 22.6 ptt180 -105.56 170.14 8.06 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.978 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.525 HG22 ' H ' ' A' ' 4' ' ' LYS . 1.1 mt -144.41 179.41 1.36 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.852 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.525 ' H ' HG22 ' A' ' 3' ' ' ILE . 0.0 OUTLIER -144.24 103.81 4.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.363 0.601 . . . . 0.0 110.382 -179.528 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.43 ' HA2' ' H ' ' A' ' 27' ' ' LEU . . . -90.71 -179.09 43.54 Favored Glycine 0 CA--C 1.522 0.527 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.268 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.1 t -145.59 137.14 19.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.919 0.39 . . . . 0.0 109.987 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 74.3 t -74.72 140.37 17.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.69 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 43.1 mt -107.52 -45.42 4.06 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.687 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.2 p -162.84 125.92 2.81 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.92 0.391 . . . . 0.0 111.082 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -101.49 97.65 8.08 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.306 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 17.7 ttm180 -89.17 142.87 27.27 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.348 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -104.57 61.11 0.71 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.878 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.0 t 36.65 60.18 0.95 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.503 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 30.3 mmtt -38.78 -80.09 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.958 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -66.1 -88.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 21.7 t30 -163.89 102.69 0.89 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.253 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.499 ' HG3' HH22 ' A' ' 70' ' ' ARG . 9.1 tp60 -124.18 -38.7 2.42 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.451 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -169.69 -59.25 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.4 p30 166.72 -32.59 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 114.964 -1.017 . . . . 0.0 110.401 178.364 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 -159.0 116.42 2.78 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.493 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.421 HG12 ' N ' ' A' ' 22' ' ' MET . 98.6 t -106.74 154.78 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.05 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.421 ' N ' HG12 ' A' ' 21' ' ' VAL . 41.9 ttm -145.39 115.85 7.6 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.717 0.294 . . . . 0.0 110.506 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 6.4 mt -96.07 129.42 46.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.435 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.531 HG22 ' N ' ' A' ' 25' ' ' LYS . 83.0 mt -133.56 162.61 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.547 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.531 ' N ' HG22 ' A' ' 24' ' ' ILE . 45.1 tttm -142.51 105.25 5.46 Favored Pre-proline 0 CA--C 1.531 0.224 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.804 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -61.44 87.54 0.09 OUTLIER 'Trans proline' 0 C--N 1.313 -1.327 0 C-N-CA 122.315 2.01 . . . . 0.0 112.276 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.43 ' H ' ' HA2' ' A' ' 5' ' ' GLY . 2.7 tp 36.32 -133.82 0.07 Allowed 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.377 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.471 ' O ' ' C ' ' A' ' 29' ' ' VAL . 1.3 p-10 -44.04 -92.73 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 111.593 0.22 . . . . 0.0 111.593 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.745 ' O ' HG12 ' A' ' 29' ' ' VAL . 55.1 t 41.1 43.64 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 -178.159 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.413 ' OD1' ' N ' ' A' ' 30' ' ' ASN . 2.6 p30 -82.6 41.69 0.73 Allowed 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 113.819 -1.537 . . . . 0.0 110.58 -178.014 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.3 p -158.87 126.89 5.1 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.907 178.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 35.9 ttt180 -59.15 -25.72 64.14 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -63.19 -54.18 41.56 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.456 178.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -66.16 -43.32 87.31 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.977 179.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.566 ' O ' HD23 ' A' ' 38' ' ' LEU . . . -59.95 -60.69 3.42 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.301 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 27.7 t -52.31 -22.52 4.61 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.654 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.9 tptt -69.97 -64.74 0.83 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.094 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.566 HD23 ' O ' ' A' ' 35' ' ' ALA . 0.5 OUTLIER -79.59 13.34 2.08 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.307 -179.058 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 18.5 tt -48.52 -19.88 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.341 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -108.25 18.22 33.55 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 121.154 -0.546 . . . . 0.0 111.994 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.442 ' HA ' ' NE ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -71.09 172.57 8.92 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 117.2 0.5 . . . . 0.0 110.547 179.777 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.564 ' O ' HG23 ' A' ' 86' ' ' ILE . 5.0 tp -118.87 121.63 40.44 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.5 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.624 HG23 ' O ' ' A' ' 43' ' ' VAL . 6.4 m -88.03 110.43 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.422 ' H ' ' HA ' ' A' ' 86' ' ' ILE . 2.1 tp -105.55 102.86 12.29 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.773 ' CD1' HG12 ' A' ' 84' ' ' VAL . 4.7 t90 -83.32 105.15 14.04 Favored 'General case' 0 C--O 1.235 0.332 0 O-C-N 125.135 1.522 . . . . 0.0 110.302 -178.648 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 54.2 tttp -84.5 88.43 7.3 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.729 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.477 ' OG ' ' N ' ' A' ' 51' ' ' LYS . 11.5 p -64.04 171.95 2.21 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.79 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -77.0 -48.34 0.12 Allowed 'Trans proline' 0 N--CA 1.491 1.351 0 C-N-CA 123.031 2.488 . . . . 0.0 112.759 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 10.5 p -69.66 5.07 1.57 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.972 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.61 5.66 78.17 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.318 -0.713 . . . . 0.0 111.318 179.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.477 ' N ' ' OG ' ' A' ' 47' ' ' SER . 1.1 tmtm? -72.64 94.26 1.71 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.916 0.388 . . . . 0.0 109.965 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 12.1 mm -83.08 112.55 20.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.917 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 60.0 mt -98.1 126.21 43.45 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.18 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 60.8 mttt -96.41 104.75 16.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.917 -179.299 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -103.44 168.12 17.26 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 178.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -152.74 130.15 11.36 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 117.193 0.496 . . . . 0.0 111.261 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 71.5 mt -71.42 134.06 30.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.52 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -106.1 -28.78 2.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.398 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.1 ptp180 -164.89 154.47 13.22 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 120.63 -0.428 . . . . 0.0 112.018 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.584 HG13 ' O ' ' A' ' 60' ' ' VAL . 9.5 p -97.71 116.44 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.417 178.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 13.0 t60 -142.06 115.08 8.73 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 120.126 -0.63 . . . . 0.0 112.054 -179.29 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.414 ' O ' ' OG1' ' A' ' 63' ' ' THR . . . 147.19 -14.33 1.47 Allowed Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.646 -0.582 . . . . 0.0 111.646 179.051 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.614 ' C ' ' H ' ' A' ' 65' ' ' GLY . 12.5 p 55.95 156.41 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 122.613 0.365 . . . . 0.0 110.769 -179.246 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.452 ' HZ2' ' HB3' ' A' ' 64' ' ' LYS . 0.5 OUTLIER 68.98 -21.05 0.15 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.985 0.421 . . . . 0.0 109.926 -178.194 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.614 ' H ' ' C ' ' A' ' 63' ' ' THR . . . 141.41 122.45 1.83 Allowed Glycine 0 CA--C 1.52 0.37 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 179.085 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.564 ' O ' HG23 ' A' ' 60' ' ' VAL . . . 176.38 147.57 0.1 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.443 HG13 ' O ' ' A' ' 66' ' ' ALA . 15.5 m -156.6 137.16 4.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.933 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 21.6 ttm-85 -89.02 154.51 20.15 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -145.07 161.06 40.36 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.051 0.453 . . . . 0.0 110.866 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.499 HH22 ' HG3' ' A' ' 17' ' ' GLN . 78.4 mtt-85 -146.45 116.7 7.42 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.171 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.472 ' C ' ' H ' ' A' ' 73' ' ' LYS . 17.2 m-85 -95.89 135.46 37.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.57 -179.603 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 82.6 mt-10 -61.07 -1.64 0.48 Allowed 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.476 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.472 ' H ' ' C ' ' A' ' 71' ' ' PHE . 5.8 tmtm? -156.28 -65.19 0.11 Allowed 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.642 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 134.86 -171.61 22.32 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.465 HD23 ' N ' ' A' ' 75' ' ' LEU . 1.3 mt -92.06 171.05 8.27 Favored Pre-proline 0 C--N 1.327 -0.392 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -75.3 114.37 3.98 Favored 'Trans proline' 0 C--N 1.313 -1.335 0 C-N-CA 122.655 2.237 . . . . 0.0 112.064 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 75.97 -65.23 2.62 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.574 HE22 HD12 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -169.01 -69.25 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.645 0.259 . . . . 0.0 110.594 179.472 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 64.13 24.23 13.4 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.969 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.574 HD12 HE22 ' A' ' 78' ' ' GLN . 1.5 tt -60.58 104.08 0.31 Allowed 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.575 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 110.5 5.71 27.74 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 111.652 -0.579 . . . . 0.0 111.652 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -73.98 144.09 45.35 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.726 0.263 . . . . 0.0 110.3 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -69.88 113.49 7.16 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.773 HG12 ' CD1' ' A' ' 45' ' ' TRP . 30.2 m -90.87 169.68 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -150.0 156.4 41.64 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.272 0.558 . . . . 0.0 110.985 -178.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.633 HG22 ' O ' ' A' ' 86' ' ' ILE . 9.7 mt -105.76 72.74 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 177.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.338 0.1 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.918 -178.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.6 mtt . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 22.9 mtm-85 -115.74 161.2 19.06 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.968 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.4 mt -147.76 145.3 18.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.079 0.466 . . . . 0.0 111.055 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.3 mmmm -90.07 178.59 6.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.282 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 84' ' ' VAL . . . -173.75 173.64 45.91 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.0 t -148.98 137.01 14.38 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 CA-C-O 120.914 0.388 . . . . 0.0 110.705 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 91.4 t -80.4 148.32 5.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.158 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 49.4 mt -106.41 -44.45 4.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.249 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.9 m -168.53 137.08 2.21 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.603 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -94.67 115.37 27.46 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.333 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.487 ' O ' ' N ' ' A' ' 21' ' ' VAL . 89.2 mtt180 -91.19 97.52 11.18 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.921 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 64.8 ttt180 -83.18 59.0 4.73 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.985 0.421 . . . . 0.0 110.436 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.457 ' OG ' ' N ' ' A' ' 14' ' ' LYS . 30.5 t -178.48 -124.27 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.132 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.467 ' O ' ' N ' ' A' ' 16' ' ' ASN . 16.0 tttm 66.98 0.42 1.97 Allowed 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.254 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.465 ' C ' ' ND2' ' A' ' 16' ' ' ASN . 7.2 mt-10 63.08 -73.23 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.627 -0.261 . . . . 0.0 110.662 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.467 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.0 OUTLIER 39.19 -109.71 0.09 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.562 179.484 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.416 ' CD ' ' O ' ' A' ' 17' ' ' GLN . 0.0 OUTLIER -151.79 36.33 0.56 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.993 0.425 . . . . 0.0 110.117 -179.766 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.415 ' H ' ' H ' ' A' ' 19' ' ' ASN . 15.9 m80 -163.85 -9.48 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.557 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.415 ' H ' ' H ' ' A' ' 18' ' ' HIS . 1.1 m-80 66.91 9.67 7.02 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.839 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -157.75 109.44 2.31 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.822 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.59 HG12 ' N ' ' A' ' 22' ' ' MET . 53.0 t -109.27 167.1 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.318 179.305 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.59 ' N ' HG12 ' A' ' 21' ' ' VAL . 2.6 ptp -147.03 135.99 22.33 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.917 0.389 . . . . 0.0 110.848 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.458 HG22 ' N ' ' A' ' 24' ' ' ILE . 87.0 mt -94.89 156.84 3.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.195 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.458 ' N ' HG22 ' A' ' 23' ' ' ILE . 23.5 mt -143.51 158.14 16.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.68 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.451 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 49.4 tttm -140.69 101.49 6.55 Favored Pre-proline 0 C--O 1.235 0.308 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.195 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -58.89 144.96 98.54 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 121.706 1.604 . . . . 0.0 110.466 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.487 HD12 ' HA ' ' A' ' 27' ' ' LEU . 6.8 tp -34.05 -82.91 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -178.338 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.473 ' CG ' ' H ' ' A' ' 29' ' ' VAL . 3.6 p-10 -87.09 -86.84 0.15 Allowed 'General case' 0 CA--C 1.521 -0.163 0 C-N-CA 120.251 -0.58 . . . . 0.0 110.259 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.737 ' O ' HG12 ' A' ' 29' ' ' VAL . 41.2 t 41.42 56.68 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.14 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -179.089 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -91.98 33.82 1.04 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.365 -1.289 . . . . 0.0 111.513 -177.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 24.4 m -159.48 131.03 6.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.759 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.453 ' HA ' ' HB3' ' A' ' 35' ' ' ALA . 9.8 ttp180 -57.81 -26.6 62.2 Favored 'General case' 0 CA--C 1.521 -0.14 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.332 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -61.58 -37.38 83.65 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.325 178.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -87.82 -39.07 15.16 Favored 'General case' 0 CA--C 1.527 0.087 0 CA-C-N 115.63 -0.713 . . . . 0.0 109.611 178.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.623 ' O ' HD23 ' A' ' 38' ' ' LEU . . . -61.21 -58.38 8.57 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 41.9 t -55.48 -23.3 25.01 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.732 178.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.1 tttm -68.83 -58.01 4.78 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.619 -179.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.623 HD23 ' O ' ' A' ' 35' ' ' ALA . 0.5 OUTLIER -80.19 8.89 6.39 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.231 -178.828 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.735 HD13 ' O ' ' A' ' 39' ' ' ILE . 0.1 OUTLIER -45.59 -41.12 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.368 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.459 ' N ' ' CG2' ' A' ' 39' ' ' ILE . . . -103.42 96.33 1.32 Allowed Glycine 0 CA--C 1.521 0.463 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 178.208 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 11.5 ttm180 -167.62 150.3 5.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.024 0.44 . . . . 0.0 110.382 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.845 ' O ' HG23 ' A' ' 86' ' ' ILE . 3.0 tp -88.07 123.08 32.39 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.5 -178.716 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.6 m -93.83 109.76 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.739 HD22 ' O ' ' A' ' 87' ' ' VAL . 6.0 mp -105.93 102.68 12.09 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 116.348 -0.387 . . . . 0.0 109.959 -179.486 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.635 ' HE1' ' CG ' ' A' ' 82' ' ' ASP . 34.7 t90 -91.56 123.42 34.95 Favored 'General case' 0 C--O 1.236 0.384 0 O-C-N 124.749 1.281 . . . . 0.0 110.761 -179.425 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 9.3 tttm -85.32 90.29 7.88 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.682 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.424 ' HB2' ' CH2' ' A' ' 45' ' ' TRP . 4.5 p -61.59 171.87 1.22 Allowed Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.753 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -77.5 -33.19 2.53 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 122.823 2.349 . . . . 0.0 112.166 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 18.7 m -85.55 28.56 0.75 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.759 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 63.23 2.71 5.61 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.413 ' HG2' HD21 ' A' ' 53' ' ' LEU . 71.4 tttt -74.73 92.38 2.47 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.072 0.463 . . . . 0.0 110.161 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.434 HD13 ' N ' ' A' ' 52' ' ' ILE . 3.7 mm -82.49 111.6 19.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.011 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.413 HD21 ' HG2' ' A' ' 51' ' ' LYS . 45.1 mt -101.61 123.23 45.28 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.208 0.528 . . . . 0.0 111.489 -179.149 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 16.4 mttt -94.04 100.72 12.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.798 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -100.55 -172.46 29.43 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.544 -1.022 . . . . 0.0 110.544 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 39.7 tttp -155.09 138.85 16.17 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 120.428 -0.509 . . . . 0.0 111.57 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.7 mt -75.04 134.8 28.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.511 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.404 ' O ' HD11 ' A' ' 39' ' ' ILE . 0.8 OUTLIER -98.3 -50.92 10.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.855 -179.562 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 16.0 mtp180 -153.05 153.98 33.96 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.878 0.371 . . . . 0.0 110.822 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.631 HG23 HG12 ' A' ' 67' ' ' VAL . 3.4 p -71.89 157.81 6.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.085 179.21 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 12.0 t-160 -140.43 135.29 31.88 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.019 0.438 . . . . 0.0 110.825 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.429 ' O ' ' O ' ' A' ' 63' ' ' THR . . . 74.36 -15.51 3.45 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 111.487 -0.645 . . . . 0.0 111.487 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.429 ' O ' ' O ' ' A' ' 62' ' ' GLY . 81.4 p 56.35 142.47 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.021 0.438 . . . . 0.0 111.225 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.514 ' CG ' ' O ' ' A' ' 64' ' ' LYS . 16.5 ttpp 57.59 17.85 4.25 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.269 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -149.9 -126.39 1.42 Allowed Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.032 -178.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.7 -178.43 1.17 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.357 -0.922 . . . . 0.0 111.963 -178.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.631 HG12 HG23 ' A' ' 60' ' ' VAL . 6.6 m -154.33 163.89 1.63 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.158 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.364 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 56.4 ttt180 -89.51 153.95 20.39 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 178.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -149.29 156.48 42.17 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.349 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 -149.25 121.88 8.6 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.307 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -97.34 106.4 18.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.9 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -48.76 -26.04 2.15 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.609 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 53.0 mttt -81.59 -78.28 0.19 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.478 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 131.47 139.33 4.37 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -94.99 150.07 37.19 Favored Pre-proline 0 C--O 1.233 0.216 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -53.61 -81.06 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 122.409 2.073 . . . . 0.0 111.857 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 171.99 0.89 0.03 OUTLIER Glycine 0 CA--C 1.527 0.795 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.23 -22.44 16.7 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.783 0.325 . . . . 0.0 110.671 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.536 ' HB2' ' CH2' ' A' ' 45' ' ' TRP . . . -83.88 39.68 0.71 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.938 -179.479 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.2 tp -72.79 -23.69 60.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.501 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -137.53 14.94 3.66 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 121.037 -0.602 . . . . 0.0 111.94 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.635 ' CG ' ' HE1' ' A' ' 45' ' ' TRP . 19.4 t0 -72.18 143.12 49.01 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -69.26 134.04 48.68 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.308 -0.405 . . . . 0.0 109.937 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.45 ' O ' ' N ' ' A' ' 5' ' ' GLY . 33.1 m -97.57 155.99 3.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.409 ' HG3' ' O ' ' A' ' 84' ' ' VAL . 16.1 mp0 -148.26 154.49 40.11 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.08 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.845 HG23 ' O ' ' A' ' 42' ' ' LEU . 5.1 mp -100.57 72.41 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.447 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.739 ' O ' HD22 ' A' ' 44' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--O 1.227 -0.081 0 C-N-CA 119.982 -0.687 . . . . 0.0 110.238 -179.25 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.6 mmt . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 15.2 ptt180 -83.74 165.51 18.81 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.443 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.486 HG22 ' N ' ' A' ' 4' ' ' LYS . 3.7 mp -100.78 163.87 2.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.184 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.486 ' N ' HG22 ' A' ' 3' ' ' ILE . 9.9 ptpt -150.71 110.48 4.06 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 121.343 0.592 . . . . 0.0 111.874 -179.286 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -99.0 -176.13 31.96 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 178.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 24.5 t -142.05 134.37 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-O 120.991 0.424 . . . . 0.0 111.001 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 43.1 t -80.29 148.88 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 115.602 -0.727 . . . . 0.0 109.875 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -125.77 -23.16 4.06 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 121.062 -0.255 . . . . 0.0 111.402 -179.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.3 t -166.05 148.04 7.02 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.204 0.526 . . . . 0.0 111.995 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.501 ' HB2' HD21 ' A' ' 80' ' ' LEU . 6.8 t80 -107.43 163.87 12.68 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.155 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 7.2 ttp180 -152.23 111.04 3.81 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.033 0.444 . . . . 0.0 110.529 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -77.02 59.61 1.7 Allowed 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.265 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 66.22 171.7 0.24 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.469 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 15.0 tttm -170.54 49.83 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.413 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -163.64 -61.85 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.22 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.401 ' O ' ' C ' ' A' ' 17' ' ' GLN . 19.7 m120 -155.9 -164.95 1.83 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.031 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.401 ' C ' ' O ' ' A' ' 16' ' ' ASN . 85.3 mm-40 35.83 -110.76 0.06 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.91 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 14.0 t60 -173.39 25.49 0.01 OUTLIER 'General case' 0 C--O 1.234 0.247 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.3 m-20 -39.38 121.65 1.2 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.509 -178.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -81.1 103.31 10.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.328 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.3 t -108.99 146.2 14.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.307 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -150.63 148.32 28.48 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.043 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.4 mm -92.21 140.9 15.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.044 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.431 HG22 ' N ' ' A' ' 25' ' ' LYS . 96.5 mt -130.97 155.2 41.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.744 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.431 ' N ' HG22 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -136.92 100.42 9.8 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.847 179.708 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.546 ' O ' ' N ' ' A' ' 28' ' ' ASP . 3.4 Cg_exo -66.02 82.81 0.26 Allowed 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 122.451 2.101 . . . . 0.0 111.352 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.4 tp 33.04 -82.95 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.801 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.546 ' N ' ' O ' ' A' ' 26' ' ' PRO . 10.5 p30 -98.4 -87.27 0.34 Allowed 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.58 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.747 ' O ' HG12 ' A' ' 29' ' ' VAL . 43.5 t 43.02 57.55 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.238 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -178.009 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -91.81 42.01 1.09 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.584 -1.189 . . . . 0.0 110.74 -178.288 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.4 m -158.25 124.8 4.78 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.565 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.465 ' H ' ' HB3' ' A' ' 64' ' ' LYS . 0.6 OUTLIER -59.31 -26.7 65.22 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.315 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 65.6 mm-40 -60.88 -49.46 77.36 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.486 179.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -73.54 -45.71 51.98 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.211 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.26 -60.62 3.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.198 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.2 t -55.26 -38.73 68.91 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.837 179.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.1 mtpt -69.13 -20.56 64.05 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.927 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.529 ' O ' ' HG ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -85.99 -16.29 38.76 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.586 -179.624 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 68.4 mt -52.38 121.24 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-O 120.842 0.354 . . . . 0.0 110.441 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 111.75 -6.56 27.76 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.6 mmm-85 -69.96 156.83 38.54 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.823 0.344 . . . . 0.0 110.54 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.597 ' O ' HG23 ' A' ' 86' ' ' ILE . 4.0 tp -101.92 122.56 44.25 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.771 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 43' ' ' VAL . 33.7 m -92.03 106.52 17.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.712 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.725 HD21 HG23 ' A' ' 52' ' ' ILE . 6.2 tt -102.61 103.36 13.65 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.402 -179.449 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.416 ' CZ3' ' HB2' ' A' ' 47' ' ' SER . 80.1 t90 -95.64 105.49 17.49 Favored 'General case' 0 CA--C 1.53 0.205 0 O-C-N 124.91 1.381 . . . . 0.0 109.295 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.5 ttmt -81.76 102.05 10.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.223 -178.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.507 ' HB3' ' H ' ' A' ' 51' ' ' LYS . 10.1 t -62.38 141.86 96.31 Favored Pre-proline 0 C--N 1.332 -0.161 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.881 179.081 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -49.01 91.56 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 122.456 2.104 . . . . 0.0 111.898 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 56.2 p 38.69 60.86 1.3 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.172 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -140.36 -63.86 0.03 OUTLIER Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.507 ' H ' ' HB3' ' A' ' 47' ' ' SER . 9.9 ttmt -165.48 126.17 1.89 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.737 0.304 . . . . 0.0 110.23 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.725 HG23 HD21 ' A' ' 44' ' ' LEU . 1.3 mp -82.39 107.25 14.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.216 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 64.8 mt -93.95 152.18 19.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.683 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 6.3 pttt -152.3 104.18 2.92 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 120.913 0.387 . . . . 0.0 111.758 -178.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -90.29 -158.52 34.61 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.004 -1.239 . . . . 0.0 110.004 178.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 48.4 tttp -151.87 129.29 11.35 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.981 0.42 . . . . 0.0 111.009 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 32.1 mt -66.04 140.22 19.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.819 179.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -102.71 -47.86 10.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.209 -179.337 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.56 163.08 35.4 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.2 0.524 . . . . 0.0 111.333 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.2 p -78.9 154.74 4.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.514 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -140.52 130.03 24.05 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.599 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.21 -7.62 66.84 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.482 -0.647 . . . . 0.0 111.482 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.428 ' O ' ' CG ' ' A' ' 64' ' ' LYS . 38.4 p 58.67 138.57 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.892 0.377 . . . . 0.0 111.241 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.465 ' HB3' ' H ' ' A' ' 32' ' ' ARG . 5.2 ptmm? 43.99 32.17 0.6 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.053 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -149.76 -125.05 1.32 Allowed Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 111.44 -0.664 . . . . 0.0 111.44 -178.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.73 179.61 1.36 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.528 -0.836 . . . . 0.0 111.862 -178.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 28.1 m -154.73 151.3 10.94 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.841 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.6 ttp180 -88.96 148.28 23.87 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.44 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -148.71 160.78 42.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.048 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 63.5 mtt180 -145.75 121.1 10.27 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.835 0.35 . . . . 0.0 110.704 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -97.04 113.47 25.02 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.04 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -68.38 -25.73 65.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.467 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 9.8 mmtm -84.05 -80.43 0.19 Allowed 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.741 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 127.5 153.67 8.26 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.5 mt -90.36 153.46 46.32 Favored Pre-proline 0 N--CA 1.464 0.267 0 CA-C-O 120.699 0.285 . . . . 0.0 110.964 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.433 ' O ' ' C ' ' A' ' 77' ' ' GLY . 3.0 Cg_endo -66.7 157.06 62.89 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.714 2.276 . . . . 0.0 112.306 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 76' ' ' PRO . . . 29.04 -96.46 0.01 OUTLIER Glycine 0 N--CA 1.466 0.672 0 O-C-N 123.77 0.668 . . . . 0.0 111.614 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -156.05 103.42 2.21 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.832 0.349 . . . . 0.0 110.669 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -112.71 40.59 2.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.58 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.501 HD21 ' HB2' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -70.34 115.57 9.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.126 -179.483 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 108.6 -3.17 32.41 Favored Glycine 0 CA--C 1.525 0.685 0 CA-C-N 116.248 -0.433 . . . . 0.0 112.153 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -70.07 143.24 52.51 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -67.94 136.67 54.33 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.9 m -90.75 160.08 2.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -144.64 150.38 37.3 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.207 -178.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.597 HG23 ' O ' ' A' ' 42' ' ' LEU . 29.5 mt -110.1 72.79 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 178.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.455 ' H ' ' HB3' ' A' ' 44' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.463 0.203 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.03 -179.161 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.0 ptm . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 16.1 mtm180 -102.25 156.51 17.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.727 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.7 mt -147.06 147.73 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.71 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 17.5 tptt -92.88 161.43 14.49 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.309 -0.859 . . . . 0.0 111.008 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -167.8 178.7 41.54 Favored Glycine 0 CA--C 1.528 0.886 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 179.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 30.7 t -149.31 136.03 12.79 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-O 121.126 0.489 . . . . 0.0 111.29 -178.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 47.8 t -74.21 148.35 8.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.118 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.7 mt -109.49 -60.84 1.72 Allowed 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.392 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.0 t -167.04 144.32 4.69 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.876 0.37 . . . . 0.0 111.162 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -95.91 118.55 32.76 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.335 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 40.1 mtt180 -88.47 139.34 30.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.822 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 8.5 ttm-85 -132.09 79.78 1.88 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.383 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 82.7 p -47.12 165.71 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.655 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 9.1 mmtp -120.95 -96.15 0.48 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.859 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -87.48 -10.71 51.05 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.744 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 38.0 t30 -76.35 114.27 14.85 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.379 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.452 ' O ' ' CG ' ' A' ' 18' ' ' HIS . 1.4 tp-100 -58.71 100.99 0.08 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.56 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.452 ' CG ' ' O ' ' A' ' 17' ' ' GLN . 2.3 m80 -174.76 -12.11 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.634 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.45 ' H ' ' H ' ' A' ' 18' ' ' HIS . 51.9 t30 67.43 -178.02 0.21 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.19 -179.525 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -81.27 139.6 35.34 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.141 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.673 HG12 ' N ' ' A' ' 22' ' ' MET . 48.1 t -120.28 173.58 6.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.333 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.673 ' N ' HG12 ' A' ' 21' ' ' VAL . 23.9 ttt -147.45 131.57 17.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.141 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.8 mm -95.19 141.86 14.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.86 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.555 ' O ' ' HB1' ' A' ' 66' ' ' ALA . 21.8 mt -139.95 154.31 23.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.678 179.309 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.428 ' O ' ' N ' ' A' ' 27' ' ' LEU . 68.0 tttt -138.2 100.63 8.6 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.731 -179.379 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.514 ' O ' ' N ' ' A' ' 28' ' ' ASP . 4.0 Cg_exo -64.41 70.9 0.22 Allowed 'Trans proline' 0 N--CA 1.488 1.168 0 C-N-CA 122.1 1.867 . . . . 0.0 111.749 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.432 HD12 ' HA ' ' A' ' 27' ' ' LEU . 15.0 tp 51.01 -79.98 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.77 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 26' ' ' PRO . 3.2 p30 -109.81 -87.17 0.52 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.662 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.715 ' O ' HG12 ' A' ' 29' ' ' VAL . 43.4 t 45.64 57.83 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -178.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -91.88 43.3 1.13 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.295 -1.321 . . . . 0.0 110.548 -178.547 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.9 t -157.85 120.92 3.92 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.643 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 39.7 ttt-85 -58.31 -27.76 64.41 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.507 179.154 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.0 tm-20 -60.32 -39.12 85.87 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -86.27 -46.95 9.85 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.282 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.561 ' O ' HD23 ' A' ' 38' ' ' LEU . . . -56.01 -58.69 6.83 Favored 'General case' 0 CA--C 1.527 0.083 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.624 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.0 t -53.23 -24.59 11.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.712 178.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 9.6 ttpp -69.95 -60.22 2.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.761 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.561 HD23 ' O ' ' A' ' 35' ' ' ALA . 0.4 OUTLIER -78.2 8.07 5.43 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 120.915 0.388 . . . . 0.0 110.87 -179.105 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 14.1 tt -52.33 -12.36 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.725 179.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.411 ' N ' ' C ' ' A' ' 38' ' ' LEU . . . -117.16 4.72 18.21 Favored Glycine 0 CA--C 1.53 0.982 0 N-CA-C 111.87 -0.492 . . . . 0.0 111.87 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -71.01 155.28 41.02 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.976 0.417 . . . . 0.0 110.996 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.716 ' O ' HG23 ' A' ' 86' ' ' ILE . 2.8 tt -98.55 130.79 45.12 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.634 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 43' ' ' VAL . 20.7 m -94.42 121.75 45.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.451 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.536 HD23 ' C ' ' A' ' 44' ' ' LEU . 7.1 tt -120.69 100.79 7.32 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.374 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.457 ' CZ3' ' HB2' ' A' ' 47' ' ' SER . 66.4 t90 -95.93 136.5 36.28 Favored 'General case' 0 C--N 1.349 0.569 0 O-C-N 125.225 1.578 . . . . 0.0 109.358 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.6 mtpt -81.87 165.28 20.95 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.921 -178.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.457 ' HB2' ' CZ3' ' A' ' 45' ' ' TRP . 0.2 OUTLIER -173.47 79.77 0.39 Allowed Pre-proline 0 CA--C 1.533 0.313 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.577 179.633 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -73.62 152.65 48.43 Favored 'Trans proline' 0 N--CA 1.49 1.273 0 C-N-CA 123.061 2.507 . . . . 0.0 111.116 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 67.71 5.31 4.36 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.968 -179.087 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -137.17 -91.71 0.29 Allowed Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 29.6 ttpt -175.0 139.09 0.47 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.776 0.322 . . . . 0.0 111.155 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 22.7 mm -74.32 146.44 9.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 178.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 53' ' ' LEU . 67.5 mt -138.19 119.35 14.53 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.269 0.557 . . . . 0.0 111.874 -179.232 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.1 mptt -90.54 177.91 6.24 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.87 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -165.25 -176.95 37.3 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 178.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 55.4 tttt -154.66 129.62 9.47 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.765 0.317 . . . . 0.0 110.817 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 26.6 mt -72.67 130.2 35.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.641 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.5 m -102.66 -45.54 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.537 -0.302 . . . . 0.0 110.854 -179.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 22.1 mtt85 -144.42 158.97 43.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.859 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.7 p -87.39 156.17 3.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.143 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 74.5 t60 -140.84 117.7 11.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.151 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.08 5.62 63.86 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 -179.28 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.45 ' OG1' ' N ' ' A' ' 64' ' ' LYS . 32.4 p 58.69 -89.32 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 122.813 0.445 . . . . 0.0 111.513 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.45 ' N ' ' OG1' ' A' ' 63' ' ' THR . 15.4 pttm -90.84 55.51 2.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.835 0.35 . . . . 0.0 110.93 -179.478 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -159.58 -126.18 0.83 Allowed Glycine 0 N--CA 1.442 -0.952 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.555 ' HB1' ' O ' ' A' ' 24' ' ' ILE . . . -69.22 -177.65 1.15 Allowed 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.454 -0.873 . . . . 0.0 111.757 -179.125 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.1 m -148.85 158.69 6.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.197 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 14.8 ttp180 -87.35 150.17 24.01 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-O 121.056 0.455 . . . . 0.0 111.072 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -148.32 159.72 43.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.814 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 24.1 mtm180 -148.34 122.99 9.84 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.847 0.356 . . . . 0.0 110.765 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -101.21 117.65 35.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.387 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -70.76 -24.48 62.61 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -82.68 -77.87 0.22 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.628 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 126.2 150.3 7.59 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 17.3 mt -98.16 148.14 34.08 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 120.505 0.193 . . . . 0.0 110.862 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -49.16 -179.26 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 122.877 2.385 . . . . 0.0 112.494 179.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.9 -4.52 11.07 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 121.201 -0.524 . . . . 0.0 111.907 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.559 ' C ' ' H ' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -135.01 -142.71 0.19 Allowed 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.295 179.734 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.506 ' N ' ' CD ' ' A' ' 78' ' ' GLN . . . 64.32 -10.12 0.15 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.562 -178.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.559 ' H ' ' C ' ' A' ' 78' ' ' GLN . 2.1 tt -66.64 99.34 0.58 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.279 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 125.97 3.11 7.04 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -72.21 175.99 5.59 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-O 121.095 0.474 . . . . 0.0 110.716 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -92.66 128.13 38.41 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 26.3 m -92.66 156.91 3.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.233 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -147.9 153.24 38.83 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.704 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.716 HG23 ' O ' ' A' ' 42' ' ' LEU . 1.8 mp -103.65 74.08 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.41 ' O ' ' CB ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.466 0.373 0 C-N-CA 118.966 -1.094 . . . . 0.0 110.79 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.4 ptp . . . . . 0 N--CA 1.492 1.645 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 34.4 mtm105 -110.53 171.2 7.6 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.052 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.43 HG22 ' H ' ' A' ' 4' ' ' LYS . 2.0 mt -145.15 168.9 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.487 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.51 ' O ' HD13 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -152.39 120.59 6.28 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.262 0.553 . . . . 0.0 111.949 -179.499 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -107.07 -175.66 22.8 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.442 HG22 ' CE2' ' A' ' 83' ' ' TYR . 27.4 t -140.29 137.87 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-O 121.126 0.489 . . . . 0.0 110.57 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 72.3 t -71.07 144.88 13.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.841 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.41 HD11 ' HB2' ' A' ' 25' ' ' LYS . 14.8 mt -106.71 -52.6 2.75 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.391 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.6 t -166.15 154.64 10.9 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.182 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.489 ' O ' ' CG ' ' A' ' 10' ' ' TYR . 0.5 OUTLIER -99.46 126.84 45.46 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.004 0.43 . . . . 0.0 110.42 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.445 HH11 HG11 ' A' ' 21' ' ' VAL . 47.7 mtp180 -90.21 152.19 21.19 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.085 179.633 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 33.0 ttp180 -115.31 75.3 0.93 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.862 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.403 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 5.5 t -48.7 165.49 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.817 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.9 pttm -141.01 78.43 1.65 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.525 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -144.31 -55.83 0.36 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.786 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -80.15 -156.76 0.13 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.521 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 21.8 mp0 -100.87 -7.2 23.74 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.708 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.489 ' O ' ' CG ' ' A' ' 18' ' ' HIS . 86.3 t60 -156.93 21.41 0.32 Allowed 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.403 ' ND2' ' O ' ' A' ' 13' ' ' SER . 0.4 OUTLIER -40.7 148.92 0.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.149 -1.387 . . . . 0.0 111.772 -179.313 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -171.8 122.25 0.5 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 121.002 0.429 . . . . 0.0 110.95 179.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.541 HG12 ' N ' ' A' ' 22' ' ' MET . 72.9 t -116.27 164.26 12.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.884 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.541 ' N ' HG12 ' A' ' 21' ' ' VAL . 21.2 ptm -151.65 138.4 18.86 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.833 0.349 . . . . 0.0 110.881 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 55.2 mt -92.08 139.56 17.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.122 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.455 HG22 ' N ' ' A' ' 25' ' ' LYS . 77.5 mt -134.7 156.52 40.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.523 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.455 ' N ' HG22 ' A' ' 24' ' ' ILE . 71.9 tttt -144.24 120.79 6.37 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.867 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -61.14 169.36 6.27 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 121.872 1.715 . . . . 0.0 111.503 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.51 HD13 ' O ' ' A' ' 4' ' ' LYS . 0.8 OUTLIER -49.55 -77.49 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.625 -0.262 . . . . 0.0 110.951 -179.334 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.483 ' CG ' ' H ' ' A' ' 29' ' ' VAL . 2.8 p-10 -94.51 -88.61 0.24 Allowed 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.521 -0.472 . . . . 0.0 111.107 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.626 ' O ' HG12 ' A' ' 29' ' ' VAL . 82.5 t 41.32 55.7 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.165 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 -178.42 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -88.51 40.62 0.97 Allowed 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 114.365 -1.289 . . . . 0.0 110.998 -177.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 68.7 m -158.84 128.11 5.54 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.862 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 47.4 ttp180 -61.25 -25.38 67.04 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.028 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -62.32 -52.01 65.37 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.602 178.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -69.57 -38.41 77.38 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.434 178.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.524 ' O ' HD23 ' A' ' 38' ' ' LEU . . . -59.24 -60.66 3.51 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.003 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.404 ' O ' HG22 ' A' ' 39' ' ' ILE . 11.7 t -55.92 -22.96 28.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.732 179.238 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 34.4 tttp -70.86 -61.66 1.68 Allowed 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.749 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.524 HD23 ' O ' ' A' ' 35' ' ' ALA . 0.4 OUTLIER -77.52 5.94 8.05 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.243 -178.955 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.503 ' N ' HD23 ' A' ' 38' ' ' LEU . 8.1 tt -51.08 133.97 12.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.229 179.268 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.431 ' O ' ' NZ ' ' A' ' 56' ' ' LYS . . . 81.2 25.32 55.36 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.686 ' HG3' HD12 ' A' ' 57' ' ' ILE . 5.3 ptt180 -71.57 171.29 11.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.713 0.292 . . . . 0.0 110.367 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.522 ' O ' HG23 ' A' ' 86' ' ' ILE . 23.5 tp -100.82 112.18 24.54 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.135 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 43' ' ' VAL . 4.2 m -88.19 121.37 38.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.13 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.677 HD21 ' CG2' ' A' ' 52' ' ' ILE . 6.0 tt -123.49 98.41 5.83 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.73 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.461 ' CZ3' ' OG ' ' A' ' 47' ' ' SER . 75.8 t90 -100.73 109.92 21.98 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 125.089 1.493 . . . . 0.0 109.676 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 5.9 pttp -83.72 105.11 14.37 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 121.073 0.463 . . . . 0.0 111.41 -178.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.461 ' OG ' ' CZ3' ' A' ' 45' ' ' TRP . 0.9 OUTLIER -64.33 172.64 1.9 Allowed Pre-proline 0 CA--C 1.531 0.233 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.707 179.655 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -76.0 -32.88 4.01 Favored 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 122.813 2.342 . . . . 0.0 112.449 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.415 ' C ' ' H ' ' A' ' 51' ' ' LYS . 38.0 p -78.72 21.54 0.4 Allowed 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.24 -179.366 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 70.19 -7.04 4.88 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.415 ' H ' ' C ' ' A' ' 49' ' ' SER . 27.7 tttp -73.24 100.5 3.13 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.677 ' CG2' HD21 ' A' ' 44' ' ' LEU . 23.2 mm -83.49 111.15 19.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.444 -178.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 71.4 mt -100.15 143.31 30.5 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.855 179.093 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.6 pttp -150.24 116.35 5.66 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 120.945 0.403 . . . . 0.0 110.95 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -104.09 -150.64 21.27 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.431 ' NZ ' ' O ' ' A' ' 40' ' ' GLY . 0.2 OUTLIER -154.26 130.42 10.35 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.782 0.325 . . . . 0.0 110.881 179.9 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.686 HD12 ' HG3' ' A' ' 41' ' ' ARG . 34.6 mt -65.13 147.89 12.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.134 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -107.01 -40.56 5.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 C-N-CA 120.596 -0.442 . . . . 0.0 111.491 -178.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -164.55 155.14 14.66 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 120.392 -0.523 . . . . 0.0 111.853 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.571 HG13 ' O ' ' A' ' 60' ' ' VAL . 13.3 p -92.82 116.33 33.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.322 178.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -140.21 123.87 17.22 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.265 -178.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 136.24 -16.84 3.86 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 121.327 -0.463 . . . . 0.0 112.056 178.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.633 ' C ' ' H ' ' A' ' 65' ' ' GLY . 80.7 p 54.79 164.91 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.776 0.322 . . . . 0.0 111.025 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 38.2 tttp 67.1 -17.3 0.14 Allowed 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.148 0.499 . . . . 0.0 110.0 -178.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.633 ' H ' ' C ' ' A' ' 63' ' ' THR . . . 131.57 121.12 2.24 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.555 ' O ' HG23 ' A' ' 60' ' ' VAL . . . 174.68 149.01 0.08 Allowed 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.504 HG13 ' O ' ' A' ' 66' ' ' ALA . 8.7 m -157.13 139.15 5.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 120.253 -0.579 . . . . 0.0 111.404 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -90.97 146.63 23.71 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 178.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -146.35 160.1 42.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.229 0.537 . . . . 0.0 111.278 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 5.8 ttp180 -148.3 131.97 16.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.675 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.457 ' C ' ' H ' ' A' ' 73' ' ' LYS . 17.5 m-85 -92.87 141.81 28.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.991 0.424 . . . . 0.0 110.828 -179.388 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -62.35 -0.47 0.58 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.444 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.457 ' H ' ' C ' ' A' ' 71' ' ' PHE . 33.3 ttmt -154.88 -64.7 0.13 Allowed 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.629 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 142.53 -177.24 21.82 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.3 mt -95.48 165.76 16.07 Favored Pre-proline 0 CA--C 1.53 0.175 0 CA-C-O 120.705 0.288 . . . . 0.0 110.99 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -76.14 99.94 1.33 Allowed 'Trans proline' 0 N--CA 1.489 1.235 0 C-N-CA 122.971 2.447 . . . . 0.0 112.214 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 42.48 -113.06 0.54 Allowed Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.762 -0.535 . . . . 0.0 111.762 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -81.8 116.05 21.3 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.77 0.319 . . . . 0.0 110.787 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -154.4 8.14 0.32 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.322 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.5 tp -68.56 117.04 9.8 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.768 0.318 . . . . 0.0 110.491 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 118.5 -10.92 12.64 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.437 ' HB3' ' HE1' ' A' ' 45' ' ' TRP . 2.1 m-20 -68.36 131.08 44.7 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.442 ' CE2' HG22 ' A' ' 6' ' ' VAL . 5.8 m-85 -67.55 135.78 53.51 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.4 m -90.78 163.21 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.509 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 52.0 mp0 -148.14 145.11 28.22 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.533 HG22 ' O ' ' A' ' 86' ' ' ILE . 3.5 mp -101.06 73.3 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 44' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.463 0.219 0 C-N-CA 119.749 -0.78 . . . . 0.0 110.67 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.2 mmm . . . . . 0 N--CA 1.488 1.443 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 17.3 ptt85 -96.43 170.02 9.51 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.467 ' HB ' HD13 ' A' ' 86' ' ' ILE . 1.4 mt -148.4 144.88 18.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.266 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 52.0 mttt -83.17 173.45 11.66 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.646 -179.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 84' ' ' VAL . . . -171.47 174.66 45.05 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 22.0 t -149.15 143.97 18.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.262 0.553 . . . . 0.0 111.236 -178.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 75.7 t -79.88 147.46 6.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.972 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.486 HD11 ' HB2' ' A' ' 25' ' ' LYS . 13.4 mt -111.05 -52.43 2.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.644 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.7 t -163.88 124.27 2.17 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.402 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -99.36 105.67 17.68 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.325 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 35.9 mtt180 -92.01 146.43 23.74 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.772 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.411 ' O ' ' C ' ' A' ' 13' ' ' SER . 59.1 ttt-85 -120.62 70.83 0.9 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.645 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.411 ' C ' ' O ' ' A' ' 12' ' ' ARG . 38.2 m -41.47 111.15 0.2 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 120.259 -0.576 . . . . 0.0 110.115 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 76.2 mttt -79.35 -7.11 58.1 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.559 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.495 ' O ' ' N ' ' A' ' 17' ' ' GLN . 61.9 mt-10 -68.44 -7.01 28.05 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.097 -179.488 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 64.21 -47.1 0.29 Allowed 'General case' 0 N--CA 1.467 0.421 0 O-C-N 123.697 0.623 . . . . 0.0 110.56 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.495 ' N ' ' O ' ' A' ' 15' ' ' GLU . 16.1 mm-40 -77.84 45.8 0.53 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.659 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 4.7 m170 -161.74 -26.09 0.05 Allowed 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 69.92 161.15 0.21 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.212 -0.903 . . . . 0.0 109.972 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 -73.42 131.51 41.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.843 0.354 . . . . 0.0 111.319 -179.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.54 HG12 ' N ' ' A' ' 22' ' ' MET . 45.5 t -100.24 160.41 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.083 179.197 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.54 ' N ' HG12 ' A' ' 21' ' ' VAL . 13.1 ttt -148.59 112.75 5.21 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.874 -179.067 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.426 HG22 HD12 ' A' ' 8' ' ' LEU . 19.2 mt -85.19 136.26 23.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 41.2 mt -137.07 154.15 30.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.245 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.486 ' HB2' HD11 ' A' ' 8' ' ' LEU . 30.4 tttt -146.79 122.0 5.37 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.361 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -60.74 164.47 13.63 Favored 'Trans proline' 0 N--CA 1.489 1.228 0 C-N-CA 121.418 1.412 . . . . 0.0 111.152 178.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.7 tp -45.28 -80.79 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.888 -179.198 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.466 ' O ' ' C ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -93.8 -84.9 0.3 Allowed 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.964 -0.295 . . . . 0.0 110.444 179.383 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.701 ' O ' HG12 ' A' ' 29' ' ' VAL . 64.7 t 39.99 53.63 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 -178.436 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -88.53 44.36 1.2 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.441 -1.254 . . . . 0.0 110.727 -177.089 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.9 m -157.98 124.7 4.89 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.085 -0.962 . . . . 0.0 109.964 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.48 ' HA ' ' HB3' ' A' ' 35' ' ' ALA . 11.6 ttp180 -58.5 -26.95 64.0 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.333 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -61.21 -50.37 73.39 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.876 179.239 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.3 tp10 -72.46 -37.96 68.39 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.547 ' O ' HD23 ' A' ' 38' ' ' LEU . . . -60.4 -69.4 0.22 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.308 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.1 t -44.38 -18.61 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.831 0.348 . . . . 0.0 110.424 179.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.468 ' N ' ' C ' ' A' ' 35' ' ' ALA . 2.1 tmtt? -72.39 -63.04 1.23 Allowed 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.22 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.547 HD23 ' O ' ' A' ' 35' ' ' ALA . 0.5 OUTLIER -74.53 9.75 1.63 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.964 0.412 . . . . 0.0 110.324 -179.053 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.41 ' H ' ' C ' ' A' ' 37' ' ' LYS . 18.4 tt -48.63 -16.31 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.407 179.023 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -123.33 6.96 9.19 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.933 -178.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.8 mmt180 -72.15 175.68 5.81 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 117.591 0.696 . . . . 0.0 110.616 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.677 HD23 ' N ' ' A' ' 43' ' ' VAL . 6.5 tt -98.38 169.56 9.47 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.056 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.677 ' N ' HD23 ' A' ' 42' ' ' LEU . 33.8 m -140.84 99.5 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.185 0.517 . . . . 0.0 109.929 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.576 HD23 ' C ' ' A' ' 44' ' ' LEU . 5.9 tt -102.16 99.72 9.87 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.742 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.423 ' HE1' ' HB3' ' A' ' 82' ' ' ASP . 10.4 t90 -106.2 116.51 32.06 Favored 'General case' 0 C--O 1.234 0.278 0 O-C-N 124.682 1.239 . . . . 0.0 109.738 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.8 pttp -84.01 105.7 15.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.935 0.398 . . . . 0.0 110.487 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.4 t -67.38 119.98 69.26 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.245 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -60.03 -7.44 6.33 Favored 'Trans proline' 0 N--CA 1.489 1.236 0 C-N-CA 121.474 1.45 . . . . 0.0 111.645 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 31.2 t -82.71 -6.16 59.25 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.963 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 95.47 57.34 1.2 Allowed Glycine 0 CA--C 1.52 0.392 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.0 ttmm -165.16 101.06 0.74 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.661 0.267 . . . . 0.0 110.614 -179.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 28.7 mm -82.04 109.79 16.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.453 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 75.5 mt -104.51 143.55 32.89 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.063 0.459 . . . . 0.0 110.869 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -151.87 101.99 2.79 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.885 -178.47 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -104.98 -142.25 11.27 Favored Glycine 0 N--CA 1.464 0.504 0 N-CA-C 109.771 -1.331 . . . . 0.0 109.771 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 23.9 tttm -154.98 139.7 17.09 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.068 0.461 . . . . 0.0 111.122 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 80.0 mt -69.85 138.95 21.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.059 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -105.43 -34.14 3.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -178.617 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.477 ' NH2' ' NH2' ' A' ' 70' ' ' ARG . 5.0 ptt-85 -165.69 157.45 14.44 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 120.435 -0.506 . . . . 0.0 111.319 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.56 HG13 ' O ' ' A' ' 60' ' ' VAL . 7.3 p -97.98 121.44 48.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.543 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.42 ' ND1' ' O ' ' A' ' 60' ' ' VAL . 11.3 m80 -141.11 132.78 27.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.113 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.428 ' O ' ' OG1' ' A' ' 63' ' ' THR . . . 124.94 -12.8 7.66 Favored Glycine 0 CA--C 1.519 0.288 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.545 ' O ' ' N ' ' A' ' 65' ' ' GLY . 19.9 p 53.53 171.87 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 -179.117 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt 65.57 -52.94 0.36 Allowed 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -178.502 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 63' ' ' THR . . . 165.81 121.64 0.57 Allowed Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 178.062 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.578 ' O ' HG13 ' A' ' 67' ' ' VAL . . . 174.87 159.59 0.19 Allowed 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.578 HG13 ' O ' ' A' ' 66' ' ' ALA . 7.9 m -159.11 144.32 6.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 C-N-CA 120.044 -0.663 . . . . 0.0 111.212 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 23.2 ttm180 -90.51 154.89 19.29 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.227 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -146.15 168.63 20.51 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.209 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.477 ' NH2' ' NH2' ' A' ' 59' ' ' ARG . 92.8 mtt180 -147.25 111.91 5.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.216 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.482 ' CE1' ' SD ' ' A' ' 22' ' ' MET . 51.8 m-85 -96.43 109.95 22.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.748 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -82.31 -13.33 57.11 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.122 0.487 . . . . 0.0 109.835 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 45.4 mmtt -80.96 -77.6 0.2 Allowed 'General case' 0 C--O 1.231 0.116 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.742 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 135.41 154.91 7.14 Favored Glycine 0 C--N 1.335 0.508 0 N-CA-C 111.241 -0.744 . . . . 0.0 111.241 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.432 HD23 ' N ' ' A' ' 75' ' ' LEU . 0.9 OUTLIER -89.13 174.45 4.94 Favored Pre-proline 0 N--CA 1.463 0.183 0 N-CA-C 110.414 -0.217 . . . . 0.0 110.414 -179.909 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -76.06 -82.89 0.0 OUTLIER 'Trans proline' 0 C--N 1.315 -1.197 0 C-N-CA 122.305 2.003 . . . . 0.0 111.044 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -176.21 104.45 0.19 Allowed Glycine 0 N--CA 1.451 -0.304 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 179.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 70.32 62.93 0.22 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.92 0.391 . . . . 0.0 111.087 179.514 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -115.43 -0.6 13.07 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.511 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.9 tp -52.6 114.49 1.41 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.818 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 125.52 -13.27 7.37 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 111.744 -0.542 . . . . 0.0 111.744 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.423 ' HB3' ' HE1' ' A' ' 45' ' ' TRP . 46.2 m-20 -70.35 136.67 49.92 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 120.442 -0.503 . . . . 0.0 109.983 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -69.56 125.59 27.18 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.773 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.441 ' O ' ' N ' ' A' ' 5' ' ' GLY . 18.0 m -94.36 154.96 3.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -149.94 164.29 35.84 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.323 0.582 . . . . 0.0 110.65 -178.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.496 ' N ' HD12 ' A' ' 86' ' ' ILE . 5.1 mp -103.44 74.48 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 178.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.468 0.456 0 C-N-CA 120.093 -0.643 . . . . 0.0 110.946 -179.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.5 mtt . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.431 ' O ' HD13 ' A' ' 3' ' ' ILE . 11.5 mmt180 -94.13 179.12 5.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.1 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.56 HG22 ' H ' ' A' ' 4' ' ' LYS . 8.0 mm -138.13 169.85 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.56 ' H ' HG22 ' A' ' 3' ' ' ILE . 9.4 ptpt -150.81 103.85 3.12 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 121.259 0.552 . . . . 0.0 111.329 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -94.57 -177.3 38.51 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 179.391 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 p -146.5 135.38 16.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-O 121.222 0.534 . . . . 0.0 111.359 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 99.0 t -79.86 140.19 17.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.655 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 17.3 mt -105.52 -57.24 2.06 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.288 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.8 m -165.86 142.29 5.21 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.294 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -100.44 138.75 37.08 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 120.859 0.361 . . . . 0.0 110.689 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 10.6 mmt180 -89.78 117.47 28.66 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.485 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 -90.03 60.65 4.95 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.033 0.444 . . . . 0.0 110.133 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.7 m -70.15 149.42 47.57 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.032 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -148.47 -45.55 0.15 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.645 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.402 ' C ' ' H ' ' A' ' 17' ' ' GLN . 78.8 mt-10 -57.45 140.15 51.27 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.723 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 12.0 m-20 68.61 -5.95 0.9 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.077 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.402 ' H ' ' C ' ' A' ' 15' ' ' GLU . 1.1 tm0? 65.93 124.83 0.02 OUTLIER 'General case' 0 C--O 1.232 0.173 0 CA-C-O 121.031 0.443 . . . . 0.0 110.779 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 11.8 t-80 -169.7 -6.36 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.513 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 69.74 161.82 0.22 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.376 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.427 ' H ' ' ND2' ' A' ' 20' ' ' ASN . 0.2 OUTLIER -78.79 128.81 33.88 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.911 0.386 . . . . 0.0 110.732 -179.728 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.679 HG12 ' H ' ' A' ' 22' ' ' MET . 2.1 t -94.39 176.74 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.203 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.679 ' H ' HG12 ' A' ' 21' ' ' VAL . 30.8 tpp -143.65 119.18 10.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.046 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 6.2 mm -83.23 133.0 30.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.584 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.419 ' CG2' ' N ' ' A' ' 25' ' ' LYS . 12.3 mt -138.9 156.72 28.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.523 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.419 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 11.4 ttmm -140.67 119.89 8.49 Favored Pre-proline 0 C--N 1.33 -0.28 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.458 ' O ' ' N ' ' A' ' 28' ' ' ASP . 2.9 Cg_endo -67.86 59.2 0.86 Allowed 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.313 2.009 . . . . 0.0 111.273 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.0 tp 54.31 -79.76 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.638 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.572 ' CG ' ' H ' ' A' ' 29' ' ' VAL . 9.2 p-10 -101.29 -90.75 0.33 Allowed 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.503 -0.479 . . . . 0.0 111.44 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.7 ' O ' HG12 ' A' ' 29' ' ' VAL . 53.3 t 44.7 55.95 0.33 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.194 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 -178.126 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -89.23 50.29 1.91 Allowed 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 114.356 -1.293 . . . . 0.0 110.812 -178.068 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 10.1 m -158.85 108.76 1.99 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.101 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 26.9 ttt85 -47.79 -31.8 5.29 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.161 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -62.59 -55.33 28.15 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.933 179.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -65.42 -39.37 92.04 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.104 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.56 ' O ' HD23 ' A' ' 38' ' ' LEU . . . -58.93 -59.83 4.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.18 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.5 m -53.65 -22.07 8.12 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.614 179.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.0 tttp -68.96 -63.42 1.06 Allowed 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.067 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.56 HD23 ' O ' ' A' ' 35' ' ' ALA . 0.4 OUTLIER -80.32 16.8 1.19 Allowed 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 121.019 0.437 . . . . 0.0 111.053 -179.423 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.59 HD12 HG12 ' A' ' 60' ' ' VAL . 19.3 tt -50.38 -32.75 10.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.233 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -102.9 24.03 31.9 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.412 ' HG2' HD13 ' A' ' 86' ' ' ILE . 1.8 tpp180 -71.15 146.15 49.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.747 0.308 . . . . 0.0 110.569 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.571 ' O ' HG23 ' A' ' 86' ' ' ILE . 7.8 tp -96.19 121.02 37.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.156 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 43' ' ' VAL . 10.8 m -87.08 122.62 39.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.282 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.436 ' H ' ' HA ' ' A' ' 86' ' ' ILE . 0.5 OUTLIER -107.84 98.23 7.84 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.441 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 37.3 t90 -86.61 113.02 22.16 Favored 'General case' 0 C--O 1.234 0.246 0 O-C-N 125.209 1.568 . . . . 0.0 110.448 -178.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.415 ' HG3' HD11 ' A' ' 52' ' ' ILE . 75.5 tttt -83.56 93.63 7.89 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.004 -179.374 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.1 p -64.28 167.57 8.07 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.049 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -77.9 -34.9 1.58 Allowed 'Trans proline' 0 C--N 1.314 -1.277 0 C-N-CA 123.01 2.473 . . . . 0.0 112.271 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 12.7 m -72.72 4.51 3.95 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.021 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.71 -9.64 73.12 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -77.57 100.27 6.04 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.566 0.222 . . . . 0.0 110.616 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.415 HD11 ' HG3' ' A' ' 46' ' ' LYS . 1.2 mp -79.18 108.01 12.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.241 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.518 HD22 ' CA ' ' A' ' 74' ' ' GLY . 13.7 mt -90.34 126.25 35.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.375 0.607 . . . . 0.0 110.943 -178.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 28.5 mttm -91.49 110.17 21.48 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.88 -1.055 . . . . 0.0 111.281 -179.391 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -95.46 178.81 35.68 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 178.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 38.7 tttt -152.84 131.45 12.28 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.528 -0.469 . . . . 0.0 111.426 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.2 mt -75.6 142.47 14.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.867 179.164 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -104.83 -34.29 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.81 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -164.85 156.23 15.08 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.045 0.45 . . . . 0.0 111.466 179.292 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.59 HG12 HD12 ' A' ' 39' ' ' ILE . 14.9 p -98.24 139.22 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.656 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.93 ' O ' ' HB3' ' A' ' 66' ' ' ALA . 56.7 t-80 -142.2 168.77 18.95 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.46 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.515 ' C ' ' H ' ' A' ' 64' ' ' LYS . . . 91.12 -34.14 4.4 Favored Glycine 0 CA--C 1.525 0.683 0 CA-C-N 116.19 -0.459 . . . . 0.0 112.707 178.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.3 p 68.22 -34.18 0.25 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.682 0.241 . . . . 0.0 110.849 -179.042 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.515 ' H ' ' C ' ' A' ' 62' ' ' GLY . 0.8 OUTLIER -89.31 -7.42 55.39 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.579 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.423 ' O ' ' HB2' ' A' ' 66' ' ' ALA . . . 130.65 119.78 2.15 Favored Glycine 0 CA--C 1.522 0.476 0 CA-C-N 114.517 -1.22 . . . . 0.0 110.224 178.436 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.93 ' HB3' ' O ' ' A' ' 61' ' ' HIS . . . 172.68 150.26 0.06 Allowed 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.413 HG13 ' O ' ' A' ' 66' ' ' ALA . 17.4 m -156.19 141.0 9.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.539 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -88.91 150.39 22.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.421 179.292 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -146.85 163.59 35.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.963 0.411 . . . . 0.0 111.055 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 53.2 mtt180 -146.4 121.24 9.93 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.079 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.557 ' C ' ' H ' ' A' ' 73' ' ' LYS . 60.3 m-85 -97.48 138.85 34.29 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.116 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.573 ' O ' ' CB ' ' A' ' 73' ' ' LYS . 8.9 pt-20 -74.95 36.5 0.11 Allowed 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.136 178.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.573 ' CB ' ' O ' ' A' ' 72' ' ' GLU . 9.9 ttpt 93.28 -32.97 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 115.008 -0.997 . . . . 0.0 110.18 -179.485 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.518 ' CA ' HD22 ' A' ' 53' ' ' LEU . . . -10.97 -59.84 0.01 OUTLIER Glycine 0 CA--C 1.53 0.997 0 O-C-N 124.431 1.082 . . . . 0.0 113.164 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.448 ' N ' ' O ' ' A' ' 73' ' ' LYS . 10.9 mt -56.67 113.71 6.52 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-N 116.709 0.254 . . . . 0.0 110.552 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -69.34 -174.9 0.9 Allowed 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 122.436 2.091 . . . . 0.0 112.347 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -51.13 115.09 3.29 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.553 ' O ' ' HB2' ' A' ' 79' ' ' ALA . 9.3 tm0? 69.48 145.81 0.06 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.914 0.388 . . . . 0.0 110.708 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.553 ' HB2' ' O ' ' A' ' 78' ' ' GLN . . . 166.91 -21.0 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.242 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.4 tp -43.7 129.13 5.49 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.224 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 98.53 -7.64 61.64 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.827 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -71.5 135.94 47.34 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -68.58 129.41 39.86 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.1 m -90.3 170.99 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -149.88 151.16 33.02 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.571 HG23 ' O ' ' A' ' 42' ' ' LEU . 16.8 mt -108.69 73.2 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 178.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.4 t . . . . . 0 N--CA 1.464 0.231 0 C-N-CA 120.115 -0.634 . . . . 0.0 111.015 -178.628 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.4 ptt? . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 20.9 mtm180 -105.68 173.1 6.46 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.836 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.2 mt -144.32 158.51 15.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.419 -0.81 . . . . 0.0 108.86 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.78 107.85 4.05 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.467 0.651 . . . . 0.0 112.082 -178.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.419 ' C ' HG22 ' A' ' 84' ' ' VAL . . . -95.85 -177.35 36.61 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 178.343 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 75.2 t -145.42 135.68 18.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.202 0.525 . . . . 0.0 110.468 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.9 t -73.0 142.72 14.69 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.391 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 52.0 mt -110.49 -33.71 6.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.055 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.6 m -161.28 134.56 6.46 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.935 0.397 . . . . 0.0 110.886 -179.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -106.44 101.15 10.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.541 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.43 ' O ' ' O ' ' A' ' 21' ' ' VAL . 5.8 mpt_? -91.09 133.29 35.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.373 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 12.8 ptt85 -101.35 62.31 0.95 Allowed 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.184 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.1 t 59.69 164.58 0.06 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.021 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.8 ttmm -133.18 -69.67 0.55 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.386 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -111.05 43.4 1.46 Allowed 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.24 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.1 t30 46.29 81.42 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.913 0.387 . . . . 0.0 110.373 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -104.34 -27.92 11.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.55 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -175.46 -54.52 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -178.32 -153.87 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.574 178.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -75.37 126.47 31.07 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.442 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.43 ' O ' ' O ' ' A' ' 11' ' ' ARG . 88.1 t -105.64 153.1 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.468 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 15.2 ptm -145.81 143.04 29.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.961 0.41 . . . . 0.0 111.093 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 29.4 mm -92.65 143.15 12.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.106 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.625 HD12 ' CB ' ' A' ' 69' ' ' ALA . 31.5 mt -133.19 156.87 42.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.399 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.428 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -140.3 99.8 7.12 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.644 179.824 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.537 ' O ' ' N ' ' A' ' 28' ' ' ASP . 3.3 Cg_exo -65.17 74.12 0.25 Allowed 'Trans proline' 0 C--N 1.314 -1.268 0 C-N-CA 121.984 1.789 . . . . 0.0 111.051 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.415 ' N ' ' O ' ' A' ' 25' ' ' LYS . 0.9 OUTLIER 37.92 -82.64 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 114.849 -1.069 . . . . 0.0 112.097 -179.758 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.537 ' N ' ' O ' ' A' ' 26' ' ' PRO . 1.1 p-10 -99.24 -87.11 0.36 Allowed 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.363 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.778 ' O ' HG12 ' A' ' 29' ' ' VAL . 19.1 t 44.14 62.27 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-O 122.245 1.022 . . . . 0.0 108.294 -177.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -93.63 47.22 1.22 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.15 -1.386 . . . . 0.0 110.941 -178.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 70.3 m -156.72 118.99 3.94 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.541 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.439 ' H ' ' HB3' ' A' ' 64' ' ' LYS . 1.4 ttt85 -51.89 -30.93 26.12 Favored 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.429 ' O ' ' CB ' ' A' ' 37' ' ' LYS . 45.3 mt-10 -63.01 -63.15 1.29 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.643 179.038 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -54.86 -46.62 74.72 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.03 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -57.84 -69.48 0.17 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.985 179.279 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 65.0 m -50.82 -36.68 38.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.677 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.429 ' CB ' ' O ' ' A' ' 33' ' ' GLU . 60.5 tttt -71.35 -14.75 62.29 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.304 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.529 HD21 HD13 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -86.47 -11.31 52.16 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 120.853 0.358 . . . . 0.0 110.628 -179.524 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 53.7 mt -55.16 121.63 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.658 178.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 103.79 -4.05 45.94 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.714 -0.554 . . . . 0.0 111.714 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -70.37 142.33 52.13 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.854 0.359 . . . . 0.0 110.206 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.455 ' O ' HG23 ' A' ' 86' ' ' ILE . 11.6 tp -81.51 111.29 17.7 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.089 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.64 HG23 ' O ' ' A' ' 43' ' ' VAL . 6.7 m -88.81 107.4 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 121.581 0.705 . . . . 0.0 111.182 -178.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.1 mp -102.98 92.97 4.78 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 1.2 t90 -91.87 129.08 37.9 Favored 'General case' 0 C--O 1.235 0.304 0 O-C-N 124.717 1.26 . . . . 0.0 110.736 -178.065 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.401 ' HA ' ' CD1' ' A' ' 52' ' ' ILE . 1.6 ttmp? -81.76 91.96 6.57 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.966 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.405 ' CB ' ' CD ' ' A' ' 48' ' ' PRO . 0.8 OUTLIER -63.65 176.48 0.61 Allowed Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.011 179.946 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.507 ' C ' ' H ' ' A' ' 50' ' ' GLY . 2.9 Cg_endo -76.23 -41.75 0.45 Allowed 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.663 2.242 . . . . 0.0 112.491 -179.047 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.5 ' C ' ' H ' ' A' ' 51' ' ' LYS . 6.8 t -70.5 20.64 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.203 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.507 ' H ' ' C ' ' A' ' 48' ' ' PRO . . . 66.19 -9.72 0.73 Allowed Glycine 0 CA--C 1.53 0.999 0 N-CA-C 111.051 -0.819 . . . . 0.0 111.051 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.5 ' H ' ' C ' ' A' ' 49' ' ' SER . 7.0 ttpm? -73.26 119.62 17.75 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.413 ' HA ' HD13 ' A' ' 52' ' ' ILE . 28.5 mm -83.97 112.92 22.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.562 HD22 ' CA ' ' A' ' 74' ' ' GLY . 16.9 mt -99.66 125.21 45.46 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.265 0.555 . . . . 0.0 111.301 -179.109 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.3 mtpt -89.1 166.85 13.59 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.572 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -161.99 178.57 37.78 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.6 tttt -152.2 123.7 7.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.826 0.346 . . . . 0.0 111.023 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.529 HD13 HD21 ' A' ' 38' ' ' LEU . 22.4 mt -66.02 144.8 14.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.315 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.3 m -109.36 -34.54 2.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.584 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -163.37 158.02 20.7 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.745 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.4 p -88.54 153.8 3.24 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.431 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -140.86 125.08 17.45 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.25 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.3 13.82 55.13 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 -179.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.4 ' HG1' ' H ' ' A' ' 64' ' ' LYS . 82.2 p 52.92 -99.99 0.09 Allowed 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 122.44 0.296 . . . . 0.0 111.348 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.439 ' HB3' ' H ' ' A' ' 32' ' ' ARG . 16.4 pttt -88.16 55.93 3.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.829 -179.448 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -156.13 -125.41 0.9 Allowed Glycine 0 N--CA 1.446 -0.7 0 N-CA-C 111.366 -0.694 . . . . 0.0 111.366 -178.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.422 ' HB1' ' O ' ' A' ' 24' ' ' ILE . . . -67.9 -177.5 0.82 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.25 -0.975 . . . . 0.0 111.688 -178.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.3 m -153.11 156.85 5.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.099 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 8.7 tpp180 -88.88 154.49 20.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.933 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.625 ' CB ' HD12 ' A' ' 24' ' ' ILE . . . -149.85 154.38 38.29 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.199 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -148.79 128.76 13.49 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.909 0.385 . . . . 0.0 111.156 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.466 ' HB2' HD23 ' A' ' 75' ' ' LEU . 23.3 m-85 -103.96 117.05 33.39 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.54 179.332 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -80.96 -10.9 59.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.818 -178.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.466 ' O ' ' N ' ' A' ' 75' ' ' LEU . 24.7 ttpt -160.03 -45.66 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 120.36 -0.536 . . . . 0.0 111.933 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.562 ' CA ' HD22 ' A' ' 53' ' ' LEU . . . -64.84 51.77 0.1 Allowed Glycine 0 CA--C 1.529 0.968 0 O-C-N 123.513 0.508 . . . . 0.0 112.015 -178.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.466 HD23 ' HB2' ' A' ' 71' ' ' PHE . 0.2 OUTLIER -138.4 91.26 12.64 Favored Pre-proline 0 C--N 1.329 -0.289 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -59.08 -80.95 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 121.945 1.764 . . . . 0.0 112.107 -179.075 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -173.84 9.65 0.03 OUTLIER Glycine 0 CA--C 1.525 0.681 0 C-N-CA 120.743 -0.742 . . . . 0.0 111.589 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -157.87 107.35 2.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.844 0.354 . . . . 0.0 110.51 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -139.92 4.3 2.08 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.741 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.8 tp -77.15 98.94 5.23 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.265 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 123.61 -26.84 5.88 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 121.224 -0.512 . . . . 0.0 112.183 178.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -70.9 129.4 38.95 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 117.232 0.516 . . . . 0.0 109.924 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -68.59 134.02 49.36 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.419 HG22 ' C ' ' A' ' 5' ' ' GLY . 29.7 m -90.73 160.13 2.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -147.61 151.33 36.04 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.336 -0.546 . . . . 0.0 110.565 -178.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.455 HG23 ' O ' ' A' ' 42' ' ' LEU . 33.5 mt -110.01 72.05 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 178.17 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.7 t . . . . . 0 C--N 1.332 -0.195 0 C-N-CA 119.7 -0.8 . . . . 0.0 110.826 -178.824 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.122 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.419 HG22 ' N ' ' A' ' 4' ' ' LYS . 11.3 mt -145.29 163.46 12.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.926 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.419 ' N ' HG22 ' A' ' 3' ' ' ILE . 5.8 ptpt -139.04 177.08 8.16 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.111 0.482 . . . . 0.0 110.805 -179.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -170.44 -176.04 39.62 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 -178.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.9 t -140.35 127.51 23.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.086 0.47 . . . . 0.0 110.2 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 66.1 t -63.23 151.71 8.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.558 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.453 HD12 HG22 ' A' ' 23' ' ' ILE . 37.1 mt -109.86 -61.32 1.66 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.272 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.5 t -166.4 133.48 2.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.634 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -106.59 115.48 30.27 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.357 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.33 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 98.5 t . . . . . 0 N--CA 1.465 0.323 0 CA-C-O 120.629 0.252 . . . . 0.0 110.64 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.541 ' SD ' ' CE1' ' A' ' 71' ' ' PHE . 23.6 ttt -143.71 123.37 13.31 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.565 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.453 HG22 HD12 ' A' ' 8' ' ' LEU . 16.1 mm -98.97 134.77 36.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.775 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.595 ' O ' ' HB1' ' A' ' 66' ' ' ALA . 38.4 mt -125.61 153.91 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.637 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.2 ttmm -137.45 98.51 10.0 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.885 -179.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.479 ' O ' ' C ' ' A' ' 27' ' ' LEU . 3.5 Cg_exo -70.74 135.55 28.37 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 122.265 1.977 . . . . 0.0 110.722 178.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.479 ' C ' ' O ' ' A' ' 26' ' ' PRO . 7.6 mp -19.33 -85.32 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -179.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.435 ' HB2' HD22 ' A' ' 30' ' ' ASN . 5.2 p30 -93.1 -91.86 0.17 Allowed 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.526 -179.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.705 ' O ' HG12 ' A' ' 29' ' ' VAL . 91.2 t 48.19 46.39 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.145 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 -178.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.557 ' ND2' ' H ' ' A' ' 30' ' ' ASN . 1.6 p30 -89.58 51.16 2.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.841 -178.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -159.2 111.42 2.16 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.68 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.423 ' H ' ' HG2' ' A' ' 64' ' ' LYS . 14.9 ttt85 -48.26 -29.94 4.31 Favored 'General case' 0 N--CA 1.462 0.143 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -61.05 -58.19 9.45 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.754 178.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.96 -49.34 70.7 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.374 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -53.79 -60.96 2.64 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.5 t -54.65 -39.6 68.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.847 179.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 51.3 mttt -69.84 -19.95 63.44 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.486 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.504 ' O ' ' HG ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -85.34 -14.08 47.55 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.768 -179.304 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 71.7 mt -55.48 127.95 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 N-CA-C 110.148 -0.315 . . . . 0.0 110.148 178.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 107.89 -14.75 37.64 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 61.9 mtt180 -69.78 162.29 28.13 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.501 ' O ' HG23 ' A' ' 86' ' ' ILE . 3.8 tp -103.14 128.21 50.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.207 -179.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.411 HG22 ' H ' ' A' ' 43' ' ' VAL . 3.0 m -94.9 105.65 17.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.316 179.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.593 HD23 ' C ' ' A' ' 44' ' ' LEU . 6.1 tt -102.61 95.37 6.18 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.492 ' CZ3' HD12 ' A' ' 53' ' ' LEU . 15.9 t90 -99.59 136.8 38.98 Favored 'General case' 0 C--O 1.238 0.452 0 O-C-N 124.632 1.208 . . . . 0.0 111.21 -178.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.476 ' O ' ' CE2' ' A' ' 45' ' ' TRP . 58.1 mttt -82.33 169.13 16.84 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.315 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.464 0.236 0 N-CA-C 110.351 -0.24 . . . . 0.0 110.351 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.9 ttmp? . . . . . 0 C--O 1.233 0.22 0 CA-C-O 120.892 0.377 . . . . 0.0 110.803 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.539 ' CG2' HD21 ' A' ' 44' ' ' LEU . 27.1 mm -84.25 114.37 24.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.492 HD12 ' CZ3' ' A' ' 45' ' ' TRP . 10.8 mt -98.46 146.97 25.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.019 0.437 . . . . 0.0 110.493 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.06 107.02 3.98 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.546 -178.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -103.98 -151.42 21.99 Favored Glycine 0 CA--C 1.521 0.464 0 N-CA-C 109.866 -1.293 . . . . 0.0 109.866 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 24.3 tttm -155.49 140.98 17.81 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.985 0.421 . . . . 0.0 111.351 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.463 HD13 HD21 ' A' ' 38' ' ' LEU . 65.6 mt -72.84 135.27 28.09 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.583 179.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -99.0 -63.46 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.973 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.8 mtt85 -143.88 159.29 42.8 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.657 0.265 . . . . 0.0 110.574 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 6.4 p -86.78 140.27 16.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.747 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.428 ' H ' ' HA ' ' A' ' 67' ' ' VAL . 3.9 m-70 -140.74 80.09 1.73 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.595 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 153.44 11.83 0.07 OUTLIER Glycine 0 CA--C 1.521 0.424 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 69.4 p 51.1 -94.85 0.03 OUTLIER 'General case' 0 C--O 1.231 0.104 0 CA-C-N 115.277 -0.462 . . . . 0.0 110.85 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.423 ' HG2' ' H ' ' A' ' 32' ' ' ARG . 15.0 mtmt -94.5 50.17 1.33 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.115 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -156.22 -125.13 0.88 Allowed Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.526 -0.845 . . . . 0.0 111.809 -178.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.595 ' HB1' ' O ' ' A' ' 24' ' ' ILE . . . -68.29 179.54 1.57 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.243 -0.978 . . . . 0.0 111.982 -178.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.428 ' HA ' ' H ' ' A' ' 61' ' ' HIS . 4.1 m -150.73 166.66 2.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.145 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 44.9 ttt180 -88.93 148.37 23.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.841 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -147.62 166.05 28.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.323 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 60.8 mtp180 -148.01 146.99 29.14 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.28 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.541 ' CE1' ' SD ' ' A' ' 22' ' ' MET . 53.3 m-85 -133.84 117.46 16.87 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.793 -179.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -84.73 -26.32 27.72 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.104 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.1 tttm -85.08 -11.03 56.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.217 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 61.73 168.67 0.66 Allowed Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.402 ' CB ' ' CD ' ' A' ' 76' ' ' PRO . 0.6 OUTLIER -100.04 174.98 2.62 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 179.877 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.402 ' CD ' ' CB ' ' A' ' 75' ' ' LEU . 3.3 Cg_exo -73.63 171.15 18.37 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.665 2.243 . . . . 0.0 111.695 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -49.94 110.76 0.92 Allowed Glycine 0 CA--C 1.526 0.765 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 47.66 95.07 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.864 0.364 . . . . 0.0 110.911 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -130.16 22.29 5.26 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.025 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.465 ' CD2' ' N ' ' A' ' 80' ' ' LEU . 4.0 mm? -76.03 92.6 3.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.759 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 153.32 -16.19 0.67 Allowed Glycine 0 CA--C 1.528 0.894 0 C-N-CA 120.999 -0.62 . . . . 0.0 111.974 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -72.68 139.05 47.03 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 117.272 0.536 . . . . 0.0 110.118 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -69.4 137.29 52.65 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 29.3 m -91.47 158.64 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 -148.2 153.5 38.85 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.194 0.521 . . . . 0.0 110.961 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.519 HG22 ' O ' ' A' ' 86' ' ' ILE . 3.9 mp -109.4 73.49 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.432 ' H ' ' HB3' ' A' ' 44' ' ' LEU . 1.5 t . . . . . 0 CA--C 1.528 0.132 0 C-N-CA 120.018 -0.673 . . . . 0.0 111.03 -178.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 4.5 ptt-85 . . . . . 0 C--O 1.232 0.173 0 CA-C-O 120.936 0.398 . . . . 0.0 110.921 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.439 HG22 ' H ' ' A' ' 4' ' ' LYS . 0.6 OUTLIER -145.98 -177.69 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.902 179.622 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.439 ' H ' HG22 ' A' ' 3' ' ' ILE . 11.9 ptpt -146.96 107.17 4.02 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.131 0.491 . . . . 0.0 111.311 -178.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.43 ' HA2' ' H ' ' A' ' 27' ' ' LEU . . . -98.61 -176.55 32.57 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 179.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.8 t -140.16 139.12 36.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-O 121.044 0.449 . . . . 0.0 110.348 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.6 t -78.5 154.59 5.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.265 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 56.3 mt -125.24 -44.39 1.88 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.31 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -165.14 126.97 2.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.841 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -102.38 122.37 44.14 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.814 179.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 12.5 ttm-85 . . . . . 0 N--CA 1.464 0.234 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.912 -179.434 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.575 HG12 ' N ' ' A' ' 22' ' ' MET . 18.8 t . . . . . 0 N--CA 1.462 0.139 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.575 ' N ' HG12 ' A' ' 21' ' ' VAL . 9.6 ttt -147.55 121.91 9.65 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.681 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 91.9 mt -96.13 129.83 45.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.405 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.503 HG22 ' N ' ' A' ' 25' ' ' LYS . 96.8 mt -132.86 160.14 42.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.024 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.521 ' O ' ' N ' ' A' ' 27' ' ' LEU . 60.1 tttt -138.12 96.37 10.19 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.326 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -59.57 72.41 0.06 OUTLIER 'Trans proline' 0 N--CA 1.489 1.252 0 C-N-CA 122.291 1.994 . . . . 0.0 111.464 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.521 ' N ' ' O ' ' A' ' 25' ' ' LYS . 14.1 tp 51.99 -116.33 1.01 Allowed 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.353 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.474 ' CG ' ' H ' ' A' ' 29' ' ' VAL . 6.4 p-10 -74.0 -92.78 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.47 -179.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.735 ' O ' HG12 ' A' ' 29' ' ' VAL . 53.8 t 56.07 54.74 0.33 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.194 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -178.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -92.29 47.4 1.32 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.038 -178.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.7 t -158.3 123.6 4.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.11 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.476 ' HE ' ' HB ' ' A' ' 63' ' ' THR . 27.8 ttm180 -56.55 -31.75 64.49 Favored 'General case' 0 C--O 1.222 -0.382 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -61.82 -52.22 65.04 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.998 179.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.2 tp10 -65.64 -51.59 58.35 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.471 ' O ' HD23 ' A' ' 38' ' ' LEU . . . -55.59 -48.48 74.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.532 179.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.441 ' CB ' ' O ' ' A' ' 32' ' ' ARG . 93.4 p -62.34 -33.64 75.09 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.793 178.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 43.9 tttm -66.63 -61.23 2.08 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.118 -177.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.471 HD23 ' O ' ' A' ' 35' ' ' ALA . 0.8 OUTLIER -77.88 5.76 9.01 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.756 -0.377 . . . . 0.0 111.235 -178.758 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.596 HG23 ' O ' ' A' ' 39' ' ' ILE . 12.9 tt -53.22 113.94 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 178.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.432 ' H ' ' HB ' ' A' ' 57' ' ' ILE . . . 102.07 15.72 25.29 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 111.538 -0.625 . . . . 0.0 111.538 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.9 tpt180 -69.63 155.79 39.95 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 24.7 tp -84.55 105.59 15.48 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.869 0.366 . . . . 0.0 110.724 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.608 HG23 ' O ' ' A' ' 43' ' ' VAL . 33.2 m -87.37 109.39 19.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.532 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.621 HD23 ' C ' ' A' ' 44' ' ' LEU . 5.0 tt -108.37 97.15 6.87 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.451 ' CZ3' HD12 ' A' ' 53' ' ' LEU . 10.6 t90 -99.0 117.61 33.9 Favored 'General case' 0 C--O 1.237 0.406 0 O-C-N 124.824 1.328 . . . . 0.0 110.707 -179.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 43.6 tttp -85.87 100.75 12.29 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.447 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.446 ' HB2' ' O ' ' A' ' 51' ' ' LYS . 0.1 OUTLIER . . . . . 0 CA--C 1.536 0.441 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.819 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.446 ' O ' ' HB2' ' A' ' 47' ' ' SER . 3.7 ttpt . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.905 0.383 . . . . 0.0 110.399 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.526 ' CG2' HD21 ' A' ' 44' ' ' LEU . 18.1 mm -84.65 108.21 16.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.625 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.451 HD12 ' CZ3' ' A' ' 45' ' ' TRP . 16.7 mt -105.81 143.26 34.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.552 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.05 116.72 5.84 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.394 -178.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -113.8 -153.95 11.15 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 179.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt -151.51 136.75 17.54 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 121.024 0.44 . . . . 0.0 110.849 179.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.637 HG23 ' O ' ' A' ' 68' ' ' ARG . 45.8 mt -65.33 140.32 19.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.0 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -106.09 -45.14 8.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.831 -179.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 44.5 mtp85 -149.23 159.49 44.21 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.794 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.513 HG13 ' O ' ' A' ' 60' ' ' VAL . 7.1 p -93.06 117.21 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.039 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.403 ' H ' ' HA ' ' A' ' 67' ' ' VAL . 37.8 t60 -102.59 121.19 41.89 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.428 179.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.75 10.28 50.32 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 111.556 -0.617 . . . . 0.0 111.556 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.476 ' HB ' ' HE ' ' A' ' 32' ' ' ARG . 81.3 p 51.55 -88.11 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.473 ' HG2' ' H ' ' A' ' 32' ' ' ARG . 51.4 mttt -90.18 51.74 2.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.12 -179.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -156.97 -126.06 0.9 Allowed Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.43 -0.891 . . . . 0.0 112.277 -179.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.71 -177.89 1.06 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 113.859 -1.17 . . . . 0.0 112.237 -178.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.403 ' HA ' ' H ' ' A' ' 61' ' ' HIS . 4.8 m -147.19 153.59 12.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.802 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.637 ' O ' HG23 ' A' ' 57' ' ' ILE . 27.6 ttm180 -87.85 157.13 19.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.765 0.317 . . . . 0.0 110.985 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -151.04 166.23 31.37 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.035 179.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 13.9 ttt180 -149.37 116.85 6.14 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.76 0.314 . . . . 0.0 110.692 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.44 ' CD1' ' SD ' ' A' ' 22' ' ' MET . 34.4 m-85 -100.43 117.88 35.51 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.088 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -80.13 -19.95 46.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.804 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 35.3 mttt -81.55 -77.72 0.21 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.981 0.42 . . . . 0.0 110.947 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 140.92 169.74 11.87 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 -179.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.409 ' CB ' ' CD ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -97.02 175.57 2.55 Favored Pre-proline 0 C--N 1.33 -0.241 0 N-CA-C 110.272 -0.269 . . . . 0.0 110.272 -179.81 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.409 ' CD ' ' CB ' ' A' ' 75' ' ' LEU . 2.9 Cg_endo -77.39 19.32 0.73 Allowed 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.99 2.46 . . . . 0.0 111.376 179.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 97.67 -100.55 2.41 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -90.67 106.71 18.69 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.817 0.341 . . . . 0.0 110.2 179.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -163.1 23.8 0.09 Allowed 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.149 0.499 . . . . 0.0 110.085 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.1 tp -70.53 95.22 1.05 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.563 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 139.1 -1.76 2.53 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.807 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.407 ' CG ' ' HE1' ' A' ' 45' ' ' TRP . 7.9 t0 -71.28 136.99 48.2 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -69.13 129.61 40.35 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.4 m -91.29 162.58 2.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.401 ' C ' HD13 ' A' ' 86' ' ' ILE . 25.8 mt-10 -148.95 161.89 40.99 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.334 -179.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.401 HD13 ' C ' ' A' ' 85' ' ' GLU . 1.2 mm -107.97 72.46 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 178.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.417 ' O ' ' CB ' ' A' ' 44' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.462 0.154 0 C-N-CA 119.945 -0.702 . . . . 0.0 111.293 -178.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 22.6 ptt180 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.838 0.352 . . . . 0.0 110.978 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.525 HG22 ' H ' ' A' ' 4' ' ' LYS . 1.1 mt -144.41 179.41 1.36 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.852 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.525 ' H ' HG22 ' A' ' 3' ' ' ILE . 0.0 OUTLIER -144.24 103.81 4.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.363 0.601 . . . . 0.0 110.382 -179.528 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.43 ' HA2' ' H ' ' A' ' 27' ' ' LEU . . . -90.71 -179.09 43.54 Favored Glycine 0 CA--C 1.522 0.527 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.268 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.1 t -145.59 137.14 19.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.919 0.39 . . . . 0.0 109.987 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 74.3 t -74.72 140.37 17.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.69 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 43.1 mt -107.52 -45.42 4.06 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.687 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.2 p -162.84 125.92 2.81 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.92 0.391 . . . . 0.0 111.082 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -101.49 97.65 8.08 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.306 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 17.7 ttm180 . . . . . 0 C--N 1.333 -0.135 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.348 179.792 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.421 HG12 ' N ' ' A' ' 22' ' ' MET . 98.6 t . . . . . 0 N--CA 1.465 0.322 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.421 ' N ' HG12 ' A' ' 21' ' ' VAL . 41.9 ttm -145.39 115.85 7.6 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.717 0.294 . . . . 0.0 110.506 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 6.4 mt -96.07 129.42 46.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.435 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.531 HG22 ' N ' ' A' ' 25' ' ' LYS . 83.0 mt -133.56 162.61 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.547 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.531 ' N ' HG22 ' A' ' 24' ' ' ILE . 45.1 tttm -142.51 105.25 5.46 Favored Pre-proline 0 CA--C 1.531 0.224 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.804 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -61.44 87.54 0.09 OUTLIER 'Trans proline' 0 C--N 1.313 -1.327 0 C-N-CA 122.315 2.01 . . . . 0.0 112.276 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.43 ' H ' ' HA2' ' A' ' 5' ' ' GLY . 2.7 tp 36.32 -133.82 0.07 Allowed 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.377 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.471 ' O ' ' C ' ' A' ' 29' ' ' VAL . 1.3 p-10 -44.04 -92.73 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 111.593 0.22 . . . . 0.0 111.593 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.745 ' O ' HG12 ' A' ' 29' ' ' VAL . 55.1 t 41.1 43.64 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 -178.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.723 ' ND2' ' H ' ' A' ' 30' ' ' ASN . 0.0 OUTLIER -82.6 41.69 0.73 Allowed 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 113.819 -1.537 . . . . 0.0 110.58 -178.014 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.3 p -158.87 126.89 5.1 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.907 178.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 35.9 ttt180 -59.15 -25.72 64.14 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -63.19 -54.18 41.56 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.456 178.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -66.16 -43.32 87.31 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.977 179.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.566 ' O ' HD23 ' A' ' 38' ' ' LEU . . . -59.95 -60.69 3.42 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.301 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 27.7 t -52.31 -22.52 4.61 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.654 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.9 tptt -69.97 -64.74 0.83 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.094 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.566 HD23 ' O ' ' A' ' 35' ' ' ALA . 0.5 OUTLIER -79.59 13.34 2.08 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.307 -179.058 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 18.5 tt -48.52 -19.88 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.341 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -108.25 18.22 33.55 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 121.154 -0.546 . . . . 0.0 111.994 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.442 ' HA ' ' NE ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -71.09 172.57 8.92 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 117.2 0.5 . . . . 0.0 110.547 179.777 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.564 ' O ' HG23 ' A' ' 86' ' ' ILE . 5.0 tp -118.87 121.63 40.44 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.5 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.624 HG23 ' O ' ' A' ' 43' ' ' VAL . 6.4 m -88.03 110.43 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.422 ' H ' ' HA ' ' A' ' 86' ' ' ILE . 2.1 tp -105.55 102.86 12.29 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.773 ' CD1' HG12 ' A' ' 84' ' ' VAL . 4.7 t90 -83.32 105.15 14.04 Favored 'General case' 0 C--O 1.235 0.332 0 O-C-N 125.135 1.522 . . . . 0.0 110.302 -178.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 54.2 tttp -84.5 88.43 7.3 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.729 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.477 ' OG ' ' N ' ' A' ' 51' ' ' LYS . 11.5 p . . . . . 0 CA--C 1.534 0.333 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.79 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.477 ' N ' ' OG ' ' A' ' 47' ' ' SER . 1.1 tmtm? . . . . . 0 CA--C 1.527 0.08 0 CA-C-O 120.916 0.388 . . . . 0.0 109.965 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 12.1 mm -83.08 112.55 20.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.917 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 60.0 mt -98.1 126.21 43.45 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.18 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 60.8 mttt -96.41 104.75 16.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.917 -179.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -103.44 168.12 17.26 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 178.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -152.74 130.15 11.36 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 117.193 0.496 . . . . 0.0 111.261 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 71.5 mt -71.42 134.06 30.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.52 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -106.1 -28.78 2.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.398 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.1 ptp180 -164.89 154.47 13.22 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 120.63 -0.428 . . . . 0.0 112.018 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.584 HG13 ' O ' ' A' ' 60' ' ' VAL . 9.5 p -97.71 116.44 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.417 178.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 13.0 t60 -142.06 115.08 8.73 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 120.126 -0.63 . . . . 0.0 112.054 -179.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.414 ' O ' ' OG1' ' A' ' 63' ' ' THR . . . 147.19 -14.33 1.47 Allowed Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.646 -0.582 . . . . 0.0 111.646 179.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.614 ' C ' ' H ' ' A' ' 65' ' ' GLY . 12.5 p 55.95 156.41 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 122.613 0.365 . . . . 0.0 110.769 -179.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.452 ' HZ2' ' HB3' ' A' ' 64' ' ' LYS . 0.5 OUTLIER 68.98 -21.05 0.15 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.985 0.421 . . . . 0.0 109.926 -178.194 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.614 ' H ' ' C ' ' A' ' 63' ' ' THR . . . 141.41 122.45 1.83 Allowed Glycine 0 CA--C 1.52 0.37 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 179.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.564 ' O ' HG23 ' A' ' 60' ' ' VAL . . . 176.38 147.57 0.1 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.443 HG13 ' O ' ' A' ' 66' ' ' ALA . 15.5 m -156.6 137.16 4.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.933 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 21.6 ttm-85 -89.02 154.51 20.15 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -145.07 161.06 40.36 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.051 0.453 . . . . 0.0 110.866 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.413 ' NH1' HG22 ' A' ' 21' ' ' VAL . 78.4 mtt-85 -146.45 116.7 7.42 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.171 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.472 ' C ' ' H ' ' A' ' 73' ' ' LYS . 17.2 m-85 -95.89 135.46 37.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.57 -179.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 82.6 mt-10 -61.07 -1.64 0.48 Allowed 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.476 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.472 ' H ' ' C ' ' A' ' 71' ' ' PHE . 5.8 tmtm? -156.28 -65.19 0.11 Allowed 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.642 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 134.86 -171.61 22.32 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.465 HD23 ' N ' ' A' ' 75' ' ' LEU . 1.3 mt -92.06 171.05 8.27 Favored Pre-proline 0 C--N 1.327 -0.392 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -75.3 114.37 3.98 Favored 'Trans proline' 0 C--N 1.313 -1.335 0 C-N-CA 122.655 2.237 . . . . 0.0 112.064 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 75.97 -65.23 2.62 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.502 HE21 ' CA ' ' A' ' 78' ' ' GLN . 0.0 OUTLIER -169.01 -69.25 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.645 0.259 . . . . 0.0 110.594 179.472 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 64.13 24.23 13.4 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.969 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.5 tt -60.58 104.08 0.31 Allowed 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.575 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 110.5 5.71 27.74 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 111.652 -0.579 . . . . 0.0 111.652 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -73.98 144.09 45.35 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.726 0.263 . . . . 0.0 110.3 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -69.88 113.49 7.16 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.773 HG12 ' CD1' ' A' ' 45' ' ' TRP . 30.2 m -90.87 169.68 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -150.0 156.4 41.64 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.272 0.558 . . . . 0.0 110.985 -178.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.633 HG22 ' O ' ' A' ' 86' ' ' ILE . 9.7 mt -105.76 72.74 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 177.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.338 0.1 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.918 -178.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 22.9 mtm-85 . . . . . 0 C--O 1.232 0.133 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.4 mt -147.76 145.3 18.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.079 0.466 . . . . 0.0 111.055 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.3 mmmm -90.07 178.59 6.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.282 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 84' ' ' VAL . . . -173.75 173.64 45.91 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.0 t -148.98 137.01 14.38 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 CA-C-O 120.914 0.388 . . . . 0.0 110.705 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 91.4 t -80.4 148.32 5.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.158 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 49.4 mt -106.41 -44.45 4.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.249 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.9 m -168.53 137.08 2.21 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.603 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -94.67 115.37 27.46 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.333 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.511 ' O ' ' N ' ' A' ' 21' ' ' VAL . 89.2 mtt180 . . . . . 0 C--N 1.331 -0.224 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.921 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.59 HG12 ' N ' ' A' ' 22' ' ' MET . 53.0 t . . . . . 0 N--CA 1.47 0.553 0 CA-C-O 120.698 0.285 . . . . 0.0 110.318 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.59 ' N ' HG12 ' A' ' 21' ' ' VAL . 2.6 ptp -147.03 135.99 22.33 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.917 0.389 . . . . 0.0 110.848 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.458 HG22 ' N ' ' A' ' 24' ' ' ILE . 87.0 mt -94.89 156.84 3.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.195 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.458 ' N ' HG22 ' A' ' 23' ' ' ILE . 23.5 mt -143.51 158.14 16.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.68 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.451 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 49.4 tttm -140.69 101.49 6.55 Favored Pre-proline 0 C--O 1.235 0.308 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.195 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -58.89 144.96 98.54 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 121.706 1.604 . . . . 0.0 110.466 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.487 HD12 ' HA ' ' A' ' 27' ' ' LEU . 6.8 tp -34.05 -82.91 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -178.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.473 ' CG ' ' H ' ' A' ' 29' ' ' VAL . 3.6 p-10 -87.09 -86.84 0.15 Allowed 'General case' 0 CA--C 1.521 -0.163 0 C-N-CA 120.251 -0.58 . . . . 0.0 110.259 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.737 ' O ' HG12 ' A' ' 29' ' ' VAL . 41.2 t 41.42 56.68 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.14 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -179.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -91.98 33.82 1.04 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.365 -1.289 . . . . 0.0 111.513 -177.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 24.4 m -159.48 131.03 6.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.759 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.453 ' HA ' ' HB3' ' A' ' 35' ' ' ALA . 9.8 ttp180 -57.81 -26.6 62.2 Favored 'General case' 0 CA--C 1.521 -0.14 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -61.58 -37.38 83.65 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.325 178.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -87.82 -39.07 15.16 Favored 'General case' 0 CA--C 1.527 0.087 0 CA-C-N 115.63 -0.713 . . . . 0.0 109.611 178.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.623 ' O ' HD23 ' A' ' 38' ' ' LEU . . . -61.21 -58.38 8.57 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 41.9 t -55.48 -23.3 25.01 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.732 178.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.1 tttm -68.83 -58.01 4.78 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.619 -179.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.623 HD23 ' O ' ' A' ' 35' ' ' ALA . 0.5 OUTLIER -80.19 8.89 6.39 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.231 -178.828 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.735 HD13 ' O ' ' A' ' 39' ' ' ILE . 0.1 OUTLIER -45.59 -41.12 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.368 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.459 ' N ' ' CG2' ' A' ' 39' ' ' ILE . . . -103.42 96.33 1.32 Allowed Glycine 0 CA--C 1.521 0.463 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 178.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 11.5 ttm180 -167.62 150.3 5.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.024 0.44 . . . . 0.0 110.382 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.845 ' O ' HG23 ' A' ' 86' ' ' ILE . 3.0 tp -88.07 123.08 32.39 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.5 -178.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.6 m -93.83 109.76 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.739 HD22 ' O ' ' A' ' 87' ' ' VAL . 6.0 mp -105.93 102.68 12.09 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 116.348 -0.387 . . . . 0.0 109.959 -179.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.635 ' HE1' ' CG ' ' A' ' 82' ' ' ASP . 34.7 t90 -91.56 123.42 34.95 Favored 'General case' 0 C--O 1.236 0.384 0 O-C-N 124.749 1.281 . . . . 0.0 110.761 -179.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 9.3 tttm -85.32 90.29 7.88 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.682 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.424 ' HB2' ' CH2' ' A' ' 45' ' ' TRP . 4.5 p . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.753 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.413 ' HG2' HD21 ' A' ' 53' ' ' LEU . 71.4 tttt . . . . . 0 C--O 1.231 0.121 0 CA-C-O 121.072 0.463 . . . . 0.0 110.161 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.434 HD13 ' N ' ' A' ' 52' ' ' ILE . 3.7 mm -82.49 111.6 19.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.011 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.413 HD21 ' HG2' ' A' ' 51' ' ' LYS . 45.1 mt -101.61 123.23 45.28 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.208 0.528 . . . . 0.0 111.489 -179.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 16.4 mttt -94.04 100.72 12.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.798 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -100.55 -172.46 29.43 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.544 -1.022 . . . . 0.0 110.544 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 39.7 tttp -155.09 138.85 16.17 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 120.428 -0.509 . . . . 0.0 111.57 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.7 mt -75.04 134.8 28.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.511 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.404 ' O ' HD11 ' A' ' 39' ' ' ILE . 0.8 OUTLIER -98.3 -50.92 10.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.855 -179.562 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 16.0 mtp180 -153.05 153.98 33.96 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.878 0.371 . . . . 0.0 110.822 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.631 HG23 HG12 ' A' ' 67' ' ' VAL . 3.4 p -71.89 157.81 6.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.085 179.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 12.0 t-160 -140.43 135.29 31.88 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.019 0.438 . . . . 0.0 110.825 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.429 ' O ' ' O ' ' A' ' 63' ' ' THR . . . 74.36 -15.51 3.45 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 111.487 -0.645 . . . . 0.0 111.487 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.429 ' O ' ' O ' ' A' ' 62' ' ' GLY . 81.4 p 56.35 142.47 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.021 0.438 . . . . 0.0 111.225 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.514 ' CG ' ' O ' ' A' ' 64' ' ' LYS . 16.5 ttpp 57.59 17.85 4.25 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.269 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -149.9 -126.39 1.42 Allowed Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.032 -178.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.7 -178.43 1.17 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.357 -0.922 . . . . 0.0 111.963 -178.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.631 HG12 HG23 ' A' ' 60' ' ' VAL . 6.6 m -154.33 163.89 1.63 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.158 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.364 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 56.4 ttt180 -89.51 153.95 20.39 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 178.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -149.29 156.48 42.17 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.349 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 -149.25 121.88 8.6 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.307 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -97.34 106.4 18.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.9 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -48.76 -26.04 2.15 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.609 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 53.0 mttt -81.59 -78.28 0.19 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.478 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 131.47 139.33 4.37 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -94.99 150.07 37.19 Favored Pre-proline 0 C--O 1.233 0.216 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -53.61 -81.06 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 122.409 2.073 . . . . 0.0 111.857 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 171.99 0.89 0.03 OUTLIER Glycine 0 CA--C 1.527 0.795 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.23 -22.44 16.7 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.783 0.325 . . . . 0.0 110.671 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.536 ' HB2' ' CH2' ' A' ' 45' ' ' TRP . . . -83.88 39.68 0.71 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.938 -179.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.2 tp -72.79 -23.69 60.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.501 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -137.53 14.94 3.66 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 121.037 -0.602 . . . . 0.0 111.94 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.635 ' CG ' ' HE1' ' A' ' 45' ' ' TRP . 19.4 t0 -72.18 143.12 49.01 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -69.26 134.04 48.68 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.308 -0.405 . . . . 0.0 109.937 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.45 ' O ' ' N ' ' A' ' 5' ' ' GLY . 33.1 m -97.57 155.99 3.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.409 ' HG3' ' O ' ' A' ' 84' ' ' VAL . 16.1 mp0 -148.26 154.49 40.11 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.08 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.845 HG23 ' O ' ' A' ' 42' ' ' LEU . 5.1 mp -100.57 72.41 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.739 ' O ' HD22 ' A' ' 44' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--O 1.227 -0.081 0 C-N-CA 119.982 -0.687 . . . . 0.0 110.238 -179.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 15.2 ptt180 . . . . . 0 CA--C 1.528 0.12 0 CA-C-O 120.701 0.286 . . . . 0.0 110.443 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.486 HG22 ' N ' ' A' ' 4' ' ' LYS . 3.7 mp -100.78 163.87 2.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.184 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.486 ' N ' HG22 ' A' ' 3' ' ' ILE . 9.9 ptpt -150.71 110.48 4.06 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 121.343 0.592 . . . . 0.0 111.874 -179.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -99.0 -176.13 31.96 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 178.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 24.5 t -142.05 134.37 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-O 120.991 0.424 . . . . 0.0 111.001 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 43.1 t -80.29 148.88 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 115.602 -0.727 . . . . 0.0 109.875 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -125.77 -23.16 4.06 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 121.062 -0.255 . . . . 0.0 111.402 -179.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.3 t -166.05 148.04 7.02 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.204 0.526 . . . . 0.0 111.995 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.501 ' HB2' HD21 ' A' ' 80' ' ' LEU . 6.8 t80 -107.43 163.87 12.68 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.155 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 7.2 ttp180 . . . . . 0 C--O 1.232 0.174 0 CA-C-O 121.033 0.444 . . . . 0.0 110.529 179.858 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 N--CA 1.463 0.193 0 CA-C-O 120.667 0.27 . . . . 0.0 110.307 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -150.63 148.32 28.48 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.043 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.4 mm -92.21 140.9 15.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.044 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.431 HG22 ' N ' ' A' ' 25' ' ' LYS . 96.5 mt -130.97 155.2 41.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.744 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.431 ' N ' HG22 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -136.92 100.42 9.8 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.847 179.708 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.546 ' O ' ' N ' ' A' ' 28' ' ' ASP . 3.4 Cg_exo -66.02 82.81 0.26 Allowed 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 122.451 2.101 . . . . 0.0 111.352 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.4 tp 33.04 -82.95 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.801 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.546 ' N ' ' O ' ' A' ' 26' ' ' PRO . 10.5 p30 -98.4 -87.27 0.34 Allowed 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.58 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.747 ' O ' HG12 ' A' ' 29' ' ' VAL . 43.5 t 43.02 57.55 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.238 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -178.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -91.81 42.01 1.09 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.584 -1.189 . . . . 0.0 110.74 -178.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.4 m -158.25 124.8 4.78 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.565 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.465 ' H ' ' HB3' ' A' ' 64' ' ' LYS . 0.6 OUTLIER -59.31 -26.7 65.22 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.315 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 65.6 mm-40 -60.88 -49.46 77.36 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.486 179.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -73.54 -45.71 51.98 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.211 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.26 -60.62 3.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.198 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.2 t -55.26 -38.73 68.91 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.837 179.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.1 mtpt -69.13 -20.56 64.05 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.927 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.529 ' O ' ' HG ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -85.99 -16.29 38.76 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.586 -179.624 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 68.4 mt -52.38 121.24 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-O 120.842 0.354 . . . . 0.0 110.441 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 111.75 -6.56 27.76 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.6 mmm-85 -69.96 156.83 38.54 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.823 0.344 . . . . 0.0 110.54 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.597 ' O ' HG23 ' A' ' 86' ' ' ILE . 4.0 tp -101.92 122.56 44.25 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.771 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 43' ' ' VAL . 33.7 m -92.03 106.52 17.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.712 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.725 HD21 HG23 ' A' ' 52' ' ' ILE . 6.2 tt -102.61 103.36 13.65 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.402 -179.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.416 ' CZ3' ' HB2' ' A' ' 47' ' ' SER . 80.1 t90 -95.64 105.49 17.49 Favored 'General case' 0 CA--C 1.53 0.205 0 O-C-N 124.91 1.381 . . . . 0.0 109.295 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.5 ttmt -81.76 102.05 10.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.223 -178.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.416 ' HB2' ' CZ3' ' A' ' 45' ' ' TRP . 10.1 t . . . . . 0 C--N 1.332 -0.161 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.881 179.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.9 ttmt . . . . . 0 C--O 1.233 0.202 0 CA-C-O 120.737 0.304 . . . . 0.0 110.23 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.725 HG23 HD21 ' A' ' 44' ' ' LEU . 1.3 mp -82.39 107.25 14.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.216 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 64.8 mt -93.95 152.18 19.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.683 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 6.3 pttt -152.3 104.18 2.92 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 120.913 0.387 . . . . 0.0 111.758 -178.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -90.29 -158.52 34.61 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.004 -1.239 . . . . 0.0 110.004 178.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 48.4 tttp -151.87 129.29 11.35 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.981 0.42 . . . . 0.0 111.009 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 32.1 mt -66.04 140.22 19.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.819 179.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -102.71 -47.86 10.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.209 -179.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.56 163.08 35.4 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.2 0.524 . . . . 0.0 111.333 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.2 p -78.9 154.74 4.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.514 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -140.52 130.03 24.05 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.599 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.21 -7.62 66.84 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.482 -0.647 . . . . 0.0 111.482 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.428 ' O ' ' CG ' ' A' ' 64' ' ' LYS . 38.4 p 58.67 138.57 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.892 0.377 . . . . 0.0 111.241 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.465 ' HB3' ' H ' ' A' ' 32' ' ' ARG . 5.2 ptmm? 43.99 32.17 0.6 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.053 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -149.76 -125.05 1.32 Allowed Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 111.44 -0.664 . . . . 0.0 111.44 -178.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.73 179.61 1.36 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.528 -0.836 . . . . 0.0 111.862 -178.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 28.1 m -154.73 151.3 10.94 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.841 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.6 ttp180 -88.96 148.28 23.87 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.44 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -148.71 160.78 42.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.048 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 63.5 mtt180 -145.75 121.1 10.27 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.835 0.35 . . . . 0.0 110.704 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -97.04 113.47 25.02 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.04 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -68.38 -25.73 65.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.467 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 9.8 mmtm -84.05 -80.43 0.19 Allowed 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.741 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 127.5 153.67 8.26 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.5 mt -90.36 153.46 46.32 Favored Pre-proline 0 N--CA 1.464 0.267 0 CA-C-O 120.699 0.285 . . . . 0.0 110.964 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.433 ' O ' ' C ' ' A' ' 77' ' ' GLY . 3.0 Cg_endo -66.7 157.06 62.89 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.714 2.276 . . . . 0.0 112.306 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 76' ' ' PRO . . . 29.04 -96.46 0.01 OUTLIER Glycine 0 N--CA 1.466 0.672 0 O-C-N 123.77 0.668 . . . . 0.0 111.614 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 20.0 tp60 -156.05 103.42 2.21 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.832 0.349 . . . . 0.0 110.669 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -112.71 40.59 2.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.58 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.501 HD21 ' HB2' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -70.34 115.57 9.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.126 -179.483 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 108.6 -3.17 32.41 Favored Glycine 0 CA--C 1.525 0.685 0 CA-C-N 116.248 -0.433 . . . . 0.0 112.153 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -70.07 143.24 52.51 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -67.94 136.67 54.33 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.9 m -90.75 160.08 2.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -144.64 150.38 37.3 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.207 -178.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.597 HG23 ' O ' ' A' ' 42' ' ' LEU . 29.5 mt -110.1 72.79 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 178.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.455 ' H ' ' HB3' ' A' ' 44' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.463 0.203 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.03 -179.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 16.1 mtm180 . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.538 0.209 . . . . 0.0 110.727 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.7 mt -147.06 147.73 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.71 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 17.5 tptt -92.88 161.43 14.49 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.309 -0.859 . . . . 0.0 111.008 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -167.8 178.7 41.54 Favored Glycine 0 CA--C 1.528 0.886 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 179.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 30.7 t -149.31 136.03 12.79 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-O 121.126 0.489 . . . . 0.0 111.29 -178.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 47.8 t -74.21 148.35 8.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.118 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.7 mt -109.49 -60.84 1.72 Allowed 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.392 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.0 t -167.04 144.32 4.69 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.876 0.37 . . . . 0.0 111.162 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -95.91 118.55 32.76 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.335 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 40.1 mtt180 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.822 -179.859 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.673 HG12 ' N ' ' A' ' 22' ' ' MET . 48.1 t . . . . . 0 N--CA 1.461 0.113 0 CA-C-O 120.797 0.332 . . . . 0.0 110.333 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.673 ' N ' HG12 ' A' ' 21' ' ' VAL . 23.9 ttt -147.45 131.57 17.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.141 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.8 mm -95.19 141.86 14.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.86 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.555 ' O ' ' HB1' ' A' ' 66' ' ' ALA . 21.8 mt -139.95 154.31 23.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.678 179.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.428 ' O ' ' N ' ' A' ' 27' ' ' LEU . 68.0 tttt -138.2 100.63 8.6 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.731 -179.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.514 ' O ' ' N ' ' A' ' 28' ' ' ASP . 4.0 Cg_exo -64.41 70.9 0.22 Allowed 'Trans proline' 0 N--CA 1.488 1.168 0 C-N-CA 122.1 1.867 . . . . 0.0 111.749 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.432 HD12 ' HA ' ' A' ' 27' ' ' LEU . 15.0 tp 51.01 -79.98 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.77 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 26' ' ' PRO . 3.2 p30 -109.81 -87.17 0.52 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.662 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.715 ' O ' HG12 ' A' ' 29' ' ' VAL . 43.4 t 45.64 57.83 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -178.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -91.88 43.3 1.13 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.295 -1.321 . . . . 0.0 110.548 -178.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.9 t -157.85 120.92 3.92 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.643 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 39.7 ttt-85 -58.31 -27.76 64.41 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.507 179.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.0 tm-20 -60.32 -39.12 85.87 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -86.27 -46.95 9.85 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.282 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.561 ' O ' HD23 ' A' ' 38' ' ' LEU . . . -56.01 -58.69 6.83 Favored 'General case' 0 CA--C 1.527 0.083 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.0 t -53.23 -24.59 11.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.712 178.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 9.6 ttpp -69.95 -60.22 2.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.761 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.561 HD23 ' O ' ' A' ' 35' ' ' ALA . 0.4 OUTLIER -78.2 8.07 5.43 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 120.915 0.388 . . . . 0.0 110.87 -179.105 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 14.1 tt -52.33 -12.36 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.725 179.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.411 ' N ' ' C ' ' A' ' 38' ' ' LEU . . . -117.16 4.72 18.21 Favored Glycine 0 CA--C 1.53 0.982 0 N-CA-C 111.87 -0.492 . . . . 0.0 111.87 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -71.01 155.28 41.02 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.976 0.417 . . . . 0.0 110.996 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.716 ' O ' HG23 ' A' ' 86' ' ' ILE . 2.8 tt -98.55 130.79 45.12 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.634 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 43' ' ' VAL . 20.7 m -94.42 121.75 45.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.451 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.536 HD23 ' C ' ' A' ' 44' ' ' LEU . 7.1 tt -120.69 100.79 7.32 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.374 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.457 ' CZ3' ' HB2' ' A' ' 47' ' ' SER . 66.4 t90 -95.93 136.5 36.28 Favored 'General case' 0 C--N 1.349 0.569 0 O-C-N 125.225 1.578 . . . . 0.0 109.358 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.6 mtpt -81.87 165.28 20.95 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.921 -178.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.457 ' HB2' ' CZ3' ' A' ' 45' ' ' TRP . 0.2 OUTLIER . . . . . 0 CA--C 1.533 0.313 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.577 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.445 ' N ' ' HG ' ' A' ' 47' ' ' SER . 29.6 ttpt . . . . . 0 N--CA 1.463 0.192 0 CA-C-O 120.776 0.322 . . . . 0.0 111.155 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 22.7 mm -74.32 146.44 9.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 178.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 53' ' ' LEU . 67.5 mt -138.19 119.35 14.53 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.269 0.557 . . . . 0.0 111.874 -179.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.1 mptt -90.54 177.91 6.24 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.87 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -165.25 -176.95 37.3 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 178.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 55.4 tttt -154.66 129.62 9.47 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.765 0.317 . . . . 0.0 110.817 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 26.6 mt -72.67 130.2 35.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.641 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.5 m -102.66 -45.54 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.537 -0.302 . . . . 0.0 110.854 -179.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 22.1 mtt85 -144.42 158.97 43.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.859 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.7 p -87.39 156.17 3.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.143 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 74.5 t60 -140.84 117.7 11.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.151 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.08 5.62 63.86 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 -179.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.45 ' OG1' ' N ' ' A' ' 64' ' ' LYS . 32.4 p 58.69 -89.32 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 122.813 0.445 . . . . 0.0 111.513 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.45 ' N ' ' OG1' ' A' ' 63' ' ' THR . 15.4 pttm -90.84 55.51 2.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.835 0.35 . . . . 0.0 110.93 -179.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -159.58 -126.18 0.83 Allowed Glycine 0 N--CA 1.442 -0.952 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.555 ' HB1' ' O ' ' A' ' 24' ' ' ILE . . . -69.22 -177.65 1.15 Allowed 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.454 -0.873 . . . . 0.0 111.757 -179.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.1 m -148.85 158.69 6.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.197 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 14.8 ttp180 -87.35 150.17 24.01 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-O 121.056 0.455 . . . . 0.0 111.072 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -148.32 159.72 43.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.814 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 24.1 mtm180 -148.34 122.99 9.84 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.847 0.356 . . . . 0.0 110.765 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -101.21 117.65 35.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.387 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -70.76 -24.48 62.61 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -82.68 -77.87 0.22 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.628 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 126.2 150.3 7.59 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 17.3 mt -98.16 148.14 34.08 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 120.505 0.193 . . . . 0.0 110.862 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -49.16 -179.26 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 122.877 2.385 . . . . 0.0 112.494 179.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.9 -4.52 11.07 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 121.201 -0.524 . . . . 0.0 111.907 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.559 ' C ' ' H ' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -135.01 -142.71 0.19 Allowed 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.295 179.734 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.506 ' N ' ' CD ' ' A' ' 78' ' ' GLN . . . 64.32 -10.12 0.15 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.562 -178.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.559 ' H ' ' C ' ' A' ' 78' ' ' GLN . 2.1 tt -66.64 99.34 0.58 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.279 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 125.97 3.11 7.04 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -72.21 175.99 5.59 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-O 121.095 0.474 . . . . 0.0 110.716 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -92.66 128.13 38.41 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 26.3 m -92.66 156.91 3.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.233 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -147.9 153.24 38.83 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.704 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.716 HG23 ' O ' ' A' ' 42' ' ' LEU . 1.8 mp -103.65 74.08 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.41 ' O ' ' CB ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.466 0.373 0 C-N-CA 118.966 -1.094 . . . . 0.0 110.79 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 34.4 mtm105 . . . . . 0 C--O 1.233 0.218 0 CA-C-O 120.865 0.364 . . . . 0.0 111.052 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.43 HG22 ' H ' ' A' ' 4' ' ' LYS . 2.0 mt -145.15 168.9 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.487 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.51 ' O ' HD13 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -152.39 120.59 6.28 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.262 0.553 . . . . 0.0 111.949 -179.499 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -107.07 -175.66 22.8 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.442 HG22 ' CE2' ' A' ' 83' ' ' TYR . 27.4 t -140.29 137.87 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-O 121.126 0.489 . . . . 0.0 110.57 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 72.3 t -71.07 144.88 13.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.841 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.41 HD11 ' HB2' ' A' ' 25' ' ' LYS . 14.8 mt -106.71 -52.6 2.75 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.391 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.6 t -166.15 154.64 10.9 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.182 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.489 ' O ' ' CG ' ' A' ' 10' ' ' TYR . 0.5 OUTLIER -99.46 126.84 45.46 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.004 0.43 . . . . 0.0 110.42 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.445 HH11 HG11 ' A' ' 21' ' ' VAL . 47.7 mtp180 . . . . . 0 C--N 1.326 -0.432 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.085 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.541 HG12 ' N ' ' A' ' 22' ' ' MET . 72.9 t . . . . . 0 CA--C 1.528 0.111 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.541 ' N ' HG12 ' A' ' 21' ' ' VAL . 21.2 ptm -151.65 138.4 18.86 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.833 0.349 . . . . 0.0 110.881 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 55.2 mt -92.08 139.56 17.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.122 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.455 HG22 ' N ' ' A' ' 25' ' ' LYS . 77.5 mt -134.7 156.52 40.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.523 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.455 ' N ' HG22 ' A' ' 24' ' ' ILE . 71.9 tttt -144.24 120.79 6.37 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.867 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -61.14 169.36 6.27 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 121.872 1.715 . . . . 0.0 111.503 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.51 HD13 ' O ' ' A' ' 4' ' ' LYS . 0.8 OUTLIER -49.55 -77.49 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.625 -0.262 . . . . 0.0 110.951 -179.334 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.483 ' CG ' ' H ' ' A' ' 29' ' ' VAL . 2.8 p-10 -94.51 -88.61 0.24 Allowed 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.521 -0.472 . . . . 0.0 111.107 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.626 ' O ' HG12 ' A' ' 29' ' ' VAL . 82.5 t 41.32 55.7 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.165 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 -178.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -88.51 40.62 0.97 Allowed 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 114.365 -1.289 . . . . 0.0 110.998 -177.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 68.7 m -158.84 128.11 5.54 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.862 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 47.4 ttp180 -61.25 -25.38 67.04 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -62.32 -52.01 65.37 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.602 178.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -69.57 -38.41 77.38 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.434 178.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.524 ' O ' HD23 ' A' ' 38' ' ' LEU . . . -59.24 -60.66 3.51 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.003 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.404 ' O ' HG22 ' A' ' 39' ' ' ILE . 11.7 t -55.92 -22.96 28.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.732 179.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 34.4 tttp -70.86 -61.66 1.68 Allowed 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.749 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.524 HD23 ' O ' ' A' ' 35' ' ' ALA . 0.4 OUTLIER -77.52 5.94 8.05 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.243 -178.955 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.503 ' N ' HD23 ' A' ' 38' ' ' LEU . 8.1 tt -51.08 133.97 12.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.229 179.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.431 ' O ' ' NZ ' ' A' ' 56' ' ' LYS . . . 81.2 25.32 55.36 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.686 ' HG3' HD12 ' A' ' 57' ' ' ILE . 5.3 ptt180 -71.57 171.29 11.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.713 0.292 . . . . 0.0 110.367 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.522 ' O ' HG23 ' A' ' 86' ' ' ILE . 23.5 tp -100.82 112.18 24.54 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.135 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 43' ' ' VAL . 4.2 m -88.19 121.37 38.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.13 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.677 HD21 ' CG2' ' A' ' 52' ' ' ILE . 6.0 tt -123.49 98.41 5.83 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.73 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.461 ' CZ3' ' OG ' ' A' ' 47' ' ' SER . 75.8 t90 -100.73 109.92 21.98 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 125.089 1.493 . . . . 0.0 109.676 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 5.9 pttp -83.72 105.11 14.37 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 121.073 0.463 . . . . 0.0 111.41 -178.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.461 ' OG ' ' CZ3' ' A' ' 45' ' ' TRP . 0.9 OUTLIER . . . . . 0 CA--C 1.531 0.233 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.707 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 27.7 tttp . . . . . 0 C--O 1.227 -0.088 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.677 ' CG2' HD21 ' A' ' 44' ' ' LEU . 23.2 mm -83.49 111.15 19.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.444 -178.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 71.4 mt -100.15 143.31 30.5 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.855 179.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.6 pttp -150.24 116.35 5.66 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 120.945 0.403 . . . . 0.0 110.95 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -104.09 -150.64 21.27 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.431 ' NZ ' ' O ' ' A' ' 40' ' ' GLY . 0.2 OUTLIER -154.26 130.42 10.35 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.782 0.325 . . . . 0.0 110.881 179.9 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.686 HD12 ' HG3' ' A' ' 41' ' ' ARG . 34.6 mt -65.13 147.89 12.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -107.01 -40.56 5.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 C-N-CA 120.596 -0.442 . . . . 0.0 111.491 -178.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -164.55 155.14 14.66 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 120.392 -0.523 . . . . 0.0 111.853 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.571 HG13 ' O ' ' A' ' 60' ' ' VAL . 13.3 p -92.82 116.33 33.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.322 178.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -140.21 123.87 17.22 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.265 -178.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 136.24 -16.84 3.86 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 121.327 -0.463 . . . . 0.0 112.056 178.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.633 ' C ' ' H ' ' A' ' 65' ' ' GLY . 80.7 p 54.79 164.91 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.776 0.322 . . . . 0.0 111.025 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 38.2 tttp 67.1 -17.3 0.14 Allowed 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.148 0.499 . . . . 0.0 110.0 -178.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.633 ' H ' ' C ' ' A' ' 63' ' ' THR . . . 131.57 121.12 2.24 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.555 ' O ' HG23 ' A' ' 60' ' ' VAL . . . 174.68 149.01 0.08 Allowed 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.504 HG13 ' O ' ' A' ' 66' ' ' ALA . 8.7 m -157.13 139.15 5.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 120.253 -0.579 . . . . 0.0 111.404 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -90.97 146.63 23.71 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 178.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -146.35 160.1 42.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.229 0.537 . . . . 0.0 111.278 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 5.8 ttp180 -148.3 131.97 16.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.675 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.457 ' C ' ' H ' ' A' ' 73' ' ' LYS . 17.5 m-85 -92.87 141.81 28.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.991 0.424 . . . . 0.0 110.828 -179.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -62.35 -0.47 0.58 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.444 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.457 ' H ' ' C ' ' A' ' 71' ' ' PHE . 33.3 ttmt -154.88 -64.7 0.13 Allowed 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.629 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 142.53 -177.24 21.82 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.3 mt -95.48 165.76 16.07 Favored Pre-proline 0 CA--C 1.53 0.175 0 CA-C-O 120.705 0.288 . . . . 0.0 110.99 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -76.14 99.94 1.33 Allowed 'Trans proline' 0 N--CA 1.489 1.235 0 C-N-CA 122.971 2.447 . . . . 0.0 112.214 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 42.48 -113.06 0.54 Allowed Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.762 -0.535 . . . . 0.0 111.762 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.527 ' NE2' ' H ' ' A' ' 80' ' ' LEU . 0.8 OUTLIER -81.8 116.05 21.3 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.77 0.319 . . . . 0.0 110.787 -179.746 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -154.4 8.14 0.32 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.322 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.527 ' H ' ' NE2' ' A' ' 78' ' ' GLN . 5.5 tp -68.56 117.04 9.8 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.768 0.318 . . . . 0.0 110.491 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 118.5 -10.92 12.64 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.437 ' HB3' ' HE1' ' A' ' 45' ' ' TRP . 2.1 m-20 -68.36 131.08 44.7 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.442 ' CE2' HG22 ' A' ' 6' ' ' VAL . 5.8 m-85 -67.55 135.78 53.51 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.4 m -90.78 163.21 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.509 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 52.0 mp0 -148.14 145.11 28.22 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.533 HG22 ' O ' ' A' ' 86' ' ' ILE . 3.5 mp -101.06 73.3 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 44' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.463 0.219 0 C-N-CA 119.749 -0.78 . . . . 0.0 110.67 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 17.3 ptt85 . . . . . 0 C--O 1.233 0.195 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.467 ' HB ' HD13 ' A' ' 86' ' ' ILE . 1.4 mt -148.4 144.88 18.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.266 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 52.0 mttt -83.17 173.45 11.66 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.646 -179.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 84' ' ' VAL . . . -171.47 174.66 45.05 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 22.0 t -149.15 143.97 18.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.262 0.553 . . . . 0.0 111.236 -178.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 75.7 t -79.88 147.46 6.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.972 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.486 HD11 ' HB2' ' A' ' 25' ' ' LYS . 13.4 mt -111.05 -52.43 2.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.644 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.7 t -163.88 124.27 2.17 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.402 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -99.36 105.67 17.68 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.325 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 35.9 mtt180 . . . . . 0 C--N 1.331 -0.232 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.772 179.819 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.54 HG12 ' N ' ' A' ' 22' ' ' MET . 45.5 t . . . . . 0 N--CA 1.456 -0.173 0 CA-C-O 120.902 0.382 . . . . 0.0 110.083 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.54 ' N ' HG12 ' A' ' 21' ' ' VAL . 13.1 ttt -148.59 112.75 5.21 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.874 -179.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.426 HG22 HD12 ' A' ' 8' ' ' LEU . 19.2 mt -85.19 136.26 23.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 41.2 mt -137.07 154.15 30.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.245 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.486 ' HB2' HD11 ' A' ' 8' ' ' LEU . 30.4 tttt -146.79 122.0 5.37 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.361 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -60.74 164.47 13.63 Favored 'Trans proline' 0 N--CA 1.489 1.228 0 C-N-CA 121.418 1.412 . . . . 0.0 111.152 178.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.7 tp -45.28 -80.79 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.888 -179.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.466 ' O ' ' C ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -93.8 -84.9 0.3 Allowed 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.964 -0.295 . . . . 0.0 110.444 179.383 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.701 ' O ' HG12 ' A' ' 29' ' ' VAL . 64.7 t 39.99 53.63 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 -178.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.745 ' ND2' ' H ' ' A' ' 30' ' ' ASN . 0.0 OUTLIER -88.53 44.36 1.2 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.441 -1.254 . . . . 0.0 110.727 -177.089 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.9 m -157.98 124.7 4.89 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.085 -0.962 . . . . 0.0 109.964 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.48 ' HA ' ' HB3' ' A' ' 35' ' ' ALA . 11.6 ttp180 -58.5 -26.95 64.0 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -61.21 -50.37 73.39 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.876 179.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.3 tp10 -72.46 -37.96 68.39 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.547 ' O ' HD23 ' A' ' 38' ' ' LEU . . . -60.4 -69.4 0.22 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.308 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.1 t -44.38 -18.61 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.831 0.348 . . . . 0.0 110.424 179.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.468 ' N ' ' C ' ' A' ' 35' ' ' ALA . 2.1 tmtt? -72.39 -63.04 1.23 Allowed 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.22 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.547 HD23 ' O ' ' A' ' 35' ' ' ALA . 0.5 OUTLIER -74.53 9.75 1.63 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.964 0.412 . . . . 0.0 110.324 -179.053 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.41 ' H ' ' C ' ' A' ' 37' ' ' LYS . 18.4 tt -48.63 -16.31 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.407 179.023 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -123.33 6.96 9.19 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.933 -178.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.8 mmt180 -72.15 175.68 5.81 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 117.591 0.696 . . . . 0.0 110.616 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.677 HD23 ' N ' ' A' ' 43' ' ' VAL . 6.5 tt -98.38 169.56 9.47 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.056 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.677 ' N ' HD23 ' A' ' 42' ' ' LEU . 33.8 m -140.84 99.5 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.185 0.517 . . . . 0.0 109.929 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.576 HD23 ' C ' ' A' ' 44' ' ' LEU . 5.9 tt -102.16 99.72 9.87 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.742 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.423 ' HE1' ' HB3' ' A' ' 82' ' ' ASP . 10.4 t90 -106.2 116.51 32.06 Favored 'General case' 0 C--O 1.234 0.278 0 O-C-N 124.682 1.239 . . . . 0.0 109.738 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.8 pttp -84.01 105.7 15.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.935 0.398 . . . . 0.0 110.487 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.4 t . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.245 179.844 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.0 ttmm . . . . . 0 CA--C 1.527 0.078 0 CA-C-O 120.661 0.267 . . . . 0.0 110.614 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 28.7 mm -82.04 109.79 16.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.453 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 75.5 mt -104.51 143.55 32.89 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.063 0.459 . . . . 0.0 110.869 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -151.87 101.99 2.79 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.885 -178.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -104.98 -142.25 11.27 Favored Glycine 0 N--CA 1.464 0.504 0 N-CA-C 109.771 -1.331 . . . . 0.0 109.771 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 23.9 tttm -154.98 139.7 17.09 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.068 0.461 . . . . 0.0 111.122 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 80.0 mt -69.85 138.95 21.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.059 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -105.43 -34.14 3.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -178.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.477 ' NH2' ' NH2' ' A' ' 70' ' ' ARG . 5.0 ptt-85 -165.69 157.45 14.44 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 120.435 -0.506 . . . . 0.0 111.319 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.56 HG13 ' O ' ' A' ' 60' ' ' VAL . 7.3 p -97.98 121.44 48.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.543 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.42 ' ND1' ' O ' ' A' ' 60' ' ' VAL . 11.3 m80 -141.11 132.78 27.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.113 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.428 ' O ' ' OG1' ' A' ' 63' ' ' THR . . . 124.94 -12.8 7.66 Favored Glycine 0 CA--C 1.519 0.288 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.545 ' O ' ' N ' ' A' ' 65' ' ' GLY . 19.9 p 53.53 171.87 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 -179.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt 65.57 -52.94 0.36 Allowed 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -178.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 63' ' ' THR . . . 165.81 121.64 0.57 Allowed Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 178.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.578 ' O ' HG13 ' A' ' 67' ' ' VAL . . . 174.87 159.59 0.19 Allowed 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.578 HG13 ' O ' ' A' ' 66' ' ' ALA . 7.9 m -159.11 144.32 6.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 C-N-CA 120.044 -0.663 . . . . 0.0 111.212 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 23.2 ttm180 -90.51 154.89 19.29 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -146.15 168.63 20.51 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.209 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.477 ' NH2' ' NH2' ' A' ' 59' ' ' ARG . 92.8 mtt180 -147.25 111.91 5.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.216 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.482 ' CE1' ' SD ' ' A' ' 22' ' ' MET . 51.8 m-85 -96.43 109.95 22.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.748 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -82.31 -13.33 57.11 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.122 0.487 . . . . 0.0 109.835 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 45.4 mmtt -80.96 -77.6 0.2 Allowed 'General case' 0 C--O 1.231 0.116 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.742 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 135.41 154.91 7.14 Favored Glycine 0 C--N 1.335 0.508 0 N-CA-C 111.241 -0.744 . . . . 0.0 111.241 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.432 HD23 ' N ' ' A' ' 75' ' ' LEU . 0.9 OUTLIER -89.13 174.45 4.94 Favored Pre-proline 0 N--CA 1.463 0.183 0 N-CA-C 110.414 -0.217 . . . . 0.0 110.414 -179.909 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -76.06 -82.89 0.0 OUTLIER 'Trans proline' 0 C--N 1.315 -1.197 0 C-N-CA 122.305 2.003 . . . . 0.0 111.044 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -176.21 104.45 0.19 Allowed Glycine 0 N--CA 1.451 -0.304 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 179.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.499 ' NE2' ' C ' ' A' ' 78' ' ' GLN . 0.0 OUTLIER 70.32 62.93 0.22 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.92 0.391 . . . . 0.0 111.087 179.514 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -115.43 -0.6 13.07 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.511 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.9 tp -52.6 114.49 1.41 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.818 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 125.52 -13.27 7.37 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 111.744 -0.542 . . . . 0.0 111.744 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.423 ' HB3' ' HE1' ' A' ' 45' ' ' TRP . 46.2 m-20 -70.35 136.67 49.92 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 120.442 -0.503 . . . . 0.0 109.983 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -69.56 125.59 27.18 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.773 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.441 ' O ' ' N ' ' A' ' 5' ' ' GLY . 18.0 m -94.36 154.96 3.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -149.94 164.29 35.84 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.323 0.582 . . . . 0.0 110.65 -178.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.496 ' N ' HD12 ' A' ' 86' ' ' ILE . 5.1 mp -103.44 74.48 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 178.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.468 0.456 0 C-N-CA 120.093 -0.643 . . . . 0.0 110.946 -179.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.431 ' O ' HD13 ' A' ' 3' ' ' ILE . 11.5 mmt180 . . . . . 0 C--O 1.232 0.172 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.56 HG22 ' H ' ' A' ' 4' ' ' LYS . 8.0 mm -138.13 169.85 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.56 ' H ' HG22 ' A' ' 3' ' ' ILE . 9.4 ptpt -150.81 103.85 3.12 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 121.259 0.552 . . . . 0.0 111.329 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -94.57 -177.3 38.51 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 179.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 p -146.5 135.38 16.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-O 121.222 0.534 . . . . 0.0 111.359 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 99.0 t -79.86 140.19 17.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.655 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 17.3 mt -105.52 -57.24 2.06 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.288 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.8 m -165.86 142.29 5.21 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.294 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -100.44 138.75 37.08 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 120.859 0.361 . . . . 0.0 110.689 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 10.6 mmt180 . . . . . 0 C--N 1.331 -0.2 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.485 -179.756 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.679 HG12 ' H ' ' A' ' 22' ' ' MET . 2.1 t . . . . . 0 C--O 1.231 0.128 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.679 ' H ' HG12 ' A' ' 21' ' ' VAL . 30.8 tpp -143.65 119.18 10.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.046 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 6.2 mm -83.23 133.0 30.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.584 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.419 ' CG2' ' N ' ' A' ' 25' ' ' LYS . 12.3 mt -138.9 156.72 28.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.523 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.419 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 11.4 ttmm -140.67 119.89 8.49 Favored Pre-proline 0 C--N 1.33 -0.28 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.458 ' O ' ' N ' ' A' ' 28' ' ' ASP . 2.9 Cg_endo -67.86 59.2 0.86 Allowed 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.313 2.009 . . . . 0.0 111.273 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.0 tp 54.31 -79.76 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.638 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.572 ' CG ' ' H ' ' A' ' 29' ' ' VAL . 9.2 p-10 -101.29 -90.75 0.33 Allowed 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.503 -0.479 . . . . 0.0 111.44 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.7 ' O ' HG12 ' A' ' 29' ' ' VAL . 53.3 t 44.7 55.95 0.33 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.194 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 -178.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -89.23 50.29 1.91 Allowed 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 114.356 -1.293 . . . . 0.0 110.812 -178.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 10.1 m -158.85 108.76 1.99 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.101 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 26.9 ttt85 -47.79 -31.8 5.29 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.161 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -62.59 -55.33 28.15 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.933 179.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -65.42 -39.37 92.04 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.104 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.56 ' O ' HD23 ' A' ' 38' ' ' LEU . . . -58.93 -59.83 4.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.18 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.5 m -53.65 -22.07 8.12 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.614 179.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.0 tttp -68.96 -63.42 1.06 Allowed 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.067 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.56 HD23 ' O ' ' A' ' 35' ' ' ALA . 0.4 OUTLIER -80.32 16.8 1.19 Allowed 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 121.019 0.437 . . . . 0.0 111.053 -179.423 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.59 HD12 HG12 ' A' ' 60' ' ' VAL . 19.3 tt -50.38 -32.75 10.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.233 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -102.9 24.03 31.9 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.412 ' HG2' HD13 ' A' ' 86' ' ' ILE . 1.8 tpp180 -71.15 146.15 49.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.747 0.308 . . . . 0.0 110.569 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.571 ' O ' HG23 ' A' ' 86' ' ' ILE . 7.8 tp -96.19 121.02 37.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.156 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 43' ' ' VAL . 10.8 m -87.08 122.62 39.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.282 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.436 ' H ' ' HA ' ' A' ' 86' ' ' ILE . 0.5 OUTLIER -107.84 98.23 7.84 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.441 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 37.3 t90 -86.61 113.02 22.16 Favored 'General case' 0 C--O 1.234 0.246 0 O-C-N 125.209 1.568 . . . . 0.0 110.448 -178.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.415 ' HG3' HD11 ' A' ' 52' ' ' ILE . 75.5 tttt -83.56 93.63 7.89 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.004 -179.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.1 p . . . . . 0 CA--C 1.532 0.264 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.049 -179.968 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt . . . . . 0 CA--C 1.529 0.14 0 CA-C-O 120.566 0.222 . . . . 0.0 110.616 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.415 HD11 ' HG3' ' A' ' 46' ' ' LYS . 1.2 mp -79.18 108.01 12.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.518 HD22 ' CA ' ' A' ' 74' ' ' GLY . 13.7 mt -90.34 126.25 35.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.375 0.607 . . . . 0.0 110.943 -178.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 28.5 mttm -91.49 110.17 21.48 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.88 -1.055 . . . . 0.0 111.281 -179.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -95.46 178.81 35.68 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 178.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 38.7 tttt -152.84 131.45 12.28 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.528 -0.469 . . . . 0.0 111.426 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.2 mt -75.6 142.47 14.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.867 179.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -104.83 -34.29 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.81 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -164.85 156.23 15.08 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.045 0.45 . . . . 0.0 111.466 179.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.59 HG12 HD12 ' A' ' 39' ' ' ILE . 14.9 p -98.24 139.22 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.656 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.93 ' O ' ' HB3' ' A' ' 66' ' ' ALA . 56.7 t-80 -142.2 168.77 18.95 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.46 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.515 ' C ' ' H ' ' A' ' 64' ' ' LYS . . . 91.12 -34.14 4.4 Favored Glycine 0 CA--C 1.525 0.683 0 CA-C-N 116.19 -0.459 . . . . 0.0 112.707 178.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.3 p 68.22 -34.18 0.25 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.682 0.241 . . . . 0.0 110.849 -179.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.515 ' H ' ' C ' ' A' ' 62' ' ' GLY . 0.8 OUTLIER -89.31 -7.42 55.39 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.579 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.423 ' O ' ' HB2' ' A' ' 66' ' ' ALA . . . 130.65 119.78 2.15 Favored Glycine 0 CA--C 1.522 0.476 0 CA-C-N 114.517 -1.22 . . . . 0.0 110.224 178.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.93 ' HB3' ' O ' ' A' ' 61' ' ' HIS . . . 172.68 150.26 0.06 Allowed 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.413 HG13 ' O ' ' A' ' 66' ' ' ALA . 17.4 m -156.19 141.0 9.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.539 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -88.91 150.39 22.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.421 179.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -146.85 163.59 35.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.963 0.411 . . . . 0.0 111.055 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 53.2 mtt180 -146.4 121.24 9.93 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.079 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.557 ' C ' ' H ' ' A' ' 73' ' ' LYS . 60.3 m-85 -97.48 138.85 34.29 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.116 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.573 ' O ' ' CB ' ' A' ' 73' ' ' LYS . 8.9 pt-20 -74.95 36.5 0.11 Allowed 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.136 178.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.573 ' CB ' ' O ' ' A' ' 72' ' ' GLU . 9.9 ttpt 93.28 -32.97 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 115.008 -0.997 . . . . 0.0 110.18 -179.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.518 ' CA ' HD22 ' A' ' 53' ' ' LEU . . . -10.97 -59.84 0.01 OUTLIER Glycine 0 CA--C 1.53 0.997 0 O-C-N 124.431 1.082 . . . . 0.0 113.164 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.448 ' N ' ' O ' ' A' ' 73' ' ' LYS . 10.9 mt -56.67 113.71 6.52 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-N 116.709 0.254 . . . . 0.0 110.552 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -69.34 -174.9 0.9 Allowed 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 122.436 2.091 . . . . 0.0 112.347 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -51.13 115.09 3.29 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.553 ' O ' ' HB2' ' A' ' 79' ' ' ALA . 9.3 tm0? 69.48 145.81 0.06 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.914 0.388 . . . . 0.0 110.708 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.553 ' HB2' ' O ' ' A' ' 78' ' ' GLN . . . 166.91 -21.0 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.242 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.4 tp -43.7 129.13 5.49 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.224 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 98.53 -7.64 61.64 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.827 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -71.5 135.94 47.34 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -68.58 129.41 39.86 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.1 m -90.3 170.99 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -149.88 151.16 33.02 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.571 HG23 ' O ' ' A' ' 42' ' ' LEU . 16.8 mt -108.69 73.2 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 178.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.4 t . . . . . 0 N--CA 1.464 0.231 0 C-N-CA 120.115 -0.634 . . . . 0.0 111.015 -178.628 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 20.9 mtm180 . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.973 0.416 . . . . 0.0 110.836 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.2 mt -144.32 158.51 15.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.419 -0.81 . . . . 0.0 108.86 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.78 107.85 4.05 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.467 0.651 . . . . 0.0 112.082 -178.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.419 ' C ' HG22 ' A' ' 84' ' ' VAL . . . -95.85 -177.35 36.61 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 178.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 75.2 t -145.42 135.68 18.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.202 0.525 . . . . 0.0 110.468 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.9 t -73.0 142.72 14.69 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.391 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 52.0 mt -110.49 -33.71 6.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.055 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.6 m -161.28 134.56 6.46 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.935 0.397 . . . . 0.0 110.886 -179.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -106.44 101.15 10.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.541 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.43 ' O ' ' O ' ' A' ' 21' ' ' VAL . 5.8 mpt_? . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.373 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.43 ' O ' ' O ' ' A' ' 11' ' ' ARG . 88.1 t . . . . . 0 N--CA 1.464 0.274 0 CA-C-O 120.871 0.367 . . . . 0.0 110.468 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 15.2 ptm -145.81 143.04 29.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.961 0.41 . . . . 0.0 111.093 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 29.4 mm -92.65 143.15 12.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.106 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.625 HD12 ' CB ' ' A' ' 69' ' ' ALA . 31.5 mt -133.19 156.87 42.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.399 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.428 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -140.3 99.8 7.12 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.644 179.824 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.537 ' O ' ' N ' ' A' ' 28' ' ' ASP . 3.3 Cg_exo -65.17 74.12 0.25 Allowed 'Trans proline' 0 C--N 1.314 -1.268 0 C-N-CA 121.984 1.789 . . . . 0.0 111.051 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.415 ' N ' ' O ' ' A' ' 25' ' ' LYS . 0.9 OUTLIER 37.92 -82.64 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 114.849 -1.069 . . . . 0.0 112.097 -179.758 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.537 ' N ' ' O ' ' A' ' 26' ' ' PRO . 1.1 p-10 -99.24 -87.11 0.36 Allowed 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.363 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.778 ' O ' HG12 ' A' ' 29' ' ' VAL . 19.1 t 44.14 62.27 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-O 122.245 1.022 . . . . 0.0 108.294 -177.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.432 HD22 ' HB2' ' A' ' 28' ' ' ASP . 2.6 p30 -93.63 47.22 1.22 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.15 -1.386 . . . . 0.0 110.941 -178.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 70.3 m -156.72 118.99 3.94 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.541 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.439 ' H ' ' HB3' ' A' ' 64' ' ' LYS . 1.4 ttt85 -51.89 -30.93 26.12 Favored 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.429 ' O ' ' CB ' ' A' ' 37' ' ' LYS . 45.3 mt-10 -63.01 -63.15 1.29 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.643 179.038 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -54.86 -46.62 74.72 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.03 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -57.84 -69.48 0.17 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.985 179.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 65.0 m -50.82 -36.68 38.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.677 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.429 ' CB ' ' O ' ' A' ' 33' ' ' GLU . 60.5 tttt -71.35 -14.75 62.29 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.304 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.529 HD21 HD13 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -86.47 -11.31 52.16 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 120.853 0.358 . . . . 0.0 110.628 -179.524 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 53.7 mt -55.16 121.63 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.658 178.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 103.79 -4.05 45.94 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.714 -0.554 . . . . 0.0 111.714 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -70.37 142.33 52.13 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.854 0.359 . . . . 0.0 110.206 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.455 ' O ' HG23 ' A' ' 86' ' ' ILE . 11.6 tp -81.51 111.29 17.7 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.089 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.64 HG23 ' O ' ' A' ' 43' ' ' VAL . 6.7 m -88.81 107.4 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 121.581 0.705 . . . . 0.0 111.182 -178.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.1 mp -102.98 92.97 4.78 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 1.2 t90 -91.87 129.08 37.9 Favored 'General case' 0 C--O 1.235 0.304 0 O-C-N 124.717 1.26 . . . . 0.0 110.736 -178.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.401 ' HA ' ' CD1' ' A' ' 52' ' ' ILE . 1.6 ttmp? -81.76 91.96 6.57 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.966 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.326 -0.435 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.011 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 7.0 ttpm? . . . . . 0 CA--C 1.519 -0.226 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.413 ' HA ' HD13 ' A' ' 52' ' ' ILE . 28.5 mm -83.97 112.92 22.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.562 HD22 ' CA ' ' A' ' 74' ' ' GLY . 16.9 mt -99.66 125.21 45.46 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.265 0.555 . . . . 0.0 111.301 -179.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.3 mtpt -89.1 166.85 13.59 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.572 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -161.99 178.57 37.78 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.6 tttt -152.2 123.7 7.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.826 0.346 . . . . 0.0 111.023 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.529 HD13 HD21 ' A' ' 38' ' ' LEU . 22.4 mt -66.02 144.8 14.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.315 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.3 m -109.36 -34.54 2.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.584 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -163.37 158.02 20.7 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.745 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.4 p -88.54 153.8 3.24 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.431 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -140.86 125.08 17.45 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.25 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.3 13.82 55.13 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 -179.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.4 ' HG1' ' H ' ' A' ' 64' ' ' LYS . 82.2 p 52.92 -99.99 0.09 Allowed 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 122.44 0.296 . . . . 0.0 111.348 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.439 ' HB3' ' H ' ' A' ' 32' ' ' ARG . 16.4 pttt -88.16 55.93 3.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.829 -179.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -156.13 -125.41 0.9 Allowed Glycine 0 N--CA 1.446 -0.7 0 N-CA-C 111.366 -0.694 . . . . 0.0 111.366 -178.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.422 ' HB1' ' O ' ' A' ' 24' ' ' ILE . . . -67.9 -177.5 0.82 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.25 -0.975 . . . . 0.0 111.688 -178.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.3 m -153.11 156.85 5.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.099 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 8.7 tpp180 -88.88 154.49 20.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.933 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.625 ' CB ' HD12 ' A' ' 24' ' ' ILE . . . -149.85 154.38 38.29 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.199 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -148.79 128.76 13.49 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.909 0.385 . . . . 0.0 111.156 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.466 ' HB2' HD23 ' A' ' 75' ' ' LEU . 23.3 m-85 -103.96 117.05 33.39 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.54 179.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -80.96 -10.9 59.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.818 -178.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.466 ' O ' ' N ' ' A' ' 75' ' ' LEU . 24.7 ttpt -160.03 -45.66 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 120.36 -0.536 . . . . 0.0 111.933 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.562 ' CA ' HD22 ' A' ' 53' ' ' LEU . . . -64.84 51.77 0.1 Allowed Glycine 0 CA--C 1.529 0.968 0 O-C-N 123.513 0.508 . . . . 0.0 112.015 -178.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.466 HD23 ' HB2' ' A' ' 71' ' ' PHE . 0.2 OUTLIER -138.4 91.26 12.64 Favored Pre-proline 0 C--N 1.329 -0.289 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -59.08 -80.95 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 121.945 1.764 . . . . 0.0 112.107 -179.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -173.84 9.65 0.03 OUTLIER Glycine 0 CA--C 1.525 0.681 0 C-N-CA 120.743 -0.742 . . . . 0.0 111.589 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.87 107.35 2.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.844 0.354 . . . . 0.0 110.51 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -139.92 4.3 2.08 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.741 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.8 tp -77.15 98.94 5.23 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.265 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 123.61 -26.84 5.88 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 121.224 -0.512 . . . . 0.0 112.183 178.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -70.9 129.4 38.95 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 117.232 0.516 . . . . 0.0 109.924 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -68.59 134.02 49.36 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.419 HG22 ' C ' ' A' ' 5' ' ' GLY . 29.7 m -90.73 160.13 2.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -147.61 151.33 36.04 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.336 -0.546 . . . . 0.0 110.565 -178.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.455 HG23 ' O ' ' A' ' 42' ' ' LEU . 33.5 mt -110.01 72.05 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 178.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.7 t . . . . . 0 C--N 1.332 -0.195 0 C-N-CA 119.7 -0.8 . . . . 0.0 110.826 -178.824 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.9 tpt . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.85 174.67 9.14 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.096 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.419 HG22 ' N ' ' A' ' 4' ' ' LYS . 11.3 mt -145.29 163.46 12.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.926 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.419 ' N ' HG22 ' A' ' 3' ' ' ILE . 5.8 ptpt -139.04 177.08 8.16 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.111 0.482 . . . . 0.0 110.805 -179.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -170.44 -176.04 39.62 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 -178.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.9 t -140.35 127.51 23.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.086 0.47 . . . . 0.0 110.2 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 66.1 t -63.23 151.71 8.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.558 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.453 HD12 HG22 ' A' ' 23' ' ' ILE . 37.1 mt -109.86 -61.32 1.66 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.272 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.5 t -166.4 133.48 2.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.634 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -106.59 115.48 30.27 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.357 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.32 116.82 27.82 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.33 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.16 62.51 1.11 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.31 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.9 t -38.8 117.63 0.68 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.901 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 13.0 tttp -62.27 -61.04 2.74 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.562 -179.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.617 ' CD ' ' H ' ' A' ' 15' ' ' GLU . 1.0 OUTLIER -58.33 -162.35 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.376 179.973 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -151.8 95.44 2.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.243 0.544 . . . . 0.0 110.64 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.482 ' O ' ' CG ' ' A' ' 18' ' ' HIS . 0.0 OUTLIER -158.47 16.71 0.21 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.295 179.884 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.482 ' CG ' ' O ' ' A' ' 17' ' ' GLN . 3.0 m170 -173.79 -5.25 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.862 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.457 ' H ' ' H ' ' A' ' 18' ' ' HIS . 1.9 t30 68.3 173.66 0.28 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.42 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -78.23 142.75 37.67 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.749 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 98.5 t -113.68 154.81 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.64 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.541 ' SD ' ' CE1' ' A' ' 71' ' ' PHE . 23.6 ttt -143.71 123.37 13.31 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.565 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.453 HG22 HD12 ' A' ' 8' ' ' LEU . 16.1 mm -98.97 134.77 36.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.775 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.595 ' O ' ' HB1' ' A' ' 66' ' ' ALA . 38.4 mt -125.61 153.91 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.637 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.2 ttmm -137.45 98.51 10.0 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.885 -179.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.479 ' O ' ' C ' ' A' ' 27' ' ' LEU . 3.5 Cg_exo -70.74 135.55 28.37 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 122.265 1.977 . . . . 0.0 110.722 178.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.479 ' C ' ' O ' ' A' ' 26' ' ' PRO . 7.6 mp -19.33 -85.32 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -179.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.435 ' HB2' HD22 ' A' ' 30' ' ' ASN . 5.2 p30 -93.1 -91.86 0.17 Allowed 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.526 -179.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.705 ' O ' HG12 ' A' ' 29' ' ' VAL . 91.2 t 48.19 46.39 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.145 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 -178.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.557 ' ND2' ' H ' ' A' ' 30' ' ' ASN . 1.6 p30 -89.58 51.16 2.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.841 -178.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -159.2 111.42 2.16 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.68 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.423 ' H ' ' HG2' ' A' ' 64' ' ' LYS . 14.9 ttt85 -48.26 -29.94 4.31 Favored 'General case' 0 N--CA 1.462 0.143 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -61.05 -58.19 9.45 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.754 178.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.96 -49.34 70.7 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.374 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -53.79 -60.96 2.64 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.5 t -54.65 -39.6 68.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.847 179.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 51.3 mttt -69.84 -19.95 63.44 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.486 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.504 ' O ' ' HG ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -85.34 -14.08 47.55 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.768 -179.304 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 71.7 mt -55.48 127.95 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 N-CA-C 110.148 -0.315 . . . . 0.0 110.148 178.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 107.89 -14.75 37.64 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 61.9 mtt180 -69.78 162.29 28.13 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.501 ' O ' HG23 ' A' ' 86' ' ' ILE . 3.8 tp -103.14 128.21 50.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.207 -179.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.411 HG22 ' H ' ' A' ' 43' ' ' VAL . 3.0 m -94.9 105.65 17.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.316 179.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.593 HD23 ' C ' ' A' ' 44' ' ' LEU . 6.1 tt -102.61 95.37 6.18 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.492 ' CZ3' HD12 ' A' ' 53' ' ' LEU . 15.9 t90 -99.59 136.8 38.98 Favored 'General case' 0 C--O 1.238 0.452 0 O-C-N 124.632 1.208 . . . . 0.0 111.21 -178.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.476 ' O ' ' CE2' ' A' ' 45' ' ' TRP . 58.1 mttt -82.33 169.13 16.84 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.315 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -177.17 152.21 0.97 Allowed Pre-proline 0 N--CA 1.464 0.236 0 N-CA-C 110.351 -0.24 . . . . 0.0 110.351 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -47.96 178.11 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 123.233 2.622 . . . . 0.0 112.415 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 14.5 m 60.17 9.72 2.0 Allowed 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.13 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 63.62 9.53 32.59 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.9 ttmp? -75.74 96.19 3.58 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.892 0.377 . . . . 0.0 110.803 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.539 ' CG2' HD21 ' A' ' 44' ' ' LEU . 27.1 mm -84.25 114.37 24.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.492 HD12 ' CZ3' ' A' ' 45' ' ' TRP . 10.8 mt -98.46 146.97 25.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.019 0.437 . . . . 0.0 110.493 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.06 107.02 3.98 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.546 -178.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -103.98 -151.42 21.99 Favored Glycine 0 CA--C 1.521 0.464 0 N-CA-C 109.866 -1.293 . . . . 0.0 109.866 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 24.3 tttm -155.49 140.98 17.81 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.985 0.421 . . . . 0.0 111.351 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.463 HD13 HD21 ' A' ' 38' ' ' LEU . 65.6 mt -72.84 135.27 28.09 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.583 179.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -99.0 -63.46 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.973 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.8 mtt85 -143.88 159.29 42.8 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.657 0.265 . . . . 0.0 110.574 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 6.4 p -86.78 140.27 16.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.747 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.428 ' H ' ' HA ' ' A' ' 67' ' ' VAL . 3.9 m-70 -140.74 80.09 1.73 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.595 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 153.44 11.83 0.07 OUTLIER Glycine 0 CA--C 1.521 0.424 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 69.4 p 51.1 -94.85 0.03 OUTLIER 'General case' 0 C--O 1.231 0.104 0 CA-C-N 115.277 -0.462 . . . . 0.0 110.85 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.423 ' HG2' ' H ' ' A' ' 32' ' ' ARG . 15.0 mtmt -94.5 50.17 1.33 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.115 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -156.22 -125.13 0.88 Allowed Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.526 -0.845 . . . . 0.0 111.809 -178.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.595 ' HB1' ' O ' ' A' ' 24' ' ' ILE . . . -68.29 179.54 1.57 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.243 -0.978 . . . . 0.0 111.982 -178.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.428 ' HA ' ' H ' ' A' ' 61' ' ' HIS . 4.1 m -150.73 166.66 2.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.145 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 44.9 ttt180 -88.93 148.37 23.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.841 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -147.62 166.05 28.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.323 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 60.8 mtp180 -148.01 146.99 29.14 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.28 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.541 ' CE1' ' SD ' ' A' ' 22' ' ' MET . 53.3 m-85 -133.84 117.46 16.87 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.793 -179.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -84.73 -26.32 27.72 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.104 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.1 tttm -85.08 -11.03 56.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.217 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 61.73 168.67 0.66 Allowed Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.402 ' CB ' ' CD ' ' A' ' 76' ' ' PRO . 0.6 OUTLIER -100.04 174.98 2.62 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 179.877 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.402 ' CD ' ' CB ' ' A' ' 75' ' ' LEU . 3.3 Cg_exo -73.63 171.15 18.37 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.665 2.243 . . . . 0.0 111.695 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -49.94 110.76 0.92 Allowed Glycine 0 CA--C 1.526 0.765 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 47.66 95.07 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.864 0.364 . . . . 0.0 110.911 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -130.16 22.29 5.26 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.025 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.465 ' CD2' ' N ' ' A' ' 80' ' ' LEU . 4.0 mm? -76.03 92.6 3.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.759 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 153.32 -16.19 0.67 Allowed Glycine 0 CA--C 1.528 0.894 0 C-N-CA 120.999 -0.62 . . . . 0.0 111.974 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -72.68 139.05 47.03 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 117.272 0.536 . . . . 0.0 110.118 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -69.4 137.29 52.65 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 29.3 m -91.47 158.64 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 -148.2 153.5 38.85 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.194 0.521 . . . . 0.0 110.961 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.519 HG22 ' O ' ' A' ' 86' ' ' ILE . 3.9 mp -109.4 73.49 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.432 ' H ' ' HB3' ' A' ' 44' ' ' LEU . 1.5 t . . . . . 0 CA--C 1.528 0.132 0 C-N-CA 120.018 -0.673 . . . . 0.0 111.03 -178.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 30.0 mtt . . . . . 0 N--CA 1.492 1.657 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 4.5 ptt-85 -101.73 175.32 5.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.921 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.439 HG22 ' H ' ' A' ' 4' ' ' LYS . 0.6 OUTLIER -145.98 -177.69 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.902 179.622 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.439 ' H ' HG22 ' A' ' 3' ' ' ILE . 11.9 ptpt -146.96 107.17 4.02 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.131 0.491 . . . . 0.0 111.311 -178.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.43 ' HA2' ' H ' ' A' ' 27' ' ' LEU . . . -98.61 -176.55 32.57 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 179.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.8 t -140.16 139.12 36.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-O 121.044 0.449 . . . . 0.0 110.348 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.6 t -78.5 154.59 5.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.265 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 56.3 mt -125.24 -44.39 1.88 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.31 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -165.14 126.97 2.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.841 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -102.38 122.37 44.14 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.814 179.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 12.5 ttm-85 -88.0 108.69 19.34 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.912 -179.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.451 ' O ' ' N ' ' A' ' 14' ' ' LYS . 53.3 ttt180 -91.66 59.31 3.72 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.507 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.493 ' OG ' ' N ' ' A' ' 14' ' ' LYS . 0.1 OUTLIER 56.09 -82.74 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.077 179.838 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.493 ' N ' ' OG ' ' A' ' 13' ' ' SER . 20.8 mtmt 63.22 -170.84 0.18 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.515 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.554 ' CD ' ' H ' ' A' ' 15' ' ' GLU . 1.3 pm0 -55.34 -179.49 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.608 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 47.35 92.86 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.912 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 -37.91 133.0 0.9 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.936 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.425 ' H ' ' H ' ' A' ' 19' ' ' ASN . 11.3 t-160 -176.41 11.13 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.374 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.531 ' ND2' ' HE ' ' A' ' 70' ' ' ARG . 0.4 OUTLIER 53.7 171.29 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.98 -179.202 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.437 ' N ' HD22 ' A' ' 19' ' ' ASN . 10.8 p-10 -80.6 113.18 18.62 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.314 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.575 HG12 ' N ' ' A' ' 22' ' ' MET . 18.8 t -107.46 168.49 3.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.032 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.575 ' N ' HG12 ' A' ' 21' ' ' VAL . 9.6 ttt -147.55 121.91 9.65 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.681 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 91.9 mt -96.13 129.83 45.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.405 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.503 HG22 ' N ' ' A' ' 25' ' ' LYS . 96.8 mt -132.86 160.14 42.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.024 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.521 ' O ' ' N ' ' A' ' 27' ' ' LEU . 60.1 tttt -138.12 96.37 10.19 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.326 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -59.57 72.41 0.06 OUTLIER 'Trans proline' 0 N--CA 1.489 1.252 0 C-N-CA 122.291 1.994 . . . . 0.0 111.464 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.521 ' N ' ' O ' ' A' ' 25' ' ' LYS . 14.1 tp 51.99 -116.33 1.01 Allowed 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.353 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.474 ' CG ' ' H ' ' A' ' 29' ' ' VAL . 6.4 p-10 -74.0 -92.78 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.47 -179.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.735 ' O ' HG12 ' A' ' 29' ' ' VAL . 53.8 t 56.07 54.74 0.33 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.194 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -178.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -92.29 47.4 1.32 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.038 -178.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.7 t -158.3 123.6 4.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.11 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.476 ' HE ' ' HB ' ' A' ' 63' ' ' THR . 27.8 ttm180 -56.55 -31.75 64.49 Favored 'General case' 0 C--O 1.222 -0.382 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -61.82 -52.22 65.04 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.998 179.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.2 tp10 -65.64 -51.59 58.35 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.471 ' O ' HD23 ' A' ' 38' ' ' LEU . . . -55.59 -48.48 74.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.532 179.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.441 ' CB ' ' O ' ' A' ' 32' ' ' ARG . 93.4 p -62.34 -33.64 75.09 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.793 178.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 43.9 tttm -66.63 -61.23 2.08 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.118 -177.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.471 HD23 ' O ' ' A' ' 35' ' ' ALA . 0.8 OUTLIER -77.88 5.76 9.01 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.756 -0.377 . . . . 0.0 111.235 -178.758 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.596 HG23 ' O ' ' A' ' 39' ' ' ILE . 12.9 tt -53.22 113.94 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 178.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.432 ' H ' ' HB ' ' A' ' 57' ' ' ILE . . . 102.07 15.72 25.29 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 111.538 -0.625 . . . . 0.0 111.538 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.9 tpt180 -69.63 155.79 39.95 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 24.7 tp -84.55 105.59 15.48 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.869 0.366 . . . . 0.0 110.724 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.608 HG23 ' O ' ' A' ' 43' ' ' VAL . 33.2 m -87.37 109.39 19.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.532 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.621 HD23 ' C ' ' A' ' 44' ' ' LEU . 5.0 tt -108.37 97.15 6.87 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.451 ' CZ3' HD12 ' A' ' 53' ' ' LEU . 10.6 t90 -99.0 117.61 33.9 Favored 'General case' 0 C--O 1.237 0.406 0 O-C-N 124.824 1.328 . . . . 0.0 110.707 -179.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 43.6 tttp -85.87 100.75 12.29 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.447 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.446 ' HB2' ' O ' ' A' ' 51' ' ' LYS . 0.1 OUTLIER -64.9 178.43 0.49 Allowed Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.819 179.877 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.464 ' C ' ' H ' ' A' ' 50' ' ' GLY . 3.1 Cg_exo -74.93 -53.07 0.1 Allowed 'Trans proline' 0 N--CA 1.495 1.561 0 C-N-CA 122.823 2.349 . . . . 0.0 112.934 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.48 ' C ' ' H ' ' A' ' 51' ' ' LYS . 74.5 m -69.01 39.97 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.536 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.464 ' H ' ' C ' ' A' ' 48' ' ' PRO . . . 55.23 2.64 0.26 Allowed Glycine 0 CA--C 1.526 0.777 0 N-CA-C 111.958 -0.457 . . . . 0.0 111.958 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.48 ' H ' ' C ' ' A' ' 49' ' ' SER . 3.7 ttpt -74.76 100.67 4.08 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.905 0.383 . . . . 0.0 110.399 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.526 ' CG2' HD21 ' A' ' 44' ' ' LEU . 18.1 mm -84.65 108.21 16.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.625 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.451 HD12 ' CZ3' ' A' ' 45' ' ' TRP . 16.7 mt -105.81 143.26 34.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.552 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.05 116.72 5.84 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.394 -178.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -113.8 -153.95 11.15 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 179.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt -151.51 136.75 17.54 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 121.024 0.44 . . . . 0.0 110.849 179.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.637 HG23 ' O ' ' A' ' 68' ' ' ARG . 45.8 mt -65.33 140.32 19.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.0 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -106.09 -45.14 8.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.831 -179.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 44.5 mtp85 -149.23 159.49 44.21 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.794 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.513 HG13 ' O ' ' A' ' 60' ' ' VAL . 7.1 p -93.06 117.21 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.039 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.403 ' H ' ' HA ' ' A' ' 67' ' ' VAL . 37.8 t60 -102.59 121.19 41.89 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.428 179.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.75 10.28 50.32 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 111.556 -0.617 . . . . 0.0 111.556 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.476 ' HB ' ' HE ' ' A' ' 32' ' ' ARG . 81.3 p 51.55 -88.11 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.473 ' HG2' ' H ' ' A' ' 32' ' ' ARG . 51.4 mttt -90.18 51.74 2.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.12 -179.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -156.97 -126.06 0.9 Allowed Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.43 -0.891 . . . . 0.0 112.277 -179.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.71 -177.89 1.06 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 113.859 -1.17 . . . . 0.0 112.237 -178.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.403 ' HA ' ' H ' ' A' ' 61' ' ' HIS . 4.8 m -147.19 153.59 12.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.802 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.637 ' O ' HG23 ' A' ' 57' ' ' ILE . 27.6 ttm180 -87.85 157.13 19.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.765 0.317 . . . . 0.0 110.985 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -151.04 166.23 31.37 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.035 179.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.531 ' HE ' ' ND2' ' A' ' 19' ' ' ASN . 13.9 ttt180 -149.37 116.85 6.14 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.76 0.314 . . . . 0.0 110.692 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.44 ' CD1' ' SD ' ' A' ' 22' ' ' MET . 34.4 m-85 -100.43 117.88 35.51 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.088 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -80.13 -19.95 46.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.804 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 35.3 mttt -81.55 -77.72 0.21 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.981 0.42 . . . . 0.0 110.947 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 140.92 169.74 11.87 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 -179.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.409 ' CB ' ' CD ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER -97.02 175.57 2.55 Favored Pre-proline 0 C--N 1.33 -0.241 0 N-CA-C 110.272 -0.269 . . . . 0.0 110.272 -179.81 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.409 ' CD ' ' CB ' ' A' ' 75' ' ' LEU . 2.9 Cg_endo -77.39 19.32 0.73 Allowed 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.99 2.46 . . . . 0.0 111.376 179.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 97.67 -100.55 2.41 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -90.67 106.71 18.69 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.817 0.341 . . . . 0.0 110.2 179.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -163.1 23.8 0.09 Allowed 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.149 0.499 . . . . 0.0 110.085 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.1 tp -70.53 95.22 1.05 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.563 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 139.1 -1.76 2.53 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.807 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.407 ' CG ' ' HE1' ' A' ' 45' ' ' TRP . 7.9 t0 -71.28 136.99 48.2 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -69.13 129.61 40.35 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.4 m -91.29 162.58 2.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.401 ' C ' HD13 ' A' ' 86' ' ' ILE . 25.8 mt-10 -148.95 161.89 40.99 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.334 -179.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.401 HD13 ' C ' ' A' ' 85' ' ' GLU . 1.2 mm -107.97 72.46 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 178.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.417 ' O ' ' CB ' ' A' ' 44' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.462 0.154 0 C-N-CA 119.945 -0.702 . . . . 0.0 111.293 -178.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.6 mtt . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 22.6 ptt180 -105.56 170.14 8.06 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.978 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.525 HG22 ' H ' ' A' ' 4' ' ' LYS . 1.1 mt -144.41 179.41 1.36 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.852 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.525 ' H ' HG22 ' A' ' 3' ' ' ILE . 0.0 OUTLIER -144.24 103.81 4.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.363 0.601 . . . . 0.0 110.382 -179.528 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.43 ' HA2' ' H ' ' A' ' 27' ' ' LEU . . . -90.71 -179.09 43.54 Favored Glycine 0 CA--C 1.522 0.527 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.268 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.1 t -145.59 137.14 19.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.919 0.39 . . . . 0.0 109.987 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 74.3 t -74.72 140.37 17.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.69 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 43.1 mt -107.52 -45.42 4.06 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.687 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.2 p -162.84 125.92 2.81 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.92 0.391 . . . . 0.0 111.082 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -101.49 97.65 8.08 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.306 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 17.7 ttm180 -89.17 142.87 27.27 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.348 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -104.57 61.11 0.71 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.878 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.0 t 36.65 60.18 0.95 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.503 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 30.3 mmtt -38.78 -80.09 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.958 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -66.1 -88.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -163.89 102.69 0.89 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.253 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.499 ' HG3' HH22 ' A' ' 70' ' ' ARG . 9.1 tp60 -124.18 -38.7 2.42 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.451 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -169.69 -59.25 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.634 HD22 ' N ' ' A' ' 20' ' ' ASN . 0.2 OUTLIER 166.72 -32.59 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 114.964 -1.017 . . . . 0.0 110.401 178.364 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.634 ' N ' HD22 ' A' ' 19' ' ' ASN . 57.3 m-80 -159.0 116.42 2.78 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.493 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.421 HG12 ' N ' ' A' ' 22' ' ' MET . 98.6 t -106.74 154.78 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.05 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.421 ' N ' HG12 ' A' ' 21' ' ' VAL . 41.9 ttm -145.39 115.85 7.6 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.717 0.294 . . . . 0.0 110.506 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 6.4 mt -96.07 129.42 46.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.435 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.531 HG22 ' N ' ' A' ' 25' ' ' LYS . 83.0 mt -133.56 162.61 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.547 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.531 ' N ' HG22 ' A' ' 24' ' ' ILE . 45.1 tttm -142.51 105.25 5.46 Favored Pre-proline 0 CA--C 1.531 0.224 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.804 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -61.44 87.54 0.09 OUTLIER 'Trans proline' 0 C--N 1.313 -1.327 0 C-N-CA 122.315 2.01 . . . . 0.0 112.276 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.43 ' H ' ' HA2' ' A' ' 5' ' ' GLY . 2.7 tp 36.32 -133.82 0.07 Allowed 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.377 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.471 ' O ' ' C ' ' A' ' 29' ' ' VAL . 1.3 p-10 -44.04 -92.73 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 111.593 0.22 . . . . 0.0 111.593 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.745 ' O ' HG12 ' A' ' 29' ' ' VAL . 55.1 t 41.1 43.64 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 -178.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.723 ' ND2' ' H ' ' A' ' 30' ' ' ASN . 0.0 OUTLIER -82.6 41.69 0.73 Allowed 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 113.819 -1.537 . . . . 0.0 110.58 -178.014 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.3 p -158.87 126.89 5.1 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.907 178.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 35.9 ttt180 -59.15 -25.72 64.14 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -63.19 -54.18 41.56 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.456 178.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -66.16 -43.32 87.31 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.977 179.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.566 ' O ' HD23 ' A' ' 38' ' ' LEU . . . -59.95 -60.69 3.42 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.301 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 27.7 t -52.31 -22.52 4.61 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.654 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.9 tptt -69.97 -64.74 0.83 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.094 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.566 HD23 ' O ' ' A' ' 35' ' ' ALA . 0.5 OUTLIER -79.59 13.34 2.08 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.307 -179.058 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 18.5 tt -48.52 -19.88 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.341 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -108.25 18.22 33.55 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 121.154 -0.546 . . . . 0.0 111.994 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.442 ' HA ' ' NE ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -71.09 172.57 8.92 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 117.2 0.5 . . . . 0.0 110.547 179.777 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.564 ' O ' HG23 ' A' ' 86' ' ' ILE . 5.0 tp -118.87 121.63 40.44 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.5 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.624 HG23 ' O ' ' A' ' 43' ' ' VAL . 6.4 m -88.03 110.43 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.422 ' H ' ' HA ' ' A' ' 86' ' ' ILE . 2.1 tp -105.55 102.86 12.29 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.773 ' CD1' HG12 ' A' ' 84' ' ' VAL . 4.7 t90 -83.32 105.15 14.04 Favored 'General case' 0 C--O 1.235 0.332 0 O-C-N 125.135 1.522 . . . . 0.0 110.302 -178.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 54.2 tttp -84.5 88.43 7.3 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.729 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.477 ' OG ' ' N ' ' A' ' 51' ' ' LYS . 11.5 p -64.04 171.95 2.21 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.79 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -77.0 -48.34 0.12 Allowed 'Trans proline' 0 N--CA 1.491 1.351 0 C-N-CA 123.031 2.488 . . . . 0.0 112.759 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 10.5 p -69.66 5.07 1.57 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.972 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.61 5.66 78.17 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.318 -0.713 . . . . 0.0 111.318 179.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.477 ' N ' ' OG ' ' A' ' 47' ' ' SER . 1.1 tmtm? -72.64 94.26 1.71 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.916 0.388 . . . . 0.0 109.965 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 12.1 mm -83.08 112.55 20.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.917 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 60.0 mt -98.1 126.21 43.45 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.18 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 60.8 mttt -96.41 104.75 16.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.917 -179.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -103.44 168.12 17.26 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 178.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -152.74 130.15 11.36 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 117.193 0.496 . . . . 0.0 111.261 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 71.5 mt -71.42 134.06 30.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.52 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -106.1 -28.78 2.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.398 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.1 ptp180 -164.89 154.47 13.22 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 120.63 -0.428 . . . . 0.0 112.018 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.584 HG13 ' O ' ' A' ' 60' ' ' VAL . 9.5 p -97.71 116.44 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.417 178.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 13.0 t60 -142.06 115.08 8.73 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 120.126 -0.63 . . . . 0.0 112.054 -179.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.414 ' O ' ' OG1' ' A' ' 63' ' ' THR . . . 147.19 -14.33 1.47 Allowed Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.646 -0.582 . . . . 0.0 111.646 179.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.614 ' C ' ' H ' ' A' ' 65' ' ' GLY . 12.5 p 55.95 156.41 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 122.613 0.365 . . . . 0.0 110.769 -179.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.452 ' HZ2' ' HB3' ' A' ' 64' ' ' LYS . 0.5 OUTLIER 68.98 -21.05 0.15 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.985 0.421 . . . . 0.0 109.926 -178.194 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.614 ' H ' ' C ' ' A' ' 63' ' ' THR . . . 141.41 122.45 1.83 Allowed Glycine 0 CA--C 1.52 0.37 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 179.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.564 ' O ' HG23 ' A' ' 60' ' ' VAL . . . 176.38 147.57 0.1 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.443 HG13 ' O ' ' A' ' 66' ' ' ALA . 15.5 m -156.6 137.16 4.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.933 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 21.6 ttm-85 -89.02 154.51 20.15 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -145.07 161.06 40.36 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.051 0.453 . . . . 0.0 110.866 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.499 HH22 ' HG3' ' A' ' 17' ' ' GLN . 78.4 mtt-85 -146.45 116.7 7.42 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.171 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.472 ' C ' ' H ' ' A' ' 73' ' ' LYS . 17.2 m-85 -95.89 135.46 37.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.57 -179.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 82.6 mt-10 -61.07 -1.64 0.48 Allowed 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.476 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.472 ' H ' ' C ' ' A' ' 71' ' ' PHE . 5.8 tmtm? -156.28 -65.19 0.11 Allowed 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.642 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 134.86 -171.61 22.32 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.465 HD23 ' N ' ' A' ' 75' ' ' LEU . 1.3 mt -92.06 171.05 8.27 Favored Pre-proline 0 C--N 1.327 -0.392 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -75.3 114.37 3.98 Favored 'Trans proline' 0 C--N 1.313 -1.335 0 C-N-CA 122.655 2.237 . . . . 0.0 112.064 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 75.97 -65.23 2.62 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.502 HE21 ' CA ' ' A' ' 78' ' ' GLN . 0.0 OUTLIER -169.01 -69.25 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.645 0.259 . . . . 0.0 110.594 179.472 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 64.13 24.23 13.4 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.969 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.5 tt -60.58 104.08 0.31 Allowed 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.575 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 110.5 5.71 27.74 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 111.652 -0.579 . . . . 0.0 111.652 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -73.98 144.09 45.35 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.726 0.263 . . . . 0.0 110.3 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -69.88 113.49 7.16 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.773 HG12 ' CD1' ' A' ' 45' ' ' TRP . 30.2 m -90.87 169.68 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -150.0 156.4 41.64 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.272 0.558 . . . . 0.0 110.985 -178.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.633 HG22 ' O ' ' A' ' 86' ' ' ILE . 9.7 mt -105.76 72.74 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 177.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.338 0.1 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.918 -178.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.6 mtt . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 22.9 mtm-85 -115.74 161.2 19.06 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.968 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.4 mt -147.76 145.3 18.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.079 0.466 . . . . 0.0 111.055 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.3 mmmm -90.07 178.59 6.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.282 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 84' ' ' VAL . . . -173.75 173.64 45.91 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.0 t -148.98 137.01 14.38 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 CA-C-O 120.914 0.388 . . . . 0.0 110.705 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 91.4 t -80.4 148.32 5.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.158 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 49.4 mt -106.41 -44.45 4.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.249 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.9 m -168.53 137.08 2.21 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.603 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -94.67 115.37 27.46 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.333 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.487 ' O ' ' N ' ' A' ' 21' ' ' VAL . 89.2 mtt180 -91.19 97.52 11.18 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.921 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 64.8 ttt180 -83.18 59.0 4.73 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.985 0.421 . . . . 0.0 110.436 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.457 ' OG ' ' N ' ' A' ' 14' ' ' LYS . 30.5 t -178.48 -124.27 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.132 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.467 ' O ' ' N ' ' A' ' 16' ' ' ASN . 16.0 tttm 66.98 0.42 1.97 Allowed 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.254 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.465 ' C ' ' ND2' ' A' ' 16' ' ' ASN . 7.2 mt-10 63.08 -73.23 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.627 -0.261 . . . . 0.0 110.662 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.467 ' N ' ' O ' ' A' ' 14' ' ' LYS . 1.0 OUTLIER 39.19 -109.71 0.09 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.562 179.484 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.5 ' O ' ' CD2' ' A' ' 18' ' ' HIS . 0.0 OUTLIER -151.79 36.33 0.56 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.993 0.425 . . . . 0.0 110.117 -179.766 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.5 ' CD2' ' O ' ' A' ' 17' ' ' GLN . 34.9 m-70 -163.85 -9.48 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.415 ' H ' ' H ' ' A' ' 18' ' ' HIS . 1.1 m-80 66.91 9.67 7.02 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.839 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -157.75 109.44 2.31 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.822 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.59 HG12 ' N ' ' A' ' 22' ' ' MET . 53.0 t -109.27 167.1 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.318 179.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.59 ' N ' HG12 ' A' ' 21' ' ' VAL . 2.6 ptp -147.03 135.99 22.33 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.917 0.389 . . . . 0.0 110.848 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.458 HG22 ' N ' ' A' ' 24' ' ' ILE . 87.0 mt -94.89 156.84 3.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.195 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.458 ' N ' HG22 ' A' ' 23' ' ' ILE . 23.5 mt -143.51 158.14 16.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.68 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.451 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 49.4 tttm -140.69 101.49 6.55 Favored Pre-proline 0 C--O 1.235 0.308 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.195 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -58.89 144.96 98.54 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 121.706 1.604 . . . . 0.0 110.466 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.487 HD12 ' HA ' ' A' ' 27' ' ' LEU . 6.8 tp -34.05 -82.91 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -178.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.473 ' CG ' ' H ' ' A' ' 29' ' ' VAL . 3.6 p-10 -87.09 -86.84 0.15 Allowed 'General case' 0 CA--C 1.521 -0.163 0 C-N-CA 120.251 -0.58 . . . . 0.0 110.259 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.737 ' O ' HG12 ' A' ' 29' ' ' VAL . 41.2 t 41.42 56.68 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.14 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -179.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -91.98 33.82 1.04 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.365 -1.289 . . . . 0.0 111.513 -177.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 24.4 m -159.48 131.03 6.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.759 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.453 ' HA ' ' HB3' ' A' ' 35' ' ' ALA . 9.8 ttp180 -57.81 -26.6 62.2 Favored 'General case' 0 CA--C 1.521 -0.14 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -61.58 -37.38 83.65 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.325 178.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -87.82 -39.07 15.16 Favored 'General case' 0 CA--C 1.527 0.087 0 CA-C-N 115.63 -0.713 . . . . 0.0 109.611 178.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.623 ' O ' HD23 ' A' ' 38' ' ' LEU . . . -61.21 -58.38 8.57 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 41.9 t -55.48 -23.3 25.01 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.732 178.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.1 tttm -68.83 -58.01 4.78 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.619 -179.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.623 HD23 ' O ' ' A' ' 35' ' ' ALA . 0.5 OUTLIER -80.19 8.89 6.39 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.231 -178.828 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.735 HD13 ' O ' ' A' ' 39' ' ' ILE . 0.1 OUTLIER -45.59 -41.12 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.368 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.459 ' N ' ' CG2' ' A' ' 39' ' ' ILE . . . -103.42 96.33 1.32 Allowed Glycine 0 CA--C 1.521 0.463 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 178.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 11.5 ttm180 -167.62 150.3 5.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.024 0.44 . . . . 0.0 110.382 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.845 ' O ' HG23 ' A' ' 86' ' ' ILE . 3.0 tp -88.07 123.08 32.39 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.5 -178.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.6 m -93.83 109.76 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.739 HD22 ' O ' ' A' ' 87' ' ' VAL . 6.0 mp -105.93 102.68 12.09 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 116.348 -0.387 . . . . 0.0 109.959 -179.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.635 ' HE1' ' CG ' ' A' ' 82' ' ' ASP . 34.7 t90 -91.56 123.42 34.95 Favored 'General case' 0 C--O 1.236 0.384 0 O-C-N 124.749 1.281 . . . . 0.0 110.761 -179.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 9.3 tttm -85.32 90.29 7.88 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.682 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.424 ' HB2' ' CH2' ' A' ' 45' ' ' TRP . 4.5 p -61.59 171.87 1.22 Allowed Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.753 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -77.5 -33.19 2.53 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 122.823 2.349 . . . . 0.0 112.166 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 18.7 m -85.55 28.56 0.75 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.759 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 63.23 2.71 5.61 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.413 ' HG2' HD21 ' A' ' 53' ' ' LEU . 71.4 tttt -74.73 92.38 2.47 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.072 0.463 . . . . 0.0 110.161 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.434 HD13 ' N ' ' A' ' 52' ' ' ILE . 3.7 mm -82.49 111.6 19.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.011 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.413 HD21 ' HG2' ' A' ' 51' ' ' LYS . 45.1 mt -101.61 123.23 45.28 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.208 0.528 . . . . 0.0 111.489 -179.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 16.4 mttt -94.04 100.72 12.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.798 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -100.55 -172.46 29.43 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.544 -1.022 . . . . 0.0 110.544 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 39.7 tttp -155.09 138.85 16.17 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 120.428 -0.509 . . . . 0.0 111.57 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.7 mt -75.04 134.8 28.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.511 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.404 ' O ' HD11 ' A' ' 39' ' ' ILE . 0.8 OUTLIER -98.3 -50.92 10.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.855 -179.562 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 16.0 mtp180 -153.05 153.98 33.96 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.878 0.371 . . . . 0.0 110.822 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.631 HG23 HG12 ' A' ' 67' ' ' VAL . 3.4 p -71.89 157.81 6.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.085 179.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 12.0 t-160 -140.43 135.29 31.88 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.019 0.438 . . . . 0.0 110.825 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.429 ' O ' ' O ' ' A' ' 63' ' ' THR . . . 74.36 -15.51 3.45 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 111.487 -0.645 . . . . 0.0 111.487 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.429 ' O ' ' O ' ' A' ' 62' ' ' GLY . 81.4 p 56.35 142.47 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.021 0.438 . . . . 0.0 111.225 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.514 ' CG ' ' O ' ' A' ' 64' ' ' LYS . 16.5 ttpp 57.59 17.85 4.25 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.269 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -149.9 -126.39 1.42 Allowed Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.032 -178.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.7 -178.43 1.17 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.357 -0.922 . . . . 0.0 111.963 -178.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.631 HG12 HG23 ' A' ' 60' ' ' VAL . 6.6 m -154.33 163.89 1.63 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.158 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.364 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 56.4 ttt180 -89.51 153.95 20.39 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 178.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -149.29 156.48 42.17 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.349 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 -149.25 121.88 8.6 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.307 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -97.34 106.4 18.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.9 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -48.76 -26.04 2.15 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.609 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 53.0 mttt -81.59 -78.28 0.19 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.478 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 131.47 139.33 4.37 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -94.99 150.07 37.19 Favored Pre-proline 0 C--O 1.233 0.216 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -53.61 -81.06 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 122.409 2.073 . . . . 0.0 111.857 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 171.99 0.89 0.03 OUTLIER Glycine 0 CA--C 1.527 0.795 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.23 -22.44 16.7 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.783 0.325 . . . . 0.0 110.671 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.536 ' HB2' ' CH2' ' A' ' 45' ' ' TRP . . . -83.88 39.68 0.71 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.938 -179.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.2 tp -72.79 -23.69 60.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.501 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -137.53 14.94 3.66 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 121.037 -0.602 . . . . 0.0 111.94 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.635 ' CG ' ' HE1' ' A' ' 45' ' ' TRP . 19.4 t0 -72.18 143.12 49.01 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -69.26 134.04 48.68 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.308 -0.405 . . . . 0.0 109.937 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.45 ' O ' ' N ' ' A' ' 5' ' ' GLY . 33.1 m -97.57 155.99 3.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.409 ' HG3' ' O ' ' A' ' 84' ' ' VAL . 16.1 mp0 -148.26 154.49 40.11 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.08 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.845 HG23 ' O ' ' A' ' 42' ' ' LEU . 5.1 mp -100.57 72.41 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.739 ' O ' HD22 ' A' ' 44' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--O 1.227 -0.081 0 C-N-CA 119.982 -0.687 . . . . 0.0 110.238 -179.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.6 mmt . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 15.2 ptt180 -83.74 165.51 18.81 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.443 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.486 HG22 ' N ' ' A' ' 4' ' ' LYS . 3.7 mp -100.78 163.87 2.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.184 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.486 ' N ' HG22 ' A' ' 3' ' ' ILE . 9.9 ptpt -150.71 110.48 4.06 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 121.343 0.592 . . . . 0.0 111.874 -179.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -99.0 -176.13 31.96 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 178.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 24.5 t -142.05 134.37 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-O 120.991 0.424 . . . . 0.0 111.001 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 43.1 t -80.29 148.88 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 115.602 -0.727 . . . . 0.0 109.875 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -125.77 -23.16 4.06 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 121.062 -0.255 . . . . 0.0 111.402 -179.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.3 t -166.05 148.04 7.02 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.204 0.526 . . . . 0.0 111.995 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.501 ' HB2' HD21 ' A' ' 80' ' ' LEU . 6.8 t80 -107.43 163.87 12.68 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.155 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 7.2 ttp180 -152.23 111.04 3.81 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.033 0.444 . . . . 0.0 110.529 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -77.02 59.61 1.7 Allowed 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.265 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 66.22 171.7 0.24 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.469 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 15.0 tttm -170.54 49.83 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.413 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -163.64 -61.85 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.22 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.401 ' O ' ' C ' ' A' ' 17' ' ' GLN . 19.7 m120 -155.9 -164.95 1.83 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.031 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.401 ' C ' ' O ' ' A' ' 16' ' ' ASN . 16.7 mm100 35.83 -110.76 0.06 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.91 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 14.0 t60 -173.39 25.49 0.01 OUTLIER 'General case' 0 C--O 1.234 0.247 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -39.38 121.65 1.2 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.509 -178.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.473 ' N ' ' ND2' ' A' ' 20' ' ' ASN . 0.1 OUTLIER -81.1 103.31 10.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.328 -179.764 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.3 t -108.99 146.2 14.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.307 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -150.63 148.32 28.48 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.043 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.4 mm -92.21 140.9 15.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.044 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.431 HG22 ' N ' ' A' ' 25' ' ' LYS . 96.5 mt -130.97 155.2 41.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.744 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.431 ' N ' HG22 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -136.92 100.42 9.8 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.847 179.708 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.546 ' O ' ' N ' ' A' ' 28' ' ' ASP . 3.4 Cg_exo -66.02 82.81 0.26 Allowed 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 122.451 2.101 . . . . 0.0 111.352 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.4 tp 33.04 -82.95 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.801 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.546 ' N ' ' O ' ' A' ' 26' ' ' PRO . 10.5 p30 -98.4 -87.27 0.34 Allowed 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.58 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.747 ' O ' HG12 ' A' ' 29' ' ' VAL . 43.5 t 43.02 57.55 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.238 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -178.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -91.81 42.01 1.09 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.584 -1.189 . . . . 0.0 110.74 -178.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.4 m -158.25 124.8 4.78 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.565 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.465 ' H ' ' HB3' ' A' ' 64' ' ' LYS . 0.6 OUTLIER -59.31 -26.7 65.22 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.315 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 65.6 mm-40 -60.88 -49.46 77.36 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.486 179.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -73.54 -45.71 51.98 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.211 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.26 -60.62 3.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.198 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.2 t -55.26 -38.73 68.91 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.837 179.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.1 mtpt -69.13 -20.56 64.05 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.927 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.529 ' O ' ' HG ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -85.99 -16.29 38.76 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.586 -179.624 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 68.4 mt -52.38 121.24 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-O 120.842 0.354 . . . . 0.0 110.441 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 111.75 -6.56 27.76 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.6 mmm-85 -69.96 156.83 38.54 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.823 0.344 . . . . 0.0 110.54 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.597 ' O ' HG23 ' A' ' 86' ' ' ILE . 4.0 tp -101.92 122.56 44.25 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.771 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 43' ' ' VAL . 33.7 m -92.03 106.52 17.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.712 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.725 HD21 HG23 ' A' ' 52' ' ' ILE . 6.2 tt -102.61 103.36 13.65 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.402 -179.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.416 ' CZ3' ' HB2' ' A' ' 47' ' ' SER . 80.1 t90 -95.64 105.49 17.49 Favored 'General case' 0 CA--C 1.53 0.205 0 O-C-N 124.91 1.381 . . . . 0.0 109.295 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.5 ttmt -81.76 102.05 10.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.223 -178.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.507 ' HB3' ' H ' ' A' ' 51' ' ' LYS . 10.1 t -62.38 141.86 96.31 Favored Pre-proline 0 C--N 1.332 -0.161 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.881 179.081 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -49.01 91.56 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 122.456 2.104 . . . . 0.0 111.898 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 56.2 p 38.69 60.86 1.3 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.172 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -140.36 -63.86 0.03 OUTLIER Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.507 ' H ' ' HB3' ' A' ' 47' ' ' SER . 9.9 ttmt -165.48 126.17 1.89 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.737 0.304 . . . . 0.0 110.23 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.725 HG23 HD21 ' A' ' 44' ' ' LEU . 1.3 mp -82.39 107.25 14.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.216 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 64.8 mt -93.95 152.18 19.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.683 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 6.3 pttt -152.3 104.18 2.92 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 120.913 0.387 . . . . 0.0 111.758 -178.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -90.29 -158.52 34.61 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.004 -1.239 . . . . 0.0 110.004 178.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 48.4 tttp -151.87 129.29 11.35 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.981 0.42 . . . . 0.0 111.009 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 32.1 mt -66.04 140.22 19.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.819 179.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -102.71 -47.86 10.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.209 -179.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.56 163.08 35.4 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.2 0.524 . . . . 0.0 111.333 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.2 p -78.9 154.74 4.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.514 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -140.52 130.03 24.05 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.599 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.21 -7.62 66.84 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.482 -0.647 . . . . 0.0 111.482 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.428 ' O ' ' CG ' ' A' ' 64' ' ' LYS . 38.4 p 58.67 138.57 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.892 0.377 . . . . 0.0 111.241 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.465 ' HB3' ' H ' ' A' ' 32' ' ' ARG . 5.2 ptmm? 43.99 32.17 0.6 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.053 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -149.76 -125.05 1.32 Allowed Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 111.44 -0.664 . . . . 0.0 111.44 -178.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.73 179.61 1.36 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.528 -0.836 . . . . 0.0 111.862 -178.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 28.1 m -154.73 151.3 10.94 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.841 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.6 ttp180 -88.96 148.28 23.87 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.44 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -148.71 160.78 42.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.048 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 63.5 mtt180 -145.75 121.1 10.27 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.835 0.35 . . . . 0.0 110.704 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -97.04 113.47 25.02 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.04 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -68.38 -25.73 65.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.467 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 9.8 mmtm -84.05 -80.43 0.19 Allowed 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.741 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 127.5 153.67 8.26 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.5 mt -90.36 153.46 46.32 Favored Pre-proline 0 N--CA 1.464 0.267 0 CA-C-O 120.699 0.285 . . . . 0.0 110.964 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.433 ' O ' ' C ' ' A' ' 77' ' ' GLY . 3.0 Cg_endo -66.7 157.06 62.89 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.714 2.276 . . . . 0.0 112.306 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 76' ' ' PRO . . . 29.04 -96.46 0.01 OUTLIER Glycine 0 N--CA 1.466 0.672 0 O-C-N 123.77 0.668 . . . . 0.0 111.614 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 20.0 tp60 -156.05 103.42 2.21 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.832 0.349 . . . . 0.0 110.669 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -112.71 40.59 2.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.58 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.501 HD21 ' HB2' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -70.34 115.57 9.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.126 -179.483 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 108.6 -3.17 32.41 Favored Glycine 0 CA--C 1.525 0.685 0 CA-C-N 116.248 -0.433 . . . . 0.0 112.153 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -70.07 143.24 52.51 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -67.94 136.67 54.33 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.9 m -90.75 160.08 2.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -144.64 150.38 37.3 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.207 -178.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.597 HG23 ' O ' ' A' ' 42' ' ' LEU . 29.5 mt -110.1 72.79 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 178.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.455 ' H ' ' HB3' ' A' ' 44' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.463 0.203 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.03 -179.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.0 ptm . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 16.1 mtm180 -102.25 156.51 17.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.727 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.7 mt -147.06 147.73 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.71 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 17.5 tptt -92.88 161.43 14.49 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.309 -0.859 . . . . 0.0 111.008 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -167.8 178.7 41.54 Favored Glycine 0 CA--C 1.528 0.886 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 179.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 30.7 t -149.31 136.03 12.79 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-O 121.126 0.489 . . . . 0.0 111.29 -178.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 47.8 t -74.21 148.35 8.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.118 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.7 mt -109.49 -60.84 1.72 Allowed 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.392 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.0 t -167.04 144.32 4.69 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.876 0.37 . . . . 0.0 111.162 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -95.91 118.55 32.76 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.335 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 40.1 mtt180 -88.47 139.34 30.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.822 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 8.5 ttm-85 -132.09 79.78 1.88 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.383 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 82.7 p -47.12 165.71 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.655 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 9.1 mmtp -120.95 -96.15 0.48 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.859 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -87.48 -10.71 51.05 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.744 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -76.35 114.27 14.85 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.379 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.452 ' O ' ' CG ' ' A' ' 18' ' ' HIS . 1.4 tp-100 -58.71 100.99 0.08 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.56 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.452 ' CG ' ' O ' ' A' ' 17' ' ' GLN . 8.3 m-70 -174.76 -12.11 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.634 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.45 ' H ' ' H ' ' A' ' 18' ' ' HIS . 51.9 t30 67.43 -178.02 0.21 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.19 -179.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -81.27 139.6 35.34 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.141 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.673 HG12 ' N ' ' A' ' 22' ' ' MET . 48.1 t -120.28 173.58 6.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.333 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.673 ' N ' HG12 ' A' ' 21' ' ' VAL . 23.9 ttt -147.45 131.57 17.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.141 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.8 mm -95.19 141.86 14.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.86 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.555 ' O ' ' HB1' ' A' ' 66' ' ' ALA . 21.8 mt -139.95 154.31 23.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.678 179.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.428 ' O ' ' N ' ' A' ' 27' ' ' LEU . 68.0 tttt -138.2 100.63 8.6 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.731 -179.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.514 ' O ' ' N ' ' A' ' 28' ' ' ASP . 4.0 Cg_exo -64.41 70.9 0.22 Allowed 'Trans proline' 0 N--CA 1.488 1.168 0 C-N-CA 122.1 1.867 . . . . 0.0 111.749 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.432 HD12 ' HA ' ' A' ' 27' ' ' LEU . 15.0 tp 51.01 -79.98 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.77 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 26' ' ' PRO . 3.2 p30 -109.81 -87.17 0.52 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.662 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.715 ' O ' HG12 ' A' ' 29' ' ' VAL . 43.4 t 45.64 57.83 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -178.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -91.88 43.3 1.13 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.295 -1.321 . . . . 0.0 110.548 -178.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.9 t -157.85 120.92 3.92 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.643 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 39.7 ttt-85 -58.31 -27.76 64.41 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.507 179.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.0 tm-20 -60.32 -39.12 85.87 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -86.27 -46.95 9.85 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.282 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.561 ' O ' HD23 ' A' ' 38' ' ' LEU . . . -56.01 -58.69 6.83 Favored 'General case' 0 CA--C 1.527 0.083 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.0 t -53.23 -24.59 11.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.712 178.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 9.6 ttpp -69.95 -60.22 2.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.761 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.561 HD23 ' O ' ' A' ' 35' ' ' ALA . 0.4 OUTLIER -78.2 8.07 5.43 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 120.915 0.388 . . . . 0.0 110.87 -179.105 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 14.1 tt -52.33 -12.36 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.725 179.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.411 ' N ' ' C ' ' A' ' 38' ' ' LEU . . . -117.16 4.72 18.21 Favored Glycine 0 CA--C 1.53 0.982 0 N-CA-C 111.87 -0.492 . . . . 0.0 111.87 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -71.01 155.28 41.02 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.976 0.417 . . . . 0.0 110.996 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.716 ' O ' HG23 ' A' ' 86' ' ' ILE . 2.8 tt -98.55 130.79 45.12 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.634 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 43' ' ' VAL . 20.7 m -94.42 121.75 45.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.451 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.536 HD23 ' C ' ' A' ' 44' ' ' LEU . 7.1 tt -120.69 100.79 7.32 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.374 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.457 ' CZ3' ' HB2' ' A' ' 47' ' ' SER . 66.4 t90 -95.93 136.5 36.28 Favored 'General case' 0 C--N 1.349 0.569 0 O-C-N 125.225 1.578 . . . . 0.0 109.358 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.6 mtpt -81.87 165.28 20.95 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.921 -178.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.457 ' HB2' ' CZ3' ' A' ' 45' ' ' TRP . 0.2 OUTLIER -173.47 79.77 0.39 Allowed Pre-proline 0 CA--C 1.533 0.313 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.577 179.633 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -73.62 152.65 48.43 Favored 'Trans proline' 0 N--CA 1.49 1.273 0 C-N-CA 123.061 2.507 . . . . 0.0 111.116 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 67.71 5.31 4.36 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.968 -179.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -137.17 -91.71 0.29 Allowed Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 29.6 ttpt -175.0 139.09 0.47 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.776 0.322 . . . . 0.0 111.155 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 22.7 mm -74.32 146.44 9.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 178.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 53' ' ' LEU . 67.5 mt -138.19 119.35 14.53 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.269 0.557 . . . . 0.0 111.874 -179.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.1 mptt -90.54 177.91 6.24 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.87 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -165.25 -176.95 37.3 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 178.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 55.4 tttt -154.66 129.62 9.47 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.765 0.317 . . . . 0.0 110.817 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 26.6 mt -72.67 130.2 35.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.641 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.5 m -102.66 -45.54 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.537 -0.302 . . . . 0.0 110.854 -179.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 22.1 mtt85 -144.42 158.97 43.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.859 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.7 p -87.39 156.17 3.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.143 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 74.5 t60 -140.84 117.7 11.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.151 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.08 5.62 63.86 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 -179.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.45 ' OG1' ' N ' ' A' ' 64' ' ' LYS . 32.4 p 58.69 -89.32 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 122.813 0.445 . . . . 0.0 111.513 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.45 ' N ' ' OG1' ' A' ' 63' ' ' THR . 15.4 pttm -90.84 55.51 2.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.835 0.35 . . . . 0.0 110.93 -179.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -159.58 -126.18 0.83 Allowed Glycine 0 N--CA 1.442 -0.952 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.555 ' HB1' ' O ' ' A' ' 24' ' ' ILE . . . -69.22 -177.65 1.15 Allowed 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.454 -0.873 . . . . 0.0 111.757 -179.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.1 m -148.85 158.69 6.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.197 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 14.8 ttp180 -87.35 150.17 24.01 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-O 121.056 0.455 . . . . 0.0 111.072 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -148.32 159.72 43.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.814 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 24.1 mtm180 -148.34 122.99 9.84 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.847 0.356 . . . . 0.0 110.765 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -101.21 117.65 35.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.387 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -70.76 -24.48 62.61 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -82.68 -77.87 0.22 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.628 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 126.2 150.3 7.59 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 17.3 mt -98.16 148.14 34.08 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 120.505 0.193 . . . . 0.0 110.862 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -49.16 -179.26 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 122.877 2.385 . . . . 0.0 112.494 179.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.9 -4.52 11.07 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 121.201 -0.524 . . . . 0.0 111.907 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.559 ' C ' ' H ' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -135.01 -142.71 0.19 Allowed 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.295 179.734 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.506 ' N ' ' CD ' ' A' ' 78' ' ' GLN . . . 64.32 -10.12 0.15 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.562 -178.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.559 ' H ' ' C ' ' A' ' 78' ' ' GLN . 2.1 tt -66.64 99.34 0.58 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.279 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 125.97 3.11 7.04 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -72.21 175.99 5.59 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-O 121.095 0.474 . . . . 0.0 110.716 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -92.66 128.13 38.41 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 26.3 m -92.66 156.91 3.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.233 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -147.9 153.24 38.83 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.704 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.716 HG23 ' O ' ' A' ' 42' ' ' LEU . 1.8 mp -103.65 74.08 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.41 ' O ' ' CB ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.466 0.373 0 C-N-CA 118.966 -1.094 . . . . 0.0 110.79 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.4 ptp . . . . . 0 N--CA 1.492 1.645 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 34.4 mtm105 -110.53 171.2 7.6 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.052 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.43 HG22 ' H ' ' A' ' 4' ' ' LYS . 2.0 mt -145.15 168.9 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.487 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.51 ' O ' HD13 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -152.39 120.59 6.28 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.262 0.553 . . . . 0.0 111.949 -179.499 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -107.07 -175.66 22.8 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.442 HG22 ' CE2' ' A' ' 83' ' ' TYR . 27.4 t -140.29 137.87 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-O 121.126 0.489 . . . . 0.0 110.57 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 72.3 t -71.07 144.88 13.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.841 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.41 HD11 ' HB2' ' A' ' 25' ' ' LYS . 14.8 mt -106.71 -52.6 2.75 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.391 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.6 t -166.15 154.64 10.9 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.182 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.489 ' O ' ' CG ' ' A' ' 10' ' ' TYR . 0.5 OUTLIER -99.46 126.84 45.46 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.004 0.43 . . . . 0.0 110.42 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.445 HH11 HG11 ' A' ' 21' ' ' VAL . 47.7 mtp180 -90.21 152.19 21.19 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.085 179.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 33.0 ttp180 -115.31 75.3 0.93 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.862 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.403 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 5.5 t -48.7 165.49 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.817 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.9 pttm -141.01 78.43 1.65 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.525 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -144.31 -55.83 0.36 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.786 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -80.15 -156.76 0.13 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.521 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.485 ' NE2' ' N ' ' A' ' 17' ' ' GLN . 0.1 OUTLIER -100.87 -7.2 23.74 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.708 -179.669 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.489 ' O ' ' CG ' ' A' ' 18' ' ' HIS . 86.3 t60 -156.93 21.41 0.32 Allowed 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.403 ' ND2' ' O ' ' A' ' 13' ' ' SER . 0.4 OUTLIER -40.7 148.92 0.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.149 -1.387 . . . . 0.0 111.772 -179.313 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -171.8 122.25 0.5 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 121.002 0.429 . . . . 0.0 110.95 179.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.541 HG12 ' N ' ' A' ' 22' ' ' MET . 72.9 t -116.27 164.26 12.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.884 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.541 ' N ' HG12 ' A' ' 21' ' ' VAL . 21.2 ptm -151.65 138.4 18.86 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.833 0.349 . . . . 0.0 110.881 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 55.2 mt -92.08 139.56 17.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.122 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.455 HG22 ' N ' ' A' ' 25' ' ' LYS . 77.5 mt -134.7 156.52 40.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.523 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.455 ' N ' HG22 ' A' ' 24' ' ' ILE . 71.9 tttt -144.24 120.79 6.37 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.867 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -61.14 169.36 6.27 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 121.872 1.715 . . . . 0.0 111.503 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.51 HD13 ' O ' ' A' ' 4' ' ' LYS . 0.8 OUTLIER -49.55 -77.49 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.625 -0.262 . . . . 0.0 110.951 -179.334 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.483 ' CG ' ' H ' ' A' ' 29' ' ' VAL . 2.8 p-10 -94.51 -88.61 0.24 Allowed 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.521 -0.472 . . . . 0.0 111.107 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.626 ' O ' HG12 ' A' ' 29' ' ' VAL . 82.5 t 41.32 55.7 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.165 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 -178.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -88.51 40.62 0.97 Allowed 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 114.365 -1.289 . . . . 0.0 110.998 -177.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 68.7 m -158.84 128.11 5.54 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.862 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 47.4 ttp180 -61.25 -25.38 67.04 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -62.32 -52.01 65.37 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.602 178.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -69.57 -38.41 77.38 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.434 178.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.524 ' O ' HD23 ' A' ' 38' ' ' LEU . . . -59.24 -60.66 3.51 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.003 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.404 ' O ' HG22 ' A' ' 39' ' ' ILE . 11.7 t -55.92 -22.96 28.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.732 179.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 34.4 tttp -70.86 -61.66 1.68 Allowed 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.749 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.524 HD23 ' O ' ' A' ' 35' ' ' ALA . 0.4 OUTLIER -77.52 5.94 8.05 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.243 -178.955 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.503 ' N ' HD23 ' A' ' 38' ' ' LEU . 8.1 tt -51.08 133.97 12.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.229 179.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.431 ' O ' ' NZ ' ' A' ' 56' ' ' LYS . . . 81.2 25.32 55.36 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.686 ' HG3' HD12 ' A' ' 57' ' ' ILE . 5.3 ptt180 -71.57 171.29 11.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.713 0.292 . . . . 0.0 110.367 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.522 ' O ' HG23 ' A' ' 86' ' ' ILE . 23.5 tp -100.82 112.18 24.54 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.135 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 43' ' ' VAL . 4.2 m -88.19 121.37 38.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.13 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.677 HD21 ' CG2' ' A' ' 52' ' ' ILE . 6.0 tt -123.49 98.41 5.83 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.73 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.461 ' CZ3' ' OG ' ' A' ' 47' ' ' SER . 75.8 t90 -100.73 109.92 21.98 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 125.089 1.493 . . . . 0.0 109.676 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 5.9 pttp -83.72 105.11 14.37 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 121.073 0.463 . . . . 0.0 111.41 -178.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.461 ' OG ' ' CZ3' ' A' ' 45' ' ' TRP . 0.9 OUTLIER -64.33 172.64 1.9 Allowed Pre-proline 0 CA--C 1.531 0.233 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.707 179.655 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -76.0 -32.88 4.01 Favored 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 122.813 2.342 . . . . 0.0 112.449 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.415 ' C ' ' H ' ' A' ' 51' ' ' LYS . 38.0 p -78.72 21.54 0.4 Allowed 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.24 -179.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 70.19 -7.04 4.88 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.415 ' H ' ' C ' ' A' ' 49' ' ' SER . 27.7 tttp -73.24 100.5 3.13 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.677 ' CG2' HD21 ' A' ' 44' ' ' LEU . 23.2 mm -83.49 111.15 19.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.444 -178.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 71.4 mt -100.15 143.31 30.5 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.855 179.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.6 pttp -150.24 116.35 5.66 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 120.945 0.403 . . . . 0.0 110.95 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -104.09 -150.64 21.27 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.431 ' NZ ' ' O ' ' A' ' 40' ' ' GLY . 0.2 OUTLIER -154.26 130.42 10.35 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.782 0.325 . . . . 0.0 110.881 179.9 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.686 HD12 ' HG3' ' A' ' 41' ' ' ARG . 34.6 mt -65.13 147.89 12.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -107.01 -40.56 5.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 C-N-CA 120.596 -0.442 . . . . 0.0 111.491 -178.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -164.55 155.14 14.66 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 120.392 -0.523 . . . . 0.0 111.853 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.571 HG13 ' O ' ' A' ' 60' ' ' VAL . 13.3 p -92.82 116.33 33.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.322 178.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -140.21 123.87 17.22 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.265 -178.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 136.24 -16.84 3.86 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 121.327 -0.463 . . . . 0.0 112.056 178.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.633 ' C ' ' H ' ' A' ' 65' ' ' GLY . 80.7 p 54.79 164.91 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.776 0.322 . . . . 0.0 111.025 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 38.2 tttp 67.1 -17.3 0.14 Allowed 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.148 0.499 . . . . 0.0 110.0 -178.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.633 ' H ' ' C ' ' A' ' 63' ' ' THR . . . 131.57 121.12 2.24 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.555 ' O ' HG23 ' A' ' 60' ' ' VAL . . . 174.68 149.01 0.08 Allowed 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.504 HG13 ' O ' ' A' ' 66' ' ' ALA . 8.7 m -157.13 139.15 5.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 120.253 -0.579 . . . . 0.0 111.404 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -90.97 146.63 23.71 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 178.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -146.35 160.1 42.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.229 0.537 . . . . 0.0 111.278 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 5.8 ttp180 -148.3 131.97 16.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.675 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.457 ' C ' ' H ' ' A' ' 73' ' ' LYS . 17.5 m-85 -92.87 141.81 28.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.991 0.424 . . . . 0.0 110.828 -179.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -62.35 -0.47 0.58 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.444 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.457 ' H ' ' C ' ' A' ' 71' ' ' PHE . 33.3 ttmt -154.88 -64.7 0.13 Allowed 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.629 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 142.53 -177.24 21.82 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.3 mt -95.48 165.76 16.07 Favored Pre-proline 0 CA--C 1.53 0.175 0 CA-C-O 120.705 0.288 . . . . 0.0 110.99 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -76.14 99.94 1.33 Allowed 'Trans proline' 0 N--CA 1.489 1.235 0 C-N-CA 122.971 2.447 . . . . 0.0 112.214 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 42.48 -113.06 0.54 Allowed Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.762 -0.535 . . . . 0.0 111.762 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.527 ' NE2' ' H ' ' A' ' 80' ' ' LEU . 0.8 OUTLIER -81.8 116.05 21.3 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.77 0.319 . . . . 0.0 110.787 -179.746 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -154.4 8.14 0.32 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.322 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.527 ' H ' ' NE2' ' A' ' 78' ' ' GLN . 5.5 tp -68.56 117.04 9.8 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.768 0.318 . . . . 0.0 110.491 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 118.5 -10.92 12.64 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.437 ' HB3' ' HE1' ' A' ' 45' ' ' TRP . 2.1 m-20 -68.36 131.08 44.7 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.442 ' CE2' HG22 ' A' ' 6' ' ' VAL . 5.8 m-85 -67.55 135.78 53.51 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.4 m -90.78 163.21 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.509 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 52.0 mp0 -148.14 145.11 28.22 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.533 HG22 ' O ' ' A' ' 86' ' ' ILE . 3.5 mp -101.06 73.3 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 44' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.463 0.219 0 C-N-CA 119.749 -0.78 . . . . 0.0 110.67 -179.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.2 mmm . . . . . 0 N--CA 1.488 1.443 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 17.3 ptt85 -96.43 170.02 9.51 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.467 ' HB ' HD13 ' A' ' 86' ' ' ILE . 1.4 mt -148.4 144.88 18.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.266 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 52.0 mttt -83.17 173.45 11.66 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.646 -179.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 84' ' ' VAL . . . -171.47 174.66 45.05 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 22.0 t -149.15 143.97 18.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.262 0.553 . . . . 0.0 111.236 -178.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 75.7 t -79.88 147.46 6.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.972 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.486 HD11 ' HB2' ' A' ' 25' ' ' LYS . 13.4 mt -111.05 -52.43 2.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.644 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.7 t -163.88 124.27 2.17 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.402 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -99.36 105.67 17.68 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.325 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 35.9 mtt180 -92.01 146.43 23.74 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.772 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.411 ' O ' ' C ' ' A' ' 13' ' ' SER . 59.1 ttt-85 -120.62 70.83 0.9 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.645 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.411 ' C ' ' O ' ' A' ' 12' ' ' ARG . 38.2 m -41.47 111.15 0.2 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 120.259 -0.576 . . . . 0.0 110.115 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 76.2 mttt -79.35 -7.11 58.1 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.559 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.495 ' O ' ' N ' ' A' ' 17' ' ' GLN . 61.9 mt-10 -68.44 -7.01 28.05 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.097 -179.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 64.21 -47.1 0.29 Allowed 'General case' 0 N--CA 1.467 0.421 0 O-C-N 123.697 0.623 . . . . 0.0 110.56 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.495 ' N ' ' O ' ' A' ' 15' ' ' GLU . 0.2 OUTLIER -77.84 45.8 0.53 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.659 179.831 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 4.7 m170 -161.74 -26.09 0.05 Allowed 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 69.92 161.15 0.21 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.212 -0.903 . . . . 0.0 109.972 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.451 ' H ' ' ND2' ' A' ' 20' ' ' ASN . 2.6 p30 -73.42 131.51 41.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.843 0.354 . . . . 0.0 111.319 -179.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.54 HG12 ' N ' ' A' ' 22' ' ' MET . 45.5 t -100.24 160.41 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.083 179.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.54 ' N ' HG12 ' A' ' 21' ' ' VAL . 13.1 ttt -148.59 112.75 5.21 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.874 -179.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.426 HG22 HD12 ' A' ' 8' ' ' LEU . 19.2 mt -85.19 136.26 23.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 41.2 mt -137.07 154.15 30.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.245 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.486 ' HB2' HD11 ' A' ' 8' ' ' LEU . 30.4 tttt -146.79 122.0 5.37 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.361 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -60.74 164.47 13.63 Favored 'Trans proline' 0 N--CA 1.489 1.228 0 C-N-CA 121.418 1.412 . . . . 0.0 111.152 178.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.7 tp -45.28 -80.79 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.888 -179.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.466 ' O ' ' C ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -93.8 -84.9 0.3 Allowed 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.964 -0.295 . . . . 0.0 110.444 179.383 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.701 ' O ' HG12 ' A' ' 29' ' ' VAL . 64.7 t 39.99 53.63 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 -178.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.745 ' ND2' ' H ' ' A' ' 30' ' ' ASN . 0.0 OUTLIER -88.53 44.36 1.2 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.441 -1.254 . . . . 0.0 110.727 -177.089 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.9 m -157.98 124.7 4.89 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.085 -0.962 . . . . 0.0 109.964 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.48 ' HA ' ' HB3' ' A' ' 35' ' ' ALA . 11.6 ttp180 -58.5 -26.95 64.0 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -61.21 -50.37 73.39 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.876 179.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.3 tp10 -72.46 -37.96 68.39 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.547 ' O ' HD23 ' A' ' 38' ' ' LEU . . . -60.4 -69.4 0.22 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.308 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.1 t -44.38 -18.61 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.831 0.348 . . . . 0.0 110.424 179.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.468 ' N ' ' C ' ' A' ' 35' ' ' ALA . 2.1 tmtt? -72.39 -63.04 1.23 Allowed 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.22 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.547 HD23 ' O ' ' A' ' 35' ' ' ALA . 0.5 OUTLIER -74.53 9.75 1.63 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.964 0.412 . . . . 0.0 110.324 -179.053 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.41 ' H ' ' C ' ' A' ' 37' ' ' LYS . 18.4 tt -48.63 -16.31 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.407 179.023 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -123.33 6.96 9.19 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.933 -178.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.8 mmt180 -72.15 175.68 5.81 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 117.591 0.696 . . . . 0.0 110.616 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.677 HD23 ' N ' ' A' ' 43' ' ' VAL . 6.5 tt -98.38 169.56 9.47 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.056 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.677 ' N ' HD23 ' A' ' 42' ' ' LEU . 33.8 m -140.84 99.5 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.185 0.517 . . . . 0.0 109.929 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.576 HD23 ' C ' ' A' ' 44' ' ' LEU . 5.9 tt -102.16 99.72 9.87 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.742 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.423 ' HE1' ' HB3' ' A' ' 82' ' ' ASP . 10.4 t90 -106.2 116.51 32.06 Favored 'General case' 0 C--O 1.234 0.278 0 O-C-N 124.682 1.239 . . . . 0.0 109.738 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.8 pttp -84.01 105.7 15.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.935 0.398 . . . . 0.0 110.487 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.4 t -67.38 119.98 69.26 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.245 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -60.03 -7.44 6.33 Favored 'Trans proline' 0 N--CA 1.489 1.236 0 C-N-CA 121.474 1.45 . . . . 0.0 111.645 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 31.2 t -82.71 -6.16 59.25 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.963 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 95.47 57.34 1.2 Allowed Glycine 0 CA--C 1.52 0.392 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.0 ttmm -165.16 101.06 0.74 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.661 0.267 . . . . 0.0 110.614 -179.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 28.7 mm -82.04 109.79 16.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.453 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 75.5 mt -104.51 143.55 32.89 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.063 0.459 . . . . 0.0 110.869 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -151.87 101.99 2.79 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.885 -178.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -104.98 -142.25 11.27 Favored Glycine 0 N--CA 1.464 0.504 0 N-CA-C 109.771 -1.331 . . . . 0.0 109.771 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 23.9 tttm -154.98 139.7 17.09 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.068 0.461 . . . . 0.0 111.122 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 80.0 mt -69.85 138.95 21.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.059 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -105.43 -34.14 3.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -178.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.477 ' NH2' ' NH2' ' A' ' 70' ' ' ARG . 5.0 ptt-85 -165.69 157.45 14.44 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 120.435 -0.506 . . . . 0.0 111.319 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.56 HG13 ' O ' ' A' ' 60' ' ' VAL . 7.3 p -97.98 121.44 48.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.543 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.42 ' ND1' ' O ' ' A' ' 60' ' ' VAL . 11.3 m80 -141.11 132.78 27.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.113 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.428 ' O ' ' OG1' ' A' ' 63' ' ' THR . . . 124.94 -12.8 7.66 Favored Glycine 0 CA--C 1.519 0.288 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.545 ' O ' ' N ' ' A' ' 65' ' ' GLY . 19.9 p 53.53 171.87 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 -179.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt 65.57 -52.94 0.36 Allowed 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -178.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 63' ' ' THR . . . 165.81 121.64 0.57 Allowed Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 178.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.578 ' O ' HG13 ' A' ' 67' ' ' VAL . . . 174.87 159.59 0.19 Allowed 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.578 HG13 ' O ' ' A' ' 66' ' ' ALA . 7.9 m -159.11 144.32 6.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 C-N-CA 120.044 -0.663 . . . . 0.0 111.212 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 23.2 ttm180 -90.51 154.89 19.29 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -146.15 168.63 20.51 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.209 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.477 ' NH2' ' NH2' ' A' ' 59' ' ' ARG . 92.8 mtt180 -147.25 111.91 5.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.216 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.482 ' CE1' ' SD ' ' A' ' 22' ' ' MET . 51.8 m-85 -96.43 109.95 22.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.748 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -82.31 -13.33 57.11 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.122 0.487 . . . . 0.0 109.835 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 45.4 mmtt -80.96 -77.6 0.2 Allowed 'General case' 0 C--O 1.231 0.116 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.742 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 135.41 154.91 7.14 Favored Glycine 0 C--N 1.335 0.508 0 N-CA-C 111.241 -0.744 . . . . 0.0 111.241 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.432 HD23 ' N ' ' A' ' 75' ' ' LEU . 0.9 OUTLIER -89.13 174.45 4.94 Favored Pre-proline 0 N--CA 1.463 0.183 0 N-CA-C 110.414 -0.217 . . . . 0.0 110.414 -179.909 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -76.06 -82.89 0.0 OUTLIER 'Trans proline' 0 C--N 1.315 -1.197 0 C-N-CA 122.305 2.003 . . . . 0.0 111.044 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -176.21 104.45 0.19 Allowed Glycine 0 N--CA 1.451 -0.304 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 179.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.499 ' NE2' ' C ' ' A' ' 78' ' ' GLN . 0.0 OUTLIER 70.32 62.93 0.22 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.92 0.391 . . . . 0.0 111.087 179.514 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -115.43 -0.6 13.07 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.511 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.9 tp -52.6 114.49 1.41 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.818 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 125.52 -13.27 7.37 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 111.744 -0.542 . . . . 0.0 111.744 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.423 ' HB3' ' HE1' ' A' ' 45' ' ' TRP . 46.2 m-20 -70.35 136.67 49.92 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 120.442 -0.503 . . . . 0.0 109.983 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -69.56 125.59 27.18 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.773 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.441 ' O ' ' N ' ' A' ' 5' ' ' GLY . 18.0 m -94.36 154.96 3.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -149.94 164.29 35.84 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.323 0.582 . . . . 0.0 110.65 -178.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.496 ' N ' HD12 ' A' ' 86' ' ' ILE . 5.1 mp -103.44 74.48 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 178.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.468 0.456 0 C-N-CA 120.093 -0.643 . . . . 0.0 110.946 -179.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.5 mtt . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.431 ' O ' HD13 ' A' ' 3' ' ' ILE . 11.5 mmt180 -94.13 179.12 5.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.1 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.56 HG22 ' H ' ' A' ' 4' ' ' LYS . 8.0 mm -138.13 169.85 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.56 ' H ' HG22 ' A' ' 3' ' ' ILE . 9.4 ptpt -150.81 103.85 3.12 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 121.259 0.552 . . . . 0.0 111.329 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -94.57 -177.3 38.51 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 179.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 p -146.5 135.38 16.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-O 121.222 0.534 . . . . 0.0 111.359 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 99.0 t -79.86 140.19 17.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.655 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 17.3 mt -105.52 -57.24 2.06 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.288 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.8 m -165.86 142.29 5.21 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.294 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -100.44 138.75 37.08 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 120.859 0.361 . . . . 0.0 110.689 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 10.6 mmt180 -89.78 117.47 28.66 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.485 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 -90.03 60.65 4.95 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.033 0.444 . . . . 0.0 110.133 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.7 m -70.15 149.42 47.57 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.032 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -148.47 -45.55 0.15 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.645 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.402 ' C ' ' H ' ' A' ' 17' ' ' GLN . 78.8 mt-10 -57.45 140.15 51.27 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.723 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.0 m120 68.61 -5.95 0.9 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.077 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.402 ' H ' ' C ' ' A' ' 15' ' ' GLU . 1.1 tm0? 65.93 124.83 0.02 OUTLIER 'General case' 0 C--O 1.232 0.173 0 CA-C-O 121.031 0.443 . . . . 0.0 110.779 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 11.8 t-80 -169.7 -6.36 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.513 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 69.74 161.82 0.22 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.376 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.427 ' H ' ' ND2' ' A' ' 20' ' ' ASN . 0.2 OUTLIER -78.79 128.81 33.88 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.911 0.386 . . . . 0.0 110.732 -179.728 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.679 HG12 ' H ' ' A' ' 22' ' ' MET . 2.1 t -94.39 176.74 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.203 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.679 ' H ' HG12 ' A' ' 21' ' ' VAL . 30.8 tpp -143.65 119.18 10.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.046 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 6.2 mm -83.23 133.0 30.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.584 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.419 ' CG2' ' N ' ' A' ' 25' ' ' LYS . 12.3 mt -138.9 156.72 28.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.523 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.419 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 11.4 ttmm -140.67 119.89 8.49 Favored Pre-proline 0 C--N 1.33 -0.28 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.458 ' O ' ' N ' ' A' ' 28' ' ' ASP . 2.9 Cg_endo -67.86 59.2 0.86 Allowed 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.313 2.009 . . . . 0.0 111.273 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.0 tp 54.31 -79.76 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.638 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.572 ' CG ' ' H ' ' A' ' 29' ' ' VAL . 9.2 p-10 -101.29 -90.75 0.33 Allowed 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.503 -0.479 . . . . 0.0 111.44 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.7 ' O ' HG12 ' A' ' 29' ' ' VAL . 53.3 t 44.7 55.95 0.33 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.194 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 -178.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -89.23 50.29 1.91 Allowed 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 114.356 -1.293 . . . . 0.0 110.812 -178.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 10.1 m -158.85 108.76 1.99 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.101 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 26.9 ttt85 -47.79 -31.8 5.29 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.161 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -62.59 -55.33 28.15 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.933 179.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -65.42 -39.37 92.04 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.104 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.56 ' O ' HD23 ' A' ' 38' ' ' LEU . . . -58.93 -59.83 4.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.18 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.5 m -53.65 -22.07 8.12 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.614 179.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.0 tttp -68.96 -63.42 1.06 Allowed 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.067 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.56 HD23 ' O ' ' A' ' 35' ' ' ALA . 0.4 OUTLIER -80.32 16.8 1.19 Allowed 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 121.019 0.437 . . . . 0.0 111.053 -179.423 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.59 HD12 HG12 ' A' ' 60' ' ' VAL . 19.3 tt -50.38 -32.75 10.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.233 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -102.9 24.03 31.9 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.412 ' HG2' HD13 ' A' ' 86' ' ' ILE . 1.8 tpp180 -71.15 146.15 49.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.747 0.308 . . . . 0.0 110.569 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.571 ' O ' HG23 ' A' ' 86' ' ' ILE . 7.8 tp -96.19 121.02 37.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.156 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 43' ' ' VAL . 10.8 m -87.08 122.62 39.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.282 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.436 ' H ' ' HA ' ' A' ' 86' ' ' ILE . 0.5 OUTLIER -107.84 98.23 7.84 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.441 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 37.3 t90 -86.61 113.02 22.16 Favored 'General case' 0 C--O 1.234 0.246 0 O-C-N 125.209 1.568 . . . . 0.0 110.448 -178.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.415 ' HG3' HD11 ' A' ' 52' ' ' ILE . 75.5 tttt -83.56 93.63 7.89 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.004 -179.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.1 p -64.28 167.57 8.07 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.049 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -77.9 -34.9 1.58 Allowed 'Trans proline' 0 C--N 1.314 -1.277 0 C-N-CA 123.01 2.473 . . . . 0.0 112.271 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 12.7 m -72.72 4.51 3.95 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.021 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.71 -9.64 73.12 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -77.57 100.27 6.04 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.566 0.222 . . . . 0.0 110.616 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.415 HD11 ' HG3' ' A' ' 46' ' ' LYS . 1.2 mp -79.18 108.01 12.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.518 HD22 ' CA ' ' A' ' 74' ' ' GLY . 13.7 mt -90.34 126.25 35.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.375 0.607 . . . . 0.0 110.943 -178.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 28.5 mttm -91.49 110.17 21.48 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.88 -1.055 . . . . 0.0 111.281 -179.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -95.46 178.81 35.68 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 178.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 38.7 tttt -152.84 131.45 12.28 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.528 -0.469 . . . . 0.0 111.426 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.2 mt -75.6 142.47 14.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.867 179.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -104.83 -34.29 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.81 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -164.85 156.23 15.08 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.045 0.45 . . . . 0.0 111.466 179.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.59 HG12 HD12 ' A' ' 39' ' ' ILE . 14.9 p -98.24 139.22 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.656 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.93 ' O ' ' HB3' ' A' ' 66' ' ' ALA . 56.7 t-80 -142.2 168.77 18.95 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.46 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.515 ' C ' ' H ' ' A' ' 64' ' ' LYS . . . 91.12 -34.14 4.4 Favored Glycine 0 CA--C 1.525 0.683 0 CA-C-N 116.19 -0.459 . . . . 0.0 112.707 178.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.3 p 68.22 -34.18 0.25 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.682 0.241 . . . . 0.0 110.849 -179.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.515 ' H ' ' C ' ' A' ' 62' ' ' GLY . 0.8 OUTLIER -89.31 -7.42 55.39 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.579 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.423 ' O ' ' HB2' ' A' ' 66' ' ' ALA . . . 130.65 119.78 2.15 Favored Glycine 0 CA--C 1.522 0.476 0 CA-C-N 114.517 -1.22 . . . . 0.0 110.224 178.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.93 ' HB3' ' O ' ' A' ' 61' ' ' HIS . . . 172.68 150.26 0.06 Allowed 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.413 HG13 ' O ' ' A' ' 66' ' ' ALA . 17.4 m -156.19 141.0 9.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.539 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -88.91 150.39 22.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.421 179.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -146.85 163.59 35.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.963 0.411 . . . . 0.0 111.055 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 53.2 mtt180 -146.4 121.24 9.93 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.079 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.557 ' C ' ' H ' ' A' ' 73' ' ' LYS . 60.3 m-85 -97.48 138.85 34.29 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.116 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.573 ' O ' ' CB ' ' A' ' 73' ' ' LYS . 8.9 pt-20 -74.95 36.5 0.11 Allowed 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.136 178.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.573 ' CB ' ' O ' ' A' ' 72' ' ' GLU . 9.9 ttpt 93.28 -32.97 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 115.008 -0.997 . . . . 0.0 110.18 -179.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.518 ' CA ' HD22 ' A' ' 53' ' ' LEU . . . -10.97 -59.84 0.01 OUTLIER Glycine 0 CA--C 1.53 0.997 0 O-C-N 124.431 1.082 . . . . 0.0 113.164 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.448 ' N ' ' O ' ' A' ' 73' ' ' LYS . 10.9 mt -56.67 113.71 6.52 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-N 116.709 0.254 . . . . 0.0 110.552 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -69.34 -174.9 0.9 Allowed 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 122.436 2.091 . . . . 0.0 112.347 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -51.13 115.09 3.29 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.553 ' O ' ' HB2' ' A' ' 79' ' ' ALA . 9.3 tm0? 69.48 145.81 0.06 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.914 0.388 . . . . 0.0 110.708 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.553 ' HB2' ' O ' ' A' ' 78' ' ' GLN . . . 166.91 -21.0 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.242 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.4 tp -43.7 129.13 5.49 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.224 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 98.53 -7.64 61.64 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.827 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -71.5 135.94 47.34 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -68.58 129.41 39.86 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.1 m -90.3 170.99 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -149.88 151.16 33.02 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.571 HG23 ' O ' ' A' ' 42' ' ' LEU . 16.8 mt -108.69 73.2 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 178.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.4 t . . . . . 0 N--CA 1.464 0.231 0 C-N-CA 120.115 -0.634 . . . . 0.0 111.015 -178.628 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.4 ptt? . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 20.9 mtm180 -105.68 173.1 6.46 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.836 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.2 mt -144.32 158.51 15.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.419 -0.81 . . . . 0.0 108.86 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.78 107.85 4.05 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.467 0.651 . . . . 0.0 112.082 -178.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.419 ' C ' HG22 ' A' ' 84' ' ' VAL . . . -95.85 -177.35 36.61 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 178.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 75.2 t -145.42 135.68 18.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.202 0.525 . . . . 0.0 110.468 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.9 t -73.0 142.72 14.69 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.391 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 52.0 mt -110.49 -33.71 6.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.055 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.6 m -161.28 134.56 6.46 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.935 0.397 . . . . 0.0 110.886 -179.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -106.44 101.15 10.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.541 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.43 ' O ' ' O ' ' A' ' 21' ' ' VAL . 5.8 mpt_? -91.09 133.29 35.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.373 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 12.8 ptt85 -101.35 62.31 0.95 Allowed 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.184 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.1 t 59.69 164.58 0.06 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.021 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.8 ttmm -133.18 -69.67 0.55 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.386 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -111.05 43.4 1.46 Allowed 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.24 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.1 t30 46.29 81.42 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.913 0.387 . . . . 0.0 110.373 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -104.34 -27.92 11.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.55 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -175.46 -54.52 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -178.32 -153.87 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.574 178.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -75.37 126.47 31.07 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.442 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.43 ' O ' ' O ' ' A' ' 11' ' ' ARG . 88.1 t -105.64 153.1 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.468 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 15.2 ptm -145.81 143.04 29.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.961 0.41 . . . . 0.0 111.093 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 29.4 mm -92.65 143.15 12.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.106 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.625 HD12 ' CB ' ' A' ' 69' ' ' ALA . 31.5 mt -133.19 156.87 42.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.399 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.428 ' N ' ' CG2' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -140.3 99.8 7.12 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.644 179.824 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.537 ' O ' ' N ' ' A' ' 28' ' ' ASP . 3.3 Cg_exo -65.17 74.12 0.25 Allowed 'Trans proline' 0 C--N 1.314 -1.268 0 C-N-CA 121.984 1.789 . . . . 0.0 111.051 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.415 ' N ' ' O ' ' A' ' 25' ' ' LYS . 0.9 OUTLIER 37.92 -82.64 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 114.849 -1.069 . . . . 0.0 112.097 -179.758 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.537 ' N ' ' O ' ' A' ' 26' ' ' PRO . 1.1 p-10 -99.24 -87.11 0.36 Allowed 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.363 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.778 ' O ' HG12 ' A' ' 29' ' ' VAL . 19.1 t 44.14 62.27 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-O 122.245 1.022 . . . . 0.0 108.294 -177.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.432 HD22 ' HB2' ' A' ' 28' ' ' ASP . 2.6 p30 -93.63 47.22 1.22 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.15 -1.386 . . . . 0.0 110.941 -178.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 70.3 m -156.72 118.99 3.94 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.541 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.439 ' H ' ' HB3' ' A' ' 64' ' ' LYS . 1.4 ttt85 -51.89 -30.93 26.12 Favored 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.429 ' O ' ' CB ' ' A' ' 37' ' ' LYS . 45.3 mt-10 -63.01 -63.15 1.29 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.643 179.038 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -54.86 -46.62 74.72 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.03 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -57.84 -69.48 0.17 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.985 179.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 65.0 m -50.82 -36.68 38.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.677 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.429 ' CB ' ' O ' ' A' ' 33' ' ' GLU . 60.5 tttt -71.35 -14.75 62.29 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.304 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.529 HD21 HD13 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -86.47 -11.31 52.16 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 120.853 0.358 . . . . 0.0 110.628 -179.524 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 53.7 mt -55.16 121.63 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.658 178.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 103.79 -4.05 45.94 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.714 -0.554 . . . . 0.0 111.714 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -70.37 142.33 52.13 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.854 0.359 . . . . 0.0 110.206 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.455 ' O ' HG23 ' A' ' 86' ' ' ILE . 11.6 tp -81.51 111.29 17.7 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.089 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.64 HG23 ' O ' ' A' ' 43' ' ' VAL . 6.7 m -88.81 107.4 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 121.581 0.705 . . . . 0.0 111.182 -178.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.1 mp -102.98 92.97 4.78 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 1.2 t90 -91.87 129.08 37.9 Favored 'General case' 0 C--O 1.235 0.304 0 O-C-N 124.717 1.26 . . . . 0.0 110.736 -178.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.401 ' HA ' ' CD1' ' A' ' 52' ' ' ILE . 1.6 ttmp? -81.76 91.96 6.57 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.966 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.405 ' CB ' ' CD ' ' A' ' 48' ' ' PRO . 0.8 OUTLIER -63.65 176.48 0.61 Allowed Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.011 179.946 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.507 ' C ' ' H ' ' A' ' 50' ' ' GLY . 2.9 Cg_endo -76.23 -41.75 0.45 Allowed 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.663 2.242 . . . . 0.0 112.491 -179.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.5 ' C ' ' H ' ' A' ' 51' ' ' LYS . 6.8 t -70.5 20.64 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.203 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.507 ' H ' ' C ' ' A' ' 48' ' ' PRO . . . 66.19 -9.72 0.73 Allowed Glycine 0 CA--C 1.53 0.999 0 N-CA-C 111.051 -0.819 . . . . 0.0 111.051 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.5 ' H ' ' C ' ' A' ' 49' ' ' SER . 7.0 ttpm? -73.26 119.62 17.75 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.413 ' HA ' HD13 ' A' ' 52' ' ' ILE . 28.5 mm -83.97 112.92 22.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.562 HD22 ' CA ' ' A' ' 74' ' ' GLY . 16.9 mt -99.66 125.21 45.46 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.265 0.555 . . . . 0.0 111.301 -179.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.3 mtpt -89.1 166.85 13.59 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.572 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -161.99 178.57 37.78 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.6 tttt -152.2 123.7 7.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.826 0.346 . . . . 0.0 111.023 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.529 HD13 HD21 ' A' ' 38' ' ' LEU . 22.4 mt -66.02 144.8 14.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.315 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.3 m -109.36 -34.54 2.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.584 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -163.37 158.02 20.7 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.745 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.4 p -88.54 153.8 3.24 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.431 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -140.86 125.08 17.45 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.25 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.3 13.82 55.13 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 -179.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.4 ' HG1' ' H ' ' A' ' 64' ' ' LYS . 82.2 p 52.92 -99.99 0.09 Allowed 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 122.44 0.296 . . . . 0.0 111.348 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.439 ' HB3' ' H ' ' A' ' 32' ' ' ARG . 16.4 pttt -88.16 55.93 3.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.829 -179.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -156.13 -125.41 0.9 Allowed Glycine 0 N--CA 1.446 -0.7 0 N-CA-C 111.366 -0.694 . . . . 0.0 111.366 -178.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.422 ' HB1' ' O ' ' A' ' 24' ' ' ILE . . . -67.9 -177.5 0.82 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.25 -0.975 . . . . 0.0 111.688 -178.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.3 m -153.11 156.85 5.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.099 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 8.7 tpp180 -88.88 154.49 20.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.933 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.625 ' CB ' HD12 ' A' ' 24' ' ' ILE . . . -149.85 154.38 38.29 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.199 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -148.79 128.76 13.49 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.909 0.385 . . . . 0.0 111.156 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.466 ' HB2' HD23 ' A' ' 75' ' ' LEU . 23.3 m-85 -103.96 117.05 33.39 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.54 179.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -80.96 -10.9 59.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.818 -178.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.466 ' O ' ' N ' ' A' ' 75' ' ' LEU . 24.7 ttpt -160.03 -45.66 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 120.36 -0.536 . . . . 0.0 111.933 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.562 ' CA ' HD22 ' A' ' 53' ' ' LEU . . . -64.84 51.77 0.1 Allowed Glycine 0 CA--C 1.529 0.968 0 O-C-N 123.513 0.508 . . . . 0.0 112.015 -178.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.466 HD23 ' HB2' ' A' ' 71' ' ' PHE . 0.2 OUTLIER -138.4 91.26 12.64 Favored Pre-proline 0 C--N 1.329 -0.289 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -59.08 -80.95 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 121.945 1.764 . . . . 0.0 112.107 -179.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -173.84 9.65 0.03 OUTLIER Glycine 0 CA--C 1.525 0.681 0 C-N-CA 120.743 -0.742 . . . . 0.0 111.589 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.87 107.35 2.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.844 0.354 . . . . 0.0 110.51 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -139.92 4.3 2.08 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.741 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.8 tp -77.15 98.94 5.23 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.265 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 123.61 -26.84 5.88 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 121.224 -0.512 . . . . 0.0 112.183 178.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -70.9 129.4 38.95 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 117.232 0.516 . . . . 0.0 109.924 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -68.59 134.02 49.36 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.419 HG22 ' C ' ' A' ' 5' ' ' GLY . 29.7 m -90.73 160.13 2.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -147.61 151.33 36.04 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.336 -0.546 . . . . 0.0 110.565 -178.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.455 HG23 ' O ' ' A' ' 42' ' ' LEU . 33.5 mt -110.01 72.05 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 178.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.7 t . . . . . 0 C--N 1.332 -0.195 0 C-N-CA 119.7 -0.8 . . . . 0.0 110.826 -178.824 . . . . . . . . 0 0 . 1 stop_ save_